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ABSTRACT 
Octahedral d6 iridium(III) complexes possess rich photophysical properties. The most 
distinct phtotphysical properties of the Ir(III) complexes are their high triplet excited-state 
formation quantum yields, long-lived triplet excited states, and feasile structural modifications. To 
better understand the impact of ligand -conjugation on the photophysics and reverse saturable 
absorption (RSA) or PDT of the Ir(III) complexes, six series of Ir(III) complexes bearing various 
bidentate or terdentate ligands were designed and synthesized in this dissertation.  
In Chapter 1, the photophysical principles, typical electronic transitions in Ir(III) 
complexes, the prototypes of the tris-bidentate and bis-terdentate Ir(III) complexes, the state-of-
art on exploring Ir(III) complexes for RSA and PDT, and the materials design criteria are reviewed. 
In Chapters 2 and 3, sixteen cyclometalated cationic Ir(III) complexes were synthesized 
and investigated to understand how the benzannulation site on diimine ligands influences the 
characteristics of the excited states of these complexes. The site−dependent benzannulation 
influenced the spectral feature and intensity of the triplet transient absorption (TA) and T1 
lifetimes, and their RSA strength. 
In Chapter 4, ten 2-phenylpyridine based Ir(III) complexes with varied degrees of π-
conjugation and sites of benzannulation were synthesized. Benzannulation at the different sites of 
2-phenylpyridine exerted a different effect on the energies of the S1 and T1 excited states, the TA 
spectral features, and the RSA performances of the complexes. 
In Chapter 5, the synthesis, photophysics, and RSA of three Ir(III) complexes with different 
degrees of -conjugation on the diimine ligands were discussed. The impact of this structural 
variation on the RSA at 532 nm was demonstrated. 
 iv 
In Chapter 6, five Ir(III) complexes bearing terpyridine-capped fluorenyl bridging ligands 
and different terminal terdentate ligands were investigated to reveal the effects of different terminal 
ligands on the S1 and T1 excited states. Their in vitro theranostic PDT effects toward the SKMEL28 
cells were evaluated. 
In Chapter 7, the photophysics and in vitro PDT studies of five neutral Ir(III) complexes 
incorporating BODIPY-substituted N-heterocyclic carbene (NHC) ligands were studied. The 
attachment position of the BODIPY substituent did not alter the photophysical properties 
significantly but changed the dark- and photo- cytotoxicity of these complexes toward SKMEL28 
cells. 
 v 
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1. INTRODUCTION 
Iridium, a third−row transition noble metal with oxidation states of −3 to +9, was firstly 
discovered in 1803. To date, investigations of the photochemical, photophysical, and 
electrochemical properties of organoiridium compounds have attracted intense and sustained 
interests. Owing to the commercially−available hydrated iridium trichloride and ammonium 
hexachloroiridate as the precursors, diverse octahedral d6 Ir(III) complexes were synthesized, 
which have potential applications in organic light emitting diodes (OLEDs),1–4 light−emitting 
electrochemical cells (LECs),5–7 luminescent biological labeling,8–10 photocatalysts,11–13 
photodynamic therapy (PDT),14–17 and nonlinear optics.18–22 These applications are based on their 
striking structural and spectroscopic characteristics, i.e. tunable triplet excited states, photo− and 
thermal−stability, and high quantum efficiency for triplet excited-state formation, etc..23–25 
Among the variety of potential applications reported for the Ir(III) complexes, reverse 
saturable absorption (RSA) and photodynamic therapy (PDT) are the two emerging areas. RSA 
refers to a nonlinear optical phenomenon in which the absorbance of the excited state is stronger 
than that of the ground state at the same wavelength.26,27 RSA has applications in optical limiting,67 
laser pulse shaping,68 optical switching,69 and spatial light modulation,70 etc. RSA can be achieved 
by materials that possess large ratios of the excited−state absorption (ESA) cross section (σex) to 
that of the ground state (σ0) at the same wavelength. Thus, weaker ground-state absorption 
accompanied with stronger excited-state absorption are the basic requirements for reverse 
saturable absorbers. For RSA of the nanoseconds and longer laser pulses, the longer-lived triplet 
excited states play the major role. In such a case, the quantum yield of the triplet-excited state 
formation and the triplet lifetime are also important parameters for improving the RSA. 
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PDT is an emerging therapeutic modality for cancers that combines three non−toxic 
components, i.e. a photosensitizer (PS) that is non-toxic in dark but becomes phototoxic upon light 
activation, a light source, and oxygen.28–30 Upon light irradiation, the non−toxic ground-state 
oxygen (3O2) becomes toxic singlet oxygen (
1O2) and/or reactive oxygen species (ROS) through 
interacting with the excited PSs, which destroy the cancer cells directly, damage the vascular 
system in the surrounding tissues to avoid the recurrence of tumors, and may stimulate the immune 
system. To obtain a high PDT activity against cancers, PSs that are capable of efficient 1O2 and/or 
ROS generation in hypoxic cancerous environment remain to be the most desirable ones. 
The above discussion shows that the applications of the Ir(III) complexes are closely 
related to their photophysical properties. In order to improve the device performances, 
optimization of the photophysical properties of the individual complex plays a key role. To realize 
this goal, understanding the structure−property correlations holds the key. In this chapter, the basic 
concepts in photophysics will be reviewed first. Then, the synthesis, photophysics, and the current 
status of utilizing Ir(III) complexes in RSA and PDT will be reviewed. 
 
1.1. Basic photophysical concepts 
Various photophysical processes originate from the interactions between light and 
molecules. The basic principles on the photophysical processes are discussed in this chapter. 
 
1.1.1. Light 
Light, associated with our daily life, is a type of electromagnetic radiation with a speed of 
approximately 300,000 km/s in vacuum. The relationship between the light and energy is governed 
by the Planck’s equation: 
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                                                                    E = hν = hc/λ                                                            (1.1) 
Where E stands for the photon energy, h is Planck’s constant (6.63 × 10−34 joule-seconds), ν is the 
frequency of light, c is the speed of light, and λ is the wavelength of light. The nature of light has 
a wave–particle duality, due to both the wave−like and particle−like features. Since the wave–
particle duality character shared by both photons and electrons, an intimate connection between 
light and electrons has been developed as a foundation for modern photophysical research. In view 
of the two areas of applications of the Ir(III) complexes will be potentially applied to, the following 
discussion in this dissertation will be focused on a molecular level. 
 
1.1.2. The absorption of light in materials 
The absorption of light in molecules is always accompanied with electronic transitions. To 
further understand the natures of these transitions, Frank−Condon principle needs to be explained, 
which is a well−established theory in quantum chemistry and spectroscopy (Figure 1.1)31. In 
simple terms, this principle can be exploited to explain the intensity of vibronic transitions and 
absorption of photons.  
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Figure 1.1. Frank−Condon energy diagram. 
 
As depicted in Figure 1.1, electrons at the ground state (E0) are vertically excited to an 
excited state (E1) within a femtosecond timescale (~10
−15 s) upon light irradiation. Compared to 
the electrons, atomic nuclei are much heavier. Thus, the atomic nuclei cannot be moved and 
readjusted in femtoseconds during the absorption. Each energy level is marked as a solid line. The 
electronic transitions are expressed as upward arrows. Among them, the energy of absorption is 
equivalent to the length of the arrow. Based on the above Planck’s equation, the frequency of an 
absorption peak is governed by the potential energy gap between the initial and final states.  
When a light beam enters a sample solution, attenuation of the light can be observed, which 
is associated with the ability of the material’s absorption. According to the Lambert–Beer law, a 
linear relationship between the absorbance and the intrinsic properties of the absorbing species is 
expressed in the following equations:32 
T = I/Io                                                                                                   (1.2) 
A = −log T = − log (I/Io) =   l  c                                           (1.3) 
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where T is the transmittance of the light, Io is the initial light intensity, I is the intensity of the 
transmitted light, A is the measured absorbance,   (M-1 . cm-1) is the molar extinction coefficient, 
l (cm) is the path length of the sample, and c (mol/L) is the concentration of the sample solution. 
Accordingly, modern ultraviolet–visible (UV-Vis) spectroscopy is usually utilized to measure the 
absorbance and subsequently deduce the  values of a tested sample with a known concentration. 
Jablonski diagram, as an energy diagram, illustrates the electronic states and possible 
excited state pathways in a molecule, which is shown in Figure 1.2.33 By absorbing a photon, a 
molecule can be populated to its lowest singlet excited state (S1). Note that electrons can be excited 
to higher energy singlet excited states (Sn) and then relax back to S1 via internal conversion (IC) 
(known as a thermal process), due to the overlapping vibrational and electronic energy states. The 
S1 state will release that energy to go back to the ground state (S0) via radiative (fluorescence) or 
non−radiative (heat) transitions (Figure 1.2). Radiative and nonradiative transitions are denoted as 
straight and sinuate arrows, respectively. In comparison to the Sn states, the corresponding triplet 
excited states (Tn) located at lower energy levels because of the electron−electron repulsion. Since 
electron spins are paired in Sn states, the unpaired excited electrons in the triplet states lead the 
excitation to a triplet state involving a spin−forbidden transition. Except for the spin−allowed 
possess (S1→S0), S1 can relax and populate to the lowest-energy triplet excited state (T1) via a 
spin−forbidden nonradiative transition known as intersystem crossing (ISC). After a spin flip of 
an electron, the T1 deactivate to S0 through a radiative decay or nonradiative decay pathways, 
which are known as phosphorescence or ISC. 
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Figure 1.2. Jablonski diagram of molecules. IC: internal conversion, ISC: intersystem crossing, 
ESA: excited state absorption. 
 
1.1.3. Fluorescence and phosphorescence 
Based on the aforementioned fdiscussion, fluorescence and phosphorescence are the 
radiative decay pathways from the S1 and T1 states respectively (Figure 1.2). The S1 state, which 
has a higher potential energy, gives a shorter wavelength of fluorescence in contrast to the 
phosphorescence from the T1 state. As a result of vibrational relaxation within the excited states, 
the energies of both the fluorescence and phosphorescence are typically lower than that of the 
excitation energy. The energy difference between an emitted photon and an absorbed photon 
appears as the Stokes shift between the excitation and emission spectra.34  
Fluorescence, a spin−allowed possess, is a short−lived emission (the lifetime () typically 
ranged from 10 ns to 700 ns).71 Phosphorescence, however, is a spin−forbidden transition, which 
lifetime is much longer than that of fluorescence ( ≈ 1 ns - 1 ms). The lifetime of luminescence 
can be measured by time−resolved spectroscopy and fitting the obtained decay curves. Because of 
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the presence of ISC and IC, the shortened lifetime of radiative transition is observed. Therefore, 
the intrinsic lifetimes of S1 (𝜏𝑆1) and T1 (𝜏𝑇1) can be written as:
35  
 𝜏𝑆1 =  
1
𝑘𝑟
𝑓
+𝑘𝑛𝑟
𝑆1
                                                                (1.4) 
𝜏𝑇1 =  
1
𝑘𝑟
𝑝
+𝑘𝑛𝑟
𝑇1
                                                                (1.5) 
where 𝑘𝑟
𝑓 ,  𝑘𝑛𝑟
𝑆1 ,  𝑘𝑟
𝑝, and 𝑘𝑛𝑟
𝑇1  are the rate constant of fluorescence, nonradiative decay from the S1 
state, phosphorescence, and non−radiative decay from the T1 state, respectively. 
The emission quantum yield can be expressed as the ratio between the number of emitted 
photons and the number of absorbed photons. For fluorescence, the relationship of the quantum 
yield (Φ𝑓), the rate constant of fluorescence (𝑘𝑓), and the rate constant of nonradiative decay (𝑘𝑛𝑟) 
from S1 can be written as:
36 
Φ𝑓 =  
𝑘𝑓
𝑘𝑓+𝑘𝑛𝑟
                                                               (1.6) 
For phosphorescence, however, the quantum yield is susceptible to both ISC and quenching 
pathways. Thus, the phosphorescence quantum yield (Φ𝑝) can be expressed as:
37 
Φ𝑝 =  
Φ𝐼𝑆𝐶𝑘𝑝
𝑘𝑝+𝑘𝑛𝑟
                                                               (1.7)  
where Φ𝐼𝑆𝐶, 𝑘𝑝, and 𝑘𝑛𝑟 stand for the quantum yield of ISC, the rate constant of phosphorescence, 
and rate constant of nonradiative decay from T1, respectively.  
The obtained phosphorescence quantum yields in this dissertation were calculated using 
the relative actinometry method.72 A degassed acetonitrile solution of [Ru(bpy)3]Cl2 (ΦR = 0.097) 
is used as the reference (R) for the quantum yield calculations of the samples (S) following the 
equation: 
Φ𝑠 = Φ𝑅 ∗
𝐴𝑆
𝐴𝑅
∗
𝐼𝑅
𝐼𝑆
∗
(𝑛𝑆)
2
(𝑛𝑅)2
                                                  (1.8)  
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where Φ, A, I, and n are the phosphorescence quantum yield, the integrated area of the emission 
spectra, ground−state absorbance of the solution at the excitation wavelength, and the refractive 
index of the used solvent, respectively. The subscript S refers to the samples, and R refers to the 
reference. 
 
1.1.4. Heavy atom effect  
The property of T1 plays a vital role in the applications for both RSA and PDT. According 
to the above discussion, T1 state can be heavily populated through the nonradiative passway 
between the S1 and T1 states when the rate constant of ISC is high. However, the coupling and 
quantization of angular momentum and orbital angular momentum is separated, which results in a 
forbidden spin change of electron. For most organic compounds without heavy atoms, ISC yield 
is low. An increased overlap of spin angular momentum and orbital angular momentum of the 
electron can be obtained by the presence of a heavy atom. Consequently, the spin−orbit coupling 
enhances ISC yield, which is called the heavy atom effect.38 In the periodic table, the atoms beyond 
the third row are defined as heavy atoms.  
In this dissertation, strong spin−orbit coupling effect and high ISC rate are anticipated for 
all synthesized complexes due to the presence of Ir(III) ion. For example, , the rate constant of ISC 
is 6.9×1012 s−1 for complex fac−Ir(ppy)3; whereas, the rate constant of fluorescence is about 1×106 
s−1.39 As a result, a nearly unity population of the T1 state can occur.  
 
1.1.5. RSA  
With the development of laser technology, various laser sources have been employed in 
photonic and medical applications associated with our daily life. However, an urgent need for 
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optical limiters in order to protect human eyes or optical sensors from damaging laser beam is 
emerging. The performance of the optical limiters heavily depends on the optical limiting materials 
used in the devices. Such materials show excellent linear transmittance for low−intensity light. 
Under intense laser radiation, however, the transmitted laser pulses can be modulated to a safe 
intensity below the damaging threshold value. Since linear optical techniques, including 
absorption, reflection, and diffraction, cannot meet the aforementioned needs, a growing effort is 
focusing on the nonlinear absorbers.  
Among the variety of nonlinear optical phenomena that have been explored for optical 
limiting applications, multiple photon absorption (MPA) and RSA are two major methods for the 
protection of human eyes and delicate components under exposure to intense laser beams. With 
increasing intensity or fluence of the incident laser, the absorptivities of the MPA or RSA materials 
increase. MPA is a spontaneous process that depends on the intensity of the last beams and 
typically work better for ps or fs laser pulses. Whereas RSA is a fluence dependent process that 
dominates the optical limiting for ns or longer pulse width laser beams. As shown in Figure 1.2, 
an excited molecule populated to the S1 state can absorb additional photons to be populated to the 
higher energy Sn state (S1 → Sn absorption). Similarly, the excited molecules at the T1 state can 
also absorb photons to reach the Tn states with higher energies (T1 → Tn absorption). With the 
different lifetimes of S1 (fs-ns) and T1 (ns-ms), the S1 → Sn or T1 → Tn absorption will be the major 
player for the short or long laser pulse induced RSA, respectively. Since a distinct heavy−atom 
effect can be induced by Ir(III) ion, the ISC rate is greatly enhanced in Ir(III) complexes, which 
results in dominant T1 → Tn absorption in the RSA possess for Ir(III) complexes. 
In order for RSA to occur,  σex should be larger than σ0, which will induce an increased 
absorptivity with increased laser fluence. Several criteria need to be taken into account when 
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design an ideal reverse saturable absorbers, such as a large ratio of σex/σ0, long−lived 
excited−states, and high triplet excited−state quantum yield. 
 
1.1.6. PDT  
As an oxygen−dependent process, PDT is a noninvasive and precise spatiotemporal 
medical modality, in which PS is nontoxic without light activation but becomes highly phototoxic 
upon light activation. Therefore, in comparison with other cancer treatment modalities, the 
photoinitiated PDT has outstanding regioselectivity. 
A typical photosensitization diagram displaying the formation of ROS and 1O2 mediated 
by PSs is depicted in Figure 1.3.40,41 Upon photon absorption, a PS is excited from the ground state 
(S0) to its lowest singlet excited state (S1) and then relaxes to its lowest triplet excited state (T1). 
Then, the T1 of PS interacts with oxygen in its ground state (
3O2) via two pathways: energy transfer 
to convert 3O2 to 
1O2 (Type II) and electron transfer to generate ROS, such as O2
-., •OH, H2O2. etc 
(Type I).  
 
Figure 1.3. Typical pathway for a photosensitizer to generate 1O2 and ROS. 
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To date, the most clinically used PDT drugs are still based on hematoporphyrin derivatives 
(HPD), which suffers from several drawbacks, such as high dark toxicity, inability to be activated 
by near−IR (NIR) light, low 1O2/ROS generation efficiency in hypoxic solid tumors, low cancer 
selectivity, cutaneous photosensitivity, and water insolubility. To overcome these disadvantages, 
there is an urgent need for developing new PSs with good tumor−specific targeting, absorb 
strongly in the NIR region, and long−lived triplet excited state. 
Herein, PSs based on transition-metal complexes have prompted significant interest in 
recent years. In comparison to the organic PSs, transition-metal complex based PSs hold a series 
of unique merits, i.e., (i) tunable excited−state properties, (ii) high triplet excited−state quantum 
yields, and (iii) good photostability and cell permeability. Additionally, the phosphorescent heavy 
transition-metal complexes can be used as targeted bioimaging agents, providing novel theranostic 
platforms to help investigating the PDT mechanisms and thus optimizing the treatment efficacy 
by in situ monitoring of biodistribution in the tumor cell. Therefore, cationic iridium(III) 
complexes appear promising for the application of PDT, because their photophysical properties 
match the requirement of ideal bioimaging−based PSs quite well. 
 
1.2. Basic photophysics and representative examples for Ir(III) complexes  
1.2.1. Photophysics of Ir(III) complexes 
With an octahedral d6 electronic configuration, the coordinating ligands of iridium(III) 
complexes protect the metal center from the environment well. Accordingly, several metal−based 
nonradiative pathways for transition metal complexes, including ground−state aggregation and 
solvent binding, can be largely avoided.42 Due to the decreased deactivation pathways and the 
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strong spin−orbit coupling effect induced by iridium ion, population of the triplet states with a 
high quantum yield can be realized.  
Unlike pure organic chromophores, the Ir(III) ion plays a significant role in the 
photophysical processes of the Ir(III) complexes. The electronic transition diagram for typical 
biscyclometalated Ir(III) complexes is schematically illustrated in Figure 1.4. The vertical arrows 
indicate the electronic transitions from different orbitals of complexes. Among them, the 
fundamental types are listed as following: 
(1) Metal−centered (MC) or d,d transitions: the transition between the two metal-localized 
orbitals.  
(2) Ligand−centered (LC) or intraligand (IL) transitions: the →* transitions between the 
orbitals on the same ligand. 
(3) Ligand−to−ligand charge−transfer (LLCT) transitions: the →* transitions between 
the orbitals on two different ligands. 
(4) Metal−to−ligand charge−transfer (MLCT) transitions: the d→* transitions between 
the metal−centered d orbital and the ligand localized orbital. 
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Figure 1.4. Schematic energy−level diagram for a typical cationic heteroleptic Ir(III) complex. 
 
1.2.2. Three typical prototypes of Ir(III) complexes  
The rich photophysical properties of Ir(III) complexes attract  intense attention. As 
illustrated in Figure 1.4, ligands localized orbitals can be readily tuned by ligand structural 
modifications. Bathochromic or hypsochromic shifts may occur in the electronic absorption after 
adjusting the conjugation length of the ligands. Introducing electron−donating or −withdrawing 
substituents to the ligands also affects the electronic absorption. Therefore, the development of 
Ir(III) complexes with various ligands has drawn great interest. 
Three common prototypes of Ir(III) complexes, i.e. fac−Ir(ppy)3, [Ir(bpy)(ppy)2]+, and 
[Ir(tpy)2]
3+, are illustrated in Chart 1.1. In these complexes, ppy, bpy, and tpy denote 
2−phenylpyridine, 2,2'−bipyridine, and 2,2':6',2''−terpyridine, respectively. The well−known 
neutral complex, fac−Ir(ppy)3, was first developed by Martin in 1958.43 The metal center is 
surrounded by three identical ppy ligands where each of the phenyl group carries one formal 
negative charge and each of the pyridine group is neutral. Based on the subsequent theoretical 
calculations, the highest occupied molecular orbital (HOMO) in fac−Ir(ppy)3 is delocalized on the 
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π orbitals of the phenyl rings and the metal d orbitals, while the lowest unoccupied molecular 
orbital (LUMO) is mainly delocalized on the pyridine rings. Obvious low-energy 1MLCT band 
(from 320 to 500 nm) were observed in the absorption spectra, which are assigned to transitions 
between the HOMO and LUMO orbitals.44 The emission spectrum of fac−Ir(ppy)3 resembles the 
shape of the ligand emission at 77 K, which is indicative of a ligand−localized (π,π*) lowest excited 
state. The measured phosphorescence lifetime was ca. 2 µs at room temperature, indicating the 
emitting state is a mixture of 3, and 3MLCT. 
 
 
Chart 1.1. Three common prototypes of Ir(III) complexes. 
 
In comparison to the neutral complex Ir(ppy)3, replacing one cyclometalating (C^N) ligand 
by a diimine (N^N) ligand results in the monocationic complex [Ir(bpy)(ppy)2]
+. As a prototype, 
the complex shows intense 1π,π* absorption bands in high-energy region ( < 300 nm), and 
moderate 1MLCT absorption in the UV to blue spectral region.45 Interestingly, spin−forbidden 
3MLCT/3LLCT transitions exhibit a long and weak absorption tail extending to 550 nm.46 With 
the emission lifetime being hundreds of nanoseconds, the phosphorescence of the complex was 
assigned predominantly to the low−lying 3MLCT state.  
The homoleptic bis−terpyridine complex, [Ir(tpy)2]3+, features ligand−centered transitions 
with large extinction coefficients ranged from 200 to 350 nm. Besides, the absorption tail is 
attributed to 1MLCT and spin-forbidden (S0→T1) transitions.47 With the emission lifetime being 1 
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s and the similarity of the luminescence profiles to that of Zn(tpy)22+ at 77 K, the 
room−temperature vibronically resolved luminescence spectrum was ascribed to tpy−localized 
3π,π* excited state.  
 
1.2.3. Cyclometalated Ir(III) complexes with different -conjugation on ligands  
Cyclometalated complexes are defined as a type of complexes that contain at least one 
covalent metal–carbon bond. Thus, the Ir–carbon bond(s) exist(s) in the cyclometalated Ir(III) 
complexes when C^N ligands are applied. In the past two decades, numerous studies have been 
focusing on monocationic bis−cyclometalated Ir(III) complexes with a variety of C^N and N^N 
ligands. Modifications of these ligands via attaching different substituents or extending 
π−conjugation were then performed. Chart 1.2 illustrates some representative cyclometalated 
monocationic Ir(III) complexes bearing tris-bidentate ligands with different conjugation lengths. 
Huang and coworkers developed a series of monocationic Ir(III) complexes (Ir1–Ir6) 
bearing two identical cyclometalating ligands (1−phenylisoquinoline) but different N^N ligands 
with varied −conjugations.48 As shown in Figure 1.5, all complexes exhibit intense intraligand 
1π,π* absorption bands at <400 nm, moderately intense 1MLCT/1LLCT absorption bands at 400 - 
500 nm, and weak spin−forbidden 3MLCT absorption tails beyond 500 nm. Due to the different 
conjugation lengths on the N^N ligands, the emission energies were tuned from 586 nm for Ir1 
and Ir2 to 732 nm for Ir6. Considering the vibronically resolved photoluminescence spectra of 
Ir1 and Ir2, the emitting states for these two complexes were attributed to the ligand−centered 
3π,π* excited states. In contrast, the broad and structureless emission spectra for Ir3−Ir6 suggested 
mixed 3MLCT/3LLCT excited states for these complexes (Figure 1.6). 
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Chart 1.2. Representative biscyclometalated monocationic iridium(III) complexes with different 
conjugation lengths on the ligands. 
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Figure 1.5. Absorption spectra of complexes Ir1–Ir6 (Ir1 = 1, Ir2 = 2, Ir3 = 3, Ir4 = 4, Ir5 = 5, 
Ir6 = 6) in CH2Cl2 at room temperature. Reprinted with permission from Ref. 48. 
 
 
Figure 1.6. Photoluminescence spectra of complexes Ir1–Ir6 (Ir1 = 1, Ir2 = 2, Ir3 = 3, Ir4 = 4, 
Ir5 = 5, Ir6 = 6) in degassed CH2Cl2 at room temperature. Reprinted with permission from Ref. 
48. 
 
Qiao and coworkers reported three near−infrared (NIR) emitting monocationic Ir(III) 
(Ir7−Ir9 in Chart 1.2) with different ancillary ligands (Ir7: bipyridine; Ir8: 1,10−phenanthroline;: 
Ir9: 4,7−diphenyl−1,10−phenanthroline), in which large −conjugated 2-
phenylbenzo[g]quinoline was used as the cyclometalating ligand.49 All complexes hold 
ligand−centered 1π,π* transitions at < 350 nm and mixed 1MLCT/3MLCT/3LLCT transitions from 
350 to 600 nm. Complexes Ir7−Ir9 exhibited an emission maximum at 698 nm and a shoulder at 
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760 nm with a quantum yield of ca. 3%. Since the inﬂuence of the different diimine ligands on the 
emission is limited, the nature of the emitting states was assigned to the C^N ligands localized 
3π,π* mixed with 3CT characters. 
 
 
Figure 1.7. Room−temperature absorption (left) and photoluminescence (right) spectra of 
complexes Ir7−Ir9 (Ir7 = 1, Ir8 = 2, Ir9 = 3) in degassed CH2Cl2. The spectra were recorded on 
a Jobin Yvon fluorospectrophotometer (FluoroMax-3), by using the manufacturer’s procedure. 
Reprinted with permission from Ref. 49. 
 
Taking all the aforementioned examples into account, the photophysical properties of the 
heteroleptic cationic Ir(III) complexes could be easily tuned by changing the degree of π-
conjugation of the N^N and/or C^N ligands. Considering the difficulty of the benzannulation on 
the ligands, our group adopted another approach to extend the ligand π-conjugation via tethering 
the π-conjugated substituents to the N^N or C^N ligands. We reported a systematic study on the 
photophysics of four cyclometalated Ir(III) complexes (Ir10−Ir13) and explored their applications 
as reverse saturable absorbers.22 The benzothiazolylfluorene motifs were tethered on the bipyridine 
(Ir10 and Ir11) and  the phenylpyridine (Ir12 and Ir13) ligands. The effects of the extended π-
conjugation of the N^N and/or C^N ligands, and the attachment position of the substituents at the 
N^N ligand on the photophysics and RSA strength  were investigated . All complexes exhibit spin-
allowed intraligand 1π,π* transitions with large extinction coefficient below 475 nm, and very 
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weak 1,3MLCT and 1,3LLCT transitions above 475 nm (Figure 1.8). The emission bands of these 
complexes are attributed to 3MLCT/3LLCT for Ir1, 3π,π* for Ir2, and 3MLCT/3LLCT/3π,π* for 
Ir3 and Ir4. The variations of the different π-conjugation degrees in ligands alter both the 
parentage of T1 states and RSA strength. 
 
  
Figure 1.8. Absorption spectra of complexes Ir10−Ir13 (Ir10 = 1, Ir11 = 2, Ir12 = 3, Ir13 = 4) 
in CH2Cl2 at room temperature. Reprinted with permission from Ref. 22. 
 
 
Figure 1.9. Photoluminescence spectra of complexes Ir10−Ir13 (Ir10 = 1, Ir11 = 2, Ir12 = 3, 
Ir13 = 4) in degassed CH2Cl2 at room temperature. Reprinted with permission from Ref. 22. 
 
To further understand the influence of extended -conjugation of the N^N or/and C^N 
ligands via tethering -conjugated substituents on the photophysicsof the monocationic Ir(III) 
complexes, our group studied six other Ir(III) complexes (Ir14–Ir19),20 where fluoren-2-yl or 7- 
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benzothiazolylfluoren-2-yl motifs were attached on the N^N or/and C^N ligands. The obtained 
complexes hold N^N or C^N ligand-localized 1,*/1ILCT transitions below 450 nm and weak 
1,3MLCT/1,3LLCT bands above 450 nm. Modifications of the phenanthroline ligand by introducing 
fluoren-2-yl or 7-benzothiazolylfluoren-2-yl substituents led to the a red-shift of the main 
absorption band to 400 and 408 nm for Ir14 and Ir15, respectively. For complexes Ir16 and Ir17, 
the major absorption bands appear at 325 and 360 nm, respectively. When the 7- 
benzothiazolylfluoren-2-yl motifs were introduced to both the N^N and C^N ligands in complex 
Ir18, its absorption spectrum appeared to be a superimposition of the spectra of Ir15 and Ir17. 
The emission spectra of Ir14 and Ir15 were structured and the lifetimes were long (5.6 s for Ir4 
and 12.9 s for Ir5), indicating the substituted phenanthroline-localized 3π,π* state being the 
emitting states. The shorter-lived (0.37-1.38 s) and structureless emission spectra of Ir16, Ir17, 
and Ir18 were indicative of the 3CT emitting states. Complexes Ir14 and Ir15 with extended π-
conjugation at the N^N ligand exhibited longer-lived, red-shifted and stronger triplet excited-state 
absorption in comparison to their respective counterparts Ir16 and Ir17 with the -conjugated 
substituents at the C^N ligands. Therefore, Ir14 and Ir15 gave rise to stronger RSA in comparison 
to Ir16 and Ir17, respectively, at 532 nm. 
 
Figure 1.10. Experimental UV−vis absorption spectra of Ir14–Ir19 (Ir14 = 1, Ir15 = 2, Ir16 = 3, 
Ir17 = 4, Ir18 = 5, Ir19 = 6) in CH2Cl2. Reprinted with permission from Ref. 20. 
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Figure 1.11. Normalized emission spectra of Ir14–Ir19 (Ir14 = 1, Ir15 = 2, Ir16 = 3, Ir17 = 4, 
Ir18 = 5, Ir19 = 6) in deaerated CH2Cl2 solution, c =1 × 10
−5 mol L−1. Reprinted with permission 
from Ref. 20. 
 
 
1.2.4. Bis−terdentate Ir(III) complexes  
Different from the bidentate ligands, terdentate ligands, such as tpy and 
2,6−diphenylpyridine, enable one to construct a linearly arranged system of complexes. This could 
avoid the formation of geometrical fac− or mer− stereoisomers that was found in the 
triscyclometalated Ir(III) complexes. These ligands can also be used as building blocks to form 
multinuclear complexes. Moreover, the photophysical properties of bis−terpyridine Ir(III) 
complexes (Ir(tpy)2
3+) are greatly influenced by the substituents at the 4-position of tpy. In 1999, 
the synthetic procedure of a series of Ir(tpy)2
3+ complexes were reported by Collin and 
coworkers.47 Different aryl  substituents was attached to the 4-position of tpy ligand. These 
complexes featured high-lying emitting states (>2.5 eV) with high efficiencies and long lifetimes 
(1-2 s). Based on the published synthetic procedures, several homoleptic and heteroleptic 
Ir(tpy)2
3+ complexes were designed for a range of applications in recent years. As shown in Chart 
1.3, tolyl, benzyl hydroxyphenyl, aniline, methoxyphenyl, or benzoic acid groups were introduced 
to the 4-position of tpy. 
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Chart 1.3. Selected examples of bis−terdentate iridium(III) complexes. 
 
For the bis−terpyridine Ir(III) complexes (Ir20−Ir24) possessing electron−donating or 
accepting groups, varied absorption and luminescence properties have been observed.57 In contrast 
to Ir20 and Ir21, the presence of aniline in Ir22−Ir24 induced strong 1ILCT absorption bands in 
the visible spectral region (See Figure 1.12). As presented in Figure 1.13, the electron-donating 
amino substituent on the phenyl ring increased the energy level of the aryl substituent (ph) to 
surpass that of the tpy (tpy), resulting in 1ILCT (ph→tpy) transition. The homoleptic Ir(III) 
complex Ir23 that was incorporated with two amino substituents doubled the intensity of the 
1ILCT absorption band than those in the heteroleptic complexes Ir22 and Ir24. All complexes 
exhibited emission in both acetonitrile and aqueous solutions originating from the mixed 3π,π* 
(tpy→tpy) / 3ILCT (Ar→tpy) states (Figure 1.14). Following the energy−gap law, the 
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low−lying 3ILCT excited state induced by aniline in complexes Ir22−Ir24 resulted in a faster 
nonradiative decay and thus reduced the emission in these complexes. In addition, the emission 
lifetimes in degassed acetonitrile solutions (3.2−9.6 s) were shorter than those in degassed 
aqueous solutions (7.7−21 s), owing to increased nonradiative decay rates in acetonitrile.  
 
 
Figure 1.12. The ground−state absorption spectra for complexes Ir20−Ir24 (Ir20 = 1, Ir21 = 2, 
Ir22 = 3, Ir23 = 4, Ir24 = 5) in CH3CN at room temperature. Reprinted with permission from Ref. 
57. 
 
 
Figure 1.13. The proposed ILCT transition in Ir22. Reprinted with permission from Ref. 57. 
 
 
Figure 1.14. Emission spectra for complexes Ir20−Ir24 (Ir20 = 1, Ir21 = 2, Ir22 = 3, Ir23 = 4, 
Ir24 = 5) in degassed CH3CN (left) and aqueous (right) at room temperature. Reprinted with 
permission from Ref. 57. 
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Two bis−terdentate Ir(III) complexes (Ir25 and Ir26) bearing polypyridyl or 
cyclometalating ligands for DNA purine bases oxidation were reported by Elias’s group.58 
Electron-withdrawing carboxyl group was introduced to the 4′-position of phtpy and electron-
donating methoxy group was incorporated to the 4-phenyl substituent on the other terdentate 
ligand. In air-saturated solutions, a broad emission band was observed for Ir25 at 568 nm (τ = 470 
ns), whereas dual− emission was observed for Ir26 at 528 nm (τ = 1 μs) and 697 nm (τ = 260 ns), 
respectively (Figure 1.15). In the presence of a guanine unit (dGMP), the emission was quenched 
by a photo-induced electron−transfer process (Figure 1.16). A linear Stern−Volmer correlation 
between the dGMP’s concentration and the luminescence intensity was obtained, which is 
indicative of the pure dynamic quenching of the excited state for both complexes (see insets of 
Figure 1.16). The emission of Ir25 was oxidatively quenched, suggesting a high oxidizing ability 
of the excited state.  
 
 
Figure 1.15. The UV−vis absorption (solid line) and emission (dash line) spectra for complexes 
Ir25 and Ir26 (Ir25 = IrN6
3+, Ir26 = IrN4C2
+) in aerated CH3CN solutions at room temperature. 
Reprinted with permission from Ref. 58. 
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Figure 1.16. Luminescence spectra of (A) Ir25 and (B) Ir26 excited at 350 nm with increased 
concentration of dGMP. Inset: The obtained Stern−Volmer plots for complexes Ir25 and Ir26 
measured at wavelength of 560 and 514 nm, respectively. Reprinted with permission from Ref. 
58. 
 
Williams and coworkers reported a family of bis-terpyridine Ir(III) complexes 
(Ir27−Ir31), in which pyridyl or phenolic groups were attached to the para-position of the central 
pyridine ring in 2,2’:6’,2’’-terpyridine.73 The phenolic-substituted complexes (Ir28 and Ir29) 
showed a significant red-shift of the 1MLCT bands upon protonation (Figure 1.17). The appearance 
of the solution of Ir28 became deep orange by increasing the pH to 10, due to the appearance of 
the band at 468 nm in the absorption spectrum. The spectra of complexes Ir29 and Ir31 were 
similar to that of Ir27 (Figure 1.18). In addition, the weakly emissive complex Ir28 was found to 
be quenched by deprotonating of the phenol ring. 
 
 
Figure 1.17. The absorption spectra of Ir28 in aqueous solution at different pH values (5.3, 6.7, 
7.6, 8.3, 9.0, 10.1). 
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Figure 1.18. The luminescence spectra of the air-equilibrated aqueous solutions of Ir27−Ir31 
(Ir27 = 1, Ir28 = 2, Ir29 = 3, Ir30 = 4, Ir31 = 5) at pH 6.0 at room temperature (ex = 364 nm). 
 
Haga and coworkers developed two bis-terdentate Ir(III) complexes (Ir32 and Ir33), in 
which 2,6-bis(1-methyl-benzimidazol-2-yl)pyridine and 1,3-bis-(1-methyl-benzimidazol-2-
yl)benzene were used as the coordination ligands. As shown in Figure 1.19, Ir32 and Ir33 
possessed weak absorption bands in a low-energy region (>400 nm), which emanated from the 
1,3MLCT-based transitions. All Ir(III) complexes exhibited emissions at ca. 600 nm at room 
temperature (Figure 1.20). The emission spectra of Ir32 and Ir33 displayed vibrational 
progressions at 77 K. 
 
Figure 1.19. UV-vis spectra of Ir32 (solid line) and Ir33 (dashed line) in acetonitrile. 
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Figure 1.20. Emission spectra of Ir32 (a) and Ir33 (b). Solid lines are at room temperature (in 
MeCN), and dotted lines are at 77 K (in DMF-MeOH-EtOH [1:5:5(v/v)]. 
 
1.3. Cyclometalated Ir(III) complexes for RSA applications 
 As discussed in the previous section, the ground-state and excited-state properties of the 
cyclometalated Ir(III) complexes are readily tuned by structural modifications of the N^N and /or 
C^N ligands. Moreover, the broad and weaker charge transfer ground-state absorption but much 
stronger excited-state absorption in the visible spectral region, the high triplet excited-state 
formation quantum yield, and the long triplet lifetime associated with the cyclometalated Ir(III) 
complexes match the requirements for RSA quite well. Therefore, RSA of the cyclometalated 
Ir(III) complexes has been extensively investigated by our group and other groups in the past 15 
years. As shown in Chart 1.4, the RSA of several representative cyclometalated Ir(III) complexes 
will be discussed in the following part.  
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Chart 1.4. Selected examples of cyclometalated iridium(III) complexes for RSA study. 
 
The pioneering work of the RSA study on the cyclometalated Ir(III) complex (Ir34) with 
2-phenylpyridine and 4,4′-(2,2′-bipyridine-5,5′-diylbis(ethyne-2,1-diyl))bis(N,N-dihexylaniline) 
ligands was reported by Schanze’s group.21 Ir34 displayed strong transient absorption over the 
visible to the near-IR spectral regions (Figure 1.21(a)). A notable optical limiting was observed 
 29 
for ns laser at 1064 nm, which was the result of two-photon absorption (TPA) initiated excited-
state absorption (ESA) (Figure 1.21(b)). 
 
 
Figure 1.21. (a) TA spectra of Ir34 in deoxygenated THF solution (b) transmittance of pulsed 
beam at 1064 nm of Ir34 in degassed THF solution at various concentrations. Reprinted with 
permission from Ref. 21. 
 
To understand the effect of extended -conjugation of the N^N ligand on the photophysics 
and RSA of Ir(III) complexes, our group studied complexes Ir35−Ir39 in which 
2−{3−[7−(benzothiazol−2−yl)fluoren−2−yl]phenyl}pyridine and various diimine ligands, i.e., 
2−(pyridin−2−yl)quinoline (Ir35), 1,10−phenanthroline (Ir36), 2,2'−biquinoline (Ir37), and 
1,1'−biisoquinoline (Ir38), were employed as the C^N and N^N ligand(s), respectively.51 
Additionally, complex Ir39 bearing 2−(pyridin−2−yl)quinoline and 2−phenylpyridine ligands was 
chosen as the reference complex. In the UV-vis absorption spectra, all complexes displayed 1π,π* 
transitions below 400 nm, 1MLCT/1LLCT transitions in the range from 400 to 450 nm, and spin-
forbidden 3MLCT/3LLCT transitions above 450 nm (see Figure 1.22). Owing to the extended 
π−conjugation in the N^N ligands, the 3MLCT/3LLCT absorption bands were gradually 
bathochromically shifted with enhanced extinction coefficients. The emission of these complexes 
was centered at the wavelengths from 584 to 672 nm in CH2Cl2 at room temperature, which was 
assigned to 3MLCT/3LLCT states (see Figure 1.23). Upon ns laser pulses excitation at 532 nm, all 
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complexes exhibited very strong RSA effect. The RSA strength followed the trend of Ir35 ≈ Ir36 
> Ir38 > Ir37 > Ir39, which paralleled the cross−section ratios between the excited−state and 
ground−state absorption at 532 nm (see Figure 1.24). 
 
 
Figure 1.22. Experimental (a) and calculated (b) ground−state absorption spectra of all complexes 
(Ir35 = 1, Ir36 = 2, Ir37 = 3, Ir38 = 4, Ir39 = 5) in CH2Cl2. Reprinted with permission from Ref. 
51. 
 
 
Figure 1.23. Normalized emission spectra of all complexes in degassed CH2Cl2. Reprinted with 
permission from Ref. 51. 
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Figure 1.24. Reverse saturable absorption for complexes (Ir35 = 1, Ir36 = 2, Ir37 = 3, Ir38 = 4, 
Ir39 = 5) in 2 mm thick toluene (80% linear transmission) for 532 nm 4.1 ns laser pulses at room 
temperature. Reprinted with permission from Ref. 51. 
 
Unlike extending the -conjugation on the N^N ligands, our group reported seven Ir(III) 
complexes (Ir40−Ir46) bearing 2,2'−bipyridine ligand but varying the π−conjugation of the 
cyclometalating C^N ligands.50 As depicted in Figure 1.25, all complexes displayed intense 
high−energy ligand−localized 1π,π* transitions and lower−energy 1MLCT /1LLCT transitions in 
the UV−vis absorption spectra. The emission bands of these complexes could be tuned from 500 
to 670 nm with the emitting states being 3π,π*/3MLCT for Ir40, 3π,π*/3MLCT/3LMCT for Ir41, 
Ir42, and Ir43, 3π,π* transitions for Ir44 and Ir45, and 3π,π*/3MLCT/3LMCT/3LLCT for Ir46. 
Besides, these complexes possessed broadband transient absorption, as illustrated in Figure 1.26. 
The long-lived transient species in complexes Ir41, Ir42, Ir44, and Ir45 with varied TA spectra 
were measured, suggesting the C^N ligand-centered 3π,π* nature of the lowest triplet excited 
states. The complexes Ir40, Ir41, and Ir46 hold short-lived transient absorption, which are 
indicative of more 3CT characters in their transient species. Except for Ir46, all complexes 
exhibited strong RSA effects. The obtained RSA strength followed the trend of Ir46 < Ir40 < Ir43 
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< Ir45 < Ir44 ≈ Ir42 ≈ Ir41, which was approximatively associated with the ΔOD values at 532 
nm (Figure 1.27).  
 
 
Figure 1.25. Experimental ground−state absorption spectra of (a) C^N ligands (1: 
benzo[H]quinoline; 2: 1−phenylisoquinoline, 3: 1−(2−pyridyl)naphthalene, 4: 2−(2−pyridyl)− 
naphthalene, 5: 1−(2−pyridyl)pyrene, 6: 1,2−diphenyl−pyreno[4,5−d]imidazole, 7: 
3−(2−pyridyl)perylene) and (b) complexes Ir40−Ir46 (Ir40 = 1, Ir41 = 2, Ir42 = 3, Ir43 = 4, Ir44 
= 5, Ir45 = 6, Ir46 = 7) in CH2Cl2 at room temperature and (c) calculated UV−vis spectra all 
complexes in CH2Cl2 at 0 K. Reprinted with permission from Ref. 50. 
 
 
Figure 1.26. Nanosecond triplet TA spectra of complexes Ir40−Ir46 (Ir40 = 1, Ir41 = 2, Ir42 = 
3, Ir43 = 4, Ir44 = 5, Ir45 = 6, Ir46 = 7) at zero−time decay in acetonitrile. Reprinted with 
permission from Ref. 50. 
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Figure 1.27. Nonlinear transmission plot of Ir40−Ir46 (Ir40 = 1, Ir41 = 2, Ir42 = 3, Ir43 = 4, 
Ir44 = 5, Ir45 = 6, Ir46 = 7) at the linear transmittance of 80% in CH2Cl2 solution in a 2 mm 
cuvette for 532 nm 4.1 ns laser. Reprinted with permission from Ref. 50. 
 
In contrast to the benzannulation, our group also reported the photophysics and RSA study 
of complexes Ir47−Ir50 with different -conjugation lengths on the C^N ligands via tethering 
large -conjugated motifs.18 As discussed in the previous section, all complexes exhibit positive 
TA absorption at 532 nm, indicating stronger excited-state absorption than that of the ground state. 
Compared to the para-substitution, the meta-substitution results in a higher phosphorescence 
intensity and longer-lived triplet excited state. The RSA strength followed the order of Ir50＞Ir49 
≈ Ir48＞Ir47 (Figure 1.28), suggesting the complex with para-substituted C^N ligands displayed 
a stronger RSA at 532 nm.  
 
Figure 1.28. Reverse saturable absorption for Ir47−Ir50 (Ir47= 1, Ir48 = 2, Ir49 = 3, Ir50 = 4) 
in CH2Cl2 in a 2 mm cuvette for 532 nm nanosecond laser pulses. Reprinted with permission from 
Ref. 18. 
 
 34 
We also reported the TA and RSA studies of cationic heteroleptic Iridium(III) complexes 
(Ir14–Ir19) with a tethered fluoren-2-yl or 7-benzothiazolylfluoren-2-yl substituent on the 2-
phenylpyridine and/or phenanthroline ligands.20 As shown in the TA spectra (Figure 1.29), 
complexes Ir14–Ir19 possessed positive absorption signals at 532 nm, indicating that RSA could 
occur at this wavelength. The transient absorption absorption of Ir14 and Ir15 are attributed to the 
substituted phenanthroline ligand-localized 3π,π* states, while the observed TA of Ir16–Ir19 was 
attributed to predominantly the 3MLCT/3LLCT states. The RSA strength decreased as Ir18 ≈ Ir15 
> Ir17 ≈ Ir14 > Ir16, which coincided with the σex/σ0 ratios for most of the complexes (Figure 
1.30). In comparison to Ir16 and Ir17 bearing -conjugated substituents at the C^N ligands, 
tethering the -conjugated substituents to the N^N ligand (Ir14, Ir15, and Ir18) not only caused 
the red-shifted major ground-state and triplet excited-state absorption bands, but also enhanced the 
RSA strength. 
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Figure 1.29. Time-resolved triplet TA spectra of Ir14–Ir19 (Ir14 = 1, Ir15 = 2, Ir16 = 3, Ir17 = 
4, Ir18 = 5, Ir19 = 6) in toluene solution in a 1-cm cuvette (λex = 355 nm, A355 = 0.4). Reprinted 
with permission from Ref. 20. 
 
 
Figure 1.30. Reverse saturable absorption for complexes Ir14–Ir18 (Ir14 = 1, Ir15 = 2, Ir16 = 3, 
Ir17 = 4, Ir18 = 5) for 4.1 ns laser pulses at 532 nm in 2-mm thick toluene solution. Reprinted 
with permission from Ref. 20. 
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1.4. Applications of heteroleptic Ir(III) complexes in PDT 
To date, high quantum yields for triplet excited state formation and long-lived triplet 
excited states for efficient ROS generation even if under hypoxia have been reported for some 
Ir(III) complexes. Meanwhile, Ir(III) complexes were found to be specifically localized in 
mitochondria, lysosomes, endoplasmic reticulum, or nuclei in a variety of the cancer cell lines. 
More interestingly, due to their luminescence properties, these Ir(III) complexes can also be 
utilized as biomolecular probes and cellular imaging reagents. 
Because of these fascinating photophysical properties, Ir(III) complexes were explored as 
photosensitizers for PDT. To date, a variety of cyclometalated Ir(III) complexes were reported to 
exhibit high singlet oxygen generation efficiency and organelle-targeting ability.62–65  For the 
examples of cyclometalated Ir(III) complexes shown in Chart 1.5, their photophysical and 
biological properties can be substantially tuned by the peripheral ligands, which will be discussed 
below. 
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Chart 1.5. Selected examples of cyclometalated iridium(III) complexes for phototherapeutic 
studies. 
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Lo et al. developed several phosphorescent water-soluble Ir(III) complexes (Ir51 – Ir55), 
in which photophysical and photochemical characteristics were adjusted through altering the 
cyclometalating ligands.62 The attachment of PEG chains could help to minimize the cytotoxicity 
in the dark due to the decreased unfavorable interactions between PSs and biomolecules. The 
observed emission wavelengths ranged from green to orange-red due to the varied energy levels 
of the emitting states. The short-lived 3CT state and long-lived 3IL state were found to be the lowest 
triplet excited states for Ir51 – Ir53 and Ir54 – Ir55, respectively. Therefore, the quantum yield 
of 1O2 generation increased following Ir51 < Ir52 < Ir53 < Ir55 < Ir54, which is dependent on 
the triplet excited-state lifetimes of these complexes. All regents showed very low dark toxicity 
toward HeLa cells, indicating these PEG-based PSs were noncytotoxic in the dark. Their IC50 
values upon 365 nm light irradiation were in the range of 3.4 to 23.2 M. 
To red-shift the ground-state absorption and meanwhile keep a long-lived triplet excited 
state, our group reported six Ir(III) complexes (Ir56 – Ir61) with different -conjugation lengths 
on both the N^N and the C^N ligands as PSs for PDT.63 Red-shifted ground-state absorption and 
prolonged triplet excited states were observed in Ir59 – Ir61 via extending the -conjugation on 
the C^N ligands. In complexes Ir56 – Ir58, benzannulation at the N^N ligands did not alter the 
lowest ground-state absortion bands but significantly prolonded the lowest triplet excited state. 
Without light activation, Ir56 – Ir58 were accumulated on the membrane, whereas Ir59 – Ir61 
localized on the whole cancer cell. Among them, Ir61 presented the largest phototherapeutic 
indices (PI) toward SK-MEL-28 (Dark IC50: 144 ± 56.9 M, Vis IC50: 0.354 ± 0.066 M, PI = 
407) and HL60 (Dark IC50: 83.9 ± 1.40M , Vis IC50: 0.588 ± 0.052 M, PI = 143) cell lines upon 
broadband visible light (400-700 nm) activation. Such a high photosensitization efﬁciency of Ir57 
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can be attributed to its broad absorption from the visible to the NIR region and its extremely long-
lived 3,*-based lowest triplet excited states. 
To further red-shift the ground-state absorption to the far-red or NIR regions, Zhao and 
coworkers64 designed four cyclometalated Ir(III) complexes (Ir62 – Ir65) with a 
monostyryl/distyryl-substituted BODIPY motif attached to the 2,2′-bipyridine ligand. All 
complexes showed strong absorption in the regions of 644–729 nm. Owing to a stronger electron-
donating ability of the dimethylamino group at the BODIPY (Ir64 and Ir65) motif, NIR absorption 
bands were observed in Ir64 and Ir65. These complexes were found to possess very long-lived 
BODIPY-based 3,* states,i.e. 106.6 s for Ir62, 156.5 s for Ir63, 92.5 s for Ir64, and 31.4 
s for Ir65, which parrelleled their singlet oxygen generation efficiencies, i.e. 0.53 for Ir62, 0.81 
for Ir63, 0.06 for Ir64, and 0.02 for Ir65.  However, their in vitro PDT effects were marginal due 
to the high dark toxicity (IC50 = 8.16 - 16.70 M toward 1121 or LLC cell lines) and small PI 
values (1.3-3.8). 
Recently, our group developed a family of tricationic heteroleptic Ir(III) complexes (Ir66 
– Ir71) incorporating tris-diimine ligands.65 All complexes possessed two phenanthroline (phen) 
ligands and one R-phen ligand (R = H, phenyl, pyrenyl, phenylethynyl). With the increased π-
conjugation of the R substituent, the triplet lifeitmes of Ir68 and Ir70 became much longer (>30 
s). The singlet oxygen generation quantum yields for Ir68 and Ir70 were 81% and 72%, 
respectively. Their PIs toward SK-MEL-28 cells were 248 (Dark IC50: 67.0 ± 0.9 M, Vis IC50: 
0.27 ± 0.01 M) for Ir68 and >435 (Dark IC50: >300 M, Vis IC50: 0.69 ± 0.01 M) for Ir70. 
Three cyclometalated Ir(III) complexes (Ir72 – Ir74) containing N-heterocyclic carbene 
(NHC) ligands were reported by Mao and coworkers, which were used as mitochondria-targeting 
PSs for PDT study.66 Different alkyl substituents were attached on the N1 position of the NHC 
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ligand (methyl for Ir72, ethyl for Ir73, and propyl for Ir74). All complexes exhibited weak charge-
transfer absorption bands at >360 nm, which are attributed to the 1,3MLCT transitions. The 1O2 
generation capability of these complexes decreased in the following order: Ir74 ( = 0.62) > Ir73 
( = 0.59) > Ir72 ( = 0.58). In view of the anticancer activities, these Ir(III) complexes 
exhibited much higher cytotoxicity upon irradiation at 365 nm toward different cell lines, including 
HeLa, MCF-7, A549, A549R, HepG2, and LO2, which are better than cisplatin. The mitochondrial 
damage in HeLa cells was confirmed for Ir72 – Ir74 upon irradiation. Notably, PI value of Ir74 
against A549R cells is up to 3488 (Dark IC50: 3.0 ± 0.2 M, Vis IC50: 0.00086 ± 0.00002 M). 
However, these complexes can only be activated by the UV light, which prevents their potential 
applications as PDT reagents. 
 
1.5. Synthesis of Ir(III) complexes 
Generally, it is relatively challenging to carry out a coordination reaction on Ir(III) because 
of its inertness. Compared to the Ru(II) complexes, harsher reaction conditions are required for 
formation of Ir(III) complexes. To activate the metal center, a variety of methods have been 
explored for coordination of the Ir(III) ion. One feasible method is adding silver salts, such as 
AgOTf, AgNO3, and Ag2O, to remove the chloride and enhance the coordination activity of the 
center metal. Another commonly used method is increasing the reaction temperature for the 
coordination reaction. In this dissertation, the employed synthetic procedures for the tris−bidentate 
cyclometalated Ir(III) complexes and the bis−terdentate Ir(III) complexes are presented in Chart 
1.6 and Chart 1.7, respectively.50,38 
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Chart 1.6. General synthesis route for tris−bidentate cyclometalated Ir(III) complexes. 
 
For the synthesis of tris−bidentate cyclometalated Ir(III) complexes bearing N^N or 
N−heterocyclic carbene (NHC) ligands, the dinuclear [Ir(ppy)2(µ−Cl)]2 intermediates were first 
prepared by using Ir(III) chloride hydrate and two equivalents of cyclometalating ligands in the 
mixture of 2−ethoxyethanol and water (v/v = 3/1) under reflux for 24 hours. Then, the obtained 
dinuclear complex precursor was treated with two equivalence of N^N (or NHC) ligand in a mixed 
solvent of CH2Cl2 and methanol (v/v = 3/1) for the N^N ligand or 1,2−dichlrorethane for the NHC 
ligand to afford the target cyclometalated cationic (or neutral) Ir(III) complexes. To reduce the 
formation of by−products, these two−step reactions should be protected from light and oxygen. 
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Chart 1.7. General synthesis route for bis−tridentate Ir(III) complexes. 
 
The synthesis of bis−terdentate Ir(III) complexes is illustrated in Chart 1.7.47,59,60,61 In this 
procedure, tpy was treated with Ir(III) chloride hydrate in ethylene glycol for 30 min at 160 oC in 
dark to afford tpy−IrCl3 as the intermediate. To obtain the Ir(tpy)23+ based complexes, tpy−IrCl3 
reacts with another tpy ligands in ethylene glycol under reflux for 1 hour under N2 atmosphere and 
avoid light. In contrast, synthesis of the other two types of bis−terdentate Ir(III) complexes, i.e. 
(C^N^N)Irtpy2+ and (C^N^C)Irtpy+ needs harsher reaction conditions, which involves Ag+ 
catalyst and longer reaction times, due to the poorer coordination ability of carbon. For the ( 
N^C^N)Irtpy2+ complexes, however, 1,3−di(pyrid-2-yl)benzene should first react with iridium 
trichloride hydrate in mixed solvent of 2−ethoxyethanol and water (v/v = 3/1) to form a 
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[Ir(dpyb)Cl(µ−Cl)]2 as the reactive dimer. The subsequent reaction involved the dimer and tpy 
ligand in refluxed ethylene glycol for 1 h, which was similar to the synthesis of Ir(tpy)2
3+. Similar 
to the synthesis of tris−bidentate complexes, these two−step reactions need to be carried out under 
noble gas atmosphere without direct light exposure.  
 
1.6. Designing criteria for reverse saturable absorbers 
In the past two decades, our group has been focusing on develop Ir(III) complexes for RSA 
based optical limiting applications. To effectively decrease the transmittance of lasers at high 
intensity, complexes with suitable photophysical properties are required. Generally, to optimize 
the RSA strength, these complexes need a large ratio of ESA cross section (σex) relative to that of 
the ground state (σ0). To augment the σex/σ0 values, a low intensity of ground−state absorption (not 
zero) but strong ESA at the interested wavelengths is desired. Meanwhile, long−lived 
excited−states capable of undergoing a long−time light absorption before decay to its ground state, 
is another desired preliminary property. Based on the discussion in the previous sections, Ir(III) 
complexes hold spin−allowed ligand−centered 1π,π* transitions with high intensity in the UV 
spectral region and 1MLCT/1LLCT transitions with low intensity in the visible spectral region. To 
increase the RSA strength over a broad spectral region, expanding the weakly absorptive 1CT 
bands is our ultimate interest. 
In view of the metal center, the ligand field strength of transition metal partially dominates 
its excited−state properties, which increases from the first−row to the third−row metals. Generally, 
the first−row transition metal complexes commonly possess a short−lived triplet excited state due 
to the readily accessible non−radiative d,d state. As a third−row transition metal, a long−lived 
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excited state was obtained for most of the Ir(III) complexes, in which d,d state is elevated to a 
higher energy. Herein, RSA are expected for Ir(III) complexes incorporating appropriate ligands. 
 
1.7. Designing criteria for photosensitizer in PDT research 
The application of PDT to cancers mainly depends on the development of more effective 
PSs. To date, developing new PSs with tumor−specific targeting, strong absorption in the NIR 
region, long−lived triplet excited state, and high ROS production efficiency in hypoxia still 
remains to be a challenge. In general, several clinically relevant criteria need to be considered for 
designing new PSs.42  
(1) Toxicity. An appropriate PS should be capable of efficient 1O2 and/or ROS generation 
upon light irradiation at an appropriate wavelength, namely it should be highly phototoxic. 
Meanwhile, it should be non−toxic or have low toxicity without light activation. The photo− and 
dark−toxicities are closely related to the structures of PSs. 
(2) Amphiphilicity. PSs with good water−solubility travel human body easily. To meet this 
requirement, compounds with multiple charges and/or hydrophilic moieties are desired. On the 
other hand, a PS needs to pass the cell membrane to enter the cell, which requires some 
lipophilicity. Therefore, an suitable PS should be amphiphilic.  
(3) Penetration depths. In biological tissues, penetration of the light is proportional to its 
wavelength. For instance, the penetration depth for light at a wavelength of 400 nm is 1 mm; 
whereas, light at a wavelength of 630 nm results in about 10 mm depth. To utilize PDT for the 
treatment of deep−seated tumors, red− (or NIR−) light activatable PSs are desired. By using 
dyes−tethered molecules, the absorption wavelength of PSs can be tuned to the desired spectral 
region. 
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(4) T1 state. Long−lived T1 state with an appropriate energy level and a high quantum yield 
of formation is the most important feature for an PS to effectively convert photon energy into 1O2 
and/or ROS. For the development of Ir(III) complex PSs, * nature for the T1 state yields long 
T1 lifetime, which can be realized by tethering -conjugated organic chromophores to the Ir(III) 
complex or extending the −conjugation for the ligands.  
(5) Targetability. Accumulation of PSs on tumors rather than normal tissues, and specific 
targeting of certain organelles inside of cancer cells, such as mitochondria, lysosomes, and nuclei, 
are beneficial to improve the PDT efficiency and reduce the side effects.  
(6) Cost. An effective PS at a reasonable cost will help the treatment of cancer patients. 
With all of the aforementioned criteria in mind, new PS design should fulfill as many of 
them as possible with the understanding that  some compromises need to be made at times. 
 
1.8. Objectives of my dissertation 
By design and synthesis of Ir(III) complexes with different types of ligands , three major 
goals are anticipated to be realized in this dissertation: (1) To establish a structure-property 
correlation via modification of the ligand -conjugation and/or attaching -conjugated organic 
chromophores to the core ligands. To realize this goal, spectroscopic measurement, such as the 
UV−vis absorption, emission, and transient absorption studies, and computational simulation of 
the optical spectra for the synthesized complexes were carried out; (2) Optimizing the RSA 
strength of the Ir(III) complexes at 532 nm and developing some broadband reverse saturable 
absorbers; (3) Developing red or NIR absorbing PSs with optimized triplet excited-state properties 
for theranostic PDT applications. To fulfill these objectives, six series of Ir(III) complexes bearing 
a variety of N^N or C^N ligands were synthesized and investigated: 
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(1) Tuning the Ground State and Excited State Properties of Monocationic Iridium(III) 
Complexes by Varying the Site of Benzannulation on Diimine Ligand. 
(2) Impact of Benzannulation Site at the Diimine (N^N) Ligand on the Photophysics and 
Reverse Saturable Absorption of Cyclometalated Monocationic Iridium(III) Complexes. 
(3) Effects of Varying the Benzannulation Site and π−Conjugation of Cyclometalating 
Ligand on Photophysics and Reverse Saturable Absorption of Monocationic Iridium(III) 
Complexes. 
(4) Monocationic Iridium(III) Complexes with Far−Red Charge Transfer Absorption and 
Near−IR Emission: Synthesis, Photophysics, and Reverse Saturable Absorption. 
(5) Photophysical and Photobiological Properties of Dinuclear Iridium(III) Bis−tridentate 
Complexes. 
(6) Neutral Iridium(III) Complexes Bearing BODIPY−Substituted N−Heterocyclic 
Carbene (NHC) Ligands: Synthesis, Photophysics, and Photobiological Activities. 
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2. TUNING THE GROUND STATE AND EXCITED STATE PROPERTIES OF MONO–
CATIONIC IRIDIUM(III) COMPLEXES BY VARYING THE SITE OF 
BENZANNULATON ON DIIMINE LIGAND 
 
2.1. Introduction 
In the last two decades, octahedral d6 Ir(III) complexes have attracted extensive interest 
due to the strong spin–orbit coupling induced by the Ir(III) ion, which increases the triplet excited–
state quantum yield and induces strong phosphorescence in fluid solutions at room temperature.1-
3 Many of the research has focused on monocationic iridium(III) complexes because of the facile 
synthesis of these complexes under mild reaction condition and the vast amount of choices for the 
diimine (N^N) and the cyclometalating (C^N) ligands.4-6 The interesting electronic absorption and 
emission properties of the Ir(III) complexes make them attractive candidates for applications in 
organic light emitting diodes (OLEDs), solar energy conversion, luminescent biological labeling, 
etc.7-9 
It has been well understood that the absorption and emission characteristics of the 
monocationic iridium complexes can be readily tuned by modification of the N^N and/or C^N 
ligands.10-12 Extensive electrochemical and/or computational studies show that the lowest 
unoccupied molecular orbital (LUMO) of these Ir(III) complexes is typically located on the N^N 
ligand; while the highest occupied molecular orbital (HOMO) is delocalized on the C^N ligands 
and the d–orbital of the Ir(III) center.13-15 Thus electron–donating or withdrawing substituents on 
the N^N ligand could lead to hypsochromic or bathochromic shifts of the lowest–energy charge 
transfer transition by destabilization or stabilization of LUMO.16 On the other hand, introducing 
π–conjugated substituents on the N^N ligand could alter the nature of the lowest triplet excited 
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state (T1 state).17-20 Bryce’s group,17 Schanze’s group,18 and our group19,20 had discovered that 
extending the π–conjugation of the N^N ligand via incorporating π–conjugated substituents 
admixed the N^N ligand localized 3π,π* character with the 3CT (charge transfer) characters in the 
T1 state of the Ir(III) complexes, or even switched the T1 state from the 3CT state to the 3π,π* state. 
This change increased the T1 lifetime and enhanced the triplet excited–state absorption drastically. 
Another commonly used approach to extend the π–conjugation of the ligand is 
benzannulation. It has been found, however, that benzannulation could cause either blue or red 
shifts of the absorption and / or emission bands depending on the site of benzannulation.21-30 
Although this phenomenon was mostly observed in various small organic molecules,21–24 it has 
been rarely reported in organometallic complexes.25–30 Thompson and Gordon groups discovered 
this phenomenon in a series of (N^N^N)PtCl complexes (N^N^N = 2,5–bis(2–
pyridylimino)pyrrolate and its benzannulated analogs) and explained this unusual behavior via 
molecular orbital theory.25 Balzani’s group and Turro’s group revealed the blue shifted absorption 
or emission bands of Ru(II) complexes when benzannulation occurred at the 4,5–position of the 
bipyridine ligand27 or fusion aromatic ring(s) at the 5,6–position of the phenanthroline ligand.28 In 
contrast, benzannulation at either the 3,4– or 5,6–position of the bipyridine ligand in Ir(III) 
complexes caused red shifts of the lowest energy absorption band and the emission band in 
comparison to the nonbenzannulated complex.29,30 
To understand whether the site–selective blue or red–shifts upon benzannulation of the 
N^N ligand is a general feature that could occur in other transition–metal complexes, we designed 
and synthesized a series of monocationic Ir(III) complexes (Chart 2.1). These complexes all feature 
1,2–diphenyl–9H–pyreno[4,5–d]imidazole (dppi) as the C^N ligands, but the N^N ligands contain 
varied degrees of π–conjugation via benzannulation at different positions of 2–(pyridin–2–
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yl)quinoline. Dppi was chosen as the C^N ligand because previous work demonstrated that Ir(III) 
complexes bearing this ligand had dramatically long triplet excited–state lifetimes31,32 and broad 
excited–state absorption,31 which is a desirable feature for reverse saturable absorbers19,20,31 and 
triplet photosensitizers for triplet–triplet annihilation upconversion.32 
 
Chart 2.1.  Structures of complexes 2-1 – 2-6. 
 
2.2. Experimental section 
2.2.1. Materials and synthesis 
All solvents and reagents were obtained from Aldrich or Alfa-Aesar and used as received 
without further purification unless otherwise stated. Silica gels (230−400 mesh) and Al2O3 gels 
(activated, neutral, Brockmann I) for column chromatography were obtained from Sorbent 
Technology and Aldrich, respectively. The diimine ligand 2,2'-bisquinoline (L2-3) was obtained 
from Alfa-Aesar. Ligands 2-(pyridin-2-yl)quinoline (L2-1) and 2-(pyridin-2-
yl)[7,8]benzoquinoline (L2-2) were synthesized according to the reported procedures.33,35 The 
other diimine ligands 2-(quinolin-2-yl)[7,8]benzoquinoline (L2-4), 2-(pyridin-2-
yl)[6,7]benzoquinoline (L2-5), and 2-(quinolin-2-yl)[6,7]benzoquinoline (L2-6) were prepared by 
Friedlӓnder Reaction. The C^N ligand dppi and its Ir(III) dimer [Ir(dppi)2Cl]2 were synthesized 
following the literature procedures.32 Complexes 2-1 – 2-6 were synthesized by reaction of the 
[Ir(dppi)2Cl]2 dimer and the corresponding N^N ligand in refluxed CH2Cl2/CH3OH in the presence 
of AgSO3CF3 to abstract chloride from the [Ir(dppi)2Cl]2 dimer to move the reaction forward.32 
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The Ir(III) complexes 2-1 – 2-6 were characterized by 1H NMR, ESI-HRMS and elemental 
analyses. A Varian Oxford-400 or Oxford-500 VNMR spectrometer was used to record the 1H 
NMR spectra. ESI−HRMS analyses were conducted on a Bruker BioTOF III mass spectrometer. 
NuMega Resonance Laboratories, Inc. in San Diego, California carried out the elemental analyses. 
 
Scheme 2.1. Synthetic routes for ligands L2-4 – L2-6 and complexes 2-1 – 2-6. 
 
Ligand L2-4. To a solution of 2-acetylquinoline (500 mg, 4.0 mmol) and 1-
aminonaphthalene-2-carboxaldehyde (500 mg, 4.0 mmol) in absolute EtOH (50 mL) was added 
saturated ethanolic KOH (2 mL). The solution was refluxed under Ar for 24 h. After removal of 
the solvent, the residue was purified by column chromatography on silica gel, eluted with 
CH2Cl2/hexanes (1:5, v/v), to provide L2-4 (580 mg, 65%) as yellow solid. 
1H NMR (400 MHz, 
CDCl3) δ 9.58 (d, J = 8.1 Hz, 1H), 9.11 (d, J = 8.6 Hz, 1H), 9.01 (d, J = 8.4 Hz, 1H), 8.40 (t, J = 
8.2 Hz, 2H), 8.27 (d, J = 8.5 Hz, 1H), 8.06 – 7.68 (m, 7H), 7.66 – 7.57 (m, 1H). 
Ligand L2-5. To a solution of 2-acetylpyridine (70 mg, 0.58 mmol) and 3-
aminonaphthalene- 2-carboxaldehyde (100 mg, 0.58 mmol) in absolute EtOH (50 mL) was added 
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saturated ethanolic KOH (2 mL). The solution was refluxed under Ar for 24h. After the solvent 
was removed, the residue was purified by column chromatography on alumina gel, eluted with 
CH2Cl2/hexanes (1:9, v/v), to provide L2-5 (57 mg, 38%) as yellow powder. 
1H NMR (400 MHz, 
CDCl3) δ 8.74 (dd, J = 11.9, 7.1 Hz, 3H), 8.55 (d, J = 8.9 Hz, 1H), 8.47 – 8.37 (m, 2H), 8.09 (d, J 
= 9.7 Hz, 1H), 8.03 (d, J = 9.6 Hz, 1H), 7.89 (t, J = 6.8 Hz, 1H), 7.57 – 7.46 (m, 2H), 7.40 – 7.34 
(m, 1H). 
Ligand L2-6. To a solution of 2-acetylquinoline (60 mg, 0.35 mmol) and 3-
aminonaphthalene- 2-carboxaldehyde (60 mg, 0.35 mmol) in absolute EtOH (50 mL) was added 
saturated ethanolic KOH (2 mL). The solution was refluxed under Ar for 24h. After removal of 
the solvent, the residue was purified by column chromatography on alumina gel, eluted with 
CH2Cl2/hexanes (1:3, v/v), to provide L2-6 (58 mg, 54%) as yellow powder. 
1H NMR (400 MHz, 
CDCl3) δ 8.91 (d, J = 8.6 Hz, 1H), 8.87 – 8.79 (m, 2H), 8.47 (d, J = 8.6 Hz, 1H), 8.44 (s, 1H), 8.34 
(d, J = 8.7 Hz, 1H), 8.23 (d, J = 8.3 Hz, 1H), 8.14 – 8.08 (m, 1H), 8.04 (ddd, J = 7.0, 2.6, 0.9 Hz, 
1H), 7.91 – 7.85 (m, 1H), 7.75 (ddd, J = 8.4, 6.8, 1.4 Hz, 1H), 7.62 – 7.55 (m, 1H), 7.55 – 7.48 
(m, 2H). 
General Procedure for the Synthesis of 2-1 – 2-6.  The [Ir(dppi)2Cl]2 dimer (0.03 mmol), 
diimine ligand (0.06 mmol) and AgSO3CF3 (0.06 mmol) were added into the mixed solvent 
(CH2Cl2:MeOH = 2:1 (v/v), 45 mL) and the reaction mixture was degassed and heated to reflux 
for 24 h. The solution was cooled to room temperature and NH4PF6 (0.3 mmol) was added to stir 
at r.t. for 2 h. After removal of the solvent, the residue was purified by column chromatography 
on neutral alumina gel, eluted with CH2Cl2/hexane (3:1 - 1:0, v/v), followed by recrystallization 
from dichloromethane and hexanes. 
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Complex 2-1. A red powder (51 mg) was obtained as the product (yield: 74%). 1H NMR 
(CDCl3, 400 MHz): δ 8.84 (d, J = 7.1 Hz, 1H), 8.42 (d, J = 4.8 Hz, 1H), 8.15 – 7.64 (m, 22H), 7.63 
– 7.52 (m, 3H), 7.38 (d, J = 7.7 Hz, 2H), 7.25 (s, 1H), 7.14 – 7.00 (m, 4H), 6.88 – 6.76 (m, 3H), 
6.74 – 6.66 (m, 2H), 6.57 (dd, J = 12.7, 7.0 Hz, 3H), 6.34 (d, J = 7.9 Hz, 1H), 6.22 (t, J = 7.9 Hz, 
1H). ESI-HRMS (m/z): calcd. for [C72H44N6Ir]
+, 1185.3263; found, 1185.3329. Anal. Calcd. for 
C72H44N6IrPF6.0.6CH2Cl2.1.7C6H14: C, 65.09; H, 4.55; N, 5.50. Found: C, 64.93; H, 4.69; N, 5.82. 
Complex 2-2. An orange powder (46 mg) was obtained as the product (yield: 66%).  1H 
NMR (CDCl3, 400 MHz): δ 9.52 (d, J = 7.4 Hz, 1H), 9.05 (d, J = 8.9 Hz, 1H), 8.59 (d, J = 4.2 Hz, 
1H), 8.26 – 7.88 (m, 13H), 7.87 – 7.78 (m, 1H), 7.78 – 7.51 (m, 8H), 7.37 (d, J = 8.7 Hz, 1H), 7.24 
(d, J = 12.9 Hz, 2H), 7.15 (t, J = 7.7 Hz, 1H), 7.07 – 7.00 (m, 2H), 6.97 (d, J = 8.1 Hz, 1H), 6.88 
(dd, J = 16.8, 8.1 Hz, 2H), 6.78 (d, J = 7.8 Hz, 2H), 6.73 – 6.54 (m, 4H), 6.47 (d, J = 8.0 Hz, 1H), 
6.19 – 6.09 (m, 2H), 6.04 (d, J = 7.6 Hz, 2H), 5.35 (d, J = 6.7 Hz, 1H). ESI-HRMS (m/z): calcd. 
for [C76H46N6Ir]
+, 1235.3420; found, 1235.3466. Anal. Calcd. for C76H46N6IrPF6.H2O: C, 65.27; 
H, 3.46; N, 6.01. Found: C, 64.93; H, 3.23; N, 6.18. 
Complex 2-3. A red powder (42 mg) was obtained as the product (yield: 60%). 1H NMR 
(CDCl3, 400 MHz): δ 8.44 (d, J = 8.5 Hz, 2H), 8.19 (d, J = 7.7 Hz, 2H), 8.04 (d, J = 7.8 Hz, 4H), 
7.94 (dd, J = 17.0, 8.5 Hz, 4H), 7.88 – 7.66 (m, 12H), 7.64 – 7.55 (m, 4H), 7.45 (t, J = 7.4 Hz, 
2H), 7.16 (d, J = 7.9 Hz, 2H), 7.03 – 6.85 (m, 6H), 6.72 (td, J = 7.6, 1.1 Hz, 2H), 6.62 – 6.52 (m, 
2H), 6.25 (t, J = 7.8 Hz, 2H), 6.17 – 6.08 (m, 2H). ESI-HRMS (m/z): calcd. for [C76H46N6Ir]+, 
1235.3420; found, 1235.3453. Anal. Calcd. for C76H46N6IrPF6: C, 66.13; H, 3.36; N, 6.09. Found: 
C, 65.76; H, 3.69; N, 5.96. 
Complex 2-4. A red powder (44 mg) was obtained as the product (yield: 60%). 1H NMR 
(CDCl3, 400 MHz): δ 9.16 (d, J = 7.2 Hz, 1H), 9.05 (d, J = 8.1 Hz, 1H), 8.46-8.43 (m, 2H), 8.27-
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8.23 (m, 1H), 8.17 (dd, J = 7.6, 4.4 Hz, 2H), 8.12-8.00 (m, 4H), 7.98-7.77 (m, 9H), 7.71 (t, J = 8.0 
Hz, 2H), 7.64-7.54 (m, 4H), 7.40 (d, J = 7.6 Hz, 1H), 7.29-7.20 (m, 3H), 7.19-7.16 (m, 5H), 7.11 
(d, J = 7.6 Hz, 1H), 6.98-7.91 (m, 3H), 6.72-6.71 (m, 2H), 6.62 (td, J = 8.0, 1.2 Hz, 1H) , 6.47 (d, 
J = 7.8 Hz, 1H), 6.27 (t, J = 7.6 Hz, 1H), 6.15 (t, J = 7.7 Hz, 1H), 6.05 (t, J = 7.6 Hz, 1H), 5.94 (t, 
J = 7.6 Hz, 1H), 5.33 (dd, J = 7.9, 1.0 Hz, 1H). ESI-HRMS (m/z): calcd. for [C80H48N6Ir]
+ , 
1285.3578; found, 1285.3622. Anal. Calcd. for C80H48N6IrPF6: C,67.17; H, 3.38; N, 5.88. Found: 
C, 66.95; H, 3.20; N, 5.83. 
Complex 2-5. A dark red powder (43 mg) was obtained as the product (yield: 50%). 1H 
NMR (CDCl3, 400 MHz): δ 9.18 (d, J = 7.9 Hz, 1H), 8.69 (s, 1H), 8.53 (d, J = 4.7 Hz, 1H), 8.37 
(s, 1H), 8.14 – 7.85 (m, 14H), 7.82 (d, J = 8.8 Hz, 1H), 7.78 – 7.72 (m, 1H), 7.72 – 7.59 (m, 5H), 
7.49 (ddd, J = 19.6, 16.1, 6.9 Hz, 4H), 7.37 (dd, J = 10.7, 8.7 Hz, 2H), 7.21 (d, J = 7.1 Hz, 1H), 
7.18 – 7.13 (m, 1H), 7.09 – 6.84 (m, 6H), 6.84 – 6.74 (m, 3H), 6.65 – 6.59 (m, 1H), 6.23 (d, J = 
6.8 Hz, 1H), 6.02 (t, J = 7.8 Hz, 1H), 5.37 (d, J = 7.5 Hz, 1H). ESI-HRMS (m/z): calcd. for 
[C76H46N6Ir]
+, 1235.3420; found, 1235.3389. Anal. Calcd. for C76H46N6IrPF6.0.7CH2Cl2
.0.2C6H14: 
C, 64.21; H, 3.47; N, 5.77. Found: C, 63.88; H, 3.84; N, 6.20. 
Complex 2-6. A brown powder (51 mg) was obtained as the product (yield: 61%). 1H NMR 
(CDCl3, 400 MHz): δ 8.93 (s, 1H), 8.55 (s, 1H), 8.41 (dd, J = 13.3, 7.9 Hz, 2H), 8.32 (d, J = 7.0 
Hz, 1H), 8.26 (d, J = 8.6 Hz, 1H), 8.14 – 8.04 (m, 3H), 7.97 (dt, J = 18.2, 8.8 Hz, 6H), 7.88 – 7.68 
(m, 6H), 7.68 – 7.58 (m, 6H), 7.56 (d, J = 9.0 Hz, 2H), 7.52 – 7.40 (m, 2H), 7.34 (d, J = 7.2 Hz, 
1H), 7.30 (d, J = 8.2 Hz, 2H), 7.18 (d, J = 7.4 Hz, 1H), 7.11 (d, J = 7.3 Hz, 1H), 6.81 (ddd, J = 
13.7, 8.9, 5.2 Hz, 5H), 6.63 – 6.49 (m, 3H), 6.41 (t, J = 7.9 Hz, 1H), 6.06 (t, J = 7.8 Hz, 2H), 5.98 
(d, J = 8.9 Hz, 1H). ESI-HRMS (m/z): calcd. for [C80H48N6Ir]
+, 1285.3578; found, 1285.3577. 
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Anal. Calcd. for C80H48N6IrPF6.0.8CH2Cl2
.0.1C6H14: C, 64.87; H, 3.41; N, 5.58. Found: C, 64.60; 
H, 3.76; N, 5.68. 
 
2.2.2. Photophysical studies 
The UV−vis absorption spectra of complexes 2-1 – 2-6 were recorded using a Cary 50 
spectrophotometer in a 1-cm quartz cuvette. The emission spectra of 2-1 – 2-4 were measured on 
a HORIBA FluoroMax 4 fluorometer/phosphorometer. The spectra of 2-5 and 2-6 were detected 
with an InGaAs detector from 670 nm to 1225 nm (λex = 473 nm) with a 500 nm long pass filter. 
The emission quantum yields were obtained using the relative actinometry method in degassed 
solutions.56 The reference used for complexes 2-1 – 2-4 was a degassed acetonitrile solution of 
[Ru(bpy)3]Cl2 (Φem = 0.097, λex = 436 nm).57 For complexes 2-5 and 2-6, IR26 (Φem = 0.0005)58 
was used as the reference. The quantum yield reported for 2-5 and 2-6 are only for the emission in 
the region of 700-850 nm detected by the Hamamatsu Photomultiplier tube (PMT) R928. 
Acetonitrile solution of [Ru(bpy)3]Cl2 was used as the reference in this case. 
The ns transient absorption (TA) measurements (TA spectra, triplet lifetimes and quantum 
yields) were conducted on a laser flash photolysis spectrometer (Edinburgh LP920) excited by the 
third-harmonic output (355 nm) of a Quantel Brilliant Nd:YAG laser with a pulse duration of 4.1 
ns and a repetition rate of 1 Hz. Before measurement, all sample solutions were purged with Ar 
for 30 min. The triplet excited-state molar extinction coefficients (εT) were determined by the 
singlet depletion method.55 After the εT value was obtained, the triplet excited-state quantum yield 
was calculated via the relative actinometry,54 using SiNc in benzene as the reference (ε590 = 70,000 
M−1 cm−1, ΦT = 0.20).59 
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2.2.3. Computational methods  
Gaussian 09 quantum computing software package60 was implemented for all calculations, 
i.e. geometry optimization and the electronic structure for ground and excited states. Density 
functional theory (DFT) and time-dependent DFT (TDDFT) was implemented using the functional 
PBE1PBE61 with mixed basis set LANL2DZ for Ir ion62 and 6-31G* for light elements (H, C and 
N).63-64 Similar methodologies have been proven to successfully describe structural and optical 
properties of various Ir(III) complexes.17,20,30,31,39,65-67 Additionally, the solvent effect was 
implicitly included by Conductor Polarized Continuum Model (CPCM)68,69 for both 
dichloromethane and acetonitrile. Absorption spectrums were obtained using the TDDFT with the 
same functional and basis set specified above. The lowest 100 transitions were calculated and then 
broadened using the Gaussian function with line-width of σ = 0.1 eV in order to reproduce the 
thermal broadening correlated with the experimental absorption spectra.  
To theoretically investigate the nature of the emitting state for each complex, two 
approaches were used. The first method is the SCF,70,71 where the phosphorescence energies are 
found by taking the differences between the total energies at the triplet and singlet spin 
configurations of the complexes. The second method used is a modification of the SCF, where 
the energies are found from TDDFT using the ground state geometry at the triplet spin 
configuration. Both methods provide qualitative agreement in phosphorescence energies. 
Additionally, TDDFT-based SCF provides natural transition orbitals38 (NTOs) used for analysis 
of the excited state character. To characterize the electronic transitions contributing to absorption 
and emission, NTOs were calculated using Gaussian 09 and visualized using GaussView 5.09 
graphical software72 with isovaule of 0.02. 
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2.2.4. Electrochemical measurements 
The redox potentials of 2-1 − 2-6 were measured by cyclic voltammetry on a Pine 
WaveDriver potentiostat/galvanostat voltammetric analyzer in 110-3 M anhydrous acetonitrile 
solutions with a scan rate of 50 mV/s. The electrolytic cell used a platinum plate as the working 
electrode, Ag/AgCl as the reference electrode, and a platinum wire as the counter electrode. The 
supporting electrolyte was a 0.1 M solution of tetrabutylammonium hexafluorophosphate 
(TBAPF6). The electrochemical potentials were recorded in volts against the Ag/AgCl reference 
electrode with the ferrocenium/ferrocene (Fc+/Fc) couple as the internal standard. The reported 
redox potentials were calculated against the Fc+/Fc couple. The solution was deaerated with 
prepurified argon gas for 15 min before each measurement. 
 
2.3. Results and discussion 
2.3.1. Electronic absorption 
The UV−vis absorption spectra of complexes 2-1 – 2-6 were recorded in CH2Cl2 and are 
shown in Figure 2.1. The absorption band maxima and molar extinction coefficients are compiled 
in Table 2.1. The strong absorption bands with large extinction coefficients at wavelengths shorter 
than 430 nm are assigned to dppi and N^N ligands spin–allowed intraligand (IL) 1π,π* transitions. 
The tails in the region of 430 – 700 nm are attributed to 1,3MLCT (metal–to–ligand charge transfer) 
/ 1,3LLCT (ligand–to–ligand charge transfer) transitions based on the small extinction coefficients 
and the DFT calculation results (see the natural transition orbitals (NTOs)38 in Tables 2.2 and 2.3, 
and discussions in the following paragraphs), which is in line with the reported Ir(III) complexes 
with extended π–conjugated N^N ligand.29,30,39,40 
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Figure 2.1. UV−vis absorption spectra of 2-1 – 2-6 in CH2Cl2. 
 
Table 2.1. Electronic absorption, emission, and triplet excited–state absorption parameters for 
complexes 2-1 − 2-6. 
 λabs /nm (log ε)a λem/nm (τem/μs); emb λT1‑Tn/nm (τTA/μs; log T1‑Tn ; T)c 
2-1 290 (5.12), 340 (4.96), 
406 (4.66), 498 (3.00) 
625 (0.94); 0.13 775 (0.67; 4.85; 0.091) 
2-2 292 (5.20), 339 (4.98), 
401 (4.64), 445 (3.60) 
593 (0.15); 0.017 545 (16.1; 5.24; 0.075) 
2-3 290 (5.15), 344 (5.04), 
405 (4.69), 496 (3.37), 
580 (3.13) 
657 (0.93); 0.12 390 (0.56; 5.01; 0.23) 
2-4 291 (5.25), 328 (5.12), 
384 (4.86), 485 (3.39) 
645 (1.34); 0.085 425 (14.9; 5.17; 0.10) 
2-5 292 (5.20), 309 (5.13), 
357 (4.90), 405 (4.68), 
444 (3.89), 469 (3.48), 
550 (2.89) 
755 (2.21), 845 (–), 
938 (–), 1054 (–); 
0.0017 
665 (2.82; 5.37; 0.027) 
2-6 292 (5.27), 336 (5.07), 
386 (4.81), 402 (4.74), 
480 (3.62), 599 (3.31) 
780 (0.86), 904 (–), 
967 (–), 1087 (–); 
0.0019 
785 (0.87; 5.13; 0.018) 
a Absorption band maxima and molar extinction coefficients of the UV−vis absorption in CH2Cl2 
at room temperature. b Emission band maxima and decay lifetimes in CH2Cl2 at room temperature, 
c = 1 × 10−5 mol/L. The emission characteristics of 2-1 – 2-4 were measured using Hamamatsu 
R928 PMT as the detector, while an InGaAs array was used to measure the emission of 2-5 and 2-
6. The reference used was a degassed CH3CN solution of [Ru(bpy)3]Cl2 (Φem = 0.097, λex = 436 
nm) for 2-1 – 2-4, and IR26 (Φem = 0.0005) for 2-5 and 2-6. c Nanosecond TA band maxima, triplet 
extinction coefficients, triplet excited–state lifetimes, and quantum yields measured in CH3CN at 
room temperature. SiNc in C6H6 was used as the reference. (ε590 = 70,000 L mol−1 cm−1, ΦT = 
0.20). 
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Table 2.2. Natural transition orbitals (NTOs) representing singlet transitions contributing to the 
low-energy absorption bands of complexes 2-1 – 2-6 in CH2Cl2. 
 Sn       Hole   Electron   Hole Electron 
2-1 S1 
527 nm 
f = 0.001 
  
2-4 S1 
545 nm 
f = 0.006 
  
S2 
494 nm 
f = 0.002 
  
S2 
513 nm 
f = 0.017 
  
S3 
440 nm 
f = 0.002 
  
S3 
454 nm 
f = 0.015 
  
2-2 S1 
501 nm 
f = 0.005 
  
2-5 S1 
583 nm 
f = 0.001 
  
S2 
466 nm 
f = 0.007 
  
S2 
542 nm 
f = 0.002 
  
S3 
420 nm 
f = 0.010 
  
S3 
476 nm 
f = 0.004 
  
S4 
401 nm 
f = 0.104 
  
S4 
453 nm 
f = 0.060 
  
2-3 S1 
570 nm 
f = 0.010 
  
2-6 S1 
612 nm 
f = 0.012 
  
S2 
540 nm 
f = 0.019 
  
S2 
581 nm 
f = 0.145 
  
S3 
468 nm 
f = 0.011 
  
S3 
498 nm 
f = 0.267 
  
S4 
425 nm 
f = 0.031 
  
S4 
484 nm 
f = 0.024 
  
 
S5 
420 nm 
f = 0.034   
S5 
444 nm 
f = 0.010 
  
    S6 
439 nm 
f = 0.015 
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Table 2.3. Characterization of molecular orbitals for the first five HOMOs and LUMOs of 
complexes 2-1 – 2-6 in CH2Cl2. 
 2-1 2-2 2-3 2-4 
LUMO+4 π*(C^N) π*(C^N)/d(Ir) π*† π*† 
LUMO+3 π*(C^N-N^N) π*(C^N) π*(C^N) π*(N) 
LUMO+2 π*(C^N) π*(pyr) π*(C^N) π*† 
LUMO+1 π*(C^N) π*† π*(N^N) π*(N^N)/π*(Ph) 
LUMO π*(N^N) π*(N^N) π*(N^N)/ d(Ir) π*(N^N) 
HOMO d(Ir)/ π(C^N) d(Ir)/ π(C^N) d(Ir)/ π(C^N) d(Ir)/ π(C^N) 
HOMO-1 π(C^N)/d(Ir) π(C^N) π(C^N) π(C^N) 
HOMO-2 d(Ir)/ π(C^N) π† d(Ir)/ π(C^N) d(Ir)/ π(C^N) 
HOMO-3 d(Ir)/ π(C^N) π† d(Ir)/ π(C^N) π† 
HOMO-4 d(Ir) / π(C^N) π† d(Ir)/ π(C^N) d(Ir)/ π(C^N) 
 2-5 2-6  
LUMO+4 π*(C^N) π*(N^N) / d(Ir) 
LUMO+3 π*(C^N) π*(C^N) 
LUMO+2 π*(C^N) π*(C^N) 
LUMO+1 π*(C^N-N^N) π*(N^N) 
LUMO π*(N^N) / d(Ir) π*(N^N) / d(Ir) 
HOMO d(Ir)/ π(C^N) π(C^N)/ d(Ir) 
HOMO-1 π(C^N) / d(Ir) π(C^N) 
HOMO-2 d(Ir)/ π(C^N) π(N)/d(Ir)/π(C^N) 
HOMO-3 π(C^N) / d(Ir) d(Ir)/π(C^N)/π(N) 
HOMO-4 π(C^N) / d(Ir) d(Ir)/π(C^N)/π(N) 
 
Examination of the tails at 450–700 nm for complexes 2-1 – 2-6 revealed that 
benzannulation at either the 5’,6’–position of pyridine or the 6,7–position of quinoline of the N^N 
ligand caused red–shifts of the 1,3MLCT / 1,3LLCT transitions and increased the molar extinction 
coefficients (2-3, 2-5, and 2-6 vs. 2-1). In contrast, benzannulation at the 7,8–position of quinoline 
of the N^N ligand induced blue–shifts of the 1,3MLCT / 1,3LLCT transitions in complexes 2-2 and 
2-4 with respect to their corresponding complexes 2-1 and 2-3 (i.e. 2-2 vs. 2-1 and 2-4 vs. 2-3). 
This phenomenon is contrary to the previous findings that expansion of the aromatic π–system led 
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to red–shifts of the absorption band.29,30,41 However, benzannulation at the 5’,6’–position of 
pyridine in complex 2-2 still red–shifted the 1,3MLCT / 1,3LLCT transitions in 2-4. 
To understand the site selective benzannulation effect, DFT calculations were performed 
for 2-1 – 2-6 in CH2Cl2 using Gaussian09 software package and PBE1 functional. The resultant 
ground–state energy diagram for 2-1 – 2-6 is shown in Figure 2.2. The calculated electron density 
distributions of HOMO and LUMO are the same for all six complexes (see the representative 
frontier molecular orbital (FMO) plots for 2-1 in Figure 2.1, and the FMOs for the other complexes 
in Table 2.4), with the HOMO being delocalized on the dppi ligands and the d–orbital of the Ir(III) 
ion and the LUMO being exclusively on the diimine ligand. The optimized geometries of these 
complexes showed that although all complexes adopted similar octahedral geometry around the 
Ir(III) center, the dihedral angles within the N^N ligand are 8–11 degrees larger in 2-2 and 2-4 
compared to the other complexes (Table 2.4) due to the increased steric hindrance from the 
additional phenyl ring fused at the 7,8–position of quinoline upon coordination. The larger 
distortion of the N^N ligand in 2-2 and 2-4 could destabilize the N^N ligand localized LUMO, 
while the HOMO energies remain unchanged. Consequently, the HOMO–LUMO gaps increased 
in 2-2 and 2-4, and thus blue–shifts occurred. On the other hand, benzannualation at the 5’,6’–
position of pyridine or the 6,7–position of quinoline of the N^N ligand stabilized the LUMO in 2-
3, 2-5, and 2-6, resulting in decreased HOMO–LUMO gap and red–shifted charge transfer 
transitions. 
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Table 2.4. HOMO and LUMO of 2-1 – 2-6 in CH2Cl2. 
 HOMO LUMO  HOMO LUMO  
2-1 
  
2-2 
  
H-L 
2-1 
  
2-3 
  
L-L 
2-1 
  
2-5 
  
L-L 
2-5 
  
2-6 
  
L-L 
2-3 
  
2-6 
  
L-L 
2-2 
  
2-4 
  
L-L 
2-3 
  
2-4 
  
H-L 
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Figure 2.2. The ground–state molecular orbital diagram for 2-1 – 2-6 in CH2Cl2, and HOMO and 
LUMO plots for 2-1. 
 
Although the increased distortion of the N^N ligands seems reasonably explain the blue–
shifts in 2-2 and 2-4, this does not appear to be able to explain the blue–shifts in the Ru(II) 
complexes with benzannulation at the 4,5–position of the bipyridine ligand27 or fusion aromatic 
ring(s) at the 5,6–position of the phenanthroline ligand.28 In both cases, benzannulation did not 
cause distortion of the N^N ligand upon coordination. Therefore, the orbital symmetry analysis 
method reported by Thompson and Gordon for rationalizing the blue–shifts in (N^N^N)PtCl 
complexes25 was applied to complexes 2-1 – 2-6. In this method, benzannulation was considered 
occurring through interactions of the FMOs of the parent compound with those of 1,3–butadiene 
or ethene. Depending on the electron density distributions on the FMOs of the parent compound 
and 1,3–butadiene or ethene and the orbital symmetry at the site of benzannulation, either the 
HOMO or LUMO of 1,3–butadiene or ethene interacted with the LUMO of the parent compound. 
These interactions destabilized (when the HOMO of 1,3–butadiene interacted) or stabilized (when 
the LUMO of 1,3–butadiene interacted) the LUMO of the parent compound while the HOMO was 
intact, resulting in blue– or red–shifts in absorption.25 Our DFT calculations showed that the 
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HOMO–LUMO transitions of 2-1 – 2-6 contributed 64–68% (Table 2.5) to the lowest singlet 
transition (S1 state), thus the FMO analysis can be used to explain the blue– or red–shifts of 2-1 – 
2-6 upon benzannulation. The qualitative orbital diagram of the valence orbitals for 2-1, 2-2, 2-3 
and 2-5 is provided in Figure 2.3, which represents the cases when benzannulation occurs at the 
7,8–position of quinoline (2-2) or the 5’,6’–position of pyridine (2-3) or the 6,7–position of 
quinoline (2-5). 
 
Table 2.5. Percentage of HOMO-LUMO transition contributing to S1 of complexes 2-1 – 2-6 
calculated in CH2Cl2 solvent. 
 Percent HOMO-LUMO 
2-1 67% 
2-2 68% 
2-3 64% 
2-4 68% 
2-5 67% 
2-6 64% 
 
Because the HOMOs for all complexes are delocalized on one of the dppi ligands and the 
d–orbital of the Ir(III) ion while the LUMOs being exclusively on the diimine ligands, 
benzannulation at the N^N ligand did not impact the HOMO energy but only altered the energy of 
LUMO. Depending on the symmetry of MOs at the site of benzannulation, either the HOMO or 
LUMO of 1,3–butadiene interacts with the LUMO of the N^N ligand. As shown in Figure 2.3, 
when benzannulation occurs at the 7,8–position of quinoline in complex 2-2, the LUMO symmetry 
of 2-1 at the annulation site matches the HOMO symmetry of 1,3–butadiene. The LUMO–HOMO 
interactions raise the LUMO energy in 2-2 and thus cause the blue–shifted CT absorption band. 
The similar phenomenon occurs from 2-3 to 2-4 (Figure 2.4). In contrast, when benzannulation 
takes place at the 5’,6’–position of pyridine or the 6,7–position of quinoline, the LUMO symmetry 
at the respective interacting site matches the LUMO symmetry of 1,3–butadiene. The LUMO–
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LUMO interactions result in the stabilized LUMOs in 2-3 and 2-5 compared to 2-1, which 
consequently induces the red–shifts of the CT transitions in 2-3 and 2-5. This is the same case for 
complex 2-6 (Figure 2.4). 
It should be pointed out that when considering the degree of orbital mixing between the 
parent complex and 1,3–butanediene, both the orbital symmetry and orbital energy difference have 
to be taken into account. In fact, the larger the difference in orbital energies, the smaller their 
coupling (mixing), despite similarities in orbital symmetry. Our calculations show the energy 
splitting of > 2 eV between HOMO (–6.66 eV) and HOMO+1 (–8.79 eV), as well as between 
LUMO (–0.55 eV) and LUMO+1 (+2.30 eV) in 1,3–butanediene. Therefore, much larger 
difference between the LUMO energy of the parent complex and the HOMO–1/LUMO+1 energies 
of 1,3–butanediene, as compared to the HOMO/LUMO energies of 1,3–butanediene. This larger 
energy difference leads to negligible contributions of HOMO–1/LUMO+1 to the orbital mixing. 
As such, only the HOMO and LUMO of 1,3–butanediene were considered in analyzing the 
stabiliza–tion/destabilization of the LUMO of the parent complex. 
 
 
Figure 2.3. Frontier molecular orbital mixing between 2-1 and 1,3–butadiene to give rise to 2-2, 
2-3 and 2-5. 
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Figure 2.4. Frontier molecular orbital mixing between 2-2, 2-3, 2-5 and 1,3-butadiene. 
 
2.3.2. Electrochemical properties  
To confirm the impact of site–dependent benzannulation on the HOMO–LUMO gaps in 2-
1 − 2-6, electrochemical properties of 2-1 − 2-6 were investigated in degassed anhydrous CH3CN 
solutions by cyclic voltammetry (CV) using ferrocenium/ferrocene (Fc+/Fc) couple as the internal 
standard. The cyclic voltammograms of 2-1 and 2-3 are presented in Figure 2.4. The obtained 
redox potentials vs Fc+/Fc are listed in Table 2.6. While all of the other complexes exhibited 
irreversible oxidation processes with the cathodic peaks of the first oxidation waves occurring at 
approximately 0.8 V, complex 2-3 showed a reversible oxidation process with a half–wave 
potential of 0.83 V. It appears that the oxidation potentials of 2-1 – 2-6 are essentially the same, 
which is consistent with the same nature of their HOMOs obtained from the DFT calculations, i.e. 
C^N ligands and d–orbital based HOMOs. These values are also in line with the half–wave 
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oxidation potential of 0.83 V for [Ir(ppy)2(dtb–bpy)]PF6 reported in the literature15 and can be 
attributed to the oxidation of Ir(III) to Ir(IV), with some contributions from the C^N ligand 
oxidation. For complexes 2-1 – 2-5, there were additional oxidation peak(s) around 1 V or at > 1 
V, which could be ascribed to further oxidation of the cyclometalating ligands. 
In contrast, the first reduction waves for all complexes except 2-2 and 2-4 were reversible, 
and the reduction potentials varied significantly among these complexes. The half–wave reduction 
potentials decreased from 2-1, 2-3, 2-5 to 2-6; while the anodic reduction potentials for the first 
reduction waves of 2-2 and 2-4 increased compared to those of 2-1 and 2-3, respectively. However, 
the Eredpa value of 2-4 decreased from that of 2-2. These trends match the trends obtained from the 
DFT calculation for the LUMOs in these complexes, confirming that the LUMOs of these 
complexes are indeed localized on the corresponding N^N ligands. Benzannualation at the 5’,6’–
position of pyridine or the 6,7–position of quinoline of the N^N ligand stabilized the LUMOs in 
2-3, 2-5, and 2-6; while benzannulation at the 7,8–position of quinoline of the N^N ligand 
destabilized the LUMOs in 2-2 and 2-4 with respect to those in 2-1 and 2-3. The second reduction 
wave around –2.0 V can be assigned to the reduction of the cyclometalating ligands. The trend of 
the electrochemical energy gaps (Egap) of these complexes matches well with the trend of the 
calculated HOMO–LUMO gaps although there appears to be some discrepancy in the absolute 
values of the calculated HOMO–LUMO gaps with the experimental electrochemical band gaps. 
Therefore, the DFT calculations clearly confirm and explain the trend in energy level shifts upon 
benzannulation at different sites. A similar discrepancy between the calculated HOMO–LUMO 
gaps and the electrochemical energy gaps was reported in [Ir(ppy)2(dtb–bpy)]PF6 and other 
fluorinated cationic iridium complex.14,43 In addition, the electrochemical measurements were 
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carried out in CH3CN, while the DFT calculations used CH2Cl2 as the solvent. The different 
solvents may make minor contribution to the discrepancy as well. 
 
Table 2.6. Electrochemical properties of Ir(III) complexes 2-1 – 2-6. 
 Eox1/2 (V)a 
[ΔEp (mV)] 
Eoxpc (V) Ered1/2 (V) 
[ΔEp(mV)] 
Eredpa (V) Egap (V)b 
2-1 irr 0.81; 1.02 –1.57 [37] –1.59, –2.32 2.40 
2-2 irr 0.76; 0.92; 
1.22; 1.34 
irr –1.72; –2.21; –2.34 2.48 
2-3 0.83 [69] 0.81; 1.00 –1.41 [75];  –2.06 [77] –1.43; –2.05 2.24 
2-4 irr 0.77; 1.11 irr –1.68; –2.25 2.45 
2-5 irr 0.81; 1.02 –1.41 [67] –1.39; –2.07 2.20 
2-6 irr 0.88 –1.27 [85] –1.26; –1.91 2.14 
aE1/2 = (Epa+Epc)/2, where Epa and Epc are the anodic and cathodic peak potentials vs 
ferrocinium/ferrocene (Fc) couple measured in CH3CN and ΔEp=|Epa−Epc|. bEgap  = (first wave) 
Eoxpa – (first wave) Eredpc. 
 
-2.0 -1.5 -1.0 1.0 1.5 2.0
 Potential vs NHE (V)
2-1
2-3
 
Figure 2.4. Cyclic voltammograms of 2-1 and 2-3 in degassed anhydrous CH3CN solutions 
(110−3 M) in the presence of 0.1 M tetrabutylammonium hexafluorophosphate as the supporting 
electrolyte and ferrocenium/ferrocene (Fc+/Fc) couple as the internal standard.  The potentials were 
recorded against an Ag/AgCl reference electrode. 
 
2.3.3. Photoluminescence  
To understand the effects of site–selective benzannulation on the triplet excited states, the 
emission characteristics of 2-1 – 2-6 at room temperature were investigated. Figure 2.5 displays 
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the normalized emission spectra of 2-1 – 2-6 in CH2Cl2. The emission band maxima and lifetimes 
are summarized in Table 2.1. The emission of 2-1 – 2-6 is relatively long–lived (~100 ns – 2.2 s), 
quite sensitive to oxygen quenching, and exhibit obvious red–shifts in comparison to their 
corresponding excitation wavelengths. Thus, they are phosphorescence from the triplet excited 
states, which is in line with the other reported Ir(III) complexes.1–20,29-32,37,39,44,45 However, the 
spectral features of 2-1 – 2-4 are distinctively different from those of 2-5 and 2-6. The spectra of 
2-1 – 2-4 are broad and featureless, while the spectra of 2-5 and 2-6 exhibit clear vibronic 
progressions. According to that reported for other Ir(III) complexes44,45 and the triplet NTOs shown 
in Table 2.7, the emission of 2-1 – 2-4 is attributed to 3MLCT / 3LLCT phosphorescence in nature, 
mixed with minor N^N ligand–centered 3π,π* character. In contrary, with the extended π–
conjugation along the 5’,6’–position of pyridine or 6,7–position of quinoline, the N^N ligand–
centered 3π,π* states became the lowest triplet excited states in 2-5 and 2-6. Thus, the emission of 
2-5 and 2-6 emanates from the ligand–center 3π,π* state. The emission was clearly blue–shifted 
upon benzannulation at the 7,8–position of quinoline (2-2 vs 2-1, and 2-4 vs 2-3). Opposed to this 
trend, benzannulation at the 5’,6’–position of pyridine or the 6,7–position of quinoline caused 
salient red–shifts going from 2-1 to 2-3 to 2-5 and 2-6 although the natures of the emitting states 
of 2-5 and 2-6 are distinct from those of 2-1 – 2-4. This trend is consistent with that observed for 
the low–energy electronic absorption bands. Thus, the site–dependent benzannulation effect 
applies not only to the lowest singlet excited states, but also to the lowest triplet excited states. 
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Figure 2.5. Normalized emission spectra of 2-1 – 2-6 at room temperature in CH2Cl2. The spectra 
of 2-1 – 2-4 were measured on a HORIBA FluoroMax 4 fluorometer/phosphorometer with a 
Hamamatsu PMT R928 as the detector, while the spectra of 2-5 and 2-6 were detected with an 
InGaAs sensor from 670 nm to 1225 nm (λex = 473 nm) with a 500 nm long pass filter. The vertical 
lines represent the triplet emission wavelengths calculated by TDDFT based SCF method. 
 
Table 2.7. NTOs representing transitions corresponding to the triplet emission of 2-1 to 2-6 in 
CH2Cl2 calculated by TDDFT–based SCF. 
Complexes T1 / nm Hole Electron 
2-1 671 (656) 
  
2-2 645 (638) 
  
2-3 733 (714) 
  
2-4 735 (702) 
  
2-5 1356 (765) 
  
2-6 1398 (804) 
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2.3.4. Transient absorption (TA)  
The nanosecond TA spectra of 2-1 – 2-6 were studied in acetonitrile to further understand 
the triplet excited state characteristics. The triplet excited–state lifetimes, extinction coefficients, 
and quantum yields are deduced or calculated, and the results are summarized in Table 2.1. The 
nanosecond TA spectra of 2-1 – 2-6 in acetonitrile immediately after 355 nm laser pulse excitation 
are presented in Figure 2.6, and the time–resolved spectra for each complex are provided in Figure 
2.7. For comparison purpose, the time–resolved TA spectra of the corresponding N^N ligand for 
each complex (L2-1 – L2-6) were measured in acetonitrile as well and the spectra are shown in 
Figure 2.8. 
Complexes 2-1 – 2-6 all possessed broad positive absorption bands in the region of 
400−800 nm, except that 2-1 – 2-3 exhibited a sharp bleaching band at 403–416 nm. The spectral 
features of 2-1 and 2-3, and 2-2 and 2-4 resembled each other. However, the spectral of 2-5 and 2-
6 differred from each other and from those of 2-1 – 2-4. For complexes 2-1, 2-3, 2-5, and 2-6 that 
have benzannulation at the 5’,6’–position of pyridine or the 6,7–position of quinoline of the 
diimine ligand, the triplet lifetimes deduced from the decay of TA are consistent with those 
obtained from the decay of emission in CH3CN (Table 2.1). Thus, the excited states giving rise to 
the observed TA in these four complexes should be their emitting states, i.e. predominantly 3MLCT 
/ 3LLCT state for 2-1 and 2-3, and 3π,π* localized on the N^N ligand for 2-5 and 2-6. This 
conclusion is further supported by the fact that the TA spectra of 2-5 and 2-6 resembled those of 
their respective N^N ligands shown in Figure 2.8. The intensity difference in the 350–450 nm 
region in these two complexes compared to those of their ligands should arise from the stronger 
ground–state absorption in this region that is much weaker or absent in their corresponding ligand. 
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For 2-2 and 2-4 that have benzannulation occurred at 7,8–position of quinoline, the major 
absorption band at 400–480 nm was blue–shifted compared to those of 2-1 and 2-3, respectively. 
However, a broad and strong absorption band appeared at 480–700 nm in 2-2 and 2-4. The TA 
spectral features of 2-2 and2- 4 resemble those of their corresponding N^N ligands (Figure 2.8). 
More strikingly, the transient species in 2-2 and 2-4 exhibited one order of magnitude longer 
lifetimes than those of 2-1 and 2-3, and the TA lifetimes were 1–2 orders of magnitude longer than 
their emission lifetimes. These features suggest that the transient absorbing excited states in 2-2 
and 2-4 differ from their emitting states. As discussed in the photoluminescence section, the 
emitting states in 2-2 and 2-4 predominantly have the 3MLCT / 3LLCT character. However, the 
much longer TA lifetimes and the drastically different TA spectral features at 480–800 nm in 2-2 
and 2-4 with respect to those of 2-1 and 2-3 suggest that the transient absorbing states in these two 
complexes are likely to be the N^N ligand based 3π,π* state. Although such a phenomenon is rare, 
it has been reported for other Ir(III),46 Pt(II),47,48 and Ru(II)49-52 complexes, in which those 
complexes possessed a short–lived 3CT emitting state and a long–lived nonemissive ligand–
localized 3π,π* transient absorbing state. Our TDDFT calculations for the triplet excited states of 
2-1 – 2-6 revealed that the T2 states in 2-2 and 2-4 predominantly had the N^N ligand localized 
3π,π* character in nature (Figure 2.8). Due to the increased energy of the T1 states in 2-2 and 2-4 
upon benzannulation at the 7,8–position of quinoline, as reflected by the blue–shifted emission in 
these two complexes, the T1 states became more closer to the 3π,π* dominated T2 state (Figure 
2.9). This could facilitate the mixing of the T1 and T2 states in these two complexes and led to the 
transient absorbing species in 2-2 and 2-4 having more N^N ligand–centered 3π,π* character. 
Alternatively, for reasons that are not clearly understood at this time, the nonemissive T2 states in 
2-2 and 2-4 gave rise to the observed TA. 
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It is interesting to note that the triplet quantum yields for these complexes all appeared to 
be quite low, which is inconsistent to that expected for heavy–metal containing transition–metal 
complexes, in which heavy–metal induced strong spin–orbit coupling should result in almost unity 
intersystem crossing. This phenomenon can be rationalized by the following factors: (1) When the 
–conjugation of the ligand increases, the contribution of the d–orbital to the FMOs of the 
complexes decreases, which reduces the spin–orbit coupling as reported by Schanze and co–
workers for phenylene vinylene platinum(II) acetylides;53 (2) When intersystem cross occurs in 
transition–metal complexes, it is possible to populate two triplet excited states simultaneously.46–
52 However, the triplet quantum yields were measured from the TA measurements, which did not 
take into account the population of the other triplet excited state that does not contribute to the 
observed TA; (3) The triplet quantum yields were obtained using the relative actinometry,54 in 
which the triplet excited–state absorption coefficient had to be known. In our studies, we used the 
singlet depletion method55 to estimate the triplet excited–state absorption coefficients, which 
assumed that the compound had no excited–state absorption at the valley of the bleaching band 
and no ground–state absorption at the peak of the TA band. If these conditions can’t be fully met, 
the errors in the obtained triplet excited state absorption coefficient could be large. This may 
influence the calculated triplet quantum yield as well. 
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Figure 2.6. Nanosecond transient difference absorption spectra of complexes 2-1 – 2-6 in 
acetonitrile immediately after 355 nm laser pulse excitation. A355 = 0.4 in a 1-cm cuvette. 
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Figure 2.7. Nanosecond time-resolved transient differential absorption spectra of 2-1 – 2-6 in 
acetonitrile.  λex = 355 nm, A355 = 0.4 in a 1-cm cuvette. 
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Figure 2.8. Nanosecond time-resolved transient differential absorption spectra of L2-1 − L2-6 in 
acetonitrile. λex = 355 nm, A355 = 0.4 in a 1-cm cuvette. 
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Figure 2.9. Calculated triplet excited state energy diagram for complexes 2-1 – 2-6 in CH3CN. 
 
2.4. Conclusion 
We demonstrated the first time that extending the π–conjugation of that N^N ligand could 
cause either blue– or red–shifts of the lowest–energy absorption and emission bands depending on 
the site of benzannulation in Ir(III) complexes. Molecular orbital symmetry analysis was applied 
to rationalize this unusual phenomenon. The site–dependent destabilization or stabilization of the 
LUMO (or LUTO in cases of excited state) upon benzannulation appears to be a general feature 
for small organic molecules and transition–metal complexes. The site–dependent benzannulation 
also influences the triplet excited–state absorption drastically. This discovery would enable a 
rational design of organic or organometallic compounds that require a pre–determined absorption 
and/or emission energies and could potentially advance the photonic fields such as OLED, solar 
energy conversion, luminescent biological labeling, etc. In addition, the complexes reported in this 
paper exhibited weak ground–state absorption at 430 – 700 nm, but stronger triplet excited–state 
absorption in this spectral region. Therefore, they have the potential to be developed into 
broadband reverse saturable absorbers. This study is currently undergoing and will be reported in 
the near future. 
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3. IMPACT OF BENZANNULATION SITE AT THE DIIMINE (N^N) LIGAND ON THE 
PHOTOPHYSICS AND REVERSE SATURABLE ABSORPTION OF 
CYCLOMETALATED MONOCATIONIC IRIDIUM(III) COMPLEXES 
 
3.1. Introduction  
Among the diverse transition−metal complexes, pseudo−octahedral d6 iridium(III) 
complexes have attracted growing interest in both academia and industry during the past two 
decades.1−4 The strong spin−orbit coupling induced by the Ir(III) ion enhances the intersystem 
crossing (ISC) rate and promotes triplet excited−state formation. These characteristics spark 
research interest in exploring potential binding geometries with novel ancillary ligands. After the 
seminal work by Watts et. al. on triply ortho−metalated iridium(III) complexes in the 1980s,5 
diverse mono−, bis− and triscyclometallated complexes with different polypyridine ligands or 
cyclometallating ligands have been reported.6,7 Among these complexes, cyclometalated 
monocationic Ir(III) complexes have been reported to play a crucial role in various applications, 
such as sensitized photo−upconversion,3 organic light emitting diodes (OLEDs),8−11 light−emitting 
electrochemical cells (LEECs),12,13 photodynamic therapy,14−16 nonlinear optics,17−19 
photocatalysis,20−22 and bioimaging and biosensing.23 
In view of the structures of the monocationic Ir(III) complexes [(N^N)Ir(C^N)2]
+ (where 
N^N refers to the diimine ligand and C^N refers to the cyclometalating ligand), the combination 
of one N^N ligand and two identical C^N ligands provides the opportunity to tune the 
photophysical properties of these complexes via a diverse selection and combination of ligands. 
Generally, the electron−deficient N^N ligand is the major contributor to the lowest unoccupied 
molecular orbital (LUMO) in these Ir(III) complexes, while the C^N ligands and the d−orbital of 
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the Ir(III) ion hold the majority of the highest occupied molecular orbital (HOMO).24−26 
Consequently, extending −conjugation or introducing electron−donating/withdrawing 
substituents on the N^N ligand would alter the LUMO exclusively. It has been reported that 
incorporation of electron−donating substituents, such as an amino or methoxy group, to the N^N 
ligand raised the LUMO and blue−shifted the low−energy absorption bands of Ir(III) complexes. 
In contrast, Ir(III) complexes bearing electron−withdrawing substituents at the N^N ligand, such 
as ﬂuoro or cyano, displayed red−shifted low−energy absorption bands due to the stabilized 
LUMOs.26,27 Another approach to tune the LUMO energy is to bring π−conjugated units to the 
N^N ligand by benzannulation. It was reported that the energy of the LUMO decreased from −3.15 
eV to −3.38 eV for the Ir(III) complex bearing 2−(pyridin−2−yl)quinoline ligand upon 
benzannulation at the 2,2′−bipyridine ligand.26 Additionally, extending the π−conjugation of the 
N^N ligand via benzannulation or incorporation of −conjugated substituents simultaneously 
induces more 3π,π* character into the lowest triplet excited state (T1).17,28−33 In contrast to the 
charge−transfer based T1 state (3CT), the 3π,π* based T1 state typically exhibits a longer lifetime, 
structured emission bands, and a higher emission quantum yield. Therefore, extending 
π−conjugation on the N^N ligand can serve as an adjuster for both the lowest singlet excited state 
and the lowest triplet excited state. 
In the reported work on benzannulation on organic compounds, either hypsochromic or 
bathochromic shifts of the absorption and emission bands have been observed depending on the 
site of benzannulation.34−37 Despite finding this unusual phenomenon in small organic molecules, 
examples featuring the impacts of varied site of benzannulation on the ligands on organometallic 
complexes are still rare.32,38 In seeking a better understanding of the effects of benzannulation site 
at the ligands on the photophysics of these complexes, the seminal report by Thompson and 
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Gordon38 on the (N^N^N)PtCl derivatives has intrigued our interest in other heavy 
transition−metal complexes, such as the Ir(III) complexes. In our previous work, we explored a 
series of cyclometalated monocationic Ir(III) complexes employing 
1,2−diphenyl−9H−pyreno[4,5−d]imidazole as the C^N ligands, and 2−(pyridin−2−yl)quinoline 
and its derivatives as the N^N ligand.32 Compared to the parent complex bearing the 
2−(pyridin−2−yl)quinoline ligand, pronounced red− or blue−shift of the absorption and emission 
bands was observed via benzannulation at the different sites of the N^N ligand. This effect was 
rationalized by symmetry analysis of the frontier molecular orbitals at the benzannulation site of 
the parent complex via theoretical calculations. While this phenomenon has been well explained 
for our previously studied complexes, validation of the prediction from our aforementioned work 
on tuning the photophysical properties of the Ir(III) complexes through benzannulation at the 
previously undeveloped sites of N^N ligand is still needed. Moreover, because of their readily 
adjustable ground−state and triplet excited−state absorption, these Ir(III) complexes have the 
potential for use as reverse saturable absorbers, which is worthy of in−depth study.17−19,29−31,33,39−42 
Targeting these goals, we have synthesized ten cyclometalated monocationic Ir(III) 
complexes (Chart 3.1). These complexes utilized 2−phenylquinoline as the cyclometalating 
ligands and 2,2′−bipyridine (bpy) derivatives with a varied degree of −conjugation as the diimine 
ligand. Extending −conjugation of the bpy ligand was realized via benzannulation at one pyridine 
ring (3-1 − 3-4), at the bridge of the two pyridine rings (3-5 – 3-7), or at the different sites (i.e. 
5,6−/5′,6′−, 4,5−/4′,5′−, or 3,4−/3′,4′−) of both pyridine rings (3-8 – 3-10). Complexes 3-2 – 3-4, 
3-6, 3-7, 3-9 and 3-10 are new complexes that are first reported herein. Although complexes 3-1,43 
3-544 and 3-845 are known in the literature, previous work has focused on their 
biological/biomedical activities, and no systematic photophysical or reverse saturable absorption 
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(RSA) studies have been reported for these complexes. More importantly, these complexes fall 
naturally into our focus on a comprehensive understanding of the impact of benzannulation site at 
the N^N ligand on the photophysics and RSA of the cyclometalated monocationic Ir(III) 
complexes. 
 
Chart 3.1.  Structures of complexes 3-1 – 3-10. 
 
3.2. Experimental section  
3.2.1. Materials and synthesis  
All reagents and solvents were purchased from Alfa Aesar or VWR International and used 
as received unless otherwise stated. Al2O3 gels (activated, neutral) and silica gels (230−400 mesh) 
for column chromatography were purchased from Sorbent Technology. The N^N ligands 
2,2′−bipyridine (L3-1), phenanthroline (L3-5), and 2,2′−bisquinoline (L3-8) were obtained from 
Alfa Aesar. The synthesis of 2−(pyridin−2−yl)quinoline (L3-2),46 2−(pyridin−2−yl)[6,7] 
benzoquinoline (L3-3),47 and 2−(pyridin−2−yl)−[7,8]benzoquinoline (L3-4)48 was carried out 
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using the reported methods. The synthesis of benzo[f][1,10]phenanthroline (L3-6),49 
naphtho[2,3−f][1,10]phenanthroline (L3-7)50, 3,3′−biisoquinoline (L3-9)51, and 1,1′−biiso- 
quinoline (L3-10)51,52 followed published procedures. 2−Phenylquinoline (C^N ligand) and its 
Ir(III) µ−chloro−bridged dimers [Ir(C^N)2Cl]2 were synthesized following reported procedures.53  
1H NMR spectroscopy, high−resolution mass spectrometry (HRMS), and elemental analyses were 
used to characterize these complexes. 1H NMR spectra were obtained on a Varian Oxford 400 or 
Bruker 400 spectrometer in CDCl3 or d6−DMSO using tetramethylsilane (TMS) as the internal 
standard. A Bruker BioTOF III mass spectrometer was used for ESI−HRMS analyses. Elemental 
analyses were carried out by NuMega Resonance Laboratories, Inc. in San Diego, California.  
General procedure for the synthesis of 3-1 – 3-10. The Ir(III) dimer [Ir(C^N)2Cl]2 (0.03 
mmol), N^N ligand (0.06 mmol), and AgSO3CF3 (0.06 mmol) were added in the mixed solvent of 
CH2Cl2 and MeOH (v/v = 2:1, 30 mL). The reaction mixture was degassed and heated to reflux 
under a nitrogen atmosphere for 24 h without light illumination. After cooling to room 
temperature, NH4PF6 (0.3 mmol) was added to the reaction mixture and stirred at r.t. for 2 h. Then, 
the solvent was removed under vacuum, and the crude product was purified by column 
chromatography (neutral alumina gel, dichloromethane/hexane (3:1 − 1:0, v/v)) to obtain the target 
Ir(III) complexes. 
Complex 3-1. An orange solid was obtained as the product (36 mg, yield: 66%). 1H NMR 
(400 MHz, CDCl3): δ 8.27 (d, J = 8.3 Hz, 2H), 8.23−8.07 (m, 6H), 8.05−7.91 (m, 4H), 7.71 (dd, J 
= 8.1, 1.4 Hz, 2H), 7.43−7.32 (m, 4H), 7.25 (d, 2H), 7.20−7.13 (m, 2H), 6.99 (ddd, J = 8.7, 6.1, 
1.5 Hz, 2H), 6.86−6.79 (m, 2H), 6.55 (dd, J = 7.7, 0.7 Hz, 2H). ESI−HRMS (m/z): calcd. for 
[C40H28N4Ir]
+, 757.1943; found, 757.1955.Anal. Calcd. (%) for C40H28F6IrN4P: C, 53.27; H, 3.13; 
N, 6.21. Found: C, 53.59; H, 3.48; N, 5.99. 
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Complex 3-2. An orange solid was obtained as the product (31 mg, yield: 54%). 1H NMR 
(400 MHz, CDCl3) δ 8.46−8.37 (m, 2H), 8.37−8.21 (m, 3H), 8.18−8.10 (m, 1H), 8.09−8.00 (m, 
2H), 7.84 (dd, J = 7.8, 4.2 Hz, 2H), 7.79 (d, J = 7.2 Hz, 1H), 7.61 (dd, J = 15.7, 7.9 Hz, 3H), 7.51 
(dd, J = 14.7, 8.3 Hz, 2H), 7.45−7.35 (m, 3H), 7.25 (s, 1H), 7.16 (ddd, J = 15.8, 12.3, 4.7 Hz, 3H), 
7.08 (t, J = 7.1 Hz, 1H), 7.02−6.80 (m, 4H), 6.54 (d, J = 7.2 Hz, 1H), 6.34 (d, J = 7.4 Hz, 1H). 
ESI−HRMS (m/z): calcd. for [C44H30N4Ir]+, 807.2100; found, 807.2136. Anal. Calcd. (%) for 
C44H30F6IrN4P.0.3C6H14 (C6H14: hexane): C, 56.50; H, 3.64; N, 5.68. Found: C, 56.63; H, 3.26; N, 
5.46. 
Complex 3-3. An orange solid was obtained as the product (34 mg, yield: 57%). 1H NMR 
(400 MHz, d6−DMSO): δ 8.72 (dt, J = 9.0, 6.9 Hz, 3H), 8.67 (s, 1H), 8.38 (d, J = 7.0 Hz, 1H), 8.28 
(t, J = 8.0 Hz, 2H), 8.21–8.09 (m, 4H), 8.06 (ddd, J = 9.3, 7.1, 1.2 Hz, 2H), 7.86 (dd, J = 7.7, 0.8 
Hz, 1H), 7.82−7.70 (m, 3H), 7.66−7.62 (m, 1H), 7.58−7.52 (m, 1H), 7.45−7.35 (m, 2H), 7.24−7.15 
(m, 2H), 7.08−6.95 (m, 3H), 6.87 (ddd, J = 15.5, 12.7, 5.3 Hz, 4H), 6.38 (dd, J = 10.8, 7.7 Hz, 
2H). ESI−HRMS (m/z): calcd. for [C48H32N4Ir]+, 857.2256; found, 857.2241. Anal. Calcd. for 
C48H32F6IrN4P.0.9CH2Cl2: C, 54.46; H, 3.16; N, 5.20. Found: C, 54.20; H, 3.15; N, 5.39. 
Complex 3-4. An orange solid was obtained as the product (52 mg, yield: 87%). 1H NMR 
(400 MHz, CDCl3): δ 9.22 (d, J = 8.8 Hz, 1H), 8.63 (d, J = 8.2 Hz, 1H), 8.52 (d, J = 8.6 Hz, 1H), 
8.43 (d, J = 8.9 Hz, 1H), 8.31 (d, J = 8.2 Hz, 1H), 8.13 (t, J = 7.8 Hz, 1H), 8.05 (d, J = 6.8 Hz, 
1H), 7.93 (dd, J = 10.4, 8.1 Hz, 3H), 7.84 (d, J = 8.7 Hz, 1H), 7.69−7.58 (m, 3H), 7.48 (dt, J = 9.5, 
6.9 Hz, 3H), 7.34−7.21 (m, 4H), 7.14−6.99 (m, 3H), 6.77 (d, J = 8.7 Hz, 1H), 6.68 (t, J = 7.5 Hz, 
1H), 6.64−6.54 (m, 2H), 6.50 (t, J = 7.2 Hz, 2H), 6.32 (t, J = 7.6 Hz, 1H), 6.12 (d, J = 8.1 Hz, 1H). 
ESI−HRMS (m/z): calcd. for [C48H32N4Ir]+, 857.2256; found, 857.2289. Anal. Calcd. for 
C48H32F6IrN4P.0.5CH2Cl2: C, 55.77; H, 3.18; N, 5.36. Found: C, 55.37; H, 3.32; N, 5.36. 
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Complex 3-5. An orange solid was obtained as the product (32 mg, yield: 58%). 1H NMR 
(400 MHz, d6−DMSO) δ 8.74 (dd, J = 8.2, 1.4 Hz, 2H), 8.60 (d, J = 9.0 Hz, 2H), 8.51−8.45 (m, 
4H), 8.36 (d, J = 7.3 Hz, 2H), 8.09 (s, 2H), 8.05 (dd, J = 8.2, 5.2 Hz, 2H), 7.81 (dd, J = 8.1, 1.3 
Hz, 2H), 7.23 (ddd, J = 15.0, 8.0, 1.0 Hz, 4H), 7.11 (d, J = 9.0 Hz, 2H), 6.91−6.78 (m, 4H), 6.54 
(dd, J = 7.7, 0.8 Hz, 2H). ESI−HRMS (m/z): calcd. for [C42H28N4Ir]+, 781.1943; found, 781.1966. 
Anal. Calcd. for C42H28F6IrN4P: C, 54.48; H, 3.05; N, 6.05. Found: C, 54.25; H, 2.98; N, 6.02. 
Complex 3-6. An orange solid was obtained as the product (41 mg, yield: 70%). 1H NMR 
(400 MHz, CDCl3) δ 9.04 (d, J = 8.1 Hz, 2H), 8.51−8.43 (m, 4H), 8.20 (d, J = 8.9 Hz, 2H), 8.16 
(d, J = 8.6 Hz, 2H), 8.06 (d, J = 8.0 Hz, 2H), 7.88 (dd, J = 8.4, 5.2 Hz, 2H), 7.59−7.51 (m, 4H), 
7.23−7.05 (m, 6H), 6.83 (td, J = 7.5, 1.3 Hz, 2H), 6.76 (ddd, J = 8.6, 6.9, 1.4 Hz, 2H), 6.66−6.55 
(m, 2H). ESI−HRMS (m/z): calcd. for [C46H30N4Ir]+, 831.2100; found, 831.2123. Anal. Calcd. for 
C46H30F6IrN4P.0.5C6H14.2H2O (C6H14: hexane): C, 55.78; H, 3.92; N, 5.31. Found: C, 55.70; H, 
4.20; N, 5.64. 
Complex 3-7. An orange solid was obtained as the product (51 mg, yield: 83%). 1H NMR 
(400 MHz, d6−DMSO) δ 9.57−9.46 (m, 4H), 8.63 (d, J = 9.0 Hz, 2H), 8.53 (d, J = 8.7 Hz, 2H), 
8.42−8.32 (m, 4H), 8.20 (dd, J = 6.3, 3.3 Hz, 2H), 8.10 (dd, J = 8.4, 5.2 Hz, 2H), 7.83 (dd, J = 8.1, 
1.2 Hz, 2H), 7.76 (dd, J = 6.4, 3.2 Hz, 2H), 7.22 (ddd, J = 8.8, 7.4, 6.3 Hz, 6H), 6.96−6.85 (m, 
4H), 6.54−6.48 (m, 2H). ESI−HRMS (m/z): calcd. for [C50H32N4Ir]+, 881.2256; found, 881.2291. 
Anal. Calcd. for C50H32F6IrN4P.0.3CH2Cl2: C, 57.46; H, 3.13; N, 5.33. Found: C, 57.37; H, 3.07; 
N, 5.37. 
Complex 3-8. A red solid was obtained as the product (38 mg, yield: 63%). 1H NMR (400 
MHz, d6−DMSO) δ 8.72 (d, J = 8.6 Hz, 2H), 8.50 (d, J = 8.7 Hz, 2H), 8.32 (d, J = 8.8 Hz, 2H), 
8.22 (d, J = 9.0 Hz, 2H), 8.11−8.03 (m, 2H), 8.01−7.88 (m, 4H), 7.60−7.49 (m, 4H), 7.47−7.35 
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(m, 4H), 7.10 (ddd, J = 8.6, 6.9, 1.4 Hz, 2H), 7.06−6.98 (m, 2H), 6.89−6.79 (m, 4H), 6.36−6.28 
(m, 2H). ESI−HRMS (m/z): calcd. for [C48H32N4Ir]+, 857.2256; found, 857.2233. Anal. Calcd. for 
C48H32F6IrN4P.1.1CH2Cl2: C, 53.84; H, 3.15; N, 5.11. Found: C, 53.94; H, 2.95; N, 5.13. 
Complex 3-9. An orange solid was obtained as the product (20 mg, yield: 33%). 1H NMR 
(400 MHz, d6−DMSO) δ 9.49 (s, 2H), 9.13 (d, J = 8.9 Hz, 2H), 8.68 (d, J = 8.7 Hz, 2H), 8.54 (s, 
2H), 8.46 (d, J = 9.0 Hz, 2H), 8.30 (s, 2H), 8.16 (d, J = 8.2 Hz, 2H), 7.96 (d, J = 7.9 Hz, 2H), 7.86 
(d, J = 7.3 Hz, 2H), 7.78−7.66 (m, 6H), 7.27 (s, 2H), 6.87 (s, 2H), 6.58−6.52 (m, 2H), 6.03 (d, J = 
7.8 Hz, 2H). ESI−HRMS (m/z): calcd. for [C48H32N4Ir]+, 857.2256; found, 857.2241. Anal. Calcd. 
for C48H32F6IrN4P.0.2C6H14 (C6H14: hexane): C, 57.98; H, 3.44; N, 5.50. Found: C, 58.00; H, 3.58; 
N, 5.20. 
Complex 3-10. A red solid was obtained as the product (34 mg, yield: 56%). 1H NMR (500 
MHz, d6−DMSO) δ 8.52 (d, J = 9.0 Hz, 2H), 8.44 (d, J = 8.8 Hz, 2H), 8.26 (d, J = 8.2 Hz, 2H), 
8.03 (dt, J = 14.1, 5.9 Hz, 8H), 7.82−7.76 (m, 2H), 7.72 (d, J = 8.0 Hz, 2H), 7.48 (d, J = 6.3 Hz, 
4H), 7.24 (t, J = 7.5 Hz, 2H), 7.15 (t, J = 9.9 Hz, 4H), 6.83 (t, J = 7.4 Hz, 2H), 6.29 (d, J = 7.4 Hz, 
2H). ESI−HRMS (m/z): calcd. for [C48H32N4Ir]+, 857.2256; found, 857.2283. Anal. Calcd. for 
C48H32F6IrN4P.0.9CH2Cl2: C, 54.46; H, 3.16; N, 5.20. Found: C, 54.59; H, 2.99; N, 5.31. 
 
3.2.2. Photophysical studies 
Spectroscopic−grade solvents were used for the photophysical studies and were purchased 
from VWR International and used as received. A Varian Cary 50 spectrophotometer was used to 
record UV−vis absorption spectra. The emission spectra of 3-1 − 3-10 were measured on a 
HORIBA FluoroMax 4 fluorometer/phosphorometer. The absolute emission quantum yields (QY) 
were measured using a fiber coupled Ocean Optics integrating sphere. On the excitation side, the 
 95 
sphere was fiber coupled to a set of Delta linear−variable filters (LVFs) and then fiber coupled to 
a broad white light LED. The set of LVFs were aligned with an in−house modified Ocean Optics 
LVF mount and positioned to give a narrow excitation band peaked at 450 nm. On the detection 
side, the integrating sphere was coupled to a bifurcated fiber cable that was coupled to an Ocean 
Optics UV VIS QE65000 spectrometer and an Ocean Optics NIRQ512 spectrometer yielding an 
effective detection range of 350 nm to 1700 nm. The samples were degassed and maintained in an 
oxygen free environment prior to and during each QY measurement. 
The nanosecond transient difference absorption (TA) spectra and lifetimes of complexes 
3-1 − 3-10 were measured on a laser flash photolysis spectrometer (Edinburgh LP920) in degassed 
CH3CN solutions. The excitation source for the measurements was a third−harmonic output (355 
nm) of a Nd:YAG laser (Quantel Brilliant; pulse duration: 4.1 ns; repetition rate: 1 Hz). Each 
sample solution was purged with N2 for 40 min before measurement. The singlet depletion 
method54 was applied to determine the triplet excited−state molar extinction coefficients (εT) at the 
TA band maximum. A benzene solution of SiNc (ε590 = 70,000 M−1 cm−1, ΦT = 0.20)55 was used 
as a reference to determine the triplet excited−state quantum yield through the relative actinometry 
method.56 
 
3.2.3. Nonlinear transmission measurement 
The nonlinear transmission experiments for all complexes at 532 nm were carried out in 
CH3CN solutions in a cuvette (length: 2 mm), which linear transmission of was set to 80%.  The 
4.1 ns laser (Quantel Brilliant) with a repetition rate of 10 Hz was used as the light source. The As 
described in previous work, the same experimental setup was used in this paper.70 The beam radius 
at the focal point was approximately 96 μm, focused by an f = 40 cm plano-convex lens. 
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3.2.4. Computational methods   
Complexes 3-1 − 3-10 were computationally investigated using density functional theory 
(DFT) and linear response time−dependent DFT (TDDFT) calculations implemented in 
Gaussian09 quantum software package.57 The ground state optimization and excited state 
calculations of 3-1 − 3-10 were performed using the B3LYP58 functional with mixed basis sets 
(LANL2DZ for Ir,59 and 6−31g* for H, C, and N).60 Solvent effects were included via Conductor 
Polarized Continuum Model (CPCM)61,62 for dichloromethane. 
The theoretical absorption spectra were generated by computing the lowest 125 singlet 
excitations from the ground state singlet equilibrium geometry, and the resulting transition 
energies and oscillator strengths were broadened via Equation 2 in Ref. 63 with a line width of 
0.12 eV to model the thermal broadening of optical bands to be comparable to experimental 
spectra. The emission of complexes 3-1 − 3-10 was simulated using TDDFT SCF approach, 
which computed the phosphorescence energy by calculating the triplet excited state transitions 
using TDDFT based on the triplet equilibrium geometry.38,64 The nature of the triplet and singlet 
transitions were characterized by computing the natural transition orbitals (NTOs)65 via 
Gaussian09 and visualized using VMD with 0.02 isovalue.66 
 
3.3. Results and discussion 
3.3.1. Electronic absorption 
The absorption spectra of complexes 3-1 − 3-10 were measured in different solvents at 
room temperature. The spectra in dichloromethane are displayed in Figure 3.1 and the absorption 
band maxima and molar extinction coefficients are tabulated in Table 3.1. The normalized 
absorption spectra in other solvents are provided in Figure 3.2. These spectra generally can be 
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divided into four regions: the high−energy, strong absorbing band(s) below 310 nm; the structured 
medium−energy bands at ca. 310−400 nm; the lower−energy featureless band at ca. 400−500 nm; 
and the very weakly absorbing band(s) between 500 and 600 nm. According to the shape of these 
absorption bands and the corresponding molar extinction coefficients, these bands can be attributed 
to the ligand−localized 1π,π* transitions, the dominant 1π,π* transitions mixed with charge transfer 
(1CT, i.e. metal−to−ligand charge transfer (1MLCT)/ligand−to−ligand charge transfer (1LLCT)) 
transitions, the 1MLCT/1LLCT/1ILCT (intraligand charge transfer) transitions, and the mixed 
1,3MLCT/1,3LLCT transitions, respectively. These assignments are supported by the TDDFT 
calculation results (see NTOs in Table 3.2 – 3-4) and are in accordance with the other reported 
cyclometalated monocationic Ir(III) complexes.18,19,27,67 
Examination of the lowest−energy absorption bands (500−600 nm) of complexes 3-1 − 3-
10 revealed that benzannulation at the 5,6−position of pyridine (3-2 vs. 3-1), 6,7−position of 
quinoline (3-3 vs. 3-2), 5,6− and 5′,6′−position of 2,2′−bipyridine (3-8 vs. 3-1), and 3,4− and 
3′,4′−position of 2,2′−bipyridine (3-10 vs. 3-1) resulted in a red−shift of the 1,3MLCT/1,3LLCT 
absorption bands with an increased molar extinction coefficient compared to their corresponding 
parent complexes. In contrast, benzannulation at the 7,8−position of quinoline (3-4 vs. 3-2), 4,5− 
and 4′,5′−position of 2,2′−bipyridine (3-9 vs. 3-1), or 2,2′,3,3′−position of 2,2′−bipyridine (3-5 vs. 
3-1) essentially did not impact the energy of the 1,3MLCT/1,3LLCT absorption band compared to 
their corresponding parent complex. In addition, fusing a phenyl or a naphthyl ring to the 
5,6−position of 1,10−phenanthroline did not affect the energies of the 1,3MLCT/1,3LLCT 
transitions in complexes 3-6 and 3-7 with respect to their corresponding parent compound 3-5. 
The site−dependent benzannulation effect was more clearly evidenced in the calculated S1 
state energies for these complexes. As listed in Table 3.2, benzannulation at the 5,6−/5′,6′−position 
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or 3,4−/3′,4′−position of 2,2′−bipyridine stabilized the S1 states in complexes 3-2, 3-8, and 3-10, 
respectively, compared to the S1 state of their parent complex 3-1; while benzannulation at the 
4,5−/4′,5′−positions of 2,2′−bipyridine destabilized the S1 state in 3-9 in comparison to that of 3-
1. In contrast, benzannulation at the 2,2′,3,3′−position 2,2′−bipyridine and further benzannulation 
at phenanthroline essentially had no impact on the S1 state energies of 3-5 – 3-7 compared to that 
of 3-1. While benzannulation at the 6,7−position of quinoline lowered the S1 state in 3-3, 
benzannulation at the 7,8−position of quinoline raised the S1 state in 3-4. This trend matched well 
with experimental observations and was in accordance with that reported by our group earlier for 
another series of cyclometalated monocationic Ir(III) complexes with different C^N ligands.32 
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Figure 3.1. UV−vis absorption spectra of 3-1−3-10 in CH2Cl2 at room temperature. The insets 
are the expanded spectra in the region of 450−625 nm. 
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Figure 3.2. Normalized experimental absorption spectra of 3-1 – 3-10 in different solvents. 
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Table 3.1. Electronic absorption, emission, and triplet excited−state absorption parameters for 
complexes 3-1−3-10. 
 abs/nm (log ) a em/nm (em/μs); 
emb 
kr / s-1 c knr / s-1 d T1‑Tn/nm (TA/μs; log  T1‑Tn); 
T e 
3-1 281 (4.68), 307 (4.35), 339 
(4.34), 440 (3.73), 519 (2.79) 
553 (2.16); 0.41 1.90105 2.73105 407 (2.14; −), 573 (2.13, −), 
783 (−; −); − g 
3-2 280 (4.79), 337 (4.52), 433 
(3.84), 518 (3.02) 
613 (0.52); 0.081 1.56105 1.77106 380 (0.30; −), 782 (0.33; −); 
− g 
3-3 280 (4.85), 307 (4.65), 351 
(4.51), 436 (3.76), 523 (3.20) 
738 (2.62); 
0.0031 
1.18103 3.80105 339 (−,−), 390 (3.42; −), 555 
(3.32; −), 660 (3.47; −); − g 
3-4 283 (4.87), 312 (4.82), 347 
(4.46), 438 (3.99), 500 (3.18) 
583 (− f); 0.0022 − − 398 (4.52; −), 555 (4.44; −), 
795 (4.46; −); − g 
3-5 280 (4.75), 333 (4.38), 350 
(4.31), 438 (3.77), 518 (2,73) 
554 (2.77); 0.71 2.56105 1.05105 363 (−; −), 407 (2.82; −), 578 
(2.93; −), 797 (2.87; −); − g 
3-6 281 (4.79), 333 (4.49), 439 
(3.78), 518 (2.79) 
553 (2.71); 0.78 2.88105 8.12104 360 (−; −), 407 (2.79; −), 575 
(2.81; −), 797 (2.79; −); − g 
3-7 284 (4.94), 331 (4.57), 348 
(4.51), 439 (3.79), 518 (2.85) 
554 (31.0); 0.27 8.71103 2.35104 412 (sh., 19.6; −), 475 (19.6; 
−); − g 
3-8 280 (4.91), 352 (4.63), 365 
(4.56), 430 (3.96), 527 (3.19) 
645 (1.00); 0.084 1.56105 1.70106 390 (0.61; −), 449 (0.63; −), 
641 (0.63; 4.35), 782 (0.63; 
4.64); 0.54 
3-9 280 (4.82), 334 (4.55), 350 
(4.47), 437 (3.75), 517 (2.96) 
582 (− f); 0.0013 − − 741 (0.04; − ); − g 
3-10 280 (4.85), 339 (4.65), 350 
(4.65), 431 (3.99), 529 (3.10) 
651 (0.49); 0.075 5.47105 6.74106 533 (0.25; 4.42), 695 (0.25; 
4.40); 0.28 
a Absorption band maxima (abs) and molar extinction coefficients (log ) of the UV−vis absorption in CH2Cl2 at room 
temperature. b The emission band maxima (em) and lifetimes (em) for 3-1 − 3-10 in CH2Cl2 (c = 1 × 10−5 mol/L) at 
room temperature. A degassed acetonitrile solution of [Ru(bpy)3]Cl2 (Φem = 0.097, λex = 436 nm) was used as reference 
for the emission quantum yield measurement. The quantum yields were measured using a fiber coupled Ocean Optics 
integrating sphere. ex = 450 nm, the emission signals in the wavelength range of 380 – 820 nm were integrated for 
all of the complexes except for 3-3. The integration range for 3-3 was 380-900 nm.  c,d Radiative decay rates (kr) and 
nonradiative decay rates (knr) calculated by kr = em/(Tem) and knr = (1-em)/(Tem), respectively. For 3-8 and 3-
10, the estimated triplet quantum yields (T) from the TA measurement were used. For the other complexes, T was 
assumed to be 1.  e Nanosecond TA band maxima (T1‑Tn), triplet excited state lifetimes (TA), triplet extinction 
coefficients (log T1‑Tn), and triplet quantum yields (T) measured in CH3CN at room temperature. f Too weak to be 
measured. g Due to lack of bleaching band, the T1‑Tn values cannot be estimated using the singlet depletion method, 
the T values cannot be determined, either. 
 
Table 3.2. NTOs of the low−energy transitions contributing to the 400−500 nm absorption band 
of complexes 3-1 − 3-10 in CH2Cl2. 
Excited state 
and properties 
Hole Electron Excited   state 
and properties 
Hole Electron 
3-1 S1 
485 nm 
f = 0.002 
  
3-7 
 
 
S1 
482 nm 
f = 0.000 
  
S2 
454 nm 
f = 0.047 
  
S2 
458 nm 
f = 0.001 
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Table 3.2. NTOs of the low−energy transitions contributing to the 400−500 nm absorption band 
of complexes 3-1 − 3-10 in CH2Cl2. (continued) 
Excited state 
and properties 
Hole Electron Excited   state 
and properties 
Hole Electron 
 S3 
454 nm 
f = 0.024 
  
 S3 
455 nm 
f = 0.069 
  
3-2 S1 
517 nm 
f = 0.004 
  
3-8 S1 
537 nm 
f = 0.010 
  
S2 
449 nm 
f = 0.063 
  
S2 
450 nm 
f = 0.045 
  
S4 
412 nm 
f = 0.019 
  
S3 
439 nm 
f = 0.016 
 
 
69% 
 
69% 
S5 
399 nm 
f = 0.003 
  
 
 
29% 
 
29% 
3-3 S1 
560 nm 
f = 0.002 
  
S4 
433 nm 
f = 0.015 
 
 
68% 
 
68% 
S2 
477 nm 
f = 0.051 
  
 
 
31% 
 
31% 
S3 
450 nm 
f = 0.063 
  
S5 
425 nm 
f = 0.006 
  
S5 
436 nm 
f = 0.008 
  
S6 
402 nm 
f = 0.038 
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Table 3.2. NTOs of the low−energy transitions contributing to the 400−500 nm absorption band 
of complexes 3-1 − 3-10 in CH2Cl2. (continued) 
 
Excited state 
and properties 
Hole Electron Excited   state 
and properties 
Hole Electron 
3-4 S1 
487 nm 
f = 0.025 
  
3-9 S1 
461 nm 
f = 0.004 
 
56% 56% 
S2 
449 nm 
f = 0.005 
  
 
20% 20% 
S3 
445 nm 
f = 0.031 
  
S2 
458 nm 
f = 0.055 
  
3-5 S1 
483 nm 
f = 0.001 
  
 S3 
444 nm 
f = 0.012 
  
S2 
470 nm 
f = 0.000 
  
S4 
414 nm 
f = 0.003 
  
S3 
455 nm 
f = 0.070 
  
S5 
397 nm 
f = 0.016 
  
S4 
427 nm 
f = 0.007 
  
3-10 S1 
556 nm 
f = 0.002 
  
3-6 S1 
483 nm 
f = 0.000 
  
S3 
454 nm 
f = 0.067 
  
S2 
460 nm 
f = 0.001 
  
S4 
430 nm 
f = 0.035 
  
S3 
455 nm 
f = 0.070 
  
S5 
412 nm 
f = 0.003 
  
S4 
408 nm 
f = 0.006 
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Table 3.3. NTOs for the optical transitions at 300 – 400 nm for 3-1 – 3-10 in CH2Cl2. The isovalue 
is set to 0.03. 
 State Hole Electron  State Hole Electron 
3-1 S4 
383 nm 
f = 0.026 
  
3-6 S5 
382 nm 
f = 0.058 
  
 S6 
365 nm 
f = 0.042 
  
 S10 
354 nm 
f = 0.055 
  
 S10 
347 nm 
f = 0.081 
  
 S12 
347 nm 
f = 0.059 
  
 S12 
339 nm 
f = 0.213 
  
 S13 
344 nm 
f = 0.191 
  
 S19 
320 nm 
f = 0.229 
 
 
54% 
 
54% 
 S23 
321 nm 
f = 0.129 
 
 
56% 
 
56% 
  
 
39% 
 
39% 
  
 
27% 
 
27% 
3-2 S6 
379 nm 
f = 0.055 
  
 S24 
321 nm 
f = 0.164 
 
 
54% 
 
54% 
 S10 
351 nm 
f = 0.077 
  
  
 
32% 
 
32% 
 S15 
341 nm 
f = 0.124 
  
 S29 
310 nm 
f = 0.188 
 
 
58% 
 
58% 
 S16 
341 nm 
f = 0.083 
  
  
 
27% 
 
27% 
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Table 3.3. NTOs for the optical transitions at 300 – 400 nm for 3-1 – 3-10 in CH2Cl2. The 
isovalue is set to 0.03. (continued) 
 State Hole Electron  State Hole Electron 
 S23 
318 nm 
f = 0.130 
  
3-7 S5 
400 nm 
f = 0.034 
  
 S24 
317 nm 
f = 0.204 
 
 
53% 
 
53% 
 S7 
383 nm 
f = 0.066 
  
  
 
28% 
 
28% 
 S9 
369 nm 
f = 0.101 
  
3-3 S7 
395 nm 
f = 0.014 
  
 S10 
368 nm 
f = 0.043 
 
 
75% 
 
75% 
 S8 
391 nm 
f = 0.010 
  
  
 
22% 
 
22% 
 S9 
383 nm 
f = 0.013 
  
 S14 
354 nm 
f = 0.073 
  
 S12 
362 nm 
f = 0.030 
  
 S15 
349 nm 
f = 0.073 
  
 S13 
361 nm 
f = 0.026 
  
 S16 
348 nm 
f = 0.075 
  
 S15 
355 nm 
f = 0.077 
 
 
69% 
 
69% 
 S18 
343 nm 
f = 0.194 
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Table 3.3. NTOs for the optical transitions at 300 – 400 nm for 3-1 – 3-10 in CH2Cl2. The 
isovalue is set to 0.03. (continued) 
 State Hole Electron  State Hole Electron 
  
 
21% 
 
21% 
 S24 
328 nm 
f = 0.123 
 
 
57% 
 
57% 
 S16 
351 nm 
f = 0.109 
  
  
 
32% 
 
32% 
 S21 
335 nm 
f = 0.105 
  
 S28 
321 nm 
f = 0.297 
 
 
54% 
 
54% 
 S22 
335 nm 
f = 0.142 
  
  
 
27% 
 
27% 
 S25 
319 nm 
f = 0.515 
  
3-8 S8 
374 nm 
f = 0.034 
  
 S30 
308 nm 
f = 0.291 
 
 
52% 
 
52% 
 S14 
352 nm 
f = 0.097 
 
 
59% 
 
59% 
  
 
31% 
 
31% 
  
 
37% 
 
37% 
3-4 S4 
391 nm 
f = 0.009 
  
 S17 
344 nm 
f = 0.115 
  
 S5 
381 nm 
f = 0.036 
  
 S18 
336 nm 
f = 0.241 
  
 S8 
365 nm 
f = 0.106 
  
 S23 
326 nm 
f = 0.111 
  
 106 
Table 3.3. NTOs for the optical transitions at 300 – 400 nm for 3-1 – 3-10 in CH2Cl2. The 
isovalue is set to 0.03. (continued) 
 State Hole Electron  State Hole Electron 
 S11 
355 nm 
f = 0.107 
 
 
38% 
 
38% 
 S28 
314 nm 
f = 0.126 
 
 
43% 
 
43% 
  
 
29% 
 
29% 
  
 
29% 
 
29% 
  
 
21% 
 
21% 
 S32 
304 nm 
f = 0.108 
  
 S17 
341 nm 
f = 0.119 
  
3-9 S6 
373 nm 
f = 0.040 
  
 S20 
328 nm 
f = 0.098 
 
 
54% 
 
54% 
 S9 
352 nm 
f = 0.064 
  
  
 
34% 
 
34% 
 S13 
344 nm 
f = 0.114 
  
 S26 
315 nm 
f = 0.191 
 
 
48% 
 
48% 
 S14 
343 nm 
f = 0.174 
  
  
 
23% 
 
23% 
 S23 
328 nm 
f = 0.116 
 
 
50% 
 
50% 
3-5 S5 
382 nm 
f = 0.046 
  
  
 
25% 
 
25% 
 S6 
376 nm 
f = 0.045 
  
 S24 
323 nm 
f = 0.374 
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Table 3.3. NTOs for the optical transitions at 300 – 400 nm for 3-1 – 3-10 in CH2Cl2. The 
isovalue is set to 0.03. (continued) 
 State Hole Electron  State Hole Electron 
 S9 
356 nm 
f = 0.043 
 
 
46% 
 
46% 
 S28 
319 nm 
f = 0.143 
  
  
 
33% 
 
33% 
 S38 
299 nm 
f = 0.210 
  
 S12 
348 nm 
f = 0.114 
  
3-10 S6 
389 nm 
f = 0.015 
  
 S13 
346 nm 
f = 0.099 
  
 S7 
377 nm 
f = 0.119 
  
 S22 
322 nm 
f = 0.274 
  
 S10 
368 nm 
f = 0.117 
 
 
57% 
 
57% 
      
 
40% 
 
40% 
     S14 
349 nm 
f = 0.098 
  
     S18 
339 nm 
f = 0.131 
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Table 3.4. NTOs for the high energy optical transitions (<300 nm) of 3-1 – 3-10 in CH2Cl2. The 
isovalue is set to 0.03. 
 State Hole Electron  State Hole Electron 
3-1 S33 
282 nm 
f = 0.194 
 
 
45% 
 
45% 
3-6 S53 
269 nm 
f = 0.458 
 
 
37% 
 
37% 
  
 
30% 
 
30% 
  
 
29% 
 
29% 
 S37 
276 nm 
f = 0.170 
  
 S72 
252 nm 
f = 0.346 
 
 
40% 
 
40% 
 S43 
267 nm 
f = 0.283 
  
  
 
22% 
 
22% 
3-2 S58 
271 nm 
f = 0.330 
 
 
39% 
 
39% 
3-7 S42 
296 nm 
f = 0.279 
  
  
 
31% 
 
31% 
 S44 
293 nm 
f = 0.295 
 
 
73% 
 
73% 
3-3 S47 
272 nm 
f = 0.341 
  
  
 
23% 
 
23% 
3-4 S49 
275 nm 
f = 0.178 
 
 
37% 
 
37% 
 S54 
278 nm 
f = 0.264 
 
 
58% 
 
58% 
  
 
33% 
 
33% 
  
 
26% 
 
26% 
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Table 3.4. NTOs for the high energy optical transitions (<300 nm) of 3-1 – 3-10 in CH2Cl2. The 
isovalue is set to 0.03. (continued) 
 State Hole Electron  State Hole Electron 
 S53 
271 nm 
f = 0.219 
 
 
49% 
 
49% 
 S63 
266 nm 
f = 0.318 
  
  
 
33% 
 
33% 
3-8 S53 
275 nm 
f = 0.318 
  
3-5 S40 
279 nm 
f = 0.136 
 
 
42% 
 
42% 
 S56 
272 nm 
f = 0.232 
  
  
 
38% 
 
38% 
 S69 
258 nm 
f = 0.266 
 
 
52% 
 
52% 
 S44 
270 nm 
f = 0.332 
 
 
37% 
 
37% 
  
 
34% 
 
34% 
  
 
23% 
 
23% 
3-9 S56 
270 nm 
f = 0.395 
 
 
45% 
 
45% 
  
 
21% 
 
21% 
  
 
23% 
 
23% 
 S45 
270 nm 
f = 0.298 
  
 S66 
256 nm 
f = 0.384 
 
 
57% 
 
57% 
 S50 
263 nm 
f = 0.383 
 
 
 
 
 
  
 
21% 
 
21% 
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Table 3.4. NTOs for the high energy optical transitions (<300 nm) of 3-1 – 3-10 in CH2Cl2. The 
isovalue is set to 0.03. (continued) 
     State Hole Electron 
    3-10 S56 
272 nm 
f = 0.317 
  
     S59 
269 nm 
f = 0.143 
  
     S70 
256 nm 
f = 0.152 
  
 
Table 3.5.  HOMOs and LUMOs of 3-1 – 3-10 in CH2Cl2 and the contribution of HOMO→LUMO 
transition to the S1 state. 
 HOMO LUMO 
Percentage Contribution of H/L 
Transition to S1 State 
3-1 
  
70% 
3-2 
  
70% 
3-3 
  
70% 
3-4 
  
68% 
3-5 
  
70% 
3-6 
  
70% 
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Table 3.5.  HOMOs and LUMOs of 3-1 – 3-10 in CH2Cl2 and the contribution of 
HOMO→LUMO transition to the S1 state. (continued) 
 HOMO LUMO 
Percentage Contribution of H/L 
Transition to S1 State 
3-7 
  
69% 
3-8 
  
70% 
3-9 
  
S1 H/L 0%; H/L+1 69% 
S2 H/L 43% 
S3 H/L 56% 
S4 H/L 70% 
3-10 
  
70% 
 
The DFT calculation showed that the HOMO→LUMO transition was the dominant 
contributor (~70%) to the S1 states of all of the complexes except for 3-9 (see Table 3.5). Electron 
density distribution plots of the HOMOs and LUMOs in 3-1 – 3-10 (Table 3.5) clearly 
demonstrated that the HOMOs of these complexes were predominantly distributed on the phenyl 
rings of the 2−phenylquinoline ligands and the d−orbital of the Ir(III) center, while the LUMOs 
were exclusively localized on the diimine ligand. Thus, benzannulation at the diimine ligand would 
mainly impact the LUMO energies. As depicted in Figure 3.3, the ground−state MO energy 
diagram for 3-1 – 3-10 manifested that benzannulation drastically changed the LUMO energies 
but had a minor effect on the HOMO energies. Benzannulation at the 5,6−/5′,6′−position or 
3,4−/3′,4′−position of 2,2′−bipyridine or at the 6,7−position of quinoline significantly stabilized 
the LUMOs in complexes 3-2, 3-3, 3-8, and 3-10; whereas benzannulation at the other sites of 
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2,2′−bipyridine or the 7,8−position of quinoline either did not affect or slightly raised the LUMOs 
in 3-4 – 3-7 and 3-9 compared to that of 3-1. 
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Figure 3.3. Ground−state molecular orbital diagram for 3-1 − 3-10 in CH2Cl2 (HOMO and LUMO 
of 3-1 are plotted as representative). 
 
 
 
Figure 3.4. Frontier molecular orbital mixing between cis-1,3−butadiene or ethene and parent 
molecules. 
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According to Thompson / Gordon’s work38 and our previous work,32 benzannulation on 
the diimine ligand can be viewed as the interaction between the LUMO of the parent compound 
and the HOMO or LUMO of cis−1,3−butadiene or ethene, depending on the MO symmetry at the 
site of benzannulation. As exemplified in Figure 3.4, when benzannulation occurred at the 
5,6−position of one of the pyridine rings, the symmetry of the 3-1 LUMO at this site matched the 
symmetry of the LUMO of cis−1,3−butadiene and led to a LUMO−LUMO interaction. The 
LUMO−LUMO interactions resulted in a stabilized LUMO in 3-2 and thus the red−shifted CT 
absorption band in its UV−vis absorption spectrum compared to that of 3-1. Similarly, the 
symmetry of the LUMO of 3-1 at the 5′,6′−position and the 3,4−/3′,4′−position matched the 
symmetry of LUMO of cis−1,3−butadiene, resulting in stabilized LUMOs and red−shifted CT 
absorption bands in complexes 3-8 and 3-10 (Figure 3.4). In contrast, when benzannulation 
occurred at the 4,5−/4′,5′−position of 2,2′−bipyridine in 3-1, the symmetry of the LUMO of 3-1 at 
these positions matched the symmetry of the HOMO of cis−1,3−butadiene. The HOMO−LUMO 
interactions gave rise to a destabilized LUMO in complex 3-9 and thus an enlarged 
HOMO−LUMO energy gap and a blue−shifted CT absorption band. From complex 3-1 to 3-5, 
benzannulation at the 2,2′,3,3′−position of 2,2′−bipyridine in 3-1 can be considered as the 
interaction between the LUMO of 3-1 and the HOMO of ethene due to symmetry matching 
requirement. Such an interaction showed a negligible impact on the LUMO of 3-5 and essentially 
did not affect the CT transition in 3-5 compared to that of 3-1. A similar MO symmetry analysis 
was applied to the other complexes and the results are provided in Figure 3.4. 
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3.3.2. Photoluminescence 
To evaluate the site−dependent benzannulation effect on the triplet excited states of 
complexes 3-1−3-10, the emission characteristics of these complexes were investigated in different 
solvents at room temperature. The emission spectra in CH2Cl2 are displayed in Figure 3.5 and the 
emission parameters (lifetime and quantum yield) in CH2Cl2 are tabulated in Table 3.1. The 
normalized emission spectra in other solvents are presented in Figure 3.6 and the emission 
parameters are compiled in Table 3.6. The emission of these complexes was sensitive to oxygen 
quenching and was moderately long−lived (0.52−31.0 s) (except for 3-4 and 3-9, in which the 
emission signals were too weak to be measured), indicating the phosphorescent nature of the 
emission. These features are consistent with the other reported Ir(III) complexes.17-19,24-33,39-42 
Except for 3-3 that exhibited emission in the near−IR region with clear vibronic structures, the 
emission of all of the other complexes were broad and almost featureless. 
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Figure 3.5. Normalized emission spectra of 3-1 − 3-10 in CH2Cl2 at room temperature. (λex = 438 
nm for 3-1, 430 nm for 3-2, 439 nm for 3-3, 436 nm for 3-4, 438 nm for 3-5, 437 nm for 3-6, 440 
nm for 3-7, 428 nm for 3-8, 436 nm for 3-9, and 437 nm for 3-10. 
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Table 3.6. Emission characteristics of complexes 3-1 − 3-10 in different solvents at room 
temperature. 
λem/nm (τem/μs)a; emb 
 Acetonitrile THF Toluene/5% CH2Cl2 
3-1 557 (2.48); 0.47 555 (2.22); 0.75 557 (2.15); 0.34 
3-2 608 (0.30); 0.035 618 (0.36); 0.050 616 (0.18); 0.045 
3-3 733 (0.63); 0.0044 735 (2.06); 0.0098 733 (-)c; 0.0061 
3-4 572 (-)c; - c 587 (1.10); 0.0032 562 (-)c; - c 
3-5 558 (2.91); 0.59 556 (2.47); 0.62 560 (2.09); 0.56 
3-6 557 (2.69); 0.56 556 (2.37); 0.65 562 (2.11); 0.61 
3-7 559 (19.2); 0.22 558 (16.2); 0.17 562 (11.9); 0.24 
3-8 649 (0.64); 0.037 644 (0.69); 0.042 653 (0.41); 0.032 
3-9 560 (-)c; 0.0026 596 (-)c; 0.0013 560 (-)c; 0.0038 
3-10 653 (0.25); 0.035 656 (0.28); 0.076 596 (0.03); 0.025 
a The emission band maxima (em) and lifetimes (em) for 3-1 − 3-10 at room temperature. b 
Absolute QY measurements were performed using a fiber coupled Ocean Optics integrating 
sphere. ex = 450 nm, detection wavelength range was 350 – 1700 nm. The integration range was 
380-820 nm for 3-1 − 3-10 except for 3-3, for which the integration was done in the range of 380-
900 nm. c Too weak to be measured. 
 
In comparison to the parent complex 3-1, benzannulation at the 3,4−/3′,4′−position, 
4,5−/4′,5′−position, or 5,6−/5′,6′−position of 2,2′−bipyridine all caused a red−shift of the emission 
spectra for 3-2, 3-8, 3-9, and 3-10, accompanied by a shortened lifetime and a reduced emission 
quantum yield; while benzannulation at the 2,2′,3,3′−position of 2,2′−bipyridine essentially had no 
impact on the emission energy of 3-5, but with a slightly longer lifetime and an increased emission 
quantum yield. A drastically red−shifted emission into the NIR region was observed for 3-3 after 
fusion of an additional phenyl ring at the 6,7−position of quinoline in 3-2. In contrast, 
benzannulation at the 7,8−position of quinoline in 3-2 induced a salient blue−shift of the emission 
of 3-4 and a lower quantum yield compared to those of 3-2 and 3-3. Going from 3-5 to 3-7, further 
extending the −conjugation along the 5,6−position of 1,10−phenanthroline did not alter the 
emission energies of complexes 3-6 and 3-7. However, the emission lifetime of 3-7 was more than 
one order of magnitude longer than those of 3-5 and 3-6, but its emission quantum yield is less 
than half of those for 3-5 and 3-6. Similar to the trend discovered for the S1 states in these 
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complexes based on the electronic absorption, the site−dependent benzannulation influenced the 
energies of the lowest triplet excited states (T1) in a similar manner, but the impact is more 
pronounced on the T1 state than on the S1 state. 
Table 3.7. NTOs representing the lowest triplet transitions (T1) of 3-1 − 3-10 in CH2Cl2. 
 T1/nm Hole Electron  T1/nm Hole Electron 
3-1 625 
  
3-6 606 
  
3-2 659 
  
3-7 610 
  
3-3 1146 
  
3-8 733 
  
3-4 647 
  
3-9 647 
  
3-5 600 
  
3-10 744 
  
 
To understand the electronic configurations of the emitting states for 3-1 – 3-10, TDDFT 
calculations were performed and the NTOs representing the emitting T1 states are displayed in 
Table 3.7. The trend of the calculated emission energies matched the trend of the experimental 
energies very well Figure 3.6. For complexes 3-1, 3-2, 3-5 − 3-7, their holes are almost exclusively 
distributed on the phenyl rings of the C^N ligands and on the metal d−orbital; while the electrons 
are localized on the diimine ligands and the d−orbital. Therefore, the emitting states in these 
complexes are assigned to predominantly the 3MLCT/3LLCT states, mixed with some 3LMCT/3d,d 
 117 
configurations. For complex 3-3, both the hole and electron are almost exclusively on the 
benzoquinoline part of the N^N ligand, with minor contribution from the metal d orbitals. This 
indicates the dominant 3,* nature with minor 3d,d character for the emitting state in 3-3. The 
NTOs show that the emitting state of 3-9 also has predominant 3,* configuration with minor 
3d,d contribution. However, both the hole and electron are mainly distributed on one of the C^N 
ligands. The remaining complexes 3-4, 3-8 and 3-10 all have holes on the phenyl rings of the C^N 
ligands and the d−orbitals, with some contributions from the N^N ligands; while their electrons 
are distributed on the N^N ligands and the d−orbitals. Therefore, the emitting states in these 
complexes have mixed 3MLCT/3LLCT/3,* configurations with minor contribution from the 
3LMCT/3d,d configurations. It is noted that the electrons in 3-5 – 3-7 are only localized on the 
phenanthroline motif, they did not extend to the additional phenyl ring(s). Therefore, the emission 
energies in these three complexes are essentially the same. 
For complexes 3-1, 3-2, 3-8 and 3-10 that have dominant charge transfer configurations in 
their emitting states, benzannulation reduced the energies of their emitting states, which 
significantly increased the nonradiative decay rate constants (see knr in Table 3.1) in 3-2, 3-8, and 
3-10 compared to that in 3-1 without pronouncedly altering their radiative decay rate constants 
(kr). This trend is in accordance with the energy gap law.
68,69 For complexes 3-5 and 3-6, they have 
the similar krs to that of 3-1, but their knrs are smaller than that of 3-1. The reduced knrs in 3-5 and 
3-6 can be attributed to the rigidity of phenanthroline and its derivatives compared to bipyridine. 
Consequently, their emission quantum yields are higher than that of 3-1. Interestingly, the emission 
energy and the T1 state configuration of 3-7 resemble those of 3-5 and 3-6, but its lifetime is one 
order of magnitude longer than those of 3-5 and 3-6 and its emission quantum yield is less than 
half of those for 3-5 and 3-6. Examination of the triplet energy diagram obtained from the TDDFT 
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calculation (Figure 3.7) reveals that unlike the other complexes, the second triplet excited state 
(T2) in 3-7 lies closely to its T1 state, which makes it possible to be configurationally mixed with 
T1 state and reaches an equilibrium. Because the T2 state of 3-7 has a 
3,* configuration (Table 
3.8), admixing T2 with T1 drastically reduces the kr and knr in 3-7 compared to those in 3-5 and 3-
6, which dramatically prolongs the emission lifetime of 3-7. 
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Figure 3.6. Comparing experimental emission spectra to TDDFT SCF energy for 3-1 – 3-10 in 
dichloromethane. 
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Figure 3.7. Triplet excited state energy diagram for 3-1 – 3-10 in CH2Cl2. 
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Table 3.8. NTOs for the second triplet excited states (T2) of 3-1 – 3-10 in CH2Cl2. 
    HOTO    LUTO    HOTO    LUTO 
3-1 
  
3-6 
  
3-2 
  
3-7 
  
3-3 
  
3-8 
  
3-4 
  
3-9 
  
3-5 
  
3-10 
  
 
3.3.3. Transient absorption (TA) 
The nanosecond TA of complexes 3-1 – 3-10 in acetonitrile was investigated to further 
understand their triplet excited state characteristics. The TA spectra of 3-1 – 3-10 immediately 
after laser excitation are shown in Figure 3.8, and the time–resolved TA spectra are presented in 
Figure 3.9. The TA band maxima, triplet excited−state lifetimes, triplet extinction coefficients and 
quantum yields (when applicable), are listed in Table 3.1. The triplet excited−state lifetimes 
deduced from the decay profiles of the TA signals resembled the lifetimes obtained from the decay 
of emission in acetonitrile. Accordingly, we can tentatively assign the transient absorbing excited 
states to the emitting excited states except for 3-7. 
The TA spectra in Figure 3.8 and the data in Table 3.1 manifested that 3-1, 3-5 and 3-6 
possessed identical TA spectra, and their triplet lifetimes were on the same order. The TA spectral 
feature of 3-4 appeared to resemble those of 3-1, 3-5 and 3-6, but was somewhat blue-shifted 
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accompanied by a longer lifetime. The TA spectra of 3-2 and 3-8 were similar in shape but the TA 
band maximum was red−shifted for 3-8 compared to 3-2, and the lifetime of 3-8 is longer than that 
of 3-2. The TA spectra of 3-3 and 3-10 were similar in the region of 450−800 nm with very broad 
and moderately strong absorption. However, the triplet lifetime of 3-3 is one order of magnitude 
longer than that of 3-10, reflecting the different natures of the T1 states in these two complexes. In 
addition, the spectra of 3-2, 3-3, 3-4, and 3-8 all resembled those of their corresponding Ir(III) 
complexes bearing the same N^N ligand but with different C^N ligands.32 Considering the natures 
of the T1 states in these complexes (discussed in the photoluminescence section) and comparing 
these spectra to those of their corresponding N^N ligands and those of their Zn2+ perturbed ligands 
(Figure 3.10), we attribute the observed TA to 3MLCT/3LLCT for 3-1, 3-2, 3-5, and 3-6, to N^N 
localized 3,* to 3-3 and 3-7, to 3,*/3MLCT/3LLCT to 3-4, and to 3MLCT/3LLCT/3,* for 3-
8 and 3-10. No TA signals were observed from 3-9, which is consistent with the C^N ligand 
localized 3,* nature for its T1 state because we reported earlier that neither 2−phenylquinoline 
(pq) nor its chloro−bridged dinuclear Ir(III) precursor [(Ir(pq)2Cl]2 produced any TA signals.31 The 
drastically different TA spectra and lifetimes of 3-8, 3-9 and 3-10 clearly manifested the distinct 
effects that variations of the benzannulation site at the N^N ligand exerted on the triplet excited-
state absorption. 
Complex 3-7 exhibited a quite distinct TA spectrum from the other complexes, with a very 
strong absorption band at 475 nm and a quite long triplet lifetime. This TA spectral feature was 
identical to that of its N^N ligand (Figure 3.10). Therefore, the observed TA for 3-7 is ascribed to 
the 3,* state localized on the N^N ligand. As discussed in the previous section, the T2 state in 3-
7 has the N^N ligand localized 3,* configuration and is energetically closed to its T1 state. Thus, 
it can configurationally mix with the T1 state and predominantly contribute to the TA of 3-7. 
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Figure 3.8. Nanosecond transient differential absorption spectra of complexes 3-1 − 3-10 in 
acetonitrile solution immediately after laser pulse excitation (A355 = 0.4 in a 1−cm cuvette, λex = 
355 nm). 
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Figure 3.9. Nanosecond time-resolved transient differential absorption spectra of 3-1 – 3-10 at 
zero-time decay in acetonitrile. λex = 355 nm, A355 = 0.4 in a 1-cm cuvette. 
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Figure 3.10. Nanosecond time-resolved transient absorption (TA) spectra of the diimine ligands 
used in complexes 3-2 − 3-4, 3-6 − 3-8 and 3-10 and their corresponding ZnCl2 complexes in 
CH3CN. The diimine ligands used in 3-1, 3-5 and 3-9 and their corresponding ZnCl2 complexes 
did not show any TA signals. ex = 355 nm, and A355 = 0.4 in a 1-cm cuvette. 
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3.3.4. Reverse saturable absorption 
The results and discussions in the previous sections revealed that the ground−state and 
excited−state absorption and the triplet lifetimes were affected remarkably by the site of 
benzannulation at the N^N ligand in complexes 3-1 − 3-10. In addition, the TA signals for all 
complexes except for 3-9 were positive at 532 nm, implying a stronger excited−state absorption 
than the ground−state absorption at this wavelength. This phenomenon set up the condition for 
reverse saturable absorption (RSA, a nonlinear optical phenomenon in which the absorptivity of a 
compound increases with increased incident fluence) to occur. To demonstrate the RSA, nonlinear 
transmission measurement for all complexes was performed in acetonitrile solutions in a 2−mm 
cuvette using the 532 nm 4.1 ns laser pulses as the light source. For convenient comparison, the 
linear transmission of each sample solution was adjusted to 80% at 532 nm in the 2−mm cuvette. 
The resultant transmission vs. incident energy curves are presented in Figure 3.11. With increased 
incident energy, the transmission of all complexes decreased pronouncedly, indicating the 
occurrence of RSA. The strength of the RSA decreased following the sequence of 3-7 > 3-5 ≈ 3-6 
> 3-1 > 3-3 > 3-2 > 3-4 > 3-10 > 3-8 > 3-9, with 3-7 exhibiting the strongest RSA by reducing the 
transmission from 80% to 25% at the incident energy of 709 J. The RSA trend matched well with 
their OD values at 532 nm (see Table 3.9). It is well known that the strength of RSA is mainly 
determined by the ratio of the excited−state absorption cross section vs. the ground−state 
absorption cross section (ex/0) at the interested wavelength. A decreased ground−state 
absorption and/or increased excited−state absorption would induce a strong RSA. The 0 values 
can be obtained by converting the molar extinction coefficients at 532 nm using the equation  = 
2303/NA (where NA is the Avogadro’s constant). Unfortunately, the ex values for most of the 
complexes could not be obtained due to the lack of obvious bleaching bands in the TA 
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measurement so that the singlet depletion method could not be applied to estimate the ex values. 
Nevertheless, the OD values that measure the absorptivity difference between the excited state 
and the ground state can serve as a good indicator for the strength of the excited−state absorption. 
A general trend is that the complexes with increased ground−state absorption at 532 nm due to 
benzannulation, i.e. 3-2, 3-4, 3-8, 3-9 and 3-10, exhibited weaker excited−state absorption at 
532nm. The combination of these changes reduced the RSA strength for these complexes. 
Although 3-3 had an increased 0 value at 532 nm, its much stronger excited−state absorption at 
this wavelength counteracted the increased ground−state absorption and consequently gave rise to 
a stronger RSA than 3-2, 3-4, 3-8, 3-9 and 3-10. 
Table 3.9. Ground−state absorption cross sections (σ0) and OD values of 3-1 − 3-10 at 532 nm. 
 3-1 3-2 3-3 3-4 3-5 3-6 3-7 3-8 3-9 3-10 
σ0/10−18 cm2 1.39 3.06 5.65 2.47 1.28 1.37 1.52 5.80 2.42 4.61 
ODb 0.018 0.011 0.020 0.014 0.020 0.020 0.024 0.007 −c 0.015 
a Measured in CH2Cl2. 
b Measured in CH3CN. 
c Too weak to be measured. 
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Figure 3.11. Transmission vs incident energy curves for 3-1 − 3-10 at the linear transmittance of 
80% in 2 mm cuvette (in acetonitrile solution) using the 532 nm 4.1 ns laser pulses. The radius of 
the beam at the focal point was approximately 96 m. 
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3.4. Conclusions 
Ten moncationic iridium(III) complexes featuring various N^N ligands were synthesized 
and their photophysical properties were systematically investigated. Extending −conjugation of 
the N^N ligand via benzannulation caused either a red− or blue−shift in their absorption and 
emission spectra compared to their corresponding parent complex. This phenomenon was 
rationalized by analyzing the molecular orbital symmetry at the site of benzannulation via DFT 
calculations. Depending on the site of benzannulation, destabilization (when benzannulation 
occurred at the 3,4−/3′,4′−position or 5,6−/5′,6′−position of 2,2′−bipyridine ligand or at the 
6,7−position of the quinoline ring on the N^N ligand) or stabilization (when benzannulation 
occurred at the 4,5−/4′,5′−position of 2,2′−bipyridine ligand or at the 7,8−position of the quinoline 
ring on the N^N ligand) or no change (when benzannulation occurred at the 2,2′,3,3′−position of 
2,2′−bipyridine or 5,6−position of phenanthroline ligand) of the LUMO was found upon 
interaction with cis−1,3−butanediene. Consequently, an enlarged or narrowed or identical 
HOMO−LUMO gap was produced compared to the parent complex and a blue− or red−shifted or 
no−changed charge transfer absorption band was observed. The similar trend was observed in the 
emission spectra of these complexes. The site of benzannulation also impacted the ns TA of these 
complexes drastically. Due to the site−dependent benzannulation effects on the ground− and 
excited−state absorption, RSA strength of these complexes at 532 nm also varied, which followed 
the trend of 3-7 > 3-5 ≈ 3-6 > 3-1 > 3-3 > 3-2 > 3-4 > 3-10 > 3-8 > 3-9. This trend correlated well 
with their OD values at 532 nm and their ground−state absorption cross sections at 532 nm. 
Benzannulation that increased ground−state absorption but reduced the excited−state absorption 
resulted in reduced RSA, while benzannulation that had minor impact on the ground−state 
absorption but increased the excited−state absorption gave rise to enhanced RSA. A detailed 
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understanding of the benzannulation site−dependent red− or blue− shift of the absorption and 
emission spectra is vital for designing organometallic complexes with predetermined 
photophysical properties for applications in OLEDs, dye−sensitized solar cells, phosphorescent 
probes, and photosensitizers for upconversion or photodynamic therapy. 
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4. EFFECTS OF VARYING THE BENZANNULATION SITE AND π CONJUGATION OF 
THE CYCLOMETALATING LIGAND ON THE PHOTOPHYSICS AND REVERSE 
SATURABLE ABSORPTION OF MONOCATIONIC IRIDIUM(III) COMPLEXES 
 
4.1. Introduction  
In the past two decades, heavy-transition-metal complexes, especially octahedral d6 
iridium(III) complexes, have attracted extensive interest because of the strong spin−orbit coupling 
of the iridium(III) ion, which enhances the intersystem crossing rate and thus facilitates the 
formation of a triplet excited state and increases the phosphorescence quantum yield.1,2 This feature 
holds great potential for a variety of applications, such as organic light-emitting devices,3,4 light-
emitting electro- chemical cells,5−8 low-power upconversion,9,10 luminescent biological labeling,11 
and nonlinear optics.12−15 In addition, iridium(III) complexes exhibit excellent chemical and 
thermal stabilities, facilitating the practical applications of these complexes in photonic and 
biophotonic areas. More importantly, the excited-state properties of the iridium(III) complexes can 
be readily tuned via ligand structural modifications for tailing a specific application.16−33  
The facile tunability of monocationic cyclometalated iridium(III) complexes, 
[(N^N)Ir(C^N)2]+, distinguishes them from their bicationic ruthenium(II) analogues, [Ru- 
(N^N)3]2+, because the cyclometalating (C^N) and diimine (N^N) ligands can be altered 
independently to tune the photophysical properties of the iridium(III) complexes.16−33 One of the 
commonly applied strategies is to incorporate electron-donating or -withdrawing substituents on 
the ligand(s).16−22 Another efficient strategy is to extend the π conjugation of the N^N and/or C^N 
ligand(s).23−33 In comparison to the former approach, extending the ligand π conjugation can alter 
the nature of the lowest singlet or triplet excited state independently. In 2006, Huang’s group 
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reported that the emission wavelength of the heteroleptic iridium(III) complexes with N^N ligands 
bearing different degrees of π conjugation can be adjusted drastically from 586 to 732 nm.23 
Bryce’s group,26 Schanze’s group,27 and our group12,13,21,24,28,30−33 reported that incorporating π-
conjugated substituents or benzannulation to extend the π-conjugation of the N^N ligand 
dramatically changed the triplet lifetime and enhanced the triplet excited-state absorption. This 
was achieved by admixing the N^N-ligand-localized 3π,π* character with the charge-transfer (3CT) 
character in the T1 state or even completely switching the T1 state to the 3π,π* state in the 
[(N^N)Ir(C^N)2]+ complexes. Interestingly, we have previously discovered that different sites of 
benzannulation on the N^N ligand caused either a red or blue shift of the absorption and emission 
spectra in the [(N^N)Ir(C^N)2]+ complexes.28 This unusual phenomenon was rationalized by 
analyzing the symmetry of the frontier molecular orbitals (FMOs) at the site of benzannulation on 
the N^N ligand.  
Alongside the studies on the impact of the π conjugation of the N^N ligand, variation of 
the π-conjugation of the C^N ligands also influences the singlet and triplet excited-state 
characteristics significantly.12,13,25,29,31−33 Particularly, benzannulation at the C^N ligand resulted 
in a strong red shift of the lowest-energy ground-state absorption band and a drastically increased 
contribution of the C^N-ligand-localized 3π,π*/ intraligand CT (3ILCT) configuration(s) to the 
lowest triplet excited state of iridium(III) complexes.25,29,33 However, it is not clear whether the 
impact of benzannulation at the C^N ligands is also site-dependent, similar to benzannulation at 
the N^N ligand.  
To thoroughly understand the impact of benzannulation at the C^N ligand on the excited-
state properties of the iridium(III) complexes for a rational design of iridium(III) complexes for 
photonic applications, a series of monocationic iridium(III) complexes bearing C^N ligands 
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derived from 2-phenylpyridine (ppy; structures shown in Chart 4-1), i.e., 2- phenylquinoline (L4-
1), 3-phenylisoquinoline (L4-2), 1-phenyl-isoquinoline (L4-3), benzo[h]quinoline (L4-4), 2-
(pyridin-2-yl)naphthalene (L4-5), 1-(pyridin-2-yl)naphthalene (L4-6), 2-(phenanthren-9-
yl)pyridine (L4-7), 2-phenylbenzo[g]quinoline (L4-8), 2-(naphthalen-2-yl)quinoline (L4-9), and 
2-(naphthalen-2-yl)benzo[g]quinoline (L4-10), were synthesized. These C^N ligands were 
obtained by varying the site of benzannulation either on the pyridine ring (ligands L4-1 − L4-4) 
or on the benzene ring (ligands L4-4 − L4-6) of the ppy ligand or through expansion of the π-
conjugation of L4-1 (ligands L4-8 − L4-10) or L4-5/L4-6 (ligand L4-7). Complex 4-0 with the 
ppy ligand was used as a reference complex for comparison purposes. To demonstrate how this 
change influences the potential applications of the [(N^N)Ir-(C^N)2]+ complexes, reverse 
saturable absorption (RSA, a nonlinear absorption phenomenon in which the absorptivity of a 
material increases with an increase of the incident light fluence due to stronger excited-state 
absorption than the ground-state absorption) of the synthesized complexes was studied using a 
nanosecond laser pulse at 532 nm. 
  
 
Chart 4.1.  Structures of heteroleptic cationic Ir(III) complexes 4-0 − 4-10. 
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4.2. Experimental section  
4.2.1. Materials and synthesis  
All chemicals and solvents were purchased from Aldrich Chemical Co. or Alfa Aesar and 
used as received unless otherwise noted. Silica gel (60 Å, 230−400 mesh) and Al2O3 gel (neutral) 
used for column chromatography were purchased from Sorbent Technology. The diimine ligand 
2-(pyridin-2-yl)-quinoline (N^N ligand) and C^N ligands L4-1 and L4-8 − L4-10 were 
synthesized by a Friedlan̈der condensation reaction according to or by modification of the literature 
procedure.34−36 3-Aminonaphthalene-2-carboxaldehyde was prepared according to the reported 
method.37 Ligand L4-2 was synthesized by a copper(I)-mediated cyclization reaction from 2-
bromobenzaldehyde and ethynylbenzene.38 Ligands L4-3 and L4-4 were purchased from Alfa 
Aesar and used as received. Ligands L5−L7 were synthesized by Stille coupling reactions from 1- 
bromonaphthalene, 2-bromonaphthalene, and 9-bromophenanthrene, respectively.39,40 The 
synthesized ligands were characterized by 1H NMR spectroscopy, while the synthesized 
complexes 4-1 − 4-10 were confirmed by 1H NMR spectroscopy, electrospray ionization high- 
resolution mass spectrometry (ESI-MS), and elemental analysis. 1H NMR was obtained on Varian 
Oxford VNMR spectrometers (400 or 500 MHz). ESI-MS analyses were conducted on a Bruker 
BioTOF III mass spectrometer. Elemental analyses were carried out by NuMega Resonance 
Laboratories, Inc. (San Diego, CA).  
Ligand L4-7. The mixture of 9-bromophenanthrene (0.64 g, 2.5 mmol), 2-(tributylstannyl) 
pyridine (1.1 g, 3 mmol), Pd(PPh3)4 (40 mg, 0.035 mmol), and toluene (50 mL) was heated to 
reflux under nitrogen for 24 h. After reaction, toluene was removed by distillation, and the resultant 
dark oil was purified by a silica gel column eluted with hexane/ethyl acetate (v/v = 20/1).  A 
colorless oil was obtained as the product (290 mg, 45%).  1H NMR (CDCl3, 400 MHz): δ 8.74-
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8.86 (m, 3H), 8.10 (dd, J = 8.0, 1.2 Hz, 1H), 8.22 (dd, J = 8.0, 1.2 Hz, 1H), 7.86-8.11 (m, 2H), 
7.59-7.72 (m, 5H), 7.40 (ddd, J = 7.6, 3.2, 1.2 Hz, 1H). 
Ligand L4-10. To a solution of 2-acetylnaphthalene (40 mg, 0.23 mmol) and 3-
aminonaphthalene-2-carboxaldehyde (40 mg, 0.23 mmol) in absolute EtOH (20 mL), saturated 
ethanolic KOH (2 mL) was added.  The solution was refluxed under Ar for 24 h.  After evaporation 
of the solvent, the residue was purified by chromatography on alumina gel column, eluting with 
CH2Cl2/hexanes (1:3), to obtain the title compound as a yellow powder (51 mg, 72%).  1H NMR 
(CDCl3, 400 MHz): δ 8.79 (s, 1H), 8.65 (s, 1H), 8.46-8.41 (m, 3H), 8.12-8.07 (m, 1H), 8.05-7.98 
(m, 4H), 7.92-7.88 (m, 1H), 7.54-7.48 (m, 4H). 
 
Scheme 4-1.  Synthetic routes for Ir(III) complexes. 
 
General synthetic procedure for Ir(III) complexes 4-1 − 4-10. The synthetic scheme for 
complexes 4-1 − 4-10 is illustrated in Scheme 4-1. The synthesis required two steps. First, the 
corresponding cyclometalating ligand (L4-1 − L4-10; 0.5 mmol) and IrCl3·3H2O (46.5 mg, 0.25 
mmol) were added to a mixed solvent of 2-methoxyethanol (15 mL) and water (5 mL). The mixture 
was degassed and then heated to 100 °C for 24 h to allow for complexation to occur under a 
nitrogen atmosphere. After the reaction, the mixture was cooled to room temperature, and the 
precipitate was filtered and washed with water and alcohol to give the crude cyclometalated chloro-
bridged iridium(III) dimer. The crude iridium(III) dimer was directly used for the following step 
reaction without further purification. Then, the mixture of obtained iridium(III) dimer (1 equiv), 
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N^N ligand (2 equiv), AgSO3CF3 (2 equiv), and CH2Cl2/methanol (2:1, v/v; 30 mL) was degassed 
and heated to reflux for 24 h. After cooling to room temperature, NH4PF6 (10 equiv) was added 
and the mixture was stirred for 2 h at room temperature. The resulting precipitate was filtered and 
purified by column chromatography on alumina gel eluted with CH2Cl2. The crude product was 
further purified by recrystallization in CH2Cl2 and hexane (or toluene) to obtain the pure complex. 
The reported yield for each complex is for the two-step reactions based on the starting C^N ligand.  
4-1.  An orange powder was obtained as the product (69 mg, yield: 29%). 1H NMR (400 
MHz, CDCl3) δ 8.46-8.37 (m, 2H), 8.37-8.21 (m, 3H), 8.18-8.10 (m, 1H), 8.09-8.00 (m, 2H), 7.84 
(dd, J = 7.8, 4.2 Hz, 2H), 7.79 (d, J = 7.2 Hz, 1H), 7.61 (dd, J = 15.7, 7.9 Hz, 3H), 7.51 (dd, J = 
14.7, 8.3 Hz, 2H), 7.45-7.35 (m, 3H), 7.25 (s, 1H), 7.16 (ddd, J = 15.8, 12.3, 4.7 Hz, 3H), 7.08 (t, 
J = 7.1 Hz, 1H), 7.02-6.80 (m, 4H), 6.54 (d, J = 7.2 Hz, 1H), 6.34 (d, J = 7.4 Hz, 1H). ESI-HRMS 
(m/z): calcd. for [C44H30N4Ir]
+, 807.2103; found, 807.2136. Anal. calcd. (%) for 
C44H30F6IrN4P.0.3C6H14 (C6H14: Hexane): C, 56.50; H, 3.64; N, 5.68. Found: C, 56.63; H, 3.26; 
N, 5.46. 
4-2.  An orange powder was obtained as the product (112 mg, yield: 47%). 1H NMR (400 
MHz, CDCl3): δ 8.99 (d, J = 7.6 Hz, 1H), 8.86 (d, J = 8.8 Hz, 1H), 8.67 (d, J = 8.4 Hz, 1H), 8.52 
(s, 1H), 8.42 (d, J = 8.8 Hz, 1H), 8.31-8.28 (m, 2H), 8.14 (s, 1H), 8.09 (s, 1H), 8.05 (dd, J = 6.4, 
1.2 Hz, 1H), 7.95-7.90 (m, 2H), 7.83 (d, J = 8.8 Hz, 2H), 7.77-7.68 (m, 4H), 7.56-7.44 (m, 5H), 
7.24 (td, J = 7.2, 1.2 Hz, 1H), 7.13-7.03 (m, 2H), 6.91 (td, J = 7.2, 1.2 Hz, 1H), 6.89 (td, J = 7.2, 
1.2 Hz, 1H), 6.32 (d, J = 7.6 Hz, 1H), 6.05 (d, J = 7.6 Hz, 1H). ESI-HRMS (m/z): calcd. for 
[C44H30N4Ir]
+, 807.2103; found, 807.2106. Anal. calcd. (%) for C44H30F6IrN4P.0.7CH2Cl2: C, 
53.08; H, 3.13; N, 5.54. Found: C, 52.89; H, 3.48; N, 5.87. 
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4-3. A red powder was obtained as the product (135 mg, yield: 57%). 1H NMR (400 MHz, 
DMSO -d6) δ 9.18-9.05 (m, 2H), 8.99 (d, J = 8.9 Hz, 1H), 8.88 (dd, J = 15.9, 8.3 Hz, 2H), 8.44 (d, 
J = 7.5 Hz, 1H), 8.34 (dd, J = 12.4, 8.5 Hz, 2H), 8.09 (dd, J = 8.3, 5.0 Hz, 2H), 8.00 (d, J = 9.4 
Hz, 2H), 7.97-7.89 (m, 2H), 7.88-7.78 (m, 2H), 7.73-7.63 (m, 2H), 7.58 (dd, J = 16.3, 7.4 Hz, 2H), 
7.51 (d, J = 6.3 Hz, 1H), 7.42 (d, J = 6.5 Hz, 1H), 7.16 (dt, J = 14.1, 8.0 Hz, 3H), 7.01-6.89 (m, 
2H), 6.28 (d, J = 7.8 Hz, 1H), 6.14 (d, J = 6.5 Hz, 1H), 5.76 (s, 1H). ESI–HRMS (m/z): calcd. for 
[C44H30N4Ir]
+, 807.2103; found, 807.2121. Anal. calcd. (%) for C44H30F6IrN4P.0.8CH2Cl2.0.3H2O: 
C, 52.48; H, 3.17; N, 5.46. Found: C, 52.47; H, 3.57; N, 5.35. 
4-4. A brown powder was obtained as the product (108 mg, yield: 48%). 1H NMR (400 
MHz, CDCl3) δ 8.94 (d, J = 8.2 Hz, 1H), 8.83 (d, J = 8.9 Hz, 1H), 8.66 (d, J = 8.7 Hz, 1H), 8.43 
(d, J = 9.0 Hz, 1H), 8.31 (dd, J = 8.1, 1.2 Hz, 1H), 8.27-8.17 (m, 2H), 8.14 (dd, J = 5.4, 1.2 Hz, 
1H), 7.92 (d, J = 8.8 Hz, 1H), 7.89-7.78 (m, 3H), 7.79-7.71 (m, 2H), 7.61 (d, J = 8.8 Hz, 1H), 7.56-
7.49 (m, 1H), 7.49-7.41 (m, 3H), 7.37 (dd, J = 8.1, 5.4 Hz, 1H), 7.32 (ddd, J = 7.6, 5.5, 1.1 Hz, 
1H), 7.22-7.16 (m, 1H), 7.16-7.10 (m, 1H), 7.04 (ddd, J = 8.2, 4.8, 1.4 Hz, 1H), 6.35 (d, J = 6.6 
Hz, 1H), 6.04 (d, J = 6.6 Hz, 1H). ESI-HRMS (m/z): calcd. for [C40H26N4Ir]
+, 755.1789; found, 
755.1821. Anal. calcd. (%) for C40H26F6IrN4P.1.4H2O: C, 51.93; H, 3.14; N, 6.06. Found: C, 51.74; 
H, 3.48; N, 5.99. 
4-5. An orange powder was obtained as the product (109 mg, yield: 46%). 1H NMR 
(DMSO-d6, 400 MHz): δ 9.06 (d, J = 7.9 Hz, 1H), 8.96 (d, J = 7.8 Hz, 1H), 8.88 (d, J = 7.9 Hz, 
1H), 8.55 (d, J = 8.2, 3.1 Hz, 2H), 8.50 (s, 1H), 8.38 (d, J = 8.1 Hz, 1H), 8.30-8.26 (m, 2H), 8.07-
8.05 (m, 2H), 7.96-7.93 (m, 2H), 7.86 (d, J = 8.4 Hz, 1H), 7.81-7.76 (m, 2H), 7.62 (t, J = 7.6 Hz, 
2H), 7.48 (t, J = 7.6 Hz, 1H), 7.26-7.15 (m, 8H), 6.89 (t, J = 8.0 Hz, 1H), 6.57 (s, 1H), 6.33 (s, 
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1H). ESI-HRMS (m/z): calcd. for [C44H30N4Ir]
+, 807.2103; found, 807.2090. Anal. calcd. (%) for 
C40H30F6IrN4P: C, 55.52; H, 3.18; N, 5.89. Found: C, 55.14; H, 3.58; N, 5.73. 
4-6. A red powder was obtained as the product (119 mg, yield: 50%). 1H NMR (CDCl3, 
400 MHz): δ 8.89 (d, J = 7.8 Hz, 1H), 8.77 (d, J = 8.2 Hz, 1H), 8.62 (dd, J = 8.2, 3.1 Hz, 2H), 8.55 
(d, J = 8.1 Hz, 1H), 8.33-8.38 (m, 2H), 8.36 (td, J = 8.1, 1.2 Hz, 1H), 7.97 (d, J = 8.0 Hz, 1H), 
7.83-7.90 (m, 3H), 7.68-7.73 (m, 3H), 7.57 (t, J = 7.8 Hz, 2H), 7.24-7.46 (m, 7H), 7.22 (d, J = 8.0 
Hz, 1H), 6.88-6.98 (m, 3H), 6.37 (d, J = 8.1 Hz, 1H), 6.23 (d, J = 8.1 Hz, 1H). ESI-HRMS (m/z): 
calcd. for [C44H30N4Ir]
+, 807.2103; found, 807.2123. Anal. calcd. (%) for 
C44H30F6IrN4P.0.8CH2Cl2. 0.5H2O: C, 52.30; H, 3.19; N, 5.45. Found: C, 52.31; H, 3.55; N, 5.58. 
4-7. A red powder was obtained as the product (110 mg, yield: 40%). 1H NMR (400 MHz, 
CDCl3) δ 8.90 (d, J = 8.1 Hz, 1H), 8.69 (dd, J = 27.7, 8.7 Hz, 2H), 8.62-8.58 (m, 1H), 8.55 (d, J = 
8.0 Hz, 1H), 8.53-8.41 (m, 3H), 8.39 (dd, J = 6.1, 3.5 Hz, 1H), 8.24 (td, J = 8.0, 1.6 Hz, 1H), 8.15 
(dd, J = 5.8, 1.0 Hz, 1H), 8.13-7.99 (m, 2H), 7.88-7.76 (m, 2H), 7.65-7.56 (m, 3H), 7.49-7.43 (m, 
1H), 7.41 (ddd, J = 8.2, 6.9, 1.4 Hz, 1H), 7.37-7.26 (m, 5H), 7.21 (ddd, J = 8.0, 7.0, 0.8 Hz, 1H), 
7.06 (d, J = 5.0 Hz, 1H), 6.93 (dd, J = 8.3, 1.1 Hz, 1H), 6.88-6.78 (m, 2H), 6.77-6.65 (m, 2H), 6.50 
(dd, J = 8.5, 1.1 Hz, 1H), 6.42 (ddd, J = 8.6, 6.9, 1.5 Hz, 1H). ESI-HRMS (m/z): calcd. for 
[C52H34N4Ir]
+, 907.2416; found, 907.2442. Anal. calcd. (%) for C52H34F6IrN4P.C6H14.3H2O: C, 
58.43; H, 4.57; N, 4.70. Found: C, 58.70; H, 4.92; N, 4.72. 
4-8. A brown powder was obtained as the product (118 mg, yield: 43%). 1H NMR (400 
MHz, CDCl3) δ 8.82 (s, 1H), 8.52 (d, J = 8.6 Hz, 1H), 8.41 (s, 1H), 8.32-8.24 (m, 2H), 8.24-8.14 
(m, 2H), 8.14-8.05 (m, 2H), 7.92 (t, J = 8.9 Hz, 3H), 7.82 (dd, J = 17.5, 8.7 Hz, 2H), 7.74-7.44 (m, 
6H), 7.40 (d, J = 8.3 Hz, 2H), 7.28-7.18 (m, 4H), 7.12 (dd, J = 13.9, 6.8 Hz, 2H), 6.90-6.81 (m, 
2H), 6.73 (d, J = 8.9 Hz, 1H), 6.60 (d, J = 7.7 Hz, 1H), 6.54 (d, J = 6.8 Hz, 1H), 6.09 (d, J = 8.5 
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Hz, 1H). ESI-HRMS (m/z): calcd. for [C52H34N4Ir]
+, 907.2416; found, 907.2460. Anal. calcd. (%) 
for C52H34F6IrN4P.0.5C6H14.3H2O: C, 57.48; H, 4.12; N, 4.88. Found: C, 57.39; H, 4.26; N, 5.25. 
4-9. A red powder was obtained as the product (94 mg, yield: 34%). 1H NMR (400 MHz, 
CDCl3) δ 8.66-8.52 (m, 2H), 8.51-8.40 (m, 2H), 8.37 (d, J = 8.9 Hz, 1H), 8.31 (d, J = 8.5 Hz, 1H), 
8.20 (s, 1H), 8.17-8.01 (m, 3H), 7.96 (d, J = 8.6 Hz, 1H), 7.90 (d, J = 8.1 Hz, 2H), 7.84-7.73 (m, 
3H), 7.68 (d, J = 7.3 Hz, 1H), 7.53-7.38 (m, 3H), 7.33 (dd, J = 13.3, 6.8 Hz, 2H), 7.25 (t, J = 4.6 
Hz, 3H), 7.23-7.15 (m, 3H), 7.10 (d, J = 8.9 Hz, 1H), 6.96 (dt, J = 8.6, 7.1 Hz, 3H), 6.88 (s, 1H), 
6.69 (s, 1H). ESI-HRMS (m/z): calcd. for [C52H34N4Ir]
+, 907.2416; found, 907.2454. Anal. calcd. 
(%) for C52H34F6IrN4P.1.8H2O: C, 57.59; H, 3.49; N, 5.17. Found: C, 57.21; H, 3.79; N, 5.55. 
4-10. A red powder was obtained as the product (149 mg, yield: 52%). 1H NMR (400 MHz, 
CDCl3) δ 8.93 (s, 1H), 8.67-8.58 (m, 2H), 8.53-8.44 (m, 2H), 8.39 (s, 1H), 8.28 (d, J = 7.0 Hz, 
3H), 8.25-8.08 (m, 4H), 8.03-7.87 (m, 5H), 7.83 (d, J = 8.8 Hz, 2H), 7.64 (s, 1H), 7.57 (ddd, J = 
8.0, 7.0, 0.9 Hz, 1H), 7.48 (dd, J = 14.2, 6.9 Hz, 2H), 7.44-7.33 (m, 3H), 7.32 (dd, J = 4.8, 3.4 Hz, 
1H), 7.27-7.21 (m, 2H), 7.19-7.12 (m, 2H), 7.12-7.03 (m, 2H), 6.94 (s, 1H), 6.89 (s, 1H), 6.69 (d, 
J = 8.1 Hz, 1H), 6.06 (d, J = 8.4 Hz, 1H). ESI-HRMS (m/z): calcd. for [C60H38N4Ir]
+, 1007.2731; 
found, 1007.2746. Anal. Calcd. (%) for C60H38F6IrN4P.1.4H2O: C, 61.21; H, 3.49; N, 4.76. Found: 
C, 60.94; H, 3.86; N, 4.77. 
 
4.2.2. Photophysical and nonlinear transmission measurements 
All spectroscopic-grade solvents used for photophysical measurement were purchased 
from Alfa Aesar and used as received. The ultraviolet−visible (UV−vis) absorption spectra of 
complexes 4-1 – 4-10 were recorded on a Varian Cary 50 spectrophotometer. The steady-state 
emission spectra in different solvents [acetonitrile (CH3CN), acetone, CH2Cl2, and toluene] were 
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collected on a Horiba FluoroMax 4 fluorometer/phosphorometer. The full spectra of 4-8 and 4-10 
in CH2Cl2 were detected with an InGaAs detector from 670 to 1225 nm (λex = 473 nm) with a 
500-nm-long pass filter. [Ru(bpy)3]Cl2 (Φem = 0.097 in CH3CN; λex = 436 nm)41 was used as the 
reference for determination of the emission quantum yields for complexes 4-1 – 4-10 using relative 
actinometry.42 In degassed CH3CN solutions, the time- resolved nanosecond transient absorption 
(TA) spectra and the triplet lifetimes were measured on an Edinburgh LP920 laser flash photolysis 
spectrometer. The third harmonic output (355 nm) from a Nd:YAG laser (Quantel Brilliant; pulse 
width = 4.1 ns; repetition rate = 1 Hz) was used as the excitation source for the TA measurements. 
Before each measurement, the sample solutions were purged with argon for 40 min.  
The nonlinear transmission of complexes 4-1 – 4-10 at 532 nm was studied using a Quantel 
Brilliant 4.1 ns laser with a repetition rate of 10 Hz as the light source. The linear transmission of 
complexes 4-1 – 4-10 in CH3CN solution was set to 80% at 532 nm in the 2 mm cuvette. The 
experimental setup and details were described previously.43 The beam radius at the focal point was 
approximately 96 μm, focused by an f = 40 cm plano-convex lens.  
 
4.2.3. Quantum chemistry calculations 
Theoretical investigations of all iridium(III) complexes were performed using density 
functional theory (DFT) and time-dependent DFT (TDDFT), implemented in a Gaussian09 
quantum software package.44 These calculations include ground-state geometry optimization using 
DFT and absorption spectral calculations using TDDFT. DFT and TDDFT calculations were 
carried out using the hybrid functional PBE1PBE45 with a mixed basis set (LANL2DZ for 
iridium46 and 6-31g* for hydrogen, carbon, and nitrogen47). The solvent effects were implicitly 
included via a conductor polarized continuum model48,49 for CH2Cl2. This method- ology has been 
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proven to provide reasonable agreement to experimental results for the structural and electronic 
absorption of iridium(III) complexes.22,24,30,31,50 Ground-state optimization at the singlet and triplet 
states was performed and used as a structural input for TDDFT calculations of the emission 
energies.  
UV−vis absorption spectra were obtained by computing the lowest 60 singlet transitions 
using TDDFT, which were then broadened by a Gaussian function with a line width of 0.1 eV to 
reproduce homogeneous broadening caused by thermal vibrations to coincide with the 
experimental spectra of these complexes. To investigate the nature of the emissive states of the 
iridium(III) complexes, a TDDFT self-consistent-field (SCF) approach was applied using the 
triplet ground-state geometry optimized using unrestricted DFT as the input for the TDDFT 
calculations of the spin-flip transition from T1 to S0.
22,28,30,50 Characterization of relevant optical 
transitions was performed by computing the natural transition orbitals (NTOs),51 as implemented 
in Gaussian09, and visualized using VMD52 and GaussView 5.0953 with the default isovalue of 
0.02. In addition, the spin-density was calculated as the difference between the SCF density for 
the lowest singlet and triplet states for each complex.  
 
4.3. Results and discussion 
4.3.1. Effect of benzannulation on the ground-state equilibrium geometry 
The main geometrical parameters characterizing the structural changes upon 
benzannulation were obtained from our DFT calculations and are shown in Table 4.1. The bond 
lengths between the coordinated atoms on the C^N ligands and the iridium(III) center showed that 
the C−Ir bonds were insignificantly affected by benzannulation, varying from 1.98 to 2.02 Å for 
all complexes. In contrast, the effect of benzannulation at the C^N ligands was more pronounced 
on the coordination bonds between nitrogen atoms and iridium(III), with the N−Ir bonds in 
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complexes 4-1 and 4-8 − 4-10 being 0.05−0.07 Å longer compared to those in complexes 4-2 − 4-
7. This trend aligns with the fact that complexes 4-1 and 4-8 − 4-10 have benzannulation at the 5 
and 6 positions of the pyridine ring of the C^N ligands, resulting in a slight elongation of the N−Ir 
coordination bond. It was noted that the C2−Ir and N2−Ir bond lengths from the C2^N2 ligand were 
slightly longer than those from the C1^N1 ligand. Moreover, the bond lengths between the two 
nitrogen atoms on the N^N ligand and the iridium(III) ion were quite distinct, with the N4−Ir bonds 
being not only obviously longer that those of the N3−Ir bonds but also more affected by 
benzannulation at the 5 and 6 positions of the C^N ligands (i.e., the N4−Ir bonds in complexes 4-
1 and 4-8 − 4-10 were 0.05−0.06 Å longer than those in complexes 4-2 − 4-7).  
The dihedral angles between the two pyridine rings (N3^N4) in the N^N ligand also pointed 
out that benzannulation at the 5 and 6 positions of the C^N ligands caused significant 
conformational changes, with the two pyridine rings being twisted to ∼20° in complexes 4-1 and 
4-8 − 4-10 compared to the ∼10° angles in complexes 4-2 − 4-7 (Table 4.1). It is interesting to 
note that the dihedral angles between the phenyl and pyridine rings in the two C^N ligands were 
both impacted pronouncedly by benzannulation at the 3 and 4 or 5′ and 6′ positions of the C^N 
ligands as well. This effect was clearly reflected by the much larger C1^N1 and C2^N2 angles in 
complexes 4-3, 4-6, and 4-7 compared to those in the other complexes.  
The benzannulation sites at the C^N ligands influenced the bond angles around the 
iridium(III) ion distinctively. Benzannulation at the 5 and 6 positions of the C^N ligands reduced 
both the N1−Ir−N3 and N1−Ir−N2 angles while increasing the N2−Ir−N3 angles in complexes 4-1 
and 4-8 − 4-10 compared to those in the other complexes. In contrast, benzannulation at either the 
5 and 6 or 5′ and 6′ positions of the C^N ligands increased the C1−Ir−C2 angles in complexes 1 
and 4-6 − 4-10 compared to those in 4-2 − 4-5. Benzannulation at the 3 and 4 positions of the C^N 
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ligands also slightly increased the C1−Ir−C2 angle in 4-3 with respect to those in 4-2, 4-4, and 4-
5. These trends indicate that benzannulation at the 5 and 6 positions of the C^N ligands in 4-1 and 
4-8 − 4-10 rotate both C^N ligands away from the quinoline rings of the N^N ligand to reduce 
steric hindrance. Additionally, benzannulation at the 5′ and 6′ positions of the C^N ligands 
expanded the C1−Ir−C2 angles in 4-6 and 4-7, especially in 4-7, as a result of avoiding steric 
hindrance.  
 
Table 4.1. Geometrical characteristics of complexes 4-1 − 4-10: bond length (B), dihedral angle 
(D) and bond angle (A) between atoms numbered in the Chart 4-1. 
 4-1 4-2 4-3 4-4 4-5 4-6 4-7 4-8 4-9 4-10 
B(Ir-C1) / Å 1.98 2.00 1.99 2.01 2.00 1.99 2.01 1.98 1.99 1.98 
B(Ir-C2) / Å 2.00 2.01 2.01 2.02 2.02 2.01 2.02 2.00 2.00 2.00 
B(Ir-N1) / Å   2.10 2.05 2.05 2.06 2.05 2.04 2.05 2.10 2.10 2.10 
B(Ir-N2) / Å 2.11 2.06 2.06 2.06 2.06 2.05 2.05 2.11 2.11 2.11 
B(Ir-N3) / Å 2.18 2.16 2.16 2.15 2.16 2.16 2.18 2.18 2.18 2.18 
B(Ir-N4) / Å 2.32 2.27 2.26 2.26 2.27 2.26 2.26 2.32 2.32 2.32 
D(C1^N1) (o) 0.2 0.7 11.4 0.3 1.0 11.1 11.6 0.3 0.6 0.6 
D(C2^N2) (o) 6.2 1.1 12.5 0.7 1.1 10.3 10.7 5.7 6.7 6.3 
D(N3^N4) (o) 19.5   10.0   9.9   9.1   10.8   11.1   9.2   20.0   20.4   20.2  
A(N1-Ir-N3) (o) 83.3   87.9   88.6   89.1   88.1   88.5   86.5   83.6   84.1   84.0  
A(N2-Ir-N3) (o) 103.8   96.5   96.9   95.6   96.8   96.8   91.5   103.9   103.3   103.5 
A(N1-Ir-N2) (o) 171.5   174.6   174.1   174.2   174.2   173.5   178.0   171.2   171.5   171.2  
A(C1-Ir-C2) (o) 86.6    84.5    85.3    83.9    84.3    86.4    94.7    86.8   86.9   86.9  
 
4.3.2. Electronic absorption  
The UV−vis absorptions of complexes 4-1 − 4-10 were studied in solvents with different 
polarities, such as CH3CN, tetrahydrofuran (THF), CH2Cl2, and toluene. The spectra in CH2Cl2 
are displayed in Figure 4.1, and the absorption parameters, i.e., absorption band maxima and molar 
extinction coefficients, are tabulated in Table 4.2. The absorption follows Beer’s law in the 
concentration range of 1×10-6 to 1×10-4 mol/L, suggesting the absence of ground-state aggregation 
in this tested concentration range. The spectra of all complexes were generally divided into three 
regions: (a) the major absorption bands at wavelengths of 270−400 nm in complexes 4-1 – 4-7, 
270−475 nm in 4-8 and 4-10, and 270−425 nm in 4-9 being predominantly attributed to the C^N 
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or N^N ligand-centered spin-allowed 1π,π* transitions, likely mixed with some CT character, in 
view of the large molar extinction coefficients and the NTOs from the TDDFT calculations (Tables 
4-5 and 4-6); (b) a weaker featureless low- energy band at 400−500 nm in 4-1 – 4-7, 475−550 nm 
in 4-8 and 4-10, and 425−550 nm in 4-9 originating mainly from the CT transitions [i.e., metal-to-
ligand CT (1MLCT), ligand-to-ligand CT (1LLCT), and also 1LLCT in 4-1 − 4-3 and 4-8 − 4-10] 
with minor 1π,π* character (Table 4.4); (c) a very weak tail beyond 500/ 550 nm attributing to 
spin-forbidden 3CT/1π,π* transitions according to literature reports for other iridium(III) 
complexes.23,24,28,29,31−33,54,55  
 
Table 4.2. Electronic absorption, emission, and excited-state absorption parameters for complexes 
4-1 – 4-10. 
 abs /nm (log ε)a em/nm (em/μs); emb T1‑Tn/nm (TA/μs)c 
4-1 280 (4.79), 337 (4.52), 
433 (3.84) 
613 (0.52); 0.075 380 (0.30), 759 (0.31), 782 (0.33) 
4-2 292 (4.85), 329 (4.48), 
345 (4.40), 381 (4.13) 
642 (0.16); 0.033 371 (0.10), 432 (0.11), 773 (0.11) 
4-3 290 (4.74), 337 (4.54), 
377 (4.25), 432 (3.98) 
618 (0.31); 0.11 363 (0.33), 393 (0.34), 511 (0.34) 
4-4 280 (4.73), 329 (4.55), 
415 (3.95) 
615 (0.27); 0.070 377 (0.15), 437 (0.12), 749 (0.13) 
4-5 280 (4.79), 330 (4.58), 
423 (3.58) 
650 (0.07); 0.020 377 (0.03), 438 (0.02), 773 (0.02) 
4-6 280 (4.80), 338 (4.53), 
416 (3.91), 440 (3.88) 
649 (0.08); 0.024 382 (0.04), 501 (0.04), 758 (0.03) 
4-7 280 (4.86), 325 (4.66), 
343 (4.52), 442 (4.10) 
663 (0.06); 0.002 390 (0.01), 502 (0.01), 792 (0.01) 
4-8 280 (4.85), 311 (4.91), 
383 (4.30), 498 (3.76) 
894 (3.11); 0.015 371 (2.93), 462 (2.92), 657 (2.89) 
4-9 280 (4.92), 352 (4.68), 
473 (3.52) 
649 (0.13); 0.019 385 (0.06), 439 (0.06), 735 (0.05) 
4-
10 
280 (5.03), 333 (5.02), 
408 (4.65), 445 (4.13) 
898 (4.33); 0.009 458 (4.11), 683 (4.15) 
a Absorption band maxima and molar extinction coefficients of the UV-vis absorption in CH2Cl2 
at room temperature. b Emission band maxima and decay lifetimes in CH2Cl2 at room temperature, 
c = 1×10-5 mol/L. The reference used was a degassed CH3CN solution of [Ru(bpy)3]Cl2 (Φem = 
0.097, λex = 436 nm). c Nanosecond TA band maxima and triplet excited-state lifetimes measured 
in CH3CN at room temperature. 
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Figure 4.1. Experimental UV-vis absorption spectra of (a) 4-0 − 4-4, (b) 4-5 − 4-7 and (c) 4-0, 4-
1, and 4-8 − 4-10 at room temperature in dichloromethane. The inset shows the expanded spectra 
at 500-800 nm. 
 
Examination of the low-energy CT bands of 4-1 − 4-10 (i.e., 400 / 425 / 475−500 / 550 nm) 
and their comparison to that of the parent complex 4-0 revealed that benzannulation at the C^N 
ligands induced a red shift of these bands and increased molar extinction coefficients except for 
those in 4-2 and 4-5. Such changes became more distinct when benzannulation occurred at the 
phenyl ring of the ppy ligand or upon fusion of the naphthyl ring to the 5 and 6 positions of the 
pyridyl ring. This observation was partially validated by the TDDFT calculation results. According 
to our calculations, the lowest-energy transition (S1 state; Table 4.3) appeared to be more site- 
dependent when benzannulation occurred at the phenyl ring. Extending π-conjugation at the phenyl 
ring of the ppy ligand drastically decreased the energies of the S1 states in complexes 4-5 − 4-7, 4-
9, and 4-10, while benzannulation at the pyridyl ring of the ppy ligand showed a minor impact on 
the S1 state energies in complexes 4-1 − 4-4 and 4-8. This trend can be rationalized by the electron-
density distribution of the holes in these complexes. As indicated by the NTOs in Table  4-3, the 
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holes in these complexes were primarily localized on the phenyl rings of the C^N ligands and the 
d orbital of the iridium(III) ion. Benzannulation at the phenyl rings of the C^N ligands thus 
drastically altered the energy of the holes, while benzannulation at the pyridyl rings had a minor 
impact on the hole energy.  
 
Table 4.3. NTOs contributing to the lowest-energy singlet transitions (S1) of complexes 4-1 − 4-
10 in CH2Cl2. 
 S1 Hole Electron  S1 Hole Electron 
4-1 486 nm 
f = 0.006  
100%  
  
4-6 530 nm  
f = 0.008  
100% 
  
4-2 511 nm 
f = 0.002  
100% 
  
4-7 606 nm  
f = 0.010  
100% 
  
4-3 497 nm  
f = 0.005  
100% 
  
4-8 496 nm  
f = 0.013  
100% 
  
4-4 499 nm  
f = 0.002  
100% 
  
4-9 516 nm  
f = 0.003  
100% 
  
4-5 517 nm  
f = 0.001  
100% 
  
4-
10 
528 nm  
f = 0.004  
100% 
  
 
Table 4.4. NTOs representing singlet transitions responsible for the low-energy absorption bands 
of complexes 4-1 − 4-10  in CH2Cl2. 
 So→Sn Hole Electron  So→Sn Hole Electron 
4-1 S2  
424 nm  
f = 0.072  
99%    
4-6 S2  
445 nm  
f = 0.001  
100%    
S3  
421 nm  
f = 0.003  
98%   
 S3  
408 nm  
f = 0.115  
98%    
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Table 4.4. NTOs representing singlet transitions responsible for the low-energy absorption bands 
of complexes 4-1 − 4-10  in CH2Cl2. (continued) 
 So→Sn Hole Electron  So→Sn Hole Electron 
 S4  
391 nm  
f = 0.028  
97%    
 S7  
370 nm  
f = 0.122  
97%    
4-2 S2  
417 nm  
f = 0.005  
100%    
 S8  
357 nm  
f = 0.074  
97%    
S3  
404 nm  
f = 0.001  
99%   
 S9  
352 nm  
f = 0.096  
95%    
S4  
390 nm  
f = 0.011  
98%    
4-7 S2  
474 nm  
f = 0.002  
99%    
4-3 S2  
427 nm  
f = 0.100  
99%    
S3  
446 nm  
f = 0.024  
99%    
S3  
415 nm  
f = 0.013  
91%    
S4  
431 nm  
f = 0.190  
99%    
S4  
409 nm  
f = 0.020  
89%    
4-8 S2  
462 nm  
f = 0.051  
98%    
4-4 S2  
413 nm  
f = 0.002  
100%    
 S3  
456 nm  
f = 0.020  
96%    
S3  
400 nm  
f = 0.000  
99%  
 
 S4  
445 nm  
f = 0.028  
95%    
S4  
388 nm  
f = 0.066  
97%    
 S6  
419 nm  
f = 0.101  
94%    
4-5 S2  
433 nm  
f = 0.002  
100%    
 S7  
415 nm  
f = 0.038  
96%    
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Table 4.4. NTOs representing singlet transitions responsible for the low-energy absorption bands 
of complexes 4-1 − 4-10  in CH2Cl2. (continued) 
 So→Sn Hole Electron  So→Sn Hole Electron 
 S3  
415 nm  
f = 0.002  
99%    
 S8  
402 nm  
f = 0.044  
92%    
 S4  
401 nm  
f = 0.036  
98%    
4-9 S2  
459 nm  
f = 0.011  
100%    
 S5  
386 nm  
f = 0.013  
95%    
S3  
456 nm  
f = 0.013  
99%    
 S6  
378 nm  
f = 0.005  
99%    
S4  
423 nm  
f = 0.006  
99%    
    S5  
404 nm  
f = 0.013  
99%    
    S7  
388 nm  
f = 0.066  
98%    
    4-10 S2  
503 nm  
f = 0.008  
100%    
    S3  
488 nm  
f = 0.005  
100%    
    S4  
453 nm  
f = 0.035  
98%    
    S6  
429 nm  
f = 0.117  
91%    
    S7  
425 nm  
f = 0.074  
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Table 4.5. NTOs representing singlet transitions responsible for the medium energy absorption 
bands of complexes 4-1 − 4-10 in CH2Cl2. 
 So→Sn Hole Electron  So→Sn Hole Electron 
4-1 S10  
335 nm  
f = 0.080  
95%    
4-6 S15  
322 nm  
f = 0.158  
90%    
S13  
329 nm  
f = 0.111  
58%    
S20  
311 nm  
f = 0.208  
43%    
25% 
  
33% 
  
S20  
311 nm  
f = 0.144  
59%    
21% 
  
23% 
  
S21  
309 nm  
f = 0.149  
58%    
S21  
307 nm  
f = 0.191  
77%    
29% 
  
4-2 S6  
376 nm  
f = 0.028  
98%    
S22  
308 nm  
f = 0.124  
73%    
S7  
374 nm  
f = 0.048  
98%    
21% 
  
S8  
357 nm  
f = 0.212  
95%    
4-7 S9  
371 nm  
f = 0.153  
93%    
4-3 S6  
374 nm  
f = 0.084  
97%    
S12  
359 nm  
f = 0.100  
83%    
 S9  
351 nm  
f = 0.088  
65%    
4-8 S13  
355 nm  
f = 0.200  
90%   
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Table 4.5. NTOs representing singlet transitions responsible for the medium energy absorption 
bands of complexes 4-1 − 4-10 in CH2Cl2. (continued) 
 So→Sn Hole Electron  So→Sn Hole Electron 
 
34% 
  
 S14  
352 nm  
f = 0.140  
80%   
 S10  
349 nm  
f = 0.101  
59%    
4-9 S9  
367 nm  
f = 0.124  
87%    
 
40% 
  
S10  
363 nm  
f = 0.201  
92%    
 S15  
325 nm  
f = 0.128  
62%    
S11  
362 nm  
f = 0.154  
85%    
 
31% 
  
S17  
334 nm  
f = 0.276  
79%    
 S18  
320 nm  
f = 0.150  
80%    
S18  
331 nm  
f = 0.122  
74%    
 S20  
311 nm  
f = 0.329  
84%    
4-
10 
S13  
390 nm  
f = 0.247  
94%    
4-4 S9  
332 nm  
f = 0.046  
81%    
S14  
379 nm  
f = 0.407  
96%    
 S14  
322 nm  
f = 0.072  
54%    
S15  
373 nm  
f = 0.172  
84%    
 
41% 
  
    
 S15  
316 nm  
f = 0.073  
55%    
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Table 4.5. NTOs representing singlet transitions responsible for the medium energy absorption 
bands of complexes 4-1 − 4-10 in CH2Cl2. (continued) 
 So→Sn Hole Electron     
 
23% 
  
    
 S18  
310 nm  
f = 0.124  
80%    
    
 S19  
309 nm  
f = 0.118  
93%    
    
4-5 S8  
360 nm  
f = 0.125  
96%    
    
S12  
336 nm  
f = 0.112  
55%    
    
42% 
  
    
S13  
334 nm  
f = 0.099  
65%    
    
32% 
  
    
S14  
325 nm  
f = 0.123  
73%    
    
S19  
311 nm  
f = 0.168  
55%    
    
36% 
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Table 4.6. NTOs representing singlet transitions responsible for the main absorption bands of 
complexes 4-1 − 4-10 in CH2Cl2. 
 So→Sn Hole Electron  So→Sn Hole Electron 
4-1 S38  
269 nm  
f = 0.208  
45%   
4-6 S38  
270 nm  
f = 0.353  
43%    
S46  
260 nm  
f = 0.249  
44%   
22% 
  
36% 
  
S50  
257 nm  
f = 0.161  
82%    
4-2 S20  
311 nm  
f = 0.297  
80%   
4-7 S25  
312 nm  
f = 0.507  
62%    
S24  
298 nm  
f = 0.227  
64%   
S43  
276 nm  
f = 0.154  
41%    
30% 
  
30% 
  
S27  
293 nm  
f = 0.460  
70%   
4-8 S29  
309 nm  
f = 0.199  
41%    
S32  
284 nm  
f = 0.213  
72%   
27% 
  
4-3 S37  
272 nm  
f = 0.418  
62%   
S34  
301 nm  
f = 0.195  
88%    
20% 
  
S37  
292 nm  
f = 0.393  
73%    
4-4 S34  
272 nm  
f = 0.110  
81%   
4-9 S26  
308 nm  
f = 0.148  
81%    
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Table 4.6. NTOs representing singlet transitions responsible for the main absorption bands of 
complexes 4-1 − 4-10 in CH2Cl2. (continued) 
 So→Sn Hole Electron  So→Sn Hole Electron 
 S42  
259 nm  
f = 0.194  
65%   
 S36  
288 nm  
f = 0.257  
63%    
4-5 S35  
276 nm  
f = 0.185  
69%   
 S43  
279 nm  
f = 0.175  
36%    
 S36  
275 nm  
f = 0.192  
59%   
 
23% 
  
 
22% 
  
 
21% 
  
 S37  
273 nm  
f = 0.173  
50%   
4-
10 
S29  
325 nm  
f = 0.123  
55%    
 
28% 
  
 
37% 
  
 S39  
272 nm  
f = 0.242  
40%   
 S31  
318 nm  
f = 0.478  
74%    
 22% 
  
 S43  
295 nm  
f = 0.510  
69%    
 
The DFT calculations indicated that the highest occupied molecular orbital (HOMO) → 
lowest unoccupied molecular orbital (LUMO) transition played the major role (68−70%; Table 
4.7) in generating the S1 excited state. Therefore, analyzing how structural modifications 
influenced the HOMO and LUMO energies became important. As the ground-state energy diagram 
(Figure 4.2) displayed, extending π-conjugation of the C^N ligand mainly influenced the HOMO, 
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especially when benzannulation occurred at the phenyl ring. The HOMO energy was also affected 
by the benzannulation site at the phenyl ring. When benzannulation occurred at the 3′ and 4′ 
positions, the HOMO of complex 4-7 was significantly raised, while destabilization of the HOMOs 
in complexes 4-5, 4-6, 4-9, and 4-10 with benzannulation at the 4′ and 5′ or 5′ and 6′ positions was 
less pronounced. 
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Figure 4.2.  HOMO and LUMO plots for 4-0 and ground-state molecular orbital diagram for 4-0 
− 4-10 in CH2Cl2. 
 
Table 4.7. Electron density distribution plots for HOMOs and LUMOs of complexes 4-1 − 4-10 
in CH2Cl2 and the percentage contribution of the HOMO-LUMO transition to the S1 excited state. 
 HOMO LUMO  HOMO LUMO 
4-1 
 
70%   
4-6 
 
70%   
4-2 
 
70%   
4-7 
 
70%   
4-3 
 
70%   
4-8 
 
68%   
4-4 
 
70% 
  
4-9 
 
70% 
  
4-5 
 
70%   
4-10 
 
69%   
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In order to rationalize the effect of site-dependent benzannulation at the C^N ligands on 
the HOMO and LUMO energies, orbital symmetry analysis was applied. This method had been 
applied to benzannulation of the N^N^N ligand for platinum(II) complexes by 
Thompson/Gordon56 and to benzannulation of the N^N ligand for iridium(III) complexes by our 
group28 to successfully explain the observed site-dependent blue or red shift of the absorption and 
emission spectra. Here, it was applied to benzannulation at the C^N ligand of the iridium(III) 
complexes. In this method, benzannulation is viewed as the interactions between the FMOs of the 
parent compound and the FMOs of cis-1,3-butadiene or ethene. Because the HOMOs of the 
iridium(III) complexes studied are essentially localized on the C^N ligand and d orbital of the 
iridium(III) ion, benzannulation at the C^N ligand should mainly consider the interactions between 
the HOMO of the parent compound and the HOMO (and/or LUMO+1) or LUMO (and/or 
HOMO−1) of cis-1,3-butadiene (or ethene) depending on the orbital symmetry at the site of 
benzannulation.  
As exemplified in Figure 4.3a, when benzannulation occurred at the 5 and 6 positions of 
the pyridyl ring of the parent complex 4-0, the symmetry of HOMO at this position matched the 
symmetry of LUMO and HOMO−1 of cis-1,3-butadiene. However, because the HOMO−1 of cis-
1,3-butadiene is more energetically close to the HOMO of 4-0 than the LUMO of cis-1,3-butadiene 
is, the HOMO−1 played the major role in interacting with the HOMO of 4-0. Such an interaction 
gave rise to a slightly raised (0.02 eV) HOMO in complex 4-1 compared to that in the parent 
complex 4-0. Meanwhile, the LUMO of 4-1 was destabilized by 0.05 eV, giving rise to a slightly 
enlarged HOMO−LUMO gap and consequently a minor hypsochromic shift of the S1 state. In 
contrast, when benzannulation took place at the 4 and 5 positions of the pyridyl ring of complex 
4-0, the HOMO symmetry at this position matched the symmetry of the HOMO and LUMO+1 of 
 156 
cis-1,3-butadiene (Figure 4.3b). Because of the much larger energy gap between the HOMO of 
complex 4-0 and the LUMO+1 of cis-1,3-butadiene, the HOMO of complex 4-0 predominantly 
interacted with the HOMO of 1,3-butadiene. This interaction raised the HOMO of complex 4-2 by 
0.13 eV, while the LUMO energy of 4-2 essentially remained the same (only an 0.01 eV increase). 
This narrowed the HOMO−LUMO gap and caused a slight bathochromic shift of the S1 state in 
complex 4-2 compared to that in complex 4-0.  
The similar molecular orbital symmetry analysis on complexes 4-5 and 4-6 revealed that 
benzannulation at the 4′ and 5′ positions of the phenyl ring of the ppy ligand in complex 4-0 raised 
the HOMO energy of complex 4-5 by 0.22 eV as a result of the HOMO−HOMO−1 interaction 
(Figure 4.3c), while the HOMO−HOMO−1 interaction gave rise to a 0.26 eV increase of the 
HOMO in complex 4-6 (Figure 4.3d). However, the LUMO of 4-6 was 0.02 eV more stabilized 
than that of  4-5, resulting in a more red-shifted S1 state in 4-6 compared to that of  4-5. The 
molecular orbital symmetry analyses for the other complexes were carried out, and the results are 
provided in Figures 4-4 − 4-7.  
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Figure 4.3. FMO mixing between the HOMO of the parent complex 4-0 and the HOMO−1 or 
HOMO of cis-1,3-butadiene to generate the FMOs of 4-1 (a), 4-2 (b), 4-5 (c), or 4-6 (d), 
respectively. 
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Figure 4.4. FMO mixing between the HOMO of the parent complex 4-0 and HOMO-1/LUMO 
of cis-1,3-butadiene or HOMO of ethane to generate the FMOs of 4-3 and 4-4, respectively. 
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Figure 4.5. FMO mixing between the HOMO of the parent complex 4-5 or 4-6 and HOMO-
1/LUMO or HOMO of cis-1,3-butadiene to generate the FMOs of 4-7. 
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Figure 4.6. FMO mixing between the HOMO of the parent complex 4-1 and HOMO-1/LUMO 
of cis-1,3-butadiene to generate the FMOs of 4-8 and 4-9. 
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Figure 4.7. FMO mixing between the HOMO of the parent complex 4-8 or 4-9 and HOMO or 
HOMO-1/LUMO of cis-1,3-butadiene to generate the FMOs of 4-10. 
 
4.3.3. Photoluminescence 
To understand the impacts of benzannulation at the different sites of the C^N ligand on the 
triplet excited states, the emission characteristics of 4-1 − 4-10 at room temperature in different 
solvents [CH3CN, THF, CH2Cl2, and toluene (with 10% CH2Cl2)] were investigated because the 
emission of iridium(III) complexes typically originates from the triplet excited state. The emission 
spectra of 4-1 − 4-10 in CH2Cl2 are shown in Figure 4.8 and displayed in Figure 4.9 for the spectra 
in other solvents. The emission lifetimes and quantum yields are tabulated in Tables 4-2 and 4-8. 
A quick survey of these data revealed that the emissions band maxima of these complexes spanned 
from ca. 610 to 900 nm, which are drastically red-shifted with respect to their UV−vis absorption 
spectra. The emission was prone to quenching by oxygen, and the lifetimes varied from tens of 
nanoseconds to several microseconds. All of these features confirmed the phosphorescence nature 
of the emission from these complexes.  
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Figure 4.8. Experimental emission spectra of 4-1 − 4-10 at room temperature in dichloromethane. 
The spectra of 4-1 − 4-7 and 4-9 were measured on a HORIBA FluoroMax 4 ﬂuorometer 
/phosphorometer with a Hamamatsu PMT R928 as the detector, while the spectra of 4-8 and 4-10 
were detected with an InGaAs sensor from 670 to 1225 nm (λex = 473 nm) with a 500 nm long 
pass ﬁlter. 
 
The emission spectra of 4-1 − 4-7 and 4-9 were structureless, and their lifetimes were tens 
to hundreds of nanoseconds, which are the characteristics of CT emission. With reference to the 
emission of other iridium(III) complexes,23−33,54,55,57 the emitting states of these complexes are 
tentatively assigned to the 3CT states (3MLCT/3LLCT). In contrast, the emission spectra of 4-8 
and 4-10 were remarkably red-shifted compared to the other complexes and exhibited clear 
vibronic structures. Their lifetimes were 3−4 μs, which were almost 1−2 orders of magnitude 
longer than the other complexes. All of these features suggest that the emission of these two 
complexes emanates from the ligand-centered 3π,π* state.28,57 This assignment is supported by the 
solvent-dependent study and by the TDDFT calculation results being discussed vide infra. 
The emission characteristics of complexes 4-1 − 4-10 in different solvents are depicted in 
Figure 4.9 and Table 4.8. Complexes 4-1 − 4-7 and 4-9 generally exhibited somewhat more solvent 
dependence than complexes 4-8 and 4-10 did, which is in line with the predominant 3CT attribution 
for the emission of 4-1 − 4-7 and 4-9 and 3π,π* emission for 4-8 and 4-10. The TDDFT calculation 
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results further supports these assignments. As the NTOs in Table 4.8 displayed, the holes in 4-1 − 
4-7 and 4-9 were primarily localized on the C^N ligands and one of the d orbitals of the iridium(III) 
ion, while the electrons were on the N^N ligand and a different d-orbital of the iridium(III) ion. 
Thus, the emitting states of 4-1 − 4-7 and 4-9 possess predominantly 3MLCT/3LLCT transitions. 
In contrast, for complexes 4-8 and 4-10, both the electrons and holes were exclusively distributed 
on the benzo[g]quinoline (bq) moiety of one of the C^N ligands and on the d orbital. This indicates 
a predominant 3π,π* character in the emitting states of  4-8 and 4-10. The spin-density distributions 
shown in Table 4.9 for these complexes agree well with the NTOs representing the excitation from 
S0 to T1.  
     
  
 
 
Figure 4.9. Normalized emission spectra of 4-1 − 4-10 (1–10) in different solvents (λex = 436 nm). 
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Table 4.8. Emission characteristic of complexes 4-1 − 4-10 in different solvents at room 
temperature.a 
λem/nm (τem/μs); Φem 
 Acetonitrile THF Dichloromethane Tolueneb 
4-1 618 (0.30); 0.033 618 (0.36); 0.047 613 (0.52); 0.075 622 (0.18); 0.042 
4-2 623 (0.12); 0.019 646 (0.11); 0.019 642 (0.16); 0.033 620 (0.15); 0.016 
4-3 608 (0.34); 0.045 615 (0.31); 0.042 618 (0.31); 0.110 593 (1.07); 0.150 
4-4 610 (0.14); 0.025 623 (0.15); 0.032 615 (0.27); 0.070 606 (0.16); 0.041 
4-5 610 (0.04); 0.011 655 (0.04); 0.012 650 (0.07); 0.020 661 (0.02); 0.010 
4-6 620 (0.04); 0.011 637 (0.04); 0.017 649 (0.08); 0.024 604 (0.03); 0.012 
4-7 613 (0.03); 0.001 673 (0.03); 0.001 663 (0.06); 0.002 658 (0.03); 0.002 
4-8 693 (2.66); 0.011 691 (3.28); 0.015 693 (3.11); 0.015 700 (1.86); 0.012 
4-9 655 (0.06); 0.009 655 (0.09); 0.013 649 (0.13); 0.019 656 (0.05); 0.011 
4-
10 
700 (3.70); 0.005 697 (4.35); 0.007 699 (4.33); 0.009 706 (0.20); 0.005 
a Ru(bpy)3Cl2 in acetonitrile was used as the reference (ex = 436 nm, em = 0.097) for the emission 
quantum yield measurements. The quantum yield for 4-8 and 4-10 are for the emission in the 
region of 700-850 nm detected by the Hamamatsu photomultiplier tube (PMT) R928. b With 10% 
CH2Cl2. 
 
Table 4.9. Spin-density for the single and triplet SCF calculations for 4-1 − 4-10. The red 
translucent isosurface represents the electron distribution, whereas the blue translucent isosurface 
represents the hole for the transition from T1 to S0. 
 Spin-Density  Spin-Density  Spin-Density 
1 
 
2 
 
3 
 
4 
 
5 
 
6 
 
7 
 
8 
 
9 
 
10 
 
 
 
 
 
 
Examination of the emission energies, lifetimes, and quantum yields of 4-1 − 4-10 found 
that benzannulation at the phenyl ring of the ppy or L4-1 ligand caused a red shift of the emission 
spectra in 4-5 − 4-7 and 4-9, with shorter emission lifetimes and lower emission quantum yields 
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compared to complexes 4-1 − 4-4 with benzannulation at the pyridyl ring of the ppy ligand. The 
reduced emission lifetime and quantum yield are the results of increased nonradiative decay when 
the emitting state is lowered, which follows the energy gap law.58,59 In contrast, although the 
emission energies of complexes 4-8 and 4-10 were dramatically red-shifted compared to the other 
complexes, their lifetimes were much longer than those of the other complexes. This is attributed 
to the parentage change of the emission in these two complexes compared to the others. The trend 
of the emission energy variation of 4-1 − 4-10 is also in accordance with that observed for the S1 
state transitions despite the fact that the nature of the emitting states of 4-8 and 4-10 changed to 
3π,π states. In addition to the aforementioned site-dependent effects of benzannulation at the phenyl 
versus pyridyl ring, the emission energy was also found to depend on the benzannulation position 
at the phenyl or pyridyl ring. Among the four complexes 4-1 − 4-4 with benzannulation at the 
pyridyl ring, complex 4-2, which has benzannulation at the 4 and 5 positions of the pyridyl ring of 
the ppy ligand, showed a ∼20 nm red shift of the emission maximum compared to the parent 
complex 4-0 and the other three complexes 4-1, 4-3, and 4-4. For the three complexes 4-5 − 4-7 
with benzannulation at the phenyl ring of the ppy ligand, benzannulation at either the 4′ and 5′ or 
5′ and 6′ positions of the phenyl ring caused red shifts (∼37 nm) of the emission in 4-5 and 4-6 
compared to that in complex 4-0. Benzannulation at both the 3′ and 4′ and 5′ and 6′ positions of 
the phenyl ring of the ppy ligand induced a further 14 nm red shift in 4-7 with respect to those in 
4-5 and 4-6. However, fusion of the naphthyl motif to the 5 and 6 positions of the pyridyl ring of 
the ppy ligand completely changed the emitting states in 4-8 and 4-10 to the bq-localized 3π,π* 
state (see the NTOs in Table 4.10, in which both the holes and electrons for 4-8 and 4-10 were 
exclusively on the bq motif). When the bq-localized 3π,π* state became the emitting triplet excited 
state in 4-8 and 4-10, benzannulation at the phenyl ring of the C^N ligand did not impact the 
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emission energy. It is worth noting that, even though complexes 4-7 − 4-9 had the same number 
of aromatic rings in their C^N ligands, their emission characteristics were drastically different. 
This provided another piece of evidence manifesting the significant impact of the benzannulation 
site at the C^N ligand on the photophysics of the iridium(III) complexes.  
 
Table 4.10. NTOs representing the triplet transitions contributing to the emission of complexes 4-
1 − 4-10 in CH2Cl2a. The NTOs were calculated by TDDFT using the triplet minimum-energy 
geometry optimized by unrestricted DFT as described in the quantum chemistry calculations 
section. 
 T1 / nm Hole Electron  T1 / nm Hole Electron 
4-1 619 
99% 
  
4-6 724 
98% 
  
4-2 688 
99% 
  
4-7 841 
98% 
  
4-3 642 
99% 
  
4-8 1176 
100% 
  
4-4 658 
99% 
  
4-9 745 
98% 
  
4-5 693 
100% 
  
4-
10 
1196 
97% 
  
 
4.3.4. TA 
 Nanosecond TA spectroscopy is a powerful technique to investigate the triplet excited-
state properties, such as the triplet excited-state absorption, triplet lifetime, and quantum yield. In 
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this work, the TA measurements of complexes 4-1 − 4-10 were carried out in CH3CN to further 
understand their triplet excited-state characteristics. CH3CN was chosen as the solvent for the TA 
study rather than CH2Cl2 because of the better stability of the complexes in CH3CN than in CH2Cl2 
upon 355 nm laser excitation. The TA spectra of 4-1 − 4-10 at zero delay after excitation and the 
time-resolved spectra for complexes 4-1 − 4-3, 4-5, 4-8, and 4-10 are shown in Figure 4.10, and 
the time-resolved TA spectra for complexes 4-4, 4-6, 4-7, and 4-9 are provided in Figure 4.11. The 
triplet excited-state lifetimes (τTA) are tabulated in Table 4.2. The τTA values of these complexes 
were similar to their emission lifetimes in CH3CN (Table 4.8), implying that the observed TA 
originated from the emitting excited states.  
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Figure 4.10. Comparison of the nanosecond TA difference spectra of complexes 4-1 − 4-10 in a 
CH3CN solution immediately after laser excitation (the top figure) and the time-resolved TA 
spectra of complexes 4-1 – 4-3, 4-5, 4-8, and 4-10 in CH3CN (λex = 355 nm; A355 = 0.4 in a 1 cm 
cuvette).  
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Figure 4.11. Nanosecond time-resolved transient difference absorption spectra of 4-4, 4-6, 4-7, 
and 4-9 in acetonitrile. λex = 355 nm, A355 = 0.4 in a 1-cm cuvette. 
 
The TA spectra of 4-1 − 4-10 essentially possessed positive absorption bands in the entire 
360−800 nm region, except for very narrow and weak ground-state bleaching band being observed 
for 4-2 in 386−392 nm, 4-7 in 440−448 nm, and 4-10 in 386−417 nm. For the four complexes 4-1 
− 4-4 with benzannulation at the pyridyl ring of the ppy ligand, the TA band maxima of 1−3 
gradually bathochromically shifted. While the TA spectrum of 4-4 resembled that of 4-2, the 
relative intensities of the two bands were diferent. The maximum TA band of 4-2 was at 432 nm, 
while the maximum intensity band appeared at 377 nm in 4-4 (Figure 4.10). For complex 4-3, its 
TA spectrum resembled that of its corresponding iridium(III) dimeric precursor [Ir(piq)2Cl]2.
29 In 
view of the structural difference among 4-1 − 4-4 and the different shapes of their TA spectra, it 
is reasonable to speculate that the observed TA of these complexes could be related to the 
difference in the heteroatom-containing motif. The similarity between the TA spectra of 4-3 and 
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its precursor [Ir(piq)2Cl]2 complex also implies that the TA spectra of these complexes are indeed 
associated with the complexed C^N ligand.  
The three complexes 4-5 − 4-7 with benzannulation at the phenyl ring of the ppy ligand 
exhibited similar TA spectral features with very short lifetimes. Their TA spectra all consisted of 
a strong but narrow band below 400 nm, a broader but weaker band at 450nm for 4-5 and ca. 
500nm for 4-6 and 4-7, and an emerging near-IR (NIR) band around 800 nm (Figure 4.10). A 
comparison of the TA spectrum of 4-9 to that of 4-1 (Figure 4.10) revealed similar spectral features, 
but 4-9 had a much shorter lifetime. The similar spectral features seemed to be related to the 
identical quinoline motifs in the C^N ligand, while the shorter lifetime appeared to be a common 
feature when benzannulation occurred at the phenyl ring of the ppy ligand (similar to the shorter 
lifetimes observed in complexes 4-5 − 4-7). Additional evidence to support the association of the 
TA spectrum with the heteroatom-containing aromatic motif came from the TA spectra of 4-8 and 
4-10. The TA spectra of these two complexes were similar to each other and consistent with that 
of their dimeric iridium(III) precursor complex [Ir(pbq)2Cl]2 (pbq refers to the 2-
phenylbenzo[g]quinoline ligand) and the other iridium(III) complex bearing the same pbq ligand.29
 
 
Combining the TA and emission studies on complexes 4-1 − 4-10, we discovered that 
benzannulation at the phenyl ring of ppy mainly affected the lowest triplet excited-state energy 
and lifetime, whereas benzannulation at the pyridyl ring mainly impacted the spectral feature of 
TA. Especially, fusion of the naphthyl group to the pyridyl ring switched the lowest-energy triplet 
excited state to the bq motif of the C^N ligand, which gave rise to much stronger TA in the red 
spectral regions.  
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4.3.5. RSA 
To demonstrate that benzannulation at the C^N ligand influences not only the photophysics 
of the Ir(III) complexes, but also their potential applications, the reverse saturable absorptions 
(RSA) of complexes 4-1 − 4-10 in CH3CN solutions were investigated.  RSA is a nonlinear optical 
phenomenon in which the absorptivity of the material increases with increased incident fluence.  
RSA is closely related to the ground and excited state absorptions.  The inherent reason for RSA 
is that the excited-state absorption is stronger than the ground-state absorption of the absorber.60-
63 In the past one decade, our group and other groups chose Ir(III) complexes as candidate materials 
for RSA because the rapid intersystem crossing induced by the heavy Ir(III) ion helps populating 
the triplet excited state.  This property along with many closely-spaced triplet excited state present 
in Ir(III) complexes induce considerably wide and strong excited-state absorption.12,13,20-
22,24,25,27,29,30,31,33,50  For lasers with pulse width longer than the intersystem crossing time, the triplet 
excited state is populated primarily instead of the singlet excited state.  In such a case, compounds 
with a higher triplet quantum yield, a strong excited-state absorption with respect to ground-state 
absorption, and a longer triplet excited-state lifetime are ideal candidates for RSA. 
The positive TA spectra of complexes 4-1 − 4-10 (Figure 4.10) imply that all complexes 
possess stronger excited-state absorption than the ground-state absorption in the visible and NIR 
spectral region. They also have longer triplet excited- state lifetimes (Table 4.2) than the 
nanosecond laser pulse width (4.1 ns). Therefore, RSA of 4-1 − 4-10 is expected to occur at 532 
nm for the 4.1-ns laser pulses. RSA was demonstrated for complexes 4-1 – 4-10 in a CH3CN 
solution with an identical linear transmittance of 80% in a 2 mm cuvette at 532 nm for an easy 
comparison of the RSA strength. With the same linear transmission at 532 nm, the same number 
of molecules would be excited to the singlet excited state. Then the degree of RSA would be 
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determined by the degree of triplet excited- state absorption, which is a composite of the triplet 
excited- state quantum yield and the excited-state absorption cross section. As shown in Figure 
4.12, complexes 4-1 − 4-10 all exhibited strong RSA. The strength of RSA decreased in the order 
of 4-3 > 4-7 ≈ 4-4 ≈ 4-9 ≈ 4-6 > 4-8 ≈ 4-1 ≈ 4-2 ≈ 4-5 > 4-10, which are related to their ground-
state absorption cross sections (σ0 values; Table 4.11) and ΔOD values at 532 nm (Table 4.11).  
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Figure 4.12. Nonlinear transmission plots of 4-1 − 4-10 at 80% linear transmittance in a 2-mm 
cuvette in CH3CN solutions for 532 nm 4.1 ns laser pulses. 
 
Table 4.11. Ground-state absorption cross sections (σ0) and OD values of 4-1 − 4-10 in CH3CN 
at 532 nm 
 4-1 4-2 4-3 4-4 4-5 4-6 4-7 4-8 4-9 4-10 
σ0/10-18 cm2 3.0 1.8 2.5 2.3 2.5 4.6 4.4 5.0 3.5 7.4 
OD/10-2 1.0 1.4 2.8 1.1 1.2 1.5 1.3 2.4 0.6 1.9 
 
A key parameter for assessing the strength of RSA is the ratio of the excited-state 
absorption cross section to that of the ground state (σex/σ0). The σ values can be obtained by 
converting the ε values at 532 nm according to the equation σ = 2303ε/NA (NA = Avogadro’s 
constant). The ground-state molar extinction coefficient (ε0) was readily deduced from the UV−vis 
absorption spectra. However, the εex values at 532 nm were unable to be obtained because of the 
lack of obvious bleaching bands in most of the complexes. Consequently, a singlet depletion 
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method64 was unable to be used to deduce the εex values. Nonetheless, the ΔOD values obtained 
from the TA measurement reflected the absorbance difference between the excited- and ground-
state absorptions at a given wave- length. Complex 4-3 possessed one of the smallest ground-state 
absorption cross sections but the largest ΔOD value at 532 nm, implying the strongest excited-
state absorption among this series of complexes. As a result, 4-3 gave rise to the strongest RSA at 
532 nm. For complex 4-10, although the ΔOD value was the third largest, its largest σ0 value 
among this series of complexes counterplayed its excited-state absorption and decreased its RSA. 
Although the RSA strengths of these complexes were affected by the ligand structural variations, 
overall this series of complexes all exhibited quite strong RSA for nanosecond laser pulses at 532 
nm.  
 
4.4. Conclusion 
We have synthesized 10 cationic iridium(III) 2-(pyridin-2- yl)quinoline complexes bearing 
cyclometalating C^N ligands with different degrees of π-conjugation via benzannulation at 
different positions of the phenyl and/or pyridyl ring. Their site-dependent electronic absorption 
and emission characteristics were systematically investigated. Benzannulation on the phenyl ring 
of the C^N ligand raised the HOMO energies in complexes 4-5 − 4-7, 4-9, and 4-10 pronouncedly 
and thus lowered the energies of the S1 states in these complexes. In contrast, benzannulation on 
the pyridyl ring of the C^N ligand showed minor effects on the HOMOs of 4-1, 4-3, 4-4, and 4-8, 
except for the fact that the HOMO of 4-2 was destabilized. This trend was followed by the triplet 
emission in all complexes other than 4-8, with the emission spectra of complexes 4-2 and 4-5 − 4-
10 being red- shifted and those of 4-1, 4-3, and 4-4 − 4-4 remaining similar to that of the parent 
complex 4-0. Accompanying the decreased emission energies in 4-2, 4-5 − 4-7, and 4-9, the 
emission lifetimes and quantum yields of these complexes were significantly shortened or 
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decreased, which was consistent with the energy gap law. However, further extending the π 
conjugation at the pyridyl ring of the C^N ligand in 4-8 and 4-10 changed the parentage of the 
lowest triplet excited state from the 3MLCT/3LLCT states in the other complexes to the bq-
originated 3π,π* states, which prolonged the emission lifetimes in these two complexes. It appeared 
that benzannulation at the phenyl ring of the C^N ligand mainly influenced the lowest singlet and 
triplet excited- state energies and the triplet lifetimes but did not affect the triplet excited-state 
absorption spectral feature pronouncedly.  
On the contrary, fusion of only one phenyl ring on the pyridyl group of the C^N ligand, in 
most cases, did not influence the singlet and triplet excited-state energies noticeably but 
significantly impacted the triplet excited-state absorption spectral feature. Fusion of the naphthyl 
group to the pyridyl ring completely changed the nature of the lowest triplet excited state, causing 
drastic changes in the emission and triplet excited-state absorption characteristics. The changes in 
the ground-state and triplet excited-state absorptions consequently affected the RSA in these 
complexes, although all of the studied complexes exhibited strong RSA for nanosecond laser 
pulses at 532 nm. The conclusion drawn from this work could shed light on the rational design of 
monocationic iridium(III) complexes with predetermined photophysical properties. 
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5. MONOCATIONIC IRIDIUM(III) COMPLEXES WITH FAR−RED CHARGE 
TRANSFER ABSORPTION AND NEAR−IR EMISSION: SYNTHESIS, 
PHOTOPHYSICS, AND REVERSE SATURABLE ABSORPTION 
 
5.1. Introduction 
In the past two decades, octahedral d6 Ir(III) complexes have attracted a particular attention 
among chemists and materials scientists due to their high triplet excited–state quantum yield, 
synthetic versatility, and chemical stability.1–4 The rich photophysical properties present in the 
Ir(III) complexes prompt their potential applications in phosphorescence–based organic light–
emitting diodes (OLEDs),5,6 low–power upconversion,7,8 biomolecular labeling and imaging,9,10 
photochemical water oxidation,11,12 photodynamic therapy (PDT)13–15, and nonlinear optics 
(NLO).16,17  
Among the different types of Ir(III) complexes, monocationic Ir(III) complexes featuring 
diimine (N^N) and cyclometalating (C^N) ligands are particular interesting because of the facile 
synthesis under a mild condition. In addition, the absorption and emission characteristics of this 
type of complexes can be efficiently tuned via exploiting novel N^N and C^N ligands.18–20 Based 
on the reported electrochemical and computational studies, electrons of the lowest unoccupied 
molecular orbitals (LUMO) of this type of complexes are typically distributed on the N^N ligand, 
whereas the electrons of the highest occupied molecular orbital (HOMO) are mainly delocalized 
on the C^N ligands and d–orbital of the metal center.21 Therefore, different N^N ligands mainly 
impact the energy of the LUMO, but have negligible effect on the energy of the HOMO.22 This 
effect makes it possible to readily tune the lowest–energy charge transfer absorption band 
corresponding to the HOMO→LUMO transition via alternation of the N^N ligand. Meanwhile, 
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the lowest triplet excited states (T1 states) of the complexes can be altered simultaneously.
23 For 
this reason, tremendous efforts have been put on extending the synthetic scope of the N^N ligands, 
with 2,2′–bipyridine (bpy) and its analogs being the most commonly explored one to date.24–26  
Reverse saturable absorption (RSA) is a nonlinear optical phenomenon in which the 
reverse saturable absorbers exhibit a linear absorption at low incident laser fluence, while their 
absorptivity increases when the incident fluence increase. RSA occurs when the absorbance of the 
excited state of an absorber is stronger than that of the ground state at the corresponding 
wavelength. In order to facilitate RSA of nanosecond laser pulses, an absorber should have a weak 
ground state absorption to populate the excited states, but long–lived triplet excited states, large 
triplet–triplet excited−state absorption coefficients, and a high quantum yield for triplet 
excited−state formation. In recent years, the RSA of heavy transition–metal complexes, such as 
octahedral Ir(III) complexes, have been extensively explored by our group14,16,17,24,27–36 and other 
groups23,37−39 because these complexes displayed the aforementioned characteristics that well 
match the requirements for RSA. In addition, by structural modifications, both the ground−state 
and the excited−state properties can be readily tuned in these complexes for optimization of the 
RSA. 
Although extensive work has been reported on Ir(III) complexes for RSA, challenges still 
exist in developing the Ir(III) complexes into broadband reverse saturable absorbers. Among which 
the lack of considerable ground−state absorption in the red to the NIR region remains to be one of 
the obstacles. In seeking solutions to red−shift the ground−state absorption, immense effects on 
exploring N^N or C^N ligands suitable for reverse saturable absorbers have been made by our 
group.14,16,17,24,27−36 We discovered that incorporation of quinoxaline or benzo[g]quinoxaline unit 
into either the N^N or C^N ligand red−shifted the spin−forbidden 1,3IL (intraligand) / 1,3CT (charge 
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transfer) absorption bands into longer wavelengths.14,30,35 However, the triplet excited−state 
lifetimes of these complexes were reduced to tens to hundreds of ns. On the other hand, we have 
reported that Ir(III) bipyridine complex bearing 1,2–diphenyl–9H–pyreno[4,5–d]imidazole (dppi) 
cyclometalating ligands displayed a long−lived strong triplet excited−state absorption in the 
spectral regions of 410 − 700 nm.24 
Inspired by these exploration, we combine these two approaches in one system, attempting 
to red−shift the ground−state absorption to the far−red / NIR regions and meanwhile keep a 
relatively long−lived and broadly absorbing triplet excited state. In this work, we synthesized and 
investigated three cationic Ir(III) complexes featuring dppi C^N ligands and pyrazine–based N^N 
ligands (structures shown in Scheme 1) as reverse saturable absorbers. The –conjugation of the 
N^N ligands are gradually extended from 5-1 to 5-3 via benzannulation at the pyrazine unit to 
red−shift the 1,3IL / 1,3CT absorption bands. The diphyridylpyrazine (dpp) moiety would not only 
cause the red–shift of the 1,3IL/1,3CT absorption bands but also serve as a bridge to construct a 
supramolecular system that will be studied in the future. In addition to the spectroscopic studies 
on the photophysical properties of these complexes, density functional theory (DFT) calculation 
were performed to provide insight into the natures of the singlet and triplet states of these Ir(III) 
complexes. RSA of these complexes at 532 nm for ns laser pulses was demonstrated. 
 
5.2. Experimental section 
5.2.1. Materials and synthesis.  
All chemicals and solvents were purchased from commercial sources and used as received 
without further purification. The ligands dpp (L5-1),40 2,3–di(2–pyridinyl)quinoxaline (L5-2),41 
2,3–di(2–pyridinyl)benzo[g]quinoxaline (L5-3),42 dppi,25 and the Ir(III) dimer [Ir(dppi)2Cl]2,21 
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were prepared following the reported procedures. Column chromatography was carried out using 
silica gel (60 Å, 230–400 mesh) or Al2O3 (activated, neutral). The obtained complexes 5-1 – 5-3 
were analyzed by 1H NMR, high–resolution electrospray ionization mass spectrometry (ESI–MS), 
and elemental analysis. The 1H NMR spectra were measured on Bruker–400 spectrometer in 
CDCl3 using tetramethylsilane [Si(CH3)4] as the internal reference. High–resolution mass (HRMS) 
analyses were carried out on a Waters Synapt G2–Si mass spectrometer. Elemental analyses were 
performed by NuMega Resonance Laboratories, Inc. in San Diego, California. 
 
 
Scheme 5-1. Synthetic route for Ir(III) complexes 5-1 − 5-3. 
 
5.2.2. General procedure for the synthesis of 5-1 − 5-3 
The [Ir(dppi)2Cl]2 dimer (61 mg, 0.03 mmol), corresponding N^N ligand (0.06 mmol), and 
AgSO3CF3 (15 mg, 0.06 mmol) were added in the solvent (CH2Cl2:MeOH= 2:1 (v/v), 30 mL). The 
obtained mixture was degassed with N2 for 30 minutes and then heated to reflux for 24 h. After 
cooling to room temperature, NH4PF6 (49 mg, 0.3 mmol) was added and stirred for another 2 
hours. Solvent was then removed in vacuum. The residue was separated by column 
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chromatography on alumina gel, eluting with CH2Cl2/hexanes (3:1 to 1:0 (v/v)) to afford the target 
complex. 
5-1. A red powder was obtained as the product (46 mg, 52%).  1H NMR (400 MHz, CDCl3) 
δ 8.86 (d, J = 2.9 Hz, 1H), 8.69 (d, J = 4.9 Hz, 1H), 8.59 (d, J = 2.9 Hz, 1H), 8.45 – 8.38 (m, 2H), 
8.12 (q, J = 7.8 Hz, 1H), 8.09 – 7.85 (m, 18H), 7.85 – 7.78 (m, 1H), 7.73 – 7.63 (m, 2H), 7.59 (t, 
J = 7.9 Hz, 1H), 7.45 – 7.36 (m, 2H), 7.34 (d, J = 8.1 Hz, 1H), 7.32 – 7.27 (m, 2H), 7.21 (dd, J = 
10.5, 3.2 Hz, 1H), 7.10 (td, J = 7.7, 1.7 Hz, 1H), 7.06 – 6.99 (m, 1H), 6.93 – 6.81 (m, 4H), 6.74 – 
6.67 (m, 1H), 6.63 (dt, J = 5.0, 3.1 Hz, 1H), 6.47 (d, J = 8.1 Hz, 1H), 5.58 (d, J = 7.7 Hz, 1H). 
ESI–HRMS (m/z): calcd. for [C72H44N8Ir]+, 1213.3325; found, 1213.3322. Anal. Calcd for 
C72H44F6IrN8P•6H2O: C, 58.97; H, 3.85; N, 7.64. Found: C, 59.25; H, 3.97; N, 7.70. 
5-2. A brownish powder was obtained as the product (47 mg, 54%). 1H NMR (400 MHz, 
CDCl3) δ 8.69 (d, J = 6.7 Hz, 2H), 8.41 (d, J = 7.1 Hz, 1H), 8.24 (d, J = 7.2 Hz, 1H), 8.20 – 8.08 
(m, 4H), 8.08 – 7.78 (m, 12H), 7.79 – 7.64 (m, 4H), 7.64 – 7.58 (m, 1H), 7.55 (t, J = 7.9 Hz, 1H), 
7.45 (d, J = 7.4 Hz, 1H), 7.39 – 7.29 (m, 4H), 7.25 – 7.15 (m, 2H), 7.09 (dd, J = 6.5, 4.9 Hz, 1H), 
7.02 (td, J = 7.7, 0.5 Hz, 2H), 6.83 (ddd, J = 11.1, 9.0, 4.4 Hz, 4H), 6.78 – 6.72 (m, 1H), 6.71 – 
6.66 (m, 1H), 6.34 (t, J = 7.8 Hz, 2H), 6.29 (d, J = 7.1 Hz, 1H), 5.67 (d, J = 7.8 Hz, 1H). ESI–
HRMS (m/z): calcd. for [C76H46N8Ir]
+, 1263.3481; found, 1263.3477. Anal. Calcd for 
C76H46F6IrN8P•3H2O: C, 63.19; H, 3.49; N, 7.76. Found: C, 62.99; H, 3.72; N, 7.40. 
5-3. A brownish powder was obtained as the product (34 mg, 39%). 1H NMR (CDCl3, 400 
MHz): δ 9.15–9.04 (m, 1H), 8.80–8.67 (m, 2H), 8.59 (s, 1H), 8.50–8.35 (m, 1H), 8.22 (d, J = 8.5 
Hz, 1H), 8.17–7.88 (m, 12H), 7.89–7.61 (m, 7H), 7.60–7.51 (m, 3H), 7.49–7.38 (m, 2H), 7.33 (t, 
J = 7.8 Hz, 1H), 7.25–7.16 (m, 3H), 7.16–7.07 (m, 2H), 7.05–6.92 (m, 2H), 6.92–6.74 (m, 5H), 
6.70 (dd, J = 8.0, 1.3 Hz, 1H), 6.20 (dd, J = 7.9, 0.9 Hz, 1H), 6.11 (t, J = 7.8 Hz, 1H), 5.39 (d, J = 
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7.7 Hz, 1H), 5.24 (d, J = 8.0 Hz, 1H). ESI–HRMS (m/z): calcd. for [C80H48N8Ir]+, 1313.3639; 
found, 1313.3652. Anal. Calcd for C80H48F6IrN8P•0.7CH2Cl2: C, 62.50; H, 3.26; N, 7.18. Found: 
C, 62.37; H, 3.41; N, 7.19. 
 
5.2.3. Photophysical and nonlinear transmission measurements 
The UV−vis absorption spectra of 5-1 – 5-3 were recorded on a Varian Cary 50 
spectrophotometer. The emission spectra of 5-1 and 5-2 were recorded on a HORIBA 
FluoroMax-4 fluorometer/phosphorometer. A PTI Quantamaster equipped with a 
Hamamatsu R5509-42 near-infrared PMT was used to record the NIR emission spectrum 
of 5-3 in CH2Cl2. The emission quantum yields were obtained in deaerated solutions using 
relative actinometry method,43 with [Ru(bpy)3]Cl2 (em = 0.097 in degassed acetonitrile 
solution, ex = 436 nm)44 being used as the reference for 5-1 and 5-2, and IRF140 (Φem = 
0.167 in degassed ethanol solution, λex = 804 nm)45 for 5-3. The nanosecond transient 
diﬀerence absorption (TA) spectra of 5-1 – 5-3 were measured on an Edinburgh LP920 
laser flash photolysis spectrometer in acetonitrile solutions. The third−harmonic output 
(355 nm) of a Nd:YAG laser (Quantel Brilliant, 4.1 ns, the repetition rate was set to 1 Hz) 
was used as the excitation source. Each sample solution was degassed with nitrogen for 40 
min. before the measurement. By using the singlet depletion method,46 the triplet 
excited−state molar extinction coefficients (εT) of 5-1 – 5-3 at the TA band maxima were 
determined. The triplet excited−state quantum yields were then obtained using the relative 
actinometry method,47 with the benzene solution of SiNc (ε590 = 70,000 M−1 cm−1, ΦT = 
0.20)48 being used as the reference. The setup and details of the nonlinear transmission 
measurement were the same as those reported earlier by our group.28,49 
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5.2.4. Computational methodology 
The ground and excited−state properties of complexes 5-1 − 5-3 were simulated via density 
functional theory (DFT) and linear response time−dependent DFT (TDDFT) calculations. 
Gaussian 0950 was used to compute the ground and excited state properties at the B3LYP51 
functional with mixed basis set (LANL2DZ for Ir,52 and 6−31g* for H, C, and N53). The effect of 
dichloromethane solvent was implicitly included through the Conductor Polarized Continuum 
Model (CPCM).54,55 
The oscillator strengths and excitation energies from the singlet ground state (S0) to singlet 
excited states (Sn, n is the excited state) were computed via TDDFT. The simulated absorption 
spectra for 5-1 − 5-3 were then generated following the equation 2 in Ref. 56 by using a line−width 
of 0.05 eV to broaden the computed transitions. The emission energies of 5-1 − 5-3 were 
investigated by TDDFT SCF. TDDFT SCF computed the phosphorescence energy at the triplet 
equilibrium geometry via the spin−flip TDDFT between the singlet ground state (S0) and first 
triplet excited state (T1).
21 The nature of the singlet absorption (S0 → Sn) and emission (T1 → S0) 
was demonstrated by computing the natural transition orbitals (NTOs)56 for relevant transitions. 
The NTOs were visualized using VMD58 with an isosurface of 0.02. 
 
5.3. Results and discussion 
5.3.1. Electronic absorption 
The ground–state absorption spectra of complexes 5-1 − 5-3 were measured in CH2Cl2 
(Figure 5.1), and the corresponding data are compiled in Table 5.1. Since the observed absorption 
obeyed the Beer’s law in the concentration range of 5×10–6 to 1×10–4 mol•L−1, we consider that no 
ground–state aggregation occurs in this concentration range. 
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Figure 5.1. Experimental (a) and theoretical (b) UV/Vis absorption spectra of 5-1 – 5-3 at room 
temperature in CH2Cl2. The inset in panel (a) shows the expanded spectra in the regions of 450 − 
800 nm. The B3LYP functional was used in the TDDFT calculations and the calculated transitions 
were broadened by a Gaussian distribution with a linewidth of 0.05 eV. 
 
Table 5.1. Photophysical properties of complexes 5-1 – 5-3. 
 abs/nm (log ) a em/nm (em/ns); em b T1‑Tn/nm (TA/ns; log εT1−Tn), T c 
5-1 290 (5.06), 338 (4.86), 
356 (4.81), 384 (4.58), 
402 (4.57), 507 (2.98) 
651 (185); 0.036 390 (119; –), 437 (110; 4.41), 
779 (108; –); 0.33 
5-2 290 (5.12), 340 (4.91), 
355 (4.90), 381 (4.66), 
402 (4.63), 544 (3.03) 
710 (70); 0.0046 390 (55; –), 444 (56; 5.08), 733 
(75; –); 0.032 
5-3 290 (5.17), 325 (5.07), 
356 (4.90), 384 (4.67), 
404 (4.72), 605 (3.04) 
825 (380), 919 (-), 1035 
(-), 1180 (-); 0.007 
423 (392; –), 549 (405; –), 696 
(377; –); – 
a Electronic absorption band maxima (abs) and molar extinction coefficients (log ) in CH2Cl2 at room 
temperature. b Room temperature emission band maxima (em) and lifetimes (em) in CH2Cl2 (c = 1 × 10−5 
mol/L). For emission quantum yields determination, [Ru(bpy)3]Cl2 (Φem = 0.097, λex = 436 nm) in a 
degassed acetonitrile solution was used as the reference for 5-1 and 5-2., while IRF140 (Φem = 0.167, λex = 
804 nm) in a degassed ethanol solution was used as the reference for 5-3 c Nanosecond TA band maxima 
(T1‑Tn), triplet excited state lifetimes (TA) and quantum yields (T) measured in CH3CN at room 
temperature. 
 
The UV−vis absorption spectra of 5-1 − 5-3 resemble each other, being all composed of 
structured, intense absorption bands in the regions of 280 − 420 nm. The molar extinction 
coefficients of these bands gradually increased from 5-1 to 5-3, and a new band appearing at 325 
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nm in 5-3. Considering the spectral features and the molar extinction coefficients, we tentatively 
attribute these absorption bands predominantly to the ligand−localized 1,* transitions. The 
gradually increased molar extinction coefficients are likely caused by the extended π–conjugation 
of the N^N ligand. All spectra also exhibited weak and broad tails above 420 nm, i.e. 420−600 nm 
for 5-1, 420−700 nm for 5-2, and 420−750 nm for 5-3 (see inset in panel (a) of Figure 5.1). Because 
of the structureless feature and small molar extinction coefficients, these band(s) likely arose from 
charge transfer (CT) transitions. The gradual red−shift of these bands with increased molar 
extinction coefficients suggested that the CT transitions likely involved the N^N ligands, which 
could be metal−to−ligand charge transfer (MLCT) and ligand−to−ligand charge transfer (LLCT). 
To unambiguously understand the natures of the ground–state absorption, time–dependent 
density functional theory (TDDFT) calculations were carried out to obtain the natural transition 
orbitals (NTOs) for each complex. As the NTOs in Table 5.2 shows, the low−energy absorption 
band(s) at >420 nm exclusively emanate from the ligand−to−ligand charge transfer (1LLCT) / 
1MLCT transitions. In view of the dark or extremely small oscillator strength of the Table 5.3 and 
5-4 transitions in these complexes, the very weak absorption bands beyond 500 nm for 5-1 and 5-
2, and beyond 575 nm for 5-3 could have contributions from the spin−forbidden 3,*/3CT 
transitions that have been reported in many other Ir(III) complexes.14,26,28-30,35,59,60  The intense 
absorption bands at 320−420 nm (Table 5.3) are dominated by the dppi ligand−localized 1,* 
transitions, mixed with some 1MLCT/1LLCT transitions. The NTOs in Table 5.4 indicate that the 
short wavelength absorption bands at 280−320 nm predominantly arise from the dppi and N^N 
ligand localized spin–allowed 1,* transitions, admixing with minor 1MLCT/1LLCT and 
intraligand charge transfer (1ILCT) characters. 
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Table 5.2. Natural transition orbitals (NTOs) corresponding to the transitions contributing to the 
low−energy absorption bands of 5-1 – 5-3 in CH2Cl2.  
State Hole Electron State Hole Electron 
5-1 S1  
601 nm  
f = 0.003  
 
   
S2  
564 nm  
f = 0.000  
 
  
 
 S3  
502 nm  
f = 0.003  
 
   
S4  
438 nm  
f = 0.016  
 
    
 S6  
421 nm  
f = 0.014  
 
    
S7  
420 nm  
f = 0.025  
 
    
5-2 S1  
640 nm  
f = 0.000  
 
    
S2  
601 nm  
f = 0.002  
 
    
 
 S3  
525 nm  
f = 0.002  
 
   
S5  
445 nm  
f = 0.011  
 
    
 S6  
442 nm  
f = 0.014  
 
   
S7  
434 nm  
f = 0.009  
 
   
5-3 S1  
707 nm  
f = 0.000  
 
   
S2  
661 nm  
f = 0.002  
 
   
 
 S3  
568 nm  
f = 0.003  
  
  
S4  
503 nm  
f = 0.031  
 
   
 S6  
471 nm  
f = 0.010  
 
    
S8  
428 nm  
f = 0.008  
 
  
79% 
 
79% 
      
 
20% 
 
20% 
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Table 5.3. Natural transition orbitals (NTOs) representing singlet transitions contributing to the 
medium energy transitions of 5-1 – 5-3 in CH2Cl2. 
 State Hole Electron State Hole Electron 
5-1 S8  
387 nm  
f = 0.216  
  
S21  
355 nm  
f = 0.103  
 
51% 
 
51% 
S11  
377 nm  
f = 0.191  
 
54% 
 
54% 
 
31% 
 
31% 
 
41% 
 
41% 
S23  
346 nm  
f = 0.048  
 
 
 
 
46% 
 
46% 
S13  
373 nm  
f = 0.152  
 
54% 
 
54% 
 
44% 
 
44% 
 
31% 
 
31% 
S29  
329 nm  
f = 0.078 
  
S16  
366 nm  
f = 0.098  
 
 
  
S30  
326 nm  
f = 0.038  
  
35% 
 
35% 
S18  
359 nm  
f = 0.161  
 
 
  
 
 
24% 
 
24% 
 S19  
357 nm  
f = 0.097  
 
 
 
47% 
 
47% 
   
 
 
40% 
 
40% 
   
5-2 S12  
385 nm  
f = 0.432  
 
 
  
S26  
342 nm  
f = 0.052  
 
 
 
62% 
 
62% 
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Table 5.3. Natural transition orbitals (NTOs) representing singlet transitions contributing to 
the medium energy transitions of 5-1 – 5-3 in CH2Cl2. (continued) 
 State Hole Electron State Hole Electron 
 S15  
371 nm  
f = 0.111  
 
 
  
 
 
28% 
 
28% 
 S19  
365 nm  
f = 0.209  
 
 
 
67% 
 
67% 
S32  
327 nm  
f = 0.081  
 
 
  
 
 
25% 
 
25% 
S33  
324 nm  
f = 0.052  
 
 
  
 S22  
354 nm  
f = 0.134  
  
S34  
323 nm  
f = 0.100  
  
 S25  
346 nm  
f = 0.066 
  
   
5-3 S13  
394 nm  
f = 0.073  
   
S24  
354 nm  
f = 0.114  
   
S15  
386 nm  
f = 0.365  
  
S27  
344 nm  
f = 0.499  
 
53% 
 
53% 
S16  
383 nm  
f = 0.132  
 
69% 
 
69% 
 
33% 
 
33% 
 
26% 
 
26% 
S36  
327 nm  
f = 0.070  
 
 
  
S18  
370 nm  
f = 0.131 
  
S39  
323 nm  
f = 0.110  
   
 S20  
365 nm  
f = 0.171  
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Table 5.4. Natural transition orbitals (NTOs) representing singlet transitions contributing to the 
high energy transitions of 5-1 – 5-3 in CH2Cl2. 
 State Hole Electron State Hole Electron 
5-1 S31  
322 nm  
f = 0.037  
 
 
  
 
44% 
 
44% 
S53  
296 nm  
f = 0.098  
 
 
  28% 
 
28% 
 
 
27% 
 
27% 
 
25% 
 
25% 
 S33  
321 nm  
f = 0.190  
 
 
  
 
41% 
 
41% 
S65  
288 nm  
f = 0.066  
 
 
  
 
44% 
 
44% 
 
 
33% 
 
33% 
 
26% 
 
26% 
 S43  
303 nm  
f = 0.088  
 
   
S67  
286 nm  
f = 0.084  
 
 
  
 
36% 
 
36% 
 S46  
301 nm  
f = 0.074   
 
42% 
 
42% 
 
25% 
 
25% 
 
 
31% 
 
31% 
S70  
285 nm  
f = 0.055  
 
   
 S47  
299 nm  
f = 0.134  
 
38% 
 
38% 
   
  
 
34% 
 
34% 
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Table 5.4. Natural transition orbitals (NTOs) representing singlet transitions contributing to 
the high energy transitions of 5-1 – 5-3 in CH2Cl2. (continued) 
 State Hole Electron State Hole Electron 
5-2 S50  
302 nm  
f = 0.108  
 
 
  
 
43% 
 
43% 
S71  
288 nm  
f = 0.068  
 
  
29% 
 
29% 
 
24% 
 
24% 
 
26% 
 
26% 
S53  
301 nm  
f = 0.137  
 
44% 
 
44% 
S74  
286 nm  
f = 0.053  
  
 
31% 
 
31% 
5-3 S41  
317 nm  
f = 0.084  
 
   
S61  
302 nm  
f = 0.277  
 
 
  
 
43% 
 
43% 
S42  
317 nm  
f = 0.087  
  
   
25% 
 
25% 
 
5.3.2. Photoluminescence 
To explore the triplet excited states properties of 5-1 − 5-3, the emission of these complexes 
was studied in different solvents at room temperature. The emission spectra and parameters in 
CH2Cl2 are provided in Figure 5.2 and Table 5.1, and the spectra and parameters in other solvents 
are given in Figure 5.3 and Table 5.5, respectively. The observed luminescence was sensitive to 
oxygen quenching, and the lifetimes were tens to hundreds of nanoseconds, indicating the 
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phosphorescence nature of the emission. Going from 5-1 to 5-3, the emission energy gradually 
decreased; however, the spectral feature changed from featureless to structured, accompanied by 
a shortened lifetime from 5-1 to 5-2, but increased for 5-3. The lack of monotonic trend for the 
spectral feature and the emission lifetime are indicative of a different emitting state for 5-3 from 
those for 5-1 and 5-2. This notion was supported by the NTOs calculated by TDDFT SCF. 
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Figure 5.2. Normalized emission spectra of 5-1 − 5-3 in CH2Cl2 at room temperature. 
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Figure 5.3. Normalized experimental emission spectra of 5-1 − 5-3 at room temperature in 
different solvents. 
 
As shown in Table 5.6, the electrons in the T1 states were all localized on the N^N ligands 
and the d orbitals of Ir(III), while the holes were on the dppi ligands and a different d orbital of 
Ir(III) in 5-1 and 5-2, and on the N^N and d orbital in 5-3. Therefore, the emitting states of 5-1 and 
5-2 have the 3LLCT/3MLCT/3LMCT (ligand−to−metal charge transfer) configurations in nature; 
whereas the emitting state of 5-3 is the N^N ligand−localized 3,* state. Because the electrons in 
all three complexes involved the N^N ligands, and the extended −conjugation could stabilize the 
 190 
electrons, the reduced electron−hole gap decreased the emission energies going from 5-1 to 5-3. 
Moreover, the same charge transfer nature of the emitting states in 5-1 and 5-2 resulted in the 
shorter emission lifetime and lower emission quantum yield when the emission energy decreased 
from 5-1 to 5-2. This trend is consistent with the energy gap law.61,62 
 
Table 5.5. Emission characteristics of 5-1 − 5-3 in different solvents at room temperature.a 
λem/nm (em/us); Φem 
 CH3CN THF CH2Cl2 Toluene  
(with 10% CH2Cl2) 
5-1 655 (0.12);0.014 649 (0.17); 0.026 651 (0.18); 0.036 654 (0.12); 0.019 
5-2 714 (0.03); 0.0014 705 (0.04); 0.0033 710 (0.07); 0.0046 712 (0.05); 0.0029 
5-3 803 (0.32); - b 808 (0.24); - b 810 (0.38); - b 791 (0.28); - b 
a Ru(bpy)3Cl2 in CH3CN was used as the reference (λex = 436 nm, Φem = 0.097) for the emission 
quantum yield measurements. b Signal was too weak to be measured. 
 
Table 5.6. NTOs representing the transitions contributing to the T1 states of 5-1 − 5-3 in CH2Cl2 
calculated by TDDFT SCF method. 
 T1 / nm Hole Electron 
5-1 794 
  
5-2 860 
  
5-3 1358 
  
 
5.3.3. Transient absorption (TA) 
The RSA performance of a reverse saturable absorber is closely related to its excited–state 
absorption, triplet quantum yield, and its triplet lifetime. Thus, the nanosecond transient difference 
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absorption spectra of 5-1 − 5-3 were investigated in deoxygenated acetonitrile to further 
understand their triplet excited−state characteristics. The time–resolved TA spectra are presented 
in Figure 5.4 (a, b, c), and the comparison of the TA spectra immediately after laser excitation are 
provided in Figure 5.4d. The excited–state absorption parameters, i.e. the triplet excited–state 
lifetimes, extinction coefficients, and quantum yields, are compiled in Table 5.1. Because the TA 
lifetimes in CH3CN are similar to the emission lifetimes measured in the same solution for 5-1 − 
5-3, the triplet excited states leading to the observed TA can be attributed to the excited states state 
that emit, i.e. 3LLCT/3MLCT/3LMCT states for 5-1 and 5-2, and 3,* state for 5-3. 
The TA spectra of 5-1 and 5-2 resembled each other, both with bleaching at ca. 360 nm 
and 405 nm, which are consistent with the UV−vis absorption band maxima in the same spectral 
regions; and positive absorption bands at 371–397 and 414–800 nm. The similar spectral feature 
reflected the similar configuration of their T1 states. The positive absorption bands are similar to 
those observed in other Ir(III) complexes bearing the dppi ligands.21,24 Taking into account the fact 
that the T1 state contains the 
3LLCT/3LMCT characters, the observed positive absorption bands 
could be ascribed to the absorption from the dppi cation radical. In contrast, the TA spectrum of 
5-3 featured a broad positive absorption band in the 363–800 nm regions except for the very narrow 
and shallow bleaching bands centered at 370 and 405 nm. The TA spectrum of 5-3 is similar to 
those observed from the other Ir(III) complex bearing the benzoquinoxaline motif in the C^N 
ligand.35,60 This feature along with the predominantly benzoquinoxaline−localized 3,* nature of 
the T1 state support the assignment that the observed TA of 5-3 was originated from the 
benzoquinoxaline−localized 3,* state. 
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Figure 5.4. Time−resolved nanosecond TA spectra of complexes 5-1 − 5-3 in deoxygenated 
acetonitrile solution (a–c), and comparison of the TA spectra of 5-1 − 5-3 immediately after laser 
excitation. A355 = 0.4 in a 1 cm cuvette, λex = 355 nm. 
 
5.3.4. Reverse saturable absorption 
As the TA spectra in Figure 3 displayed, complexes 5-1 − 5-3 all exhibited positive TA 
signals at 532 nm, implying a stronger triplet excited–state absorption at this wavelength than that 
of the ground state. Thus, RSA is anticipated to occur upon laser excitation at 532 nm. To ensure 
that identical number of complexes are excited to the singlet excited state, the concentration of 
each sample solution was adjusted to reach an 80% linear transmission in a 2 mm cuvette at 532 
nm. At this condition, the observed difference in RSA should arise from the different 
 193 
characteristics of the triplet excited state. Using the 4.1 ns laser pulses, the nonlinear transmission 
experiment of 5-1 − 5-3 in acetonitrile was carried out and the results are provided in Figure 5.5.  
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Figure 5.5. Nonlinear transmission plot of 5-1 − 5-3 at the linear transmittance of 80% in 2 mm 
cuvette in acetonitrile solution using the 4.1 ns laser pulses duration at 532 nm.  
 
It is apparent that all complexes exhibited strong RSA, with the strength of RSA decreasing 
in the order of 5-3 > 5-1  5-2. The RSA strength of 5-1 − 5-3 approximatively paralleled the 
intensity of the TA signals immediately after laser pulse excitation at 532 nm (i.e. 0.005 for 5-1 
and 5-2, and 0.017 for 5-3). Although the OD values are the same for 5-1 and 5-2, a slightly 
stronger RSA was observed for 5-1 because of its slightly weaker ground–state absorption than 
that of 5-2 (see the inset in Figure 5.1). This is because the strength of RSA is mainly determined 
by the ratio of the excited−state absorption cross section (ex) vs. that of the ground state (0) at 
the same wavelength, a weaker ground−state absorption could increase the ex/0 ratio and thus 
enhance the RSA. For 5-3, the much stronger excited−state absorption at 532 nm compared to 5-
1 and 5-2 accounted for its strongest RSA among these three complexes. Moreover, 5-3 possesses 
the much broader ground−state absorption extending to 750 nm, a broader and stronger 
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excited−state absorption in the visible spectral regions, and the longer triplet lifetime. These 
features could make it an attractive candidate as a broadband reverse saturable absorber.  
 
5.4. Conclusions 
We have reported the synthesis, photophysics, and RSA of three cationic Ir(III) complexes 
with dppi as the C^N ligand and different dipyridylpyrazine derivatives as the N^N ligand. 
Spectroscopic methods and TDDFT calculations were used to understand the influence of 
−conjugation of the N^N ligand on the UV−vis absorption and emission of the complexes. We 
found that increasing the π–conjugation of the N^N ligand caused a red−shift of the 
charge−transfer absorption bands in these complexes and increased the molar extinction 
coefficients of all of the absorption bands. Meanwhile, this structural variation switched the T1 
states from 3LLCT/3MLCT in 5-1 and 5-2 to the N^N ligand−localized 3,* state in 5-3, which 
not only red−shifted the emission spectrum of 5-3, but also prolonged the T1 lifetime and 
drastically changed the transient absorption spectral features. The impact of the −conjugation on 
the ground−state and excited−state absorption consequently influenced the RSA of these 
complexes for ns laser pulses at 532 nm. The trend of the RSA strength, i.e. 5-3 > 5-1  5-2, is the 
result of the increased excited−state absorption and decreased ground−state absorption when the 
−conjugation of the N^N ligand varied. The extended weak charge−transfer absorption band at 
420−750 nm, along with the stronger triplet excited−state absorption in this spectral region 
promoted 5-3 as a potential reverse saturable absorber. 
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6. PHOTOPHYSICAL AND PHOTOBIOLOGICAL PROPERTIES OF DINUCLEAR 
IRIDIUM(III) BIS-TRIDENTATE COMPLEXES 
 
6.1. Introduction 
In recent decades transition-metal complexes have come to the forefront in the search for 
new chemical entities in drug discovery and biological chemistry.1 Platinum (Pt)-based metal 
complexes have been investigated extensively for cancer therapy,2 with cisplatin being arguably 
the most successful anticancer drug to date. Nevertheless, there is continued focus on developing 
alternatives to cisplatin3,4 and other nonselective cytotoxic agents in an effort to reduce the 
systemic side effects associated with conventional chemotherapy approaches. Ruthenium (Ru)-
containing compounds have been widely studied as alternatives to the Pt-derived drugs, with a few 
(e.g., NAMI-A, KP1019, and IT-139) entering clinical trials5–7 but none in the clinic to date. With 
selectivity being a key consideration for any new drug, Ru(II) coordination complexes and other 
transition-metal complexes are also being considered for targeted modalities such as photodynamic 
therapy (PDT).8–11 
 PDT has been known for over a hundred years12 yet remains underexploited in mainstream 
cancer therapy despite its precise spatiotemporal selectivity. In its narrowest definition, PDT 
involves activation of an otherwise nontoxic photosensitizer with photons of appropriate energy 
to produce a triplet excited state that can relax through singlet oxygen (1O2) sensitization or the 
production of other reactive oxygen species (ROS).13 Collectively, cytotoxic ROS destroy tumors 
and tumor vasculature, and can even invoke an antitumor immune response under the right 
conditions. Porphyrin-based organic compounds (and the related chlorins, bacteriochlorins, and 
phthalocyanines) have traditionally served as ROS-generating photosensitizers for PDT.14,15 
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However, transition-metal complex photosensitizers have the potential to both (i) expand the scope 
of PDT to include oxygen-independent mechanisms of action, and thus improve PDT efficacy in 
hypoxic tissue, and (ii) broaden the wavelength range that can be used to include deeper tissue-
penetrating near-infrared (NIR) light. One recent example is our Ru(II) complex TLD1433,16 
currently in clinical trials for treating bladder cancer with PDT (ClinicalTrials.gov Identifier: 
NCT03053635), and its transferrin conjugate Rutherrin™.17 
 TLD1433 incorporates a special -expansive ligand derived from imidazo[4,5-
f][1,10]phenanthroline appended to an -terthienyl unit, which imparts a long-lived triplet 
intraligand excited state (3IL) of significant ,* character that is lower in energy than the triplet 
metal-to-ligand charge transfer (3MLCT) state that typically dominates the photophysical 
dynamics of Ru(II) polypyridyl complexes. The reduced intersystem crossing (ISC) rates 
characteristic of spin-forbidden 3,* transitions centered on the organic moiety are responsible 
for the much longer intrinsic triplet lifetimes in these constructs that are known as metal-organic 
dyads.18,19 The implication is that slow ISC back to the ground state from 3IL states provides ample 
opportunity for requisite bimolecular processes that constitute the phototoxic effects of PDT. We 
have demonstrated very potent in vitro PDT effects from a variety of Ru(II) dyads with low-lying, 
long-lived 3IL states, including both contiguously-fused -extended azaaromatic ligands20 as well 
as ligands tethered to -extended aromatic chromophores.16,21–23 More recently, we have 
incorporated -expansive ligands into Ir(III) metal complexes to extend intrinsic excited state 
lifetimes for both reverse saturable absorption (RSA) and PDT applications.24,25 
 Compared to the large number of Ru(II) systems that have been explored, investigations 
on Ir(III) complexes for in vitro PDT have been emerged in recent years.24–44 While Ir(III) 
complexes derived from diimine ligands (N^N) may fall short of the optimal absorption window 
 202 
for PDT, we have demonstrated that incorporation of two cyclometalating ligands (C^N) to form 
biscyclometalated Ir(III) complexes extends the ground-state absorption spectrum significantly, 
and that installation of a -extended N^N ligand alongside the two C^N ligands extends the 
lifetime through population of 3IL states. The result is nanomolar PDT potency with 
phototherapeutic indices (PIs) greater than 400.25 We also showed that it was possible to use -
extended C^N ligands without compromising the potent in vitro PDT effects in Ir(III)-based 
systems that act as near-infrared-emitting theranostic agents.24 
The large luminescence quantum yields for certain Ir(III) complexes combined with their 
high yields for triplet state formation and good photostability make these metal complexes very 
attractive for photobiological applications such as PDT. In addition, their excitation and emission 
energies, as well as other photophysical and biological/chemical properties, can be systematically 
tuned via minor structural changes to a highly versatile and modular architecture. Despite these 
attributes, Ir(III) complexes studied to date30 still fall short of some of the best Ru(II)-based in 
vitro PDT agents. The purpose of the present study is to use rational design principles to improve 
the water-solubility and in vitro PDT effects within the Ir(III) class of photosensitizers. 
Specifically, installing two Ir(III) centers in a single complex might simultaneously amplify 
photocytotoxicity and increase water solubility. 
The solubility of organometallic complexes in aqueous solution can be improved by 
increasing the number of charges in the complex, which should be applicable to multinuclear 
iridium(III) complexes with C^N and/or N^N ligands.45 Since the photophysical and biological 
properties of metal complexes bearing tridentate ligand(s) can be readily tuned by modification of 
the 4′-position of the tridentate ligand(s), and because the bis-tridentate ligand coordination 
prevents the formation of stereoisomers upon complexation with transition metals, tridentate 
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ligands are chosen for this Ir(III) study.46,47 Our previous work with bis-terpyridyl dinuclear Pt(II) 
complexes showed that the fluorenyl bridging group imparted these systems with intense 
absorption in the visible region (400-500 nm) and reasonably long-lived triplet excited states.48 
These desirable properties led us to investigate fluorenyl-linked Ir(III) systems as in vitro PDT 
agents. 
Herein, we report the synthesis, characterization, and photophysical/photobiological 
properties of stable dinuclear Ir(III) complexes (Chart 6-1) of +2, +4, or +6 charges, with the 
charge determined by the identities of the metal coordinating atoms of different terminal tridentate 
ligands. Fluorene was chosen as the central bridging group for the two Ir-tpy components because 
it is a rigid π-conjugated linker expected to enhance molar extinction coefficients in the visible 
spectral region. Complexes 6-1 and 6-3 – 6-5 incorporate 9,9-dioctyl-2,7-di(terpyridyl)-9H-
fluorene (L6-1) as the bridging ligand, with variation at the terminal tridentate ligands: 4'-phenyl-
2,2':6',2''-terpyridine (N^N^N), 1,3-dipyridyl-4,6-dimethylbenzene (N^C^N), 4,6-diphenyl-2,2'-
bipyridine (C^N^N), or 2,4,6-triphenyl-pyridine (C^N^C). Complex 6-2 uses 9,9-dioctyl-2,7-
bis(2-phenylethynyl)-9H-fluorene (L6-2) as the bridging ligand to extend the -conjugation 
length, which is anticipated to facilitate intraligand charge transfer (ILCT) transitions that fall in 
the PDT window and to also increase visible wavelength absorption.  
 
Chart 6-1. The molecule structure of target dinuclear Ir(III) complexes. 
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6.2. Experimental section 
6.2.1. Synthesis and characterizations 
All the chemicals and solvents were purchased from Aldrich Chemical Co. or Alfa Aesar 
and used as received unless otherwise mentioned. The bridging ligands (L6-1 and L6-2) were 
synthesized following the procedures reported by our group before.48 4'-Phenyl-2,2':6',2''-
terpyridine (N^N^N),49 1,3-dipyridyl-4,6-dimethylbenzene (N^C^N),50 4,6-diphenyl-2,2'-
bipyridine (C^N^N),51 2,4,6-triphenylpyridine (C^N^C),52 4'-phenyl-2,2':6',2''-terpyridine-IrCl3 
(N^N^N-IrCl3),
53 and {[1,3-dipyridyl-4,6-dimethylbenzene]IrCl2}2 (N^C^N Ir-dimer)
54 were 
synthesized following literature procedures. The silica gel (60 Å, 230−400 mesh) and Al2O3 gel 
(activated, neutral) used for column chromatography were purchased from Sorbent Technology. 
Complexes 6-1 – 6-5 were characterized by 1H NMR, high resolution electrospray ionization mass 
spectrometry (ESI–MS), and elemental analysis. 1H NMR spectra were obtained on Bruker-400 
spectrometer or Varian Oxford–500 spectrometer. ESI–MS analyses were conducted on Waters 
Synapt G2-Si Mass Spectrometer. Elemental analyses were carried out by NuMega Resonance 
Laboratories, Inc. in San Diego, California. 
The synthetic schemes for complexes 6-1 – 6-5 are illustrated in Scheme 6-1. 
L6-1-(IrCl3)2. A suspension of L6-1 (170.5 mg, 0.2 mmol) and IrCl3
.3H2O (141 mg, 0.4 
mmol) in degassed ethylene glycol (15 mL) was heated to 160 °C without direct light for 30 
minutes. After the mixture was cooled to room temperature, the precipitate was filtered out and 
washed with ethanol, water, and diethyl ether to give L6-1-Ir(Cl3)2 as red solid (254 mg, 88%).  
1H NMR (500 MHz, d6-DMSO) δ 9.27 (d, J = 5.0 Hz, 4H), 9.18 (t, J = 8.8 Hz, 4H), 9.06 (dd, J = 
11.3, 3.0 Hz, 2H), 8.98 – 8.94 (m, 2H), 8.70 (t, J = 9.8 Hz, 2H), 8.52 (dd, J = 8.2, 4.1 Hz, 2H), 
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8.38 (t, J = 7.8 Hz, 4H), 8.32 (d, J = 8.5 Hz, 2H), 8.06 – 8.01 (m, 4H), 2.43 (m, 4H), 0.95 – 0.69 
(m, 20H), 0.48 (m, 10H). 
 
Scheme 6.1. Synthetic routes for complexes 6-1 – 6-5. 
 
6-1.  A suspension of 4'-phenylterpyridine-IrCl3 (60.7 mg, 0.1 mmol) and L6-1 (42.6 mg, 
0.05 mmol) in degassed ethylene glycol (10 mL) was heated to 196 °C without direct light for 2 
hours. After the mixture was cooled to room temperature, saturated NH4PF6 solution (20 mL) was 
added to precipitate out the crude product. The crude product was purified by column 
chromatography (Alumina, eluted with CH2Cl2 first to remove unreacted ligand, then using 
acetone/water gradient elution from 100:0 to 95:5 (v/v)) to give a yellow solid (60 mg, 65%) as 
the desired product. 1H NMR (400 MHz, d6-DMSO) δ 9.76 (s, 4H), 9.67 (s, 4H), 9.50 – 9.34 (m, 
4H), 9.29 (d, J = 8.2 Hz, 4H), 9.05 (s, 2H), 8.88 – 8.78 (m, 2H), 8.53-8.39 (m, 14H), 8.17 – 7.93 
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(m, 8H), 7.87 (t, J = 7.6 Hz, 4H), 7.78 (t, J = 7.4 Hz, 2H), 7.62 (dd, J = 12.2, 5.8 Hz, 8H), 2.61 (m, 
4H), 0.89 (m, 20H), 0.62 (m, 10H). ESI-HRMS (m/z, in acetone): calcd. for [C101H90Ir2N12]
6+, 
309.4445; found, 309.4446. Calcd. for [C101H90Ir2N12PF6]
5+, 400.3262; found, 400.3270. Calcd. 
for [C101H90Ir2N12P2F12]
4+, 536.6489; found, 536.6503. Anal. Calcd. (%) for 
C101H90F36Ir2N12P6
.6H2O: C, 42.80; H, 3.63; N, 5.93. Found: C, 42.61; H, 3.74; N, 5.98. 
6-2.  A suspension of 4'-phenylterpyridine-IrCl3 (60.7 mg, 0.1 mmol), L6-2 (45 mg, 0.05 
mmol), and AgOTf (77 mg, 0.3 mmol) in degassed ethylene glycol (10 mL) was heated to 196 °C 
without direct light for 24 hours. After the mixture was cooled to room temperature, saturated 
NH4PF6 solution (20 mL) was added to precipitate out the crude product. The crude product was 
purified by column chromatography (Alumina, eluted with CH2Cl2 first to remove unreacted 
ligand, then using acetone/water gradient elution from 100:0 to 95:5 (v/v)) to give a dark red 
powder (37 mg, 24%) as the desired product. 1H NMR (400 MHz, d6-DMSO) δ 9.62 (t, J = 7.0 
Hz, 6H), 9.22 (m, 8H), 8.48 (m, 6H), 8.32 (m, 8H), 7.92 (m, 8H), 7.77 (m, 6H), 7.71 (m, 4H), 7.51 
(m, 10H), 2.51 (m, 4H), 1.02 (m, 20H), 0.67 (m, 10H). ESI-HRMS (m/z, in acetone): calcd. for 
[C105H90Ir2N12]
6+, 317.4445; found, 317.4442. Anal. Calcd. (%) for 
C105H90F36Ir2N12P6
.13H2O
.CH2Cl2: C, 41.16; H, 3.85; N, 5.43. Found: C, 40.83; H, 3.47; N, 5.44. 
6-3.  A suspension of {[2,2'-(4,6-dimethyl-1,3-phenylene)bis-pyridine]IrCl2}2 (72 mg, 
0.069 mmol) and L6-1 (59 mg, 0.069 mmol) in ethylene glycol (10 mL) was heated to 196 °C in 
degassed ethylene glycol without direct light for 1 hour. After cooling to room temperature, the 
reaction mixture was added to water (10 mL) and filtered. Saturated NH4PF6 solution (20 mL) was 
added to the filtrate, and the resulting yellow precipitate was collected by centrifugation, washed 
with water (310 mL), and dried under vacuum. The crude product was purified by column 
chromatography (Alumina, eluted with CH2Cl2 first to remove unreacted ligand, then using 
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acetone/water gradient elution from 100:0 to 95:5 (v/v)) to yield a yellow solid (94 mg, 58%) as 
the desired product. 1H NMR (400 MHz, d6-DMSO) δ 9.65 (td, J = 5.0, 2.5 Hz, 4H), 9.18 (t, J = 
9.9 Hz, 4H), 8.90 (m, 2H), 8.71 (m, 2H), 8.47 (dd, J = 9.6, 2.6 Hz, 2H), 8.37 (d, J = 8.4 Hz, 4H), 
8.30 (dd, J = 8.8, 4.6 Hz, 4H), 7.99 (ddd, J = 7.5, 5.9, 2.7 Hz, 4H), 7.77 (m, 2H), 7.68 (ddd, J = 
9.7, 4.8, 2.7 Hz, 4H), 7.52 (ddd, J = 6.7, 4.1, 1.2 Hz, 4H), 7.45 (dd, J = 5.7, 1.8 Hz, 2H), 7.40 (s, 
2H), 7.12 (ddd, J = 8.4, 6.5, 1.7 Hz, 4H), 2.93 (s, 12H), 2.52 (m, 4H), 0.90 (m, 20H), 0.62 (m, 
10H). ESI-HRMS (m/z, in acetone): calcd. for [C95H90Ir2N10]
4+, 439.1652; found, 439.1668. 
Calcd. for [C95H90Ir2N10PF6]
3+, 633.8750; found, 633.8768. Anal. Calcd. (%) for 
C95H90F24Ir2N10P4
.5H2O: C, 47.03; H, 4.15; N, 5.77. Found: C, 46.97; H, 4.32; N, 5.98. 
6-4.  A suspension of L6-1-(IrCl3)2 (72.4 mg, 0.05 mmol), 4,6-diphenyl-2,2'-bipyridine 
(30.8 mg, 0.1 mmol), and AgOTf (77 mg, 0.3 mmol) in degassed ethylene glycol (10 mL) was 
heated to 196 °C without direct light overnight. After the mixture was cooled to room temperature, 
saturated NH4PF6 solution (20 mL) was added to precipitate out the crude product. The crude 
product was purified by column chromatography (Alumina, eluted with CH2Cl2 first to remove 
unreacted ligand, then using acetone/water gradient elution from 100:0 to 95:5 (v/v)) to yield a 
yellow solid (38 mg, 41%) as the desired product. 1H NMR (400 MHz, d6-acetone) δ 10.05 (d, J = 
7.2 Hz, 2H), 9.49 (d, J = 8.4 Hz, 2H), 9.30 (s, 2H), 9.00 (d, J = 15.3 Hz, 4H), 8.95 – 8.77 (m, 6H), 
8.71 (s, 2H), 8.48 (dd, J = 18.4, 9.5 Hz, 8H), 8.36 (s, 2H), 8.28 (d, J = 6.3 Hz, 2H), 8.13 – 7.97 (m, 
4H), 7.86 (dd, J = 10.8, 6.6 Hz, 4H), 7.75 (s, 2H), 7.61 (s, 6H), 7.48 – 7.33 (m, 2H), 7.19 (dd, J = 
13.3, 4.5 Hz, 4H), 6.91 – 6.69 (m, 4H) 2.41 (m, 4H), 0.86 (m, 20H), 0.55 (m, 10H). ESI-HRMS 
(m/z, in acetone): calcd. for [C103H90Ir2N10PF6]
3+, 655.8756; found, 655.8798. Anal. Calcd. (%) 
for C103H90F24Ir2N10P4
.9H2O: C, 47.69; H, 4.20; N, 5.40. Found: C, 47.56; H, 4.46; N, 5.25. 
 208 
6-5.  A suspension of L6-1-(IrCl3)2 (72.4 mg, 0.05 mmol), 2,4,6-triphenylpyridine (30.7 
mg, 0.1 mmol), and AgOTf (77 mg, 0.3 mmol) in degassed ethylene glycol (10 mL) was heated to 
196 °C without direct light for 24 hours. After the mixture was cooled to room temperature, 
saturated NH4PF6 solution (20 mL) was added to precipitate out the crude product. The crude 
product was purified by column chromatography (Alumina, eluted with CH2Cl2 first to remove 
unreacted ligand, then using acetone/water gradient elution from 100:0 to 95:5 (v/v)) to yield a red 
solid (16 mg, 8%) as the desired product. 1H NMR (400 MHz, d6-DMSO) δ 9.56 (s, 4H), 9.19 – 
9.09 (m, 4H), 8.95 – 8.85 (m, 4H), 8.60 (s, 4H), 8.33 (d, J = 6.6 Hz, 8H), 8.22 (s, 6H), 7.89 (s, 
4H), 7.73 (s, 4H), 7.64 (s, 2H), 7.45 (s, 4H), 6.99 (s, 4H), 6.74 (s, 4H), 6.21 (s, 4H), 2.52 (m, 4H), 
0.85 (m, 20H), 0.55 (m, 10H). ESI-HRMS (m/z, in acetone): calcd. for [C105H90Ir2N8]
2+, 924.3283; 
found, 924.3291. Anal. Calcd. (%) for C105H90F12Ir2N8P2
.0.6CH2Cl2: C, 57.94; H, 4.20; N, 5.12. 
Found: C, 57.92; H, 3.96; N, 5.27. 
 
6.2.2. Photophysical studies 
Spectrophotometric grade solvents purchased from Alfa Aesar were used for the 
photophysical measurements in this work. The Ultraviolet−visible (UV−vis) absorption spectra of 
complexes 6-1 – 6-5 were measured on a Varian Cary 50 spectrophotometer. Steady-state emission 
spectral measurements in different solvents (acetonitrile, acetone, and dichloromethane) were 
conducted using a HORIBA FluoroMax 4 fluorometer/phosphorometer. The relative actinometry 
method55 was used to determine the emission quantum yields for complexes 6-1 – 6-5 in degassed 
CH3CN solution using [Ru(bpy)3]Cl2 (Φem = 0.097, λex = 436 nm)56 as the reference. The 
nanosecond transient absorption (TA) spectra and decays, triplet excited-state quantum yields, and 
triplet lifetimes were recorded in degassed acetonitrile solutions on an Edinburgh LP920 laser flash 
photolysis spectrometer. The third harmonic output (355 nm) of a Nd:YAG laser (Quantel 
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Brilliant, pulsewidth ∼4.1 ns, repetition rate was set to 1 Hz) was used as the excitation light 
source. Each sample solution was degassed using Ar for 40 minutes before each measurement. 
The triplet excited-state molar extinction coefficients (εT1-Tn) were determined by the singlet 
depletion method57 at the TA band maxima. The triplet excited-state quantum yields were 
measured by the relative actinometry method58 after obtaining the εT1–Tn values, with SiNc in 
benzene being used as the reference (ε590 = 70,000 M−1cm−1, ΦT = 0.20).59 
 
6.2.3. Singlet oxygen quantum yields   
Quantum yields for singlet oxygen formation were determined according to the direct 
method by measuring sensitized singlet oxygen emission centered at 1268 nm using a PTI 
Quantamaster equipped with a Hamamatsu R5509-42 near-infrared PMT.  The PF6− salts of the 
metal complexes were prepared at 5 μM in spectroscopic-grade CH3CN under an ambient 
atmosphere (21% O2). Quantum yields for singlet oxygen emission () were calculated relative 
to the standard [Ru(bpy)3](PF6)2 ( = 0.56 in aerated CH3CN)60 according to Eq 1, where I, A, 
and η are integrated emission intensity, absorbance at the excitation wavelength, and refractive 
index of the solvent, respectively. The calculated  values were reproducible to within <5%. 
                                                   (6.1.) 
 
6.2.4. DFT calculations 
Density functional theory (DFT) and time-dependent DFT (TDDFT) calculations on Ir(III) 
complexes were performed using Gaussian09 quantum software package.61 The basis sets used in 
all calculations are LANL2DZ62-64 for Ir(III) and 6-31G*65-69 for other non- metal atoms. Unlike 
the previous Ir(III) complexes studied,25,70,71 complexes 6-1 – 6-5 have two metal centers 
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connected by fluorenylbisterpyridyl ligand, which makes long-range  interactions critical for the 
description of both geometry and excited state properties. Therefore, here we used the long-range 
corrected hybrid function, ωB97XD, which was designed to capture long-range atom-atom 
dispersion.72 Implicit solvent effects were incorporated by the conductor-like polarizable 
continuous model (CPCM)73,74 simulating the effects of acetonitrile. The long aliphatic side chains 
on fluorene were replaced with butyl groups to reduce the computational cost. This reduction does 
not affect the optical properties of the complexes in the visible spectral region, since octyl groups 
do not contribute any electronic transitions in this energy range. 
The absorption spectra for the Ir(III) complexes were generated by broadening the lowest 
100 singlet vertical excitations computed by TDDFT75,76 using the functional and basis sets 
described above. To broaden the vertical excitation to generate spectra in terms of molar 
absorptivity units (L·mol-1·cm-1) the method described by Bjorgaard and co-workers was 
followed.77 The shape of the spectra generated by broadening the vertical excitation computed by 
TDDFT quantitatively agreed well, except for about ~0.6 eV blue-shift, which is expected for the 
ωB97XD functional applied to conjugated systems.78 To align the theoretical spectra with the 
experimental spectra, all transitions energy were red-shifted by -0.55 eV. To characterize the type 
of excitation for the Ir(III) complexes, natural transition orbitals (NTOs)79 were generated using 
Gaussian09 software. NTOs allow for representing an excitation as the electron and hole pair, 
while preserving the many-body nature of the excited states. Due to the high symmetry of these 
dinuclear complexes, multiple transition densities that only differ on which metal center electronic 
density is localized contribute to some excitations. Therefore, only uniquely representative NTOs 
are shown for those excitations and those states are indicated by “*” in Tables 6-2 and 6-3. The 
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visualization of the NTOs were done utilizing Visual Molecular Dynamics (VMD)80 with 
isosurface of 0.02. 
 
6.2.5. Photobiological activity studies 
The experimental details for cell culture, cytotoxicity and photocytotoxicity studies, 
confocal microscopy, and DNA mobility-shift assays are the same as those described in our 
previous published work.24,25 
 
6.3. Results and discussion 
6.3.1. Electronic absorption 
The experimental UV−vis absorption spectra of complexes 6-1 – 6-5 were recorded in 
acetonitrile (Figure 6.1a), and the absorption band maxima and molar extinction coefficients are 
compiled in Table 6.1. The absorption obeys Beer’s law in the concentration range of 5×10−6 to 
1×10−4 mol·L-1, suggesting the absence of ground–state aggregation in the concentration range 
tested. The strong absorption bands in the range of 250-350 nm and 350-500 nm are predominantly 
assigned to 1π,π* transitions localized on the terminal tridentate ligands, and the bridging ligand, 
respectively. These assignments are supported by the NTOs corresponding to the major transitions 
contributing to these bands (Table 6.2 and Table 6.3). Attribution of the absorption bands of 350-
500 nm to the bridging ligand localized 1π,π* transition is in line with that revealed in the dinuclear 
Ir(III) complexes with trisbidentate ligands and diethynylaryl substituted diketopyrrolopyrrole 
bridging ligand.81,82 However, NTOs of 6-1 – 6-4 in Table 6.2 show that some charge transfer 
transitions, i.e. 1MLCT, 1LLCT (ligand-to-ligand charge transfer) or 1ILCT (intraligand charge 
transfer) contributed to the 350-500 nm bands as well. Contributions of the charge transfer 
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configurations to the 350-500 nm absorption bands are partially reflected by the insignificant but 
noticeable negative solvatochromic effects (Figure 6.2), especially in 6-2 that has more 1ILCT 
character (see NTOs in Table 6.2). In contrast, the charge transfer transitions in 6-5 became more 
distinguishable and energetically separated from the bridging ligand localized 1π,π* transition. 
This is clearly evidenced by the appearance of the new absorption band at 520 nm in 6-5. 
 
Figure 6.1. Experimental (a) and theoretical (b) UV−vis absorption spectra of 6-1 – 6-5 at room 
temperature in acetonitrile. The inset in panel (a) is the expansion of the spectra in the region of 
450−800 nm. The theoretical spectra were computed using ωB97XD with mixed basis set. A 
redshift of 0.55 eV for the theoretical spectra in panel (b) was applied for better comparison with 
the experimental spectra. 
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Figure 6.2. Normalized experimental absorption spectra of 6-1 − 6-5 in different solvents. 
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Table 6.1. Electronic absorption, emission, and triplet excited-state absorption parameters, as 
well as singlet oxygen quantum yields for complexes 6-1 – 6-5. 
 λabs/nm (log ε 
/L·mol−1·cm−1))a 
λem/nm (τem/μs); 
Φemb 
T1-Tn/nm (TA/μs; log T1-Tn / 
L·mol−1·cm−1); Tc 
Φd (λex/nm) 
6-1 251 (5.01), 297 (5.06), 
427 (4.85) 
583 (3.57); 0.024 498 (3.09; -), 765 (3.05; 4.62); 0.44 0.28 (430) 
6-2 251 (5.03), 285 (5.03), 
364 (4.65), 420 (4.68) 
576 (1.99); 0.003 385 (1.72; -), 640 (1.75; 5.04); 0.03 0.26 (468) 
6-3 260 (4.92), 289 (4.97), 
386 (4.80), 405 (4.80) 
608 (1.47); 0.025 513 (0.03 (17%), 1.72 (83%); -), 770 
(0.03 (15%), 1.75 (85%)); 4.70); 0.14 
0.04 (411) 
6-4 294 (5.00), 321 (4.88), 
413 (4.75) 
578 (53.3); 0.22 498 (48.6; -), 800 (48.3; 4.64); 0.28 0.38 (418) 
6-5 283 (4.97), 312 (4.89), 
368 (4.72), 416 (4.65), 
520 (4.13) 
619 (1.92); 0.045 681 (2.68; 4.80), 787 (2.68; -); 0.07 0.22 (418) 
aAbsorption band maxima (λabs) and molar extinction coefficients (log ε) of the UV-vis absorption 
in acetonitrile at room temperature. bEmission band maxima (λem), lifetimes (τem), and quantum 
yields (Φem) measured in acetonitrile (c = 1 × 10−5 mol·L-1) at room temperature with Ru(bpy)3Cl2 
(in degassed acetonitrile; Φem = 0.097, λex = 436 nm) as the reference. cNanosecond TA band 
maxima (T1-Tn), triplet excited-state lifetimes (TA), triplet extinction coefficients (T1-Tn), and 
quantum yields (T) measured in acetonitrile at room temperature with SiNc (in degassed benzene; 
ε590 = 70,000 L·mol−1·cm−1, ΦT = 0.20) as the reference. λex= 355 nm. dSinglet oxygen quantum 
yields in acetonitrile. Values are correct to within 5%. 
 
Table 6.2. NTOs for low energy transitions of 6-1 – 6-5. For transitions with quasi-degenerate 
transition orbitals, only one pair of transition densities are shown and are indicated by *. 
 Sn Hole Electron  Sn Hole Electron 
6
-1
 
S1 
340 nm 
f = 2.637   
6
-4
 
S1 
351 nm 
f = 0.003   
S5 
303 nm 
f = 0.109   
S2 
350 nm 
f = 0.004   
6
-2
 
S1 
381nm 
f = 3.730   
S3* 
340 nm 
f = 2.002   
S2* 
336 nm 
f = 0.079   
6
-5
 
S1* 
395 nm 
f = 0.933   
6
-3
 
S1 
333 nm 
f = 0.010   
S6* 
372 nm 
f = 0.050   
S3 
328 nm 
f = 2.189   
 
   
S7 
311 nm 
f = 0.368   
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Table 6.3. Natural transition orbitals (NTOs) for high energy transitions for 6-1 – 6-5. Transition 
with quasi-degenerate transition orbitals only one pair of transition densities are shown and are 
indicated by *. 
 State Hole Elec.  State Hole Elec. 
6
-1
 
S7*  
291 nm   
f = 0.717    
6
-4
 
S8*   
302 nm   
f = 0.650     
S27*   
264 nm   
f = 1.256     
S19   
281 nm   
f = 0.449   
S35*   
249 nm   
f = 0.674     
S23*   
270 nm   
f = 0.620     
6
-2
 
S7*   
292 nm   
f = 0.707     
S33*   
255 nm  
f = 1.139     
S24*   
270 nm   
f = 0.723     
6
-5
 
S9*   
328 nm   
f = 0.395     
S29*   
264 nm   
f = 1.121     
S15   
305nm   
f = 1.775   
S39*   
249 nm   
f = 0.547     
S38*   
260 nm   
f = 0.889     
6
-3
 
S23   
275 nm   
f = 0.494   
S53*   
247 nm   
f = 0.718     
S32*   
260nm   
f = 0.437     
  
  
S35 *  
249nm   
f = 0.571     
  
  
 
Comparison of the absorption spectra of 6-1 and 6-2 revealed that incorporation of the CC 
bonds to the bridging ligand caused a broadening and a red-shift of the bridging ligand localized 
1π,π* absorption band due to the extended π-conjugation. Replacing the terminal terpyridyl ligands 
in 6-1 by N^C^N (1,3-dipyridyl-4,6-dimethylbenzene) ligands in 6-3 induced a blue-shift of the 
350-500 nm absorption band and incorporated more terminal ligands based 1π,π* transition and 
1LLCT/1MLCT character to this band (see NTOs for 6-3 in Table 6.2); while changing the terminal 
ligands to C^N^N (4,6-diphenyl-2,2'-bipyridine) ligands in 6-4 only caused a slight blue-shift of 
this band with respect to that in 6-1. In contrast, when the terminal ligands were changed to C^N^C 
(2,4,6-triphenylpyridine) ligands in 6-5, the transition energies, intensities, and the shape of the 
low-energy absorption bands changed pronouncedly from those of 6-1. This can be attributed to 
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the distinct nature of the lowest energy optical transition in these two complexes. As the NTOs in 
Table 6.2 indicated, the stronger -donating ability of the phenyl rings on the C^N^C ligand 
delocalized the hole of the S1 transition mainly to the 2,6-diphenyl rings and to the metal d orbitals, 
while the electron was predominantly on the terpyridyl ligands. Thus, the lowest-energy optical 
transition in 6-5 is predominantly the 1LLCT/1MLCT transition, which is in contrary to the 
bridging ligand localized 1π,π* transition in 6-1. The drastic change of the dominant optical 
transitions accounts for the different features of the low-energy absorption bands in 6-5 with 
respect to that in 6-1. 
 
6.3.2. Photoluminescence 
The emission of 6-1 – 6-5 was investigated in different solvents at room temperature.  The 
observed emission all exhibited large Stokes shifts with respect to the corresponding excitation 
wavelength, they were all long-lived (several to tens of s), and sensitive to the presence of 
oxygen.  Thus, the emission was attributed to phosphorescence.  The normalized emission spectra 
of 6-1 – 6-5 in acetonitrile are presented in Figure 6.3, and the spectra in other solvents are provided 
in Figure 6.4. The emission parameters are listed in Table 6.1 and Table 6.4.  The emission of 6-1 
and 6-4 resembled each other, both showing some vibronic structures, with much longer lifetimes 
and higher emission quantum yields compared to the other three complexes, and exhibiting minor 
solvatochromic effects.  The vibronic spacing between the 580 nm and 620 nm bands is 
approximately 1150 cm-1 and 1090 cm-1 in 6-1 and 6-4, respectively, which is in accordance with 
the aromatic vibrational mode of the terpyridyl ligands.  Thus, the emission of these two complexes 
can be assigned predominantly to the ligand localized 3,* state.  However, the lifetime of 6-1 is 
one order of magnitude shorter than that of 6-4.  This could be attributed to the weaker ligand field 
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of the terpyridyl ligand with respect to that of the C^N^N ligand that contains the stronger -
donating 6-phenyl ring.  The nonradiative metal-centered 3d,d state is thus situated more closely 
to the low-lying emissive 3,* state and becomes thermally accessible in 6-1 compared to that in 
6-4.  This adds an additional decay path for the emitting 3,* state in 6-1 and consequently reduces 
its lifetime.  For 6-2, 6-3, and 6-5, the emission spectra are featureless and broader, the lifetimes 
are less than 2 s and the emission quantum yields are quite low, and the solvatochromic effect is 
more pronounced.  All these characters imply charge transfer nature of the emitting states in these 
three complexes.  Referring to the NTOs corresponding to the low-energy singlet charge transfer 
transitions shown in Table 6.2, it is reasonable to speculate that the emitting state of 6-2 could be 
the 3ILCT state and they are the 3LLCT/3MLCT states in 6-3 and 6-5.  It appeared that either 
extending the -conjugation of the bridging ligand in 6-2, or varying the terminal tridentate ligands 
in 6-3 and 6-5 changed the nature of the emitting state from the 3,* state in 6-1 to 3CT states.  In 
addition, variation of the terminal tridentate ligands impacted the emission energies in 6-3 – 6-5 
compared to that in 6-1, with a slight blue-shift of the emission in 6-4 while a salient red-shift in 
6-3 and 6-5.  The red-shifted emission in 6-3 and 6-5 with respect to that in 6-1 could possibly be 
rationalized by the stronger -donating ability of the phenyl rings on the terminal tridentate N^C^N 
and C^N^C ligands, which raised the energies of the terminal ligand and the metal d orbital based 
holes and thus reduced the energy gaps between the holes and electrons (likely localized on the 
terpyridyl motifs).  Consequently, the 3LLCT/3MLCT emission energies of 6-3 and 6-5 are 
reduced.  
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Figure 6.3. Experimental emission spectra of 6-1 (ex = 426 nm), 6-2 (ex = 420 nm), 6-3 (ex = 
405 nm), 6-4 (ex = 413 nm), and 6-5 (ex = 415 nm) at room temperature in deoxygenated 
acetonitrile (c = 1×10−5 mol·L−1). 
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Figure 6.4. Normalized emission spectra of 6-1 – 6-5 in different solvents (λex = 436 nm). 
 
Table 6.4. Emission characteristics of complexes 6-1 – 6-5 in different solvents at room 
temperature. 
λem (nm) (τem /μs); Φem 
  THF DCM Toluene (5%DCM) 
6-1  586 (4.27); 6.82% 590 (2.71); 24.5% 584 (0.06); 1.99% 
6-2  579 (1.56); 0.44% 584 (1.78); 0.63% 555 (0.06); 0.35% 
6-3  620 (1.64); 3.25% 614 (1.54); 3.65% 659 (0.06); 0.65% 
6-4  581 (37.4); 31.8% 583 (69.7); 54.9% 581 (0.04); 3.36% 
6-5  651 (1.28); 3.87% 623 (1.61); 5.18% 672 (0.99); 1.15% 
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6.3.3. Transient absorption 
To further understand the triplet excited–state characteristics, the nanosecond transient 
absorption (TA) studies of complexes 6-1 – 6-5 were carried out in acetonitrile solutions.  The TA 
spectra of 6-1 – 6-5 at zero delay after excitation are presented in Figure 6.5 and the TA parameters 
are compiled in Table 6.1.  The time–resolved TA spectra of 6-1 – 6-5 are provided in Supporting 
Information Figure 6.6. The triplet lifetimes deduced from the decay of TA for 6-1 – 6-4 are similar 
to their emission lifetimes in acetonitrile.  Therefore, we consider that the observed TA of these 
complexes was from the excited states that emit.  In contrast, 6-3 exhibited a biexponential decay 
in its TA signals, with the longer lifetime being consistent with the emission lifetime.  This implies 
that the long-lived TA signal in 6-3 could from the emitting excited state as well. 
The TA spectra of 6-1 – 6-5 all possessed very broad positive absorption band(s) from the 
visible to the near-IR region, i.e. 463-800 nm for 6-1, 495-800 nm for 6-2, 459-800 nm for 6-3, 
455-800 nm for 6-4, and 538-800 nm for 6-5. Bleaching occurred in the region corresponding to 
the low-energy absorption bands. Considering the similar shape of the TA spectra of 6-1 and 6-4 
to that of the dinuclear platinum(II) complex with the same bridging ligand reported by our group 
previously,48 and the similar lifetimes to those of emission, we tentatively assign the excited state 
giving rise to the observed TA predominantly to the bridging ligand localized 3π,π* states. While 
for 6-2 and 6-5, the transient absorbing states are likely to be the 3CT state(s), i.e. predominantly 
3ILCT for 6-2 and 3LLCT/3MLCT states for 6-5. In contrast to 6-1, 6-2, 6-4 and 6-5 that exhibited 
monoexponential decays in their TA signals, the TA signal of 6-3 followed a biexponential decay. 
The short-lived transient species had a lifetime of ~30 ns and gave rise to a spectrum reminiscent 
to those of 6-1 and 6-4; while the long-lived species had a lifetime of ~1.7 s, which is in line with 
the lifetime obtained from the decay of emission, and the TA was much weaker and featureless. In 
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view of the different spectral features at the shorter and longer decay time and the reminiscence of 
the spectra to those of 6-1/6-4 and 6-2/6-5, respectively, we tentatively assign the short-lived 
species to the high-lying bridging ligand localized 3π,π* state; while the long-lived species to the 
emitting 3LLCT/3MLCT state. The formation of a rapidly decaying higher excited state that 
subsequently leads to the lower-lying, long-lived emitting state has been reported for a 
mononuclear Ir(III) complex [(dpb)-Ir(tpy-ph(tBu)2]
2+ that bears the same N^C^N ligand.83 
 
Figure 6.5. Nanosecond transient absorption (TA) spectra of complexes 6-1 – 6-5 in deoxygenated 
acetonitrile at zero delay after 355 nm excitation. The inset shows the TA spectra of 6-3 at different 
delay time after excitation. A355 nm = 0.4 in a 1-cm cuvette. 
 
 It is noted that the measured triplet quantum yields of these complexes are not quite high, 
especially for 6-2, 6-3 and 6-5.  This could be due to the following reasons: (i) The increased -
conjugation of the ligand would decrease the contribution of the transition metal d orbital to the 
frontier molecular orbitals of the complexes, which would reduce the spin-orbital coupling in the 
complexes and decrease the triplet quantum yield.  Such a phenomenon has been reported in many 
Pt(II) and Ir(III) complexes.25,70,84  (ii) When a transition-metal complex is excited, especially 
when high-energy excitation is utilized, population of more than one triplet excited states is 
possible.70,85-91  However, not all of the populated triplet excited states contribute to excited-state 
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absorption.  In such a case, the calculated triplet quantum yield based on the observed TA signal 
could be significantly lower than the actual intersystem crossing quantum yield. 
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Figure 6.6. Nanosecond time-resolved transient differential absorption spectra of 6-1 – 6-5 at zero-
time decay in acetonitrile. λex = 355 nm, A355 = 0.4 in a 1-cm cuvette. 
 
6.3.4. Singlet oxygen generation 
Production of 1O2 is known to have cytotoxic effects on cells, and thus compounds that 
generate 1O2 under cell-free conditions might be expected to act as in vitro PDT agents. The Ir(III) 
complexes 6-1 – 6-5 were assessed for singlet oxygen (1O2) sensitization in cell-free conditions 
through direct measurement of 1O2 emission at 1270 nm. [Ru(bpy)3](PF6)2 was used as the 
standard, with a reported 1O2 quantum yield () of 0.56 in air-saturated CH3CN.60 The calculated 
 values for all of the complexes were less than 40%. The efficiencies for 1O2 production ranged 
from 4% for 6-3 to 38% for 6-4, with 6-1, 6-2 and 6-5 yielding similar values (22-28%). Despite 
having some absorption at wavelengths longer than 500 nm, 1O2 yields were maximal with blue 
excitation. For N^N^N terminal tridentate ligands, the presence of the ethynyl groups for extending 
-conjugation did not alter the singlet oxygen quantum yield as 6-1 and 6-2 gave very similar 
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values for . When each terminal tridentate ligand of 6-1 had two of its nitrogens replaced with 
cyclometalating carbons (C^N^C) as in 6-5, the 1O2 yield decreased only slightly. These limited 
comparisons appear to indicate that substantial structural changes have little to no effect on . 
However, when only one nitrogen of each terminal tridentate ligand of 6-1 was replaced by carbon 
(C^N^N) as in 6-4, the 1O2 yield increased to almost 40%. Clearly, there are structural 
combinations in this family of complexes that do influence . The most dramatic impact on  
occurred for 6-3, where the terminal tridentate ligands were N^C^N with methyl substitution at R1 
but no phenyl group at R. In this case, the 1O2 yield decreased by almost tenfold. 
 It is also worthy of noting that the  values for 6-2, 6-4 and 6-5 are higher than the 
measured triplet quantum yields (T, Table 6.1). This is not very surprising because population of 
excited states is wavelength dependent, which could result in different decay pathways.91 In the 
T measurement, 355 nm excitation was used; while low-energy excitation (i.e. 411 – 468 nm) 
was used in the  measurement. A 355-nm excitation in the TA measurement could populate 
more than one triplet excited states,70,85-91 which might not only impact the T value measurement 
as discussed in the TA section, but could also reduce the population of the excited state that 
generates singlet oxygen because of the competing population of the other non-1O2-generating 
triplet excited states. In our previous study on the monocationic tris-bidentate Ir(N^N)(C^N)2 
complexes, we have demonstrated that the singlet oxygen generation efficiency is wavelength 
dependent, with lower-energy excitation resulting in higher  values in those Ir(III) complexes.24 
We speculate the same case for the complexes studied in this work. 
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6.3.5. Cytotoxicity and photocytotoxicity 
To understand whether the photophysical properties of these Ir(III) complexes could lead 
to photobiological effects, the cytotoxicity profiles of 6-1 – 6-5 were assessed in SK-MEL-28 
malignant melanoma cells under three conditions: (i) dark, (ii) illumination with broadband visible 
light, and (iii) illumination with red LEDs emitting at 625 nm. Cytotoxic and photocytotoxic 
activities were quantified as the effective concentration required to reduce the cell viability to 50% 
(EC50) under a given condition. Briefly, cells growing in log phase were dosed with nine 
concentrations of the complex between 1 nM and 300 µM, incubated for 16 h, and were then 
subjected to a sham (dark) or light treatment. The light treatments were delivered at a fluence of 
100 J·cm-2 with an irradiance of 35.7 mW·cm-2 or 32.3 mW·cm-2 for visible and red light, 
respectively. After a 48 h incubation period, cell viability was quantified based on the ability of 
viable cells to reduce resazurin to resorufin. EC50 values were determined from sigmoidal fits of 
the dose–response curves (Figure 6.7, Table 6.5). The phototherapeutic index (PI), a measure of 
the therapeutic margin for in vitro PDT, was calculated as the ratio of dark to light EC50 values 
and determined for each complex and irradiation condition.  The dark toxicities of 6-1 – 6-5 toward 
normal human skin fibroblasts (CCD-1064Sk) were also measured to determine any selectivity for 
cancer cells over normal cells. The ratio of the dark CCD-1064Sk EC50 value for a given complex 
and its dark SK-MEL-28 EC50 value yielded the selectivity factor (SF), where SF > 1 indicates 
selectivity toward the cancerous cell line. Selective activity toward the cancer cell line is not a 
requirement for the PDT agent as long as the dark toxicity of the photosensitizer is low, and the PI 
is relatively large. Rather, the spatiotemporal control of the light treatment provides the selectivity 
known for PDT. Nevertheless, for in vivo applications, selective activity toward cancer cells over 
normal, healthy cells is an added benefit.  
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Table 6.5. Comparison of EC50 values (M) for SK-MEL-28 cancer cells and CCD-1064Sk 
normal skin fibroblasts dosed with complexes 6-1 – 6-5. 
SK-MEL-28 cells CCD-1064Sk cells 
 Dark Visa PIb Redc PId Dark SFe 
6-1 82.6 ± 1.5 0.75 ± 0.01 111 59.7 ± 0.4 1.4 102 ± 2 1.2 
6-2 16.9 ± 0.8 0.83 ± 0.05 20 16.2 ± 0.5 1.0 32.0 ± 2.0 1.9 
6-3 49.9 ± 0.1 0.17 ± 0.01 288 49.5 ± 0.1 1.0 49.1 ± 0.1 1.0 
6-4 17.0 ± 0.7 0.17 ± 0.01 102 14.3 ± 0.3 1.2 31.8 ± 1.8 1.9 
6-5 69.5 ± 1.0 1.05 ± 0.01 66 85.1 ± 1.0 0.82 142 ± 3 2.0 
aVis-PDT: 16 hours drug-to-light interval followed by 100 J·cm-2 broadband visible light 
irradiation, bPI = phototherapeutic index (ratio of dark EC50 to visible-light EC50), 
cRed-PDT: 16 
hours drug-to-light interval followed by 100 J·cm-2 light irradiation with 625-nm LEDs, dPI = 
phototherapeutic index (ratio of dark EC50 to red-light EC50), 
eSF SK-MEL-28: selectivity factor 
(ratio of dark CCD-1064Sk EC50 to dark SK-MEL-28 EC50). 
 
The dark cytotoxicities of complexes 6-1 – 6-5 toward SK-MEL-28 melanoma cells ranged 
from 16.9 to 82.6 M, with 6-1 being the least cytotoxic in the absence of a light trigger and 6-2 
and 6-4 being the most cytotoxic (Table 6.5, Figures 6–7, and Figures 6–8). With the exception of 
6-3 (SF = 1), the other dinuclear Ir(III) complexes exhibited some selective cytotoxicity toward 
the melanoma cancer cells relative to the normal human skin fibroblast cells. SF values followed 
the order 6-5 > 6-2  6-4 > 6-1 > 6-3, with 6-5 exhibiting two-fold greater dark toxicity toward 
SK-MEL-28 cells and 6-3 showing no selectivity. The selective cytotoxicity observed for 6-2 and 
6-4 was almost as great as that for 6-5 (SF = 1.9 versus SF = 2.0). 6-1 and 6-5 had dark EC50 values 
greater than 100 M in the CCD-1064Sk cell line, and were thus considered to be completely 
nontoxic to the normal skin fibroblasts. In both cell lines, the dark toxicity was greatest for 6-2 and 
6-4 and least for 6-1 and 6-5. 
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Figure 6.7. In-vitro dose-response curves for complexes 6-1 (a), 6-2 (b), 6-3 (c), 6-4 (d), and 6-5 
(e) in SK-MEL-28 cells treated in the dark (black) and with visible (blue) or red (red) light 
activation. 
 
 
Figure 6.8. Activity plot for complexes 6-1 – 6-5 in SK-MEL-28 and CCD-1064Sk cells treated 
in the dark (black) and with visible (blue) or red (red) light activation. 
 
 All of the complexes in the series could be activated with visible light to become powerful 
phototoxins, with EC50 values ranging from 170 nM to 1 M and PIs ranging from 20 to 288. 6-3 
and 6-4 were the most phototoxic at 170 nM, while 6-1, 6-2, and 6-5 were similar (visible EC50 = 
0.75–1.0 M). Photoactivation of the complexes with red light (625 nm) did not enhance the 
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cytotoxicity over what was observed in the dark treatment, yielding PIs close to 1.0 in all cases. 
The photobiological activities of 6-1 – 6-5 were tested with red light, despite their very low molar 
extinction coefficients in this region, because other metal complex systems with -expansive 
ligands have been shown to yield potent in vitro red PDT effects even with molar extinction 
coefficients less than 100 M-1·cm-1.20 
The presence of visible PDT effects (presumably due to the shorter wavelengths) but lack 
of red PDT effects suggests that direct population of the highly photosensitizing triplet states is 
not efficient in this class of complexes and that access to these states must be gained through 
1MLCT states. The photocytotoxicity profiles in SK-MEL-28 under two irradiation conditions 
along with the dark cytotoxicity profiles in two cell lines are summarized in the activity plot in 
Figure 6.8. 
The visible PDT effect followed the order 6-3 > 6-1 > 6-4 > 6-5 > 6-2, with 6-3 being the 
most promising photosensitizer based on its PI of 288 and nanomolar photocytotoxicity. 6-1 and 
6-4 both had PIs greater than 100, but the dark toxicity associated with 6-4 in both cell lines limits 
its potential for in vivo applications. The source of the PDT effect for this series has not been 
established. The 1O2 quantum yields measured under cell-free conditions followed the order 6-4 > 
6-1 > 6-2 > 6-5 > 6-3, with 6-1 and 6-2 being very similar. 6-3 was the poorest 1O2 generator, yet 
it was one of the most phototoxic complexes of the series. On the other hand, 6-4 was the best 
sensitizer of 1O2 and was as phototoxic as 6-3. Therefore, 
1O2 may play a role in the PDT 
mechanism for some complexes but not others in this series, or the intracellular 1O2 quantum yields 
may differ from those measured under cell-free conditions. Regardless, certain members of this 
new series of dinuclear Ir(III) complexes have been identified as promising PDT agents for further 
investigation. 
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While the structural diversity in such a small library is somewhat limited, it was possible 
to identify some trends regarding structural features that affect cytotoxicity. For example, 
incorporation of ethynyl linkers as in 6-2 turned the relatively nontoxic complex 6-1 into one of 
the most potent dark cytotoxic complexes of the series (Table 6.5). Likewise, replacement of the 
terminal tridentate N^N^N ligands of 6-1 with C^N^N as in 6-4 increased the dark cytotoxicity 
substantially, while replacement with C^N^C as in 6-5 had only a very minor effect that differed 
between the two cell lines. In SK-MEL-28, the dark toxicity increased slightly, and in CCD-106Sk, 
the dark toxicity decreased slightly. The complex that departed the most structurally from the other 
complexes in the series and was identified as being the most promising PDT lead, 6-3, was 
intermediate in terms of dark cytotoxicity (EC50  50 M) with almost no difference between the 
two cell lines.  
In terms of structural features affecting photocytotoxicity, the nature of the terminal 
tridentate ligand played some role as 6-4 (C^N^N) was more than six-fold more phototoxic than 
6-5 (C^N^C). While the presence of an ethynyl linker increased the dark cytotoxicity substantially 
in both cell lines, its presence did not impact the photocytotoxicity toward SK-MEL-28 in any 
significant way. The differences in dark and light-triggered cytotoxicity toward SK-MEL-28 cells 
alongside differences in dark cytotoxicity between normal and cancerous cells for certain members 
of this series indicate that even minor structural modifications can have a major impact on 
biological activity. 
 
6.3.6. Cellular imaging  
The phosphorescence from complexes 6-1 – 6-5 was used to probe cellular uptake by SK-
MEL-28 melanoma cells with or without a light treatment (Figure 6.9). The excitation from a 
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458/488 nm argon-krypton laser matched the excitation maxima of the complexes and was used 
in conjunction with a 475-nm long pass filter to collect the emission from the complexes. The 
images were collected after a brief 1-h incubation period to ensure that some viable cells remained. 
Light-treated cells were illuminated with a broadband visible light (50 J·cm-2) that was 50% of the 
fluence used in the cellular assays in order to capture a fraction of viable cells. 
Untreated SK-MEL-28 cells have a dendritic morphology. Treatment with the dinuclear 
Ir(III) complexes with or without illumination caused a conversion from dendritic to spherical 
morphology. The complexes showed detectable phosphorescence when associated with or in 
dead/dying and compromised cells with or without a light treatment. Only 6-1 appeared to be 
readily taken up into SK-MEL-28 cells in the dark at the observation time point. However, 
phosphorescence from the Ir(III) complexes in all cells was apparent after a light treatment, 
suggesting photoactivated uptake. For light-treated cells incubated with 6-1, it was not possible to 
discern subcellular localization because only cellular debris was present at the observation time 
point. However, 6-2 and 6-4 localized to the cytoplasm and multiple nucleoli whereas 6-3 and 6-
5 were distributed throughout the cell and phosphoresced with a very intense signal by comparison. 
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Figure 6.9.  Confocal luminescence images of SK-MEL-28 cells dosed with 6-1 – 6-5 (a-e, 50 
M) in the dark (left) and with visible light (50 J·cm-2) (right). 
 
Qualitatively, SK-MEL-28 cells treated with 6-4 with or without visible illumination 
appeared the most viable with healthy morphology in the imaging experiments but were the most 
susceptible in the cellular assays, highlighting the need to exercise caution when reconciling the 
cellular assay results with confocal imaging performed at different time points post-complex-
delivery and post-irradiation and a different light fluence. When the conditions were similar, the 
imaging experiments did reflect the trends observed in the cellular assays with SK-MEL-28 but 
did not provide any information regarding uptake and localization since all cells were dead/dying 
but at slightly different stages. A quantitative comparison of the cellular uptake and induced 
morphological changes for the five complexes and correlations to cellular cytotoxicity or 
photocytotoxicity were not attempted given the need to alter incubation and illumination times to 
preserve some viable cells. Rather, the purpose of the imaging was to highlight the potential of 
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these new Ir(III) complexes as theranostic agents based on their abilities to yield visible PDT 
effects and to be simultaneously imaged by their inherent phosphorescence. 
 
6.3.7. DNA interactions 
The ability of the Ir(III) complexes to act as DNA photocleaving agents was investigated 
to establish whether light-mediated DNA damage could contribute to the observed in vitro PDT 
effects for this class of photosensitizers. Supercoiled plasmid DNA (20 M bases) was treated with 
increasing concentrations of 6-1 – 6-5 and then exposed to a visible light treatment of 14 J·cm-2 
(Figure 6.10, lanes 3–8). The fluence is less that what was used in the cellular assays because the 
DNA is more susceptible to damage by the light treatment alone when not protected by the cellular 
environment. The photolyzed samples were then electrophoresed and compared to DNA alone 
with or without a light treatment (Figure 6.10, lanes 1 and 2) and DNA exposed to the highest 
concentration of the complex without a light treatment (Figure 6.10, lane 15). The gels were cast 
either with the DNA stain ethidium bromide (EB) incorporated or without EB and stained after 
electrophoresis (non-EB). EB gels allow detection of photocleavage not compounded by DNA 
unwinding; the non-EB gels allow detection of DNA unwinding in addition to photocleavage. 
Under the conditions employed for this gel electrophoretic mobility shift assay, undamaged 
supercoiled DNA (Form I) migrates the farthest in the gel, while aggregated/condensed DNA 
(Form IV) migrates very little from the loading well. Plasmid DNA that has undergone single-
strand breaks (Form II) will relax and migrate between Forms I and IV, and plasmid DNA with 
frank double-strand breaks or double-strand breaks that arise from the build-up of single-strand 
breaks on opposing strands within about 16 base pairs (Form III) will migrate slightly faster than 
Form II. Forms I, II, and IV were detectable in both EB and non-EB gels. None of the complexes 
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acted as DNA unwinders on the non-EB gel, indicating that they most likely do not act as DNA 
intercalators. 
 
Figure 6.10. DNA photocleavage of pUC19 DNA (20 μM) dosed with metal complex (MC) 6-1 
(a), 6-2 (b), 6-3 (c), 6-4 (d), 6-5 (e) and visible light (14 J·cm-2). Gel mobility shift assays employed 
1% agarose gels (0.75 μg·mL-1 ethidium bromide) electrophoresed in 1 TAE at 8 V·cm-1 for 30 
min. Lane 1, DNA only (-hv); lane 2, DNA only (+hv); lane 3, 0.5 μM MC (+hv); lane 4, 1 μM 
MC (+hv); lane 5, 2 μM MC (+hv); lane 6, 3 μM MC (+hv); lane 7, 5 μM MC (+hv); lane 8, 8 μM 
MC (+hv); lane 9, 10 μM MC (+hv); lane 10, 12 μM MC (+hv); lane 11, 15 μM MC (+hv); lane 
12, 20 μM MC (+hv); lane 13, 50 μM MC (+hv); lane 14, 100 μM MC (+hv); lane 15, 100 μM MC 
(-hv). Forms I, II and IV DNA refer to supercoiled plasmid, nicked circular plasmid, and 
aggregated plasmid, respectively. 
 
 All of the complexes showed some ability to photocleave DNA (Figure 6.10) in a cell-free 
environment. Qualitatively, DNA photocleaving ability appeared to increase in the order 6-5 < 6-
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2 ≈ 6-3 < 6-4 < 6-1. The formation of Form IV DNA and the disappearance of gel bands precluded 
a more quantitative comparison, but some general trends could still be discerned.  
 Despite its 1O2 quantum yield of 22%, 6-5 appeared to show the weakest interactions with 
DNA (although some strand breaks to yield detectable Form II92 were observed toward the highest 
concentrations). On the other hand, 6-1, with a similar , acted as a much more potent DNA 
photocleaving agent, converting a significant amount of supercoiled Form I DNA to Form II DNA 
at a metal complex (MC) concentration of only 1 M and 20 M DNA bases (Table 6.10a, lane 
4).  At similarly low [MC]:[bases] ratios of 0.05, 6-2 – 6-5 caused no detectable strand breaks, 
which can be seen by comparing lane 4 for all of the complexes. 6-4, with the largest value for ∆, 
photocleaved DNA in a concentration-dependent manner to yield Form II DNA as expected. 
All of the complexes caused DNA aggregation/condensation, although 6-5 produced trace 
amounts of Form IV DNA only at the highest complex concentrations investigated. Interestingly, 
6-5 was the only complex that did not cause the DNA gel bands to disappear. The lack of DNA 
staining by EB for the other complexes could be due to fluorescence quenching of the EB dye by 
the complex, their competition for EB intercalation sites, or their distortion of the DNA helix that 
prevents EB binding. 
 Clearly, the structural differences between the Ir(III) complexes of this small library 
resulted in markedly different interactions with DNA, and possibly different photophysical 
interactions with the EB dye. The observation that 6-5 shows marginal DNA interactions in the 
gel electrophoretic analysis yet acts as an in vitro PDT agent suggests that DNA may not be the 
intracellular target, at least for this particular complex. In fact, DNA photodamage did not correlate 
clearly with 1O2 quantum yields across the series, which also supports the notion that another 
biological target is likely involved. However, the cell-free experiment does not accurately mimic 
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the complexity of the cellular environment and dynamic processes (e.g., uptake, efflux, 
metabolism, and localization), and in vitro DNA damage and 1O2 damage cannot be ruled out 
completely. What can be gleaned from the DNA photocleavage study is that minor structural 
changes in this series have profound effects on the complex interactions with biological 
macromolecules such as DNA, which is in agreement with their different profiles in the cellular 
assays and imaging studies. 
 
6.4. Conclusions 
The synthesis, photophysical and photobiological properties of a family of water-soluble 
cationic dinuclear iridium(III) complexes (6-1 – 6-5) were explored. The influence of the bridging 
and terminal ligands on the photophysical properties of the complexes was investigated. Compared 
to 6-1 that had the single bond connection between the fluorenyl motif and the terpyridyl ligands 
on the bridging ligand, the extended π-conjugation afforded by the ethynyl connectors of the 
bridging ligand in 6-2 red-shifted the UV-vis absorption markedly, but the low-lying 3CT state of 
6-2 accelerated nonradiative decay and resulted in weak phosphorescence. A considerable 
bathochromic shift also occurred in the absorption and emission of 6-5, owing to the stronger σ-
donating ability of the negatively charged coordinating carbon relative to nitrogen and thus more 
charge transfer from the C^N^C ligands to the terpyridyl ligands. Complexes 6-1 – 6-5 all featured 
with broad positive absorption bands spanning the visible region and NIR regions in their 
nanosecond TA spectra. However, the triplet state TA lifetimes of 6-1 and 6-4 were much longer  
(3.1 s and 48 s, respectively) than those of 6-2, 6-3 and 6-5, implying the dominant bridging 
ligand-localized 3π,π* nature for the lowest triplet states in 6-1 and 6-4 rather than the 3CT states 
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for the other three complexes. Based on photophysical properties alone, 6-4 was predicted to be 
the best in vitro PDT agent. 
All of the Ir(III) complexes of this study exhibited photobiological effects when activated 
with visible light, but were inactive with single-wavelength red light (625 nm). Thus, the in vitro 
PDT effects with broadband visible light were attributed to the shorter wavelengths. Some of the 
complexes showed selective cytotoxicity toward cancerous human melanoma cells over normal 
human skin fibroblasts. The photobiological trends could not be readily correlated to any 
differences in photophysical properties despite accessible long-lived 3π,π* states often resulting in 
red PDT activity. But the long-lived 6-4 did not yield a red PDT effect, nor did any of the other 
complexes due to the lack of ground-state absorption in the red. Rather, 6-3 emerged as a promising 
photosensitizer for further investigation owing to its nanomolar photocytotoxicity and visible PI > 
280, with 6-1 and 6-5 also having suitable profiles. This small library of just five complexes proved 
to be a rich source of photophysical and photobiological diversity with only minor structural 
modifications. They gave 1O2 quantum yields that ranged from 4 to 38%, light EC50 values from 
nanomolar to micromolar, dark toxicities that ranged from 32 to >140 M, and DNA interactions 
that were characteristic for a particular cationic complex. For in vitro PDT applications in 
particular, there was a clear indication that the terminal tridentate N^C^N ligand performed best 
when combined with methyl substituents on the central cyclometalating ring and no ethynyl linkers 
between terminal ligands and the central fluorene unit. Thus, 6-3 will serve as the lead complex 
for future studies and as the parent complex of a second-generation library. 
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7. SYNTHESIS, NEUTRAL IRIDIUM(III) COMPLEXES BEARING 
BODIPY−SUBSTITUTED N−HETEROCYCLIC CARBENE (NHC) LIGANDS: 
SYNTHESIS, PHOTOPHYSICS, AND PHOTOBIOLOGICAL ACTIVITIES 
 
7.1. Introduction 
Photodynamic therapy (PDT) is an emerging cancer treatment modality that combines a 
photosensitizer (PS), oxygen, and light to destroy tumors and tumor vasculature and induce an 
immune response.1-5 During PDT, reactive oxygen species (ROS) are formed through energy (type 
II) or electron transfer (type I) reactions that take place between ground state molecular oxygen 
and the excited triplet state of the PS. The most important mediator of the PDT effect is thought to 
be singlet oxygen (1O2) produced through the type II PDT mechanism, but superoxide (O2
-•) or 
hydroxyl radical (•OH), generated by the type I PDT mechanism may also play a role. 
PDT is inherently selective because toxicity is confined to regions where the PS, oxygen, 
and light overlap spatiotemporally.3,6,7 Therefore, PDT has the potential to be a safe, noninvasive 
alternative to conventional cancer therapies,8 but is not currently the standard of care for any type 
of cancer. The absence of PDT from mainline therapy stems, in part, from certain drawbacks 
associated with the porphyrin-based PS Photofrin, which is the only FDA-approved PS for cancer 
therapy in the USA. There has been significant effort in recent years to develop new PSs and 
treatment regimens that overcome some of the limitations of Photofrin and its derivatives. 
Certain transition metal complexes are among the numerous PSs that have been explored 
due to their (1) interesting photophysical properties, (2) reduced photobleaching, and (3) improved 
kinetic stabilities (compared to organic PSs).9  Among the metal complexes, Ru(II) systems are 
probably the most widely studied for PDT.11,12 Our Ru(II) complex TLD1433,12,13 which 
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incorporates a -expansive ligand derived from imidazo[4,5-f][1,10]phenanthroline appended to 
an -terthienyl unit, just successfully completed a Phase 1b clinical trial for treating bladder cancer 
with PDT (ClinicalTrials.gov Identifier: NCT03053635). This example demonstrates the utility of 
lowest-energy ,* triplet states, in this case centered on the oligothienyl unit, with extremely long 
lifetimes for highly efficient photosensitization. 
Some transition-metal complexes possess the distinct advantage of having singlet and 
triplet excited states that can be tuned independently for optimization of their respective 
characteristics when appropriate -conjugated ligands are chosen.  We have reported that it is 
possible to shift the singlet charge-transfer absorption to longer wavelengths (for activation by red 
wavelengths of light) by extending the -conjugation of the organic ligands, while allowing the 
lowest triplet excited state (T1) to be localized on the -expansive organic ligands.10 The ,* 
nature of the lowest triplet excited state results in very long triplet excited state lifetimes, which 
have the potential to facilitate ROS production even at low oxygen tension.  Unlike organic PSs, 
metal complexes possess high quantum yields for triplet state formation due to the heavy atom 
effect (metal-induced rapid ISC), and their triplet excited states are typically long-lived.  All of 
these properties are desirable features for next-generation PSs. 
Ir(III) complexes are also of interest because some have exhibited high efficiency for ROS 
production via electron or energy transfer.14 Many Ir(III) complexes possess high quantum yields 
for triplet excited state formation and long-lived triplet excited states for efficient ROS generation 
even under hypoxia.14  It has been reported that cationic Ir(III) complexes can target 
mitochondria,15-19 lysosomes,20,21 the endoplasmic reticulum,22,23 or nuclei24,25 in a variety of 
cancer cell lines. A mitochondria-targeted Ir(III) complex PS was reported to show improved PDT 
effects under hypoxia.15 These complexes can also display bright intracellular luminesce, 
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imparting theranostic capacity.14-21,24-26  Therefore, Ir(III) complexes have emerged as a new 
platform for theranostic PDT applications.  However, most of the currently studied Ir(III) 
complexes absorb light maximally in the UV to blue spectral regions, wavelengths of lesser interest 
for PDT because of their shallow tissue penetration due to tissue scattering and absorption.27 
Although it is possible to red-shift the charge transfer ground-state absorption bands of the 
cyclometalating monocationic Ir(III) complexes [Ir(C^N)2(N^N)]
+ (where N^N refers to the 
diimine ligand and C^N refers to the cyclometalating ligand) to longer wavelength by introducing 
electron-withdrawing substituents on the diimine ligands28 or through benzannulation at the 
diimine ligands, the molar extinction coefficients of the charge transfer absorption bands are quite 
low and the lowest triplet excited state (T1) lifetimes become much shorter (tens of ns).
29-33  In 
contrast, it has been shown that bichromophoric transition-metal complexes with -conjugated 
organic chromophores result in long-lived 3,* T1 states localized at the organic chromophore 
with simultaneous red-shifting of the ground-state absorption to the longer wavelengths.  Metal 
coordination improves -conjugation across the organic ligands through planarization, facilitating 
the interactions between ligands.  It also increases the quantum yield of triplet excited-state 
formation via heavy atom induced ISC.  Such a strategy has been applied in TLD143312 and other 
Ru(II) complexes for PDT applications,13,34-40 but is relatively rare for Ir(III) systems.41-44 
Borondipyrromethene (BODIPY) and its derivatives, a class of strong light−harvesting 
fluorophores with facile wavelength tunability, have been extensively explored as potential PSs 
for PDT applications in recently years.45-48 In addition, BODIPY appears as a promising moiety to 
be attached to a monodentate or polydentate ligand to tune the absorption wavelength of the 
transition-metal PSs to the desired spectral region.40-42,49 However, BODIPY-Ir(III) dyads for PDT 
applications are not well-studied.41,42,49 One of the few examples used BODIPY tethered cationic 
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cyclometalated Ir(III) dyads as PSs for PDT and bioimaging applications, and their in vitro PDT 
effects were marginal due to high dark toxicity (IC50 = 8.16 - 16.70 M toward 1121 or LLC cell 
lines). Phototherapeutic index (PI) values (1.3-3.8) were very small.41,42 
Recently, N−heterocyclic carbene (NHC) based iridium(III) complexes have emerged.50-54  
Unlike the numerous well−studied monocationic cyclometalated Ir(III) complexes 
[Ir(C^N)2(N^N)]
+ (where N^N refers to the diimine ligand and C^N refers to the cyclometalating 
ligand), monoanionic NHC ligands, such as 1-phenyl-3-alkylbenzimidazole, as the N^N ligand 
gives rise to neutral complexes.54,55 To date, NHC-Ir(III) complexes have largely been studied for 
their catalytic50 and optoelectronic applications.51-54 Biological activities were only reported on 
monocationic Ir(III) complexes with bis(alkylated-NHC) ligands,16,50 which possessed high dark 
toxicity and could only be activated by UV light (365 nm).  To date, the biological activities of the 
neutral Ir(C^N)2(NHC) complexes remain unexplored. 
Herein, a series of neutral iridium(III) complexes bearing BODIPY−NHC ligands (Chart 
7-1) were designed and synthesized to explore their photophysical properties and in vitro PDT 
effects.  These complexes all contain benzo[h]quinoline (bhq) as the cyclometalating ligands, but 
the NHC ligand varies from 1−(4−BODIPY−ethynylphenyl)-3−methyl−1H−benzo[d]imidazol− 
3−iumiodide (L7-1), 1−(4−BODIPY−phenyl)−3−methyl−1H−benzo[d]imidazole−3−iumiodide 
(L7-2), 1−(4−BODIPY−ethynylphenyl)−3−(2−(2−(2−methoxyethoxy)ethoxy)ethyl−1H−benzo 
[d]imidazol−3−iumiodide (L7-3), 5−(4−BODIPY−ethynylphenyl)−3−methyl−1H−benzo[d]imi-
dazole−3−iumiodide (L7-4), to 5−(4−BODIPY−ethynylphenyl)−3−(2−(2−(2−methoxyethoxy) 
ethoxy)ethyl−1H−benzo[d]imidazol−3−iumiodide (L7-5).  BODIPY was incorporated into the 
NHC ligand scaffold at different sites through a single bond (7-2) or a triple bond (7-1 and 7-3−7-
5) in order to red-shift the absorption of the complexes to longer wavelengths.  An oligoether 
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chain, 2−(2−(2−methoxyethoxy)ethoxy)ethyl, was appended to 7-3 and 7-5 to increase the 
hydrophilicity of the neutral complexes.  The photophysical properties of these five complexes 
were systematically investigated by various spectroscopic methods and simulated by density 
functional theory (DFT) calculations.  The in vitro theranostic PDT effects of the two water-soluble 
complexes 7-3 and 7-5 were investigated.  The impact of the BODIPY attachment site on the 
photophysics and PDT effects of these dyads was explored. 
 
Chart 7.1. Molecular structures of BODIPY-NHC-Ir(III) complexes 7-1 – 7-5. 
 
7.2. Experimental  
7.2.1. Materials and synthesis 
All reagents and solvents were purchased from Alfa Aesar and VWR International and 
used as received.  Al2O3 gels (activated, neutral) and silica gels (230−400 mesh) for column 
chromatography were purchased from Sorbent Technology.  Benzo[h]quinoline (C^N ligand) was 
obtained from Alfa−Aesar and its Ir(III) µ−chloro−bridged dimers [Ir(C^N)2Cl]2 was synthesized 
according to the literature procedure.56 Compounds 1-(4-bromophenyl)-1H-benzimidazole 
(compound 1 in Scheme 7-1),57 4-bromo-2-nitro-N-phenylaminobenzene (compound 6 in Scheme 
7-1),58 4-bromo-N1-phenyl-1,2-benzenediamine (compound 7 in Scheme 7-1),59 and 
2−iodo−BODIPY60 were synthesized following the reported procedures.  The synthetic route for 
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the synthesis of ligands L7-1 – L7-5 and complexes 7-1 − 7-5 are provided in Scheme 7-1.  1H 
NMR, high−resolution mass spectrometry (HRMS), and elemental analyses were used to 
characterize these complexes.  1H NMR spectra were obtained on a Varian Oxford−400 or 
Bruker−400 spectrometer in CDCl3 using tetramethylsilane (TMS) as the internal standard.  Bruker 
BioTOF III mass spectrometer was used for ESI−HRMS analyses.  NuMega Resonance 
Laboratories, Inc. in San Diego, California conducted elemental analyses. 
 
Scheme 7-1.  Synthetic route for ligands L7-1−L7-5 and complexes 7-1 − 7-5a. 
 
aReagents and conditions: (i) 1−bromo−4−iodobenzene, CuI, Cs2CO3, 1,10-phenanthroline, DMF, 
110°C, 40 hrs.; (ii) CuI, PdCl2(PPh3)2, ethynyltrimethylsilane, TEA/dioxane, 100 °C, 1 hr.; (iii) 
TBAF, THF, 0°C, 1 hr.; (iv) 2−Iodo−BODIPY, CuI, Pd(PPh3)4, TEA, THF, 50 °C, 16 hrs.; (v) 
triisopropyl borate, nBuLi, anhydrous THF, −78 °C, 1 hr., then r.t. overnight, followed by HCl, 
100 °C, 1 hr.; (vi) 2−iodo−BODIPY, K2CO3, Pd(PPh3)4, toluene, THF, water, 70 °C, overnight; 
(vii) NaOAc, aniline, 160 oC, 7 hrs.; (viii) Na2S, S, water, reflux, 6 hrs.; (ix) formic acid, 100 °C, 
overnight; (x) MeI, THF, 100 oC, 24 hrs.; (xi) 1−iodo−3,6,9−trioxadecane, toluene, 100 oC, 96 
hrs.; (xii) [Ir(benzo[h]quinoline)2(μ−Cl)]2, Ag2O, 1,2−dichloroethane, reflux, 24 hrs. 
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7.2.2. Synthesis of precursor compounds 2 − 5 and 8 − 10 
Compound 2.  A solution of 1 (544 mg, 2 mmol), CuI (19 mg, 0.1 mmol), PdCl2(PPh3)2 
(70 mg, 0.1 mmol) in trimethylamine (TEA)/dioxane (2:1, v/v) was degassed with N2 at room 
temperature for 20 minutes.  Then, ethynyltrimethylsilane (0.86 mL, 6 mmol) was added and the 
resulting reaction mixture was heated at 100 °C for 1 hour under N2.  After cooling to room 
temperature, the mixture was concentrated and purified by column chromatography over silica gel 
using hexane:ethyl acetate = 1:2 (v/v) as the eluent to give product as pale yellow solid.  This pale 
yellow solid (500 mg, 1.8 mmol) was dissolved in THF (10 ml), and THF solution of 
tetrabutylammonium fluoride (TBAF) (10 mL, 1 M in THF) was added at 0 °C.  The reaction 
mixture was stirred at room temperature for 1 hour.  Then the solution was diluted with ethyl 
acetate (EA) and washed with water and brine consequently.  The organic layer was dried over 
Na2SO4 and concentrated.  The residue was purified by column chromatography over silica gel 
using hexane:ethyl acetate= 1:2 (v/v) as the eluent to give compound 2 as pale yellow solid (360 
mg, 81%).  1H NMR (400 MHz, CDCl3) δ 8.14 (s, 1H), 7.91 (dd, J = 6.4, 2.7 Hz, 1H), 7.73 (d, J 
= 8.4 Hz, 2H), 7.57 (dd, J = 6.6, 2.7 Hz, 1H), 7.53 (d, J = 8.4 Hz, 2H), 7.43−7.34 (m, 2H), 3.22 (s, 
1H). 
Compound 3.  The solution of 2-iodo−BODIPY (200 mg, 0.44 mmol), compound 2 (97 
mg, 0.44 mmol), CuI (17 mg, 0.09 mmol), and Pd(PPh3)4 (57 mg, 0.049 mmol) in 10 mL degassed 
mixed solvent (THF/TEA = 4/1) was heated to 50 oC and stirred for 16 hours in dark.  After cooling 
to room temperature, the solvent was removed under reduced pressure and the residue was 
extracted with CH2Cl2 and washed with brine.  After removal of the solvent from the organic layer, 
the crude product was purified by flash column chromatography with CH2Cl2/acetone (v/v = 50/1) 
being used as the eluent to obtain a dark red solid (200 mg, 83%).  1H NMR (400 MHz, with 
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CDCl3) δ 8.14 (s, 1H), 7.94−7.86 (m, 1H), 7.67 (d, J = 8.4 Hz, 2H), 7.62−7.44 (m, 6H), 7.43−7.30 
(m, 4H), 6.08 (s, 1H), 2.75 (s, 3H), 2.62 (s, 3H), 1.55 (s, 3H), 1.44 (s, 3H). 
Compound 4.  Under -78 oC, nBuLi (0.5 mL, 2.5 M in hexane) was added dropwise to the 
solution of compound 1 (151 mg, 0.56 mmol) and B(OiPr)3 (157 mg, 0.83 mmol) in THF (10 mL).  
The mixture was stirred at -78oC for 1 h, and then allowed to warm up to room temperature, and 
continued stirring for overnight.  The reaction was quenched by addition of concentrated aqueous 
NH4Cl (10 mL), and the volatiles were evaporated in vacuum.  Then, HCl (10 mL, 37% aq.) was 
added to the solution and the resultant mixture was heated to reflux for 1 h.  After cooling to room 
temperature, the mixture was carefully adjusted to pH = 7 with NaOH.  The white suspension was 
extracted with CH2Cl2.  After removal of the solvent, the residue was dried under vacuum.  The 
crude product was purified by column chromatography on silica gel and eluted with acetone to 
obtain white solid as the product (47 mg, 36%).  1H NMR (400 MHz, DMSO) δ 8.60 (s, 1H), 8.24 
(s, 1H), 8.04 (d, J = 8.0 Hz, 2H), 7.79 (d, J = 7.4 Hz, 1H), 7.67 (d, J = 7.9 Hz, 2H), 7.34 (dt, J = 
13.6, 6.8 Hz, 2H). 
Compound 5.  A solution of compound 4 (44 mg, 0.18 mmol), 2-iodo-BODIPY (56 mg, 
0.12 mmol), and K2CO3 (166 mg, 1.2 mmol) in toluene (8 mL), THF (8 mL), and water (2 mL) 
was degassed with N2 at room temperature for 20 minutes.  After that, Pd(PPh3)4 (3 mg, 0.0025 
mmol) was added, and the mixture was heated to 70 oC for overnight.  After evaporation of the 
volatiles under reduced pressure, water (10 mL) was added, and the mixture was extracted with 
CH2Cl2 (310 mL).  The combined organic layers were washed with brine (100 mL), and dried 
over anhydrous MgSO4.  The solvent was then removed, and the crude product was purified by 
column chromatography on silica gel using hexane/ethyl acetate (v/v = 1:1) as the eluent to obtain 
orange solid as the target compound (79 mg, 78%).  1H NMR (400 MHz, CDCl3) δ 8.13 (d, J = 
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7.5 Hz, 1H), 7.92−7.84 (m, 1H), 7.62−7.45 (m, 7H), 7.40−7.29 (m, 5H), 6.04 (s, 1H), 2.61 (s, 3H), 
2.59 (s, 3H), 1.41 (s, 3H), 1.36 (s, 3H). 
Compound 8.  The mixture of compound 7 (880 mg, 3.36 mmol) and formic acid (20 mL) 
was stirred at 100 °C for overnight.  The reaction mixture was cooled to room temperature and 
concentrated under reduced pressure to afford a crude solid.  The crude solid was partitioned 
between ethyl acetate (250 mL) and NH3/H2O (25 mL).  The ethyl acetate layer was combined, 
dried with Na2SO4, and then concentrated under reduced pressure.  The residue was purified by 
column chromatography (silica gel, eluted with CH2Cl2) to get the target compound as off−white 
solid (860 mg, 98%).  1H NMR (400 MHz, CDCl3) δ 8.10 (s, 1H), 8.02 (d, J = 1.5 Hz, 1H), 7.59 
(dd, J = 8.2, 7.4 Hz, 2H), 7.52−7.47 (m, 3H), 7.46−7.36 (m, 2H). 
Compound 9.  Following the similar synthetic procedure for compound 2, compound 9 
was obtained with 87% yield using compound 8 as the starting material.  1H NMR (400 MHz, 
CDCl3) δ 8.13 (s, 1H), 8.06−7.96 (m, 1H), 7.59 (dd, J = 10.0, 5.5 Hz, 2H), 7.49 (dd, J = 11.7, 5.7 
Hz, 4H), 7.42 (dt, J = 13.5, 5.1 Hz, 1H), 3.07 (s, 1H). 
Compound 10.  Following the similar synthetic procedure for compound 3, compound 10 
was obtained with 41% yield using compound 9 as the starting material.  1H NMR (500 MHz, 
CDCl3) δ 8.14 (s, 1H), 7.97 (s, 1H), 7.59 (t, J = 7.7 Hz, 2H), 7.54−7.45 (m, 7H), 7.42 (d, J = 8.4 
Hz, 1H), 7.33−7.28 (m, 2H), 6.03 (s, 1H), 2.74 (s, 3H), 2.59 (s, 3H), 1.54 (s, 3H), 1.41 (s, 3H). 
 
7.2.3. General synthetic procedure for ligands L7-1 – L7-5 
In a round−bottom flask equipped with a gastight Teflon cap, the precursor NHCs 
compound 3, 5, or 10 (1 mmol) was dissolved in 10 mL of THF (for synthesizing L7-1, L7-2, or 
L7-4) or in 1 mL of toluene (for synthesizing L7-3 and L7-5).  Then 1.5 mmol CH3I (for 
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synthesizing L7-1, L7-2, or L7-4) or 1−iodo−3,6,9−trioxadecane (for synthesizing L7-3 and L7-
5) was added.  The mixture was heated to 100 oC for 24 h.  After the reaction, the solution was 
allowed to cool to room temperature.  The formed precipitate was collected by filtration and 
washed with THF, dichloroethane, and Et2O (10 mL  2) to obtain the corresponding target 
compound. 
L7-1.  A dark red powder was obtained as the product (yield: 73%).  1H NMR (400 MHz, 
DMSO) δ 10.16 (s, 1H), 8.18 (d, J = 8.4 Hz, 1H), 8.05−7.71 (m, 8H), 7.65 (d, J = 3.7 Hz, 2H), 
7.46−7.40 (m, 2H), 6.39 (s, 1H), 4.20 (s, 3H), 2.66 (s, 3H), 2.56 (s, 3H), 1.53 (s, 3H), 1.43 (s, 3H). 
L7-2.  A red powder was obtained as the product (yield: 67%).  1H NMR (400 MHz, 
DMSO) δ 10.15 (s, 1H), 8.16 (d, J = 8.2 Hz, 1H), 7.94−7.69 (m, 6H), 7.63 (dd, J = 12.4, 7.5 Hz, 
4H), 7.46 (d, J = 7.6 Hz, 2H), 6.29 (s, 1H), 4.17 (s, 3H), 2.52 (s, 3H), 2.50 (s, 3H), 1.38 (s, 3H), 
1.36 (s, 3H). 
L7-3.  A dark red powder was obtained as the product (yield: 53%).  1H NMR (500 MHz, 
CDCl3) δ 10.72 (s, 1H), 7.97 (d, J = 7.6 Hz, 1H), 7.88 (d, J = 8.7 Hz, 2H), 7.74−7.66 (m, 4H), 7.53 
(dd, J = 5.0, 1.9 Hz, 2H), 7.33−7.27 (m, 4H), 6.07 (s, 1H), 5.09−5.03 (m, 2H), 4.22−4.14 (m, 2H), 
3.74 (dd, J = 5.5, 3.4 Hz, 2H), 3.60 (dd, J = 5.4, 3.5 Hz, 2H), 3.54 (dd, J = 5.6, 3.7 Hz, 2H), 3.41 
(dd, J = 5.6, 3.7 Hz, 2H), 3.28 (s, 3H), 2.73 (s, 3H), 2.60 (s, 3H), 1.53 (s, 3H), 1.42 (s, 3H). 
L7-4.  A dark red powder was obtained as the product (yield: 58%).  1H NMR (400 MHz, 
DMSO) δ 10.17 (s, 1H), 8.36 (s, 1H), 7.82−7.73 (m, 7H), 7.62 (d, J = 3.6 Hz, 3H), 7.53−7.34 (m, 
2H), 6.37 (s, 1H), 4.17 (s, 3H), 2.66 (s, 3H), 2.54 (s, 3H), 1.52 (s, 3H), 1.41 (s, 3H). 
L7-5.  A dark red powder was obtained as the product (yield: 65%).  1H NMR (400 MHz, 
CDCl3) δ 10.61 (s, 1H), 8.19 (s, 1H), 7.97−7.88 (m, 3H), 7.79−7.68 (m, 4H), 7.64−7.54 (m, 4H), 
7.35−7.30 (m, 1H), 6.10 (s, 1H), 5.08−4.98 (m, 2H), 4.24−4.14 (m, 2H), 3.81−3.72 (m, 2H), 
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3.67−3.61 (m, 2H), 3.54 (dd, J = 5.4, 3.6 Hz, 2H), 3.45 (dd, J = 5.7, 3.7 Hz, 2H), 3.30 (s, 3H), 2.75 
(s, 3H), 2.63 (s, 3H), 1.56 (s, 3H), 1.45 (s, 3H). 
 
7.2.4. General synthetic procedure for iridium complexes 7-1 − 7-5   
The mixture of the NHC ligand (L7-1 − L7-5, 0.12 mmol), [Ir(benzo[h]quinoline)2(μ-Cl)]2 
(76 mg, 0.06 mmol), Ag2O (56 mg, 0.24 mmol), and 1,2-dichloroethane (15 mL) was heated to 
reflux in the dark for 24 h.  After the mixture was cooled to room temperature, the solvent was 
removed under reduced pressure to afford the crude product.  Purification of the crude product was 
carried out on silica gel column chromatography eluted with CH2Cl2.  The obtained product was 
further recrystallized in CH2Cl2 / hexane to give the desired pure complex.  
7-1.  A dark purple powder was obtained as the product (yield: 32%).  1H NMR (400 MHz, 
CDCl3) δ 8.39 (d, J = 5.2 Hz, 1H), 8.27 (d, J = 5.2 Hz, 1H), 8.17 (d, J = 8.2 Hz, 1H), 8.03 (dd, J = 
12.1, 7.6 Hz, 2H), 7.85−7.66 (m, 3H), 7.57−7.46 (m, 4H), 7.39−7.21 (m, 9H), 7.18−6.99 (m, 4H), 
6.87 (s, 1H), 6.74 (d, J = 6.9 Hz, 1H), 6.33 (d, J = 7.0 Hz, 1H), 5.98 (s, 1H), 3.26 (s, 3H), 2.55 (s, 
3H), 2.53 (s, 3H), 1.36 (s, 3H), 1.33 (s, 3H).  ESI-HRMS (m/z): calcd. for [C61H44BF2IrN6+H]
+, 
1103.3396; found, 1103.3384.  Anal. Calcd for C61H44BF2IrN6·5CH2Cl2·2.4C6H14 (C6H14: 
hexane): C, 55.71; H, 5.09; N, 4.85. Found: C, 55.37; H, 5.42; N, 5.15. 
7-2.  A red powder was obtained as the product (yield: 30%).  1H NMR (400 MHz, CDCl3) 
δ 8.40 (d, J = 5.2 Hz, 1H), 8.30 (d, J = 5.5 Hz, 1H), 8.18 (d, J = 8.1 Hz, 1H), 8.04 (d, J = 8.0 Hz, 
1H), 7.97 (d, J = 7.8 Hz, 1H), 7.83 (d, J = 7.9 Hz, 1H), 7.78 (d, J = 8.7 Hz, 1H), 7.69 (d, J = 8.7 
Hz, 1H), 7.60−7.40 (m, 4H), 7.35 (t, J = 8.1 Hz, 2H), 7.22 (d, J = 6.6 Hz, 6H), 7.10 (ddd, J = 22.5, 
14.7, 6.6 Hz, 4H), 6.89 (d, J = 6.9 Hz, 1H), 6.79 (d, J = 8.3 Hz, 1H), 6.43 (s, 1H), 6.26 (d, J = 7.3 
Hz, 1H), 5.91 (s, 1H), 3.28 (s, 3H), 2.52 (s, 3H), 2.15 (s, 3H), 1.33 (s, 3H), 1.26 (s, 3H).  ESI-
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HRMS (m/z): calcd. for [C59H44BF2IrN6+H]
+, 1079.3396; found, 1079.3389.  Anal. Calcd for 
C59H44BF2IrN6·0.4CH2Cl2·0.6C6H14: C, 65.02; H, 4.61; N, 7.22. Found: C, 64.62; H, 4.92; N, 7.19. 
7-3.  A dark purple powder was obtained as the product (yield: 56%).  1H NMR (400 MHz, 
CDCl3) δ 9.36 (d, J = 5.4 Hz, 1H), 8.39 (d, J = 5.9 Hz, 1H), 8.27 (dd, J = 12.3, 7.0 Hz, 2H), 8.16 
(d, J = 8.5 Hz, 1H), 8.03 (dd, J = 16.6, 8.0 Hz, 2H), 7.83 (d, J = 8.3 Hz, 1H), 7.74 (t, J = 8.2 Hz, 
2H), 7.68 (d, J = 8.8 Hz, 1H), 7.56−7.47 (m, 3H), 7.39−7.26 (m, 4H), 7.25−7.00 (m, 6H), 6.87 (d, 
J = 1.8 Hz, 1H), 6.81 (t, J = 7.6 Hz, 1H), 6.68 (d, J = 7.0 Hz, 1H), 6.28 (d, J = 7.0 Hz, 1H), 5.98 
(d, J = 7.1 Hz, 1H), 4.37−4.17 (m, 2H), 3.75 (dd, J = 10.5, 5.7 Hz, 2H), 3.39−3.32 (m, 2H), 3.29 
(s, 3H), 3.02−2.83 (m, 2H), 2.75−2.59 (m, 2H), 2.59 (s, 3H), 2.52 (s, 3H), 2.40 (dd, J = 4.1, 2.8 
Hz, 2H), 1.36 (s, 3H), 1.32 (s, 3H).  ESI-HRMS (m/z): calcd. for [C67H56BF2IrN6O3+H]
+, 
1235.4183; found, 1235.4164.  Anal. Calcd for C67H56BF2IrN6O3·1.6CH2Cl2·0.3C6H14: C, 60.57; 
H, 4.58; N, 6.02. Found: C, 60.74; H, 4.55; N, 5.75. 
7-4.  A dark purple powder was obtained as the product (yield: 57%).  1H NMR (400 MHz, 
CDCl3) δ 8.27 (d, J = 4.6 Hz, 1H), 8.20 (d, J = 5.5 Hz, 1H), 8.06 (d, J = 8.7 Hz, 1H), 8.02−7.93 
(m, 2H), 7.79−7.68 (m, 3H), 7.54−7.42 (m, 5H), 7.38 (t, J = 8.4 Hz, 1H), 7.30 (dd, J = 11.9, 7.4 
Hz, 2H), 7.22 (dd, J = 6.5, 3.1 Hz, 3H), 7.11−6.95 (m, 5H), 6.75 (d, J = 5.7 Hz, 1H), 6.68 (dd, J = 
11.5, 7.1 Hz, 2H), 6.28 (d, J = 7.1 Hz, 1H), 5.98 (s, 1H), 3.19 (s, 3H), 2.64 (s, 3H), 2.52 (s, 3H), 
1.43 (s, 3H), 1.34 (s, 3H).  ESI-HRMS (m/z): calcd. for [C61H44BF2IrN6+H]
+, 1103.3396; found, 
1103.3385.  Anal. Calcd for C61H44BF2IrN6·4.8CH2Cl2·2C6H14: C, 55.55; H, 4.89; N, 5.00. Found: 
C, 55.46; H, 5.14; N, 5.26. 
7-5.  A dark purple powder was obtained as the product (yield: 65%).  1H NMR (400 MHz, 
CDCl3) δ 8.34 (d, J = 5.5 Hz, 1H), 8.25 (d, J = 5.4 Hz, 1H), 8.11 (d, J = 8.5 Hz, 1H), 8.07−8.03 
(m, 1H), 8.02−7.98 (m, 1H), 7.83 (dd, J = 14.7, 8.1 Hz, 1H), 7.75 (dd, J = 8.9, 2.0 Hz, 2H), 7.67 
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(d, J = 1.9 Hz, 1H), 7.59−7.46 (m, 5H), 7.46−7.27 (m, 5H), 7.17−7.00 (m, 5H), 6.80 (dd, J = 5.1, 
3.6 Hz, 1H), 6.74 (t, J = 7.6 Hz, 1H), 6.67 (dd, J = 6.2, 2.5 Hz, 1H), 6.29 (dd, J = 6.3, 3.3 Hz, 1H), 
6.04 (s, 1H), 4.31−4.24 (m, 2H), 3.77−3.71 (m, 2H), 3.42−3.37 (m, 2H), 3.33−3.29 (m, 2H), 3.27 
(s, 3H), 3.25−3.22 (m, 2H), 2.96−2.85 (m, 2H), 2.70 (s, 3H), 2.58 (s, 3H), 1.50 (s, 3H), 1.40 (s, 
3H).  ESI-HRMS (m/z): calcd. for [C67H56BF2N6O3Ir+H]
+, 1235.4183; found, 1235.4169.  Anal. 
Calcd for C67H56BF2IrN6O3.0.3H2O: C, 64.92; H, 4.60; N, 6.78. Found: C, 64.97; H, 4.77; N, 6.49. 
 
7.2.5. Photophysical studies 
The spectroscopic grade solvents used for photophysical studies were purchased from 
VWR International and used as received without further purification.  The ultraviolet−visible 
(UV−vis) absorption spectra of complexes 7-1 − 7-5 were measured on a Varian Cary 50 
spectrophotometer.  Steady−state emission spectra of complexes 7-1 − 7-5 were recorded using a 
HORIBA FluoroMax 4 fluorometer/phosphorometer.  The relative actinometry method was used 
for measuring the emission quantum yields of 7-1 − 7-5.  [Ru(bpy)3]Cl2 in degassed acetonitrile 
(λmax = 436 nm, Φem = 0.097)61 was used as the reference.  The nanosecond transient absorption 
(TA) measurements, i.e. the TA spectra, triplet lifetimes, and quantum yields, were carried out on 
a laser ﬂash photolysis spectrometer (Edinburgh LP920).  The excitation source was the 
third−harmonic output (355 nm) of a Quantel Brilliant Nd:YAG laser (pulse duration, 4.1 ns; 
repetition rate was 1 Hz).  Before measurement, each sample solution was purged with nitrogen 
for 40 min.  The singlet depletion method was followed to calculate the triplet excited−state molar 
extinction coeﬃcients (εT),62 and the relative actinometry method63 was used to estimate the triplet 
excited−state quantum yields using SiNc in benzene as the reference (ε590 = 70,000 M−1cm−1, ΦT 
= 0.20).64 
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7.2.6. Computational methodology  
The ground state geometries were optimized using the Density Functional Theory (DFT)65 
employing PBE1 functional66 and the mixed basis set, where LANL2DZ67 was used for Ir(III) to 
incorporate the effective core potential for a heavy element and 6-31G* 68 basis set was used for 
all remaining atoms. The solvent effects were modeled by the Conductor-like Polarizable 
Continuum Model (CPCM) reaction field method69 for toluene.  
Linear response time dependent DFT (TDDFT)70 was employed to calculate excited state 
properties of the complexes by using the same functional and basis set that were used for the 
ground state calculations. It was previously reported for other Ir(III) complexes that both the 
ground and excited state calculations using this methodology show good agreement with the 
experimental results,71 which defined our choice of the methodology. To meet the same energy 
range of the experimental absorption spectra, the lowest 80 states were calculated by TDDFT. The 
thermal linewidths of spectra were obtained using Gaussian function with the broadening 
parameter of 0.08 eV, which well fits to the line shape of experimental absorption spectra.  
To calculate the emission energies, we have optimized the triplet excited state using the 
analytical gradient method based on TDDFT, within PBE1 functional and the mixed LANL2DZ/6-
31G* basis set. To get a better understanding of the nature of the transitions, natural transition 
orbitals (NTOs)72 were calculated, which is the compact representation of the excited electron-
hole pair obtained from the transition density matrices calculated by TDDFT. NTOs were 
visualized by VMD73 software using 0.02 iso resolution. All quantum chemical calculations were 
performed using the Gaussian09® software package.74 
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7.2.7. Cellular assays 
Metal complex solutions. Stock solutions (5 mM) of the chloride salts of 7-3 and 7-5 were 
prepared by first dissolving the solids in DMSO (10% of total aqueous solution), using sonication 
and slight heat, then deionized water (dI) water was added to the appropriate volume. The solutions 
were vortexed to mixed well and stored in the dark at -20C when not in use. Working solutions 
were made by diluting the 5 mM stock solutions in pH 7.4 Dulbecco’s phosphate buffered saline 
(DPBS, no Ca2+ or Mg2+), where DMSO in the final assay wells were kept under 0.1% at the 
highest complex concentration. 
 
7.2.8. Cell culture 
SKMEL28 cells. Adherent SKMEL28 human malignant melanoma cells (HTB-72, ATCC) 
were cultured in complete growth media EMEM plus 10% FBS and were kept incubated at 37C 
under 5% CO2. The complete growth media was prepared in 500 mL portions by combining 50 
mL Seradigm FB Essence (VWR Life Science) and 450 mL Eagle’s Minimum Essential Medium 
(MEM, Corning® 10-009-CV) then filtered in a Nalgene™ rapid-flow sterile disposable bottle top 
filter with PES 0.2 m membrane (Thermo Scientific 09-741-07). SK-MEL-28 cells were initiated 
at about 300,000 cells mL-1 in 75 cm2 tissue culture flasks and were subcultured 2-3 times per 
week under standard aseptic conditions when growth reached approximately 500,000 cells mL-1. 
Subculturing was done by discarding the spent media, rinsing the cell layer once with cold DPBS, 
followed with the dissociation of the cell monolayer with cold 1X Trypsin-EDTA solution (VWR 
Life Science Trypsin, 0.25% EDTA 1X).  Complete growth media was added to the cell suspension 
to dilute and distributed to new cell flasks. Cell assays were performed with cells at no higher than 
ten cell passages (subcultures). 
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7.2.9. Cytotoxicity and photocytoxicity cell assays 
Cell viability assays were completed in triplicate in 96-well polystyrene flat bottom TC-
treated microplates (Corning Costar 3595). The outer periphery wells were filled with 200 L 
DPBS in order to minimize evaporation from inner sample wells. SKMEL28 cells, growing in log 
phase (~500,000 cells mL-1) with at least 95% viability were transferred in 50 L aliquots to inner 
wells containing warm complete growth media (25 L) and placed in a 37C, 5% CO2 water-
jacketed incubator (Thermo Electron Corp., FormaSeries II, Model 3110, HEPA Class 100) for 3 
h to allow for cell attachment. Serial dilutions of 7-3 and 7-5 metal complexes (prepared in DPBS 
and prewarmed in 37C incubator) were added in 25 L volumes to the appropriate microplate 
wells containing cells. Control wells, with no metal complexes, were included in each microplate 
with either cells only (25 L growth media, 50 L cells, 25 L DPBS) or no cells (75 L growth 
media, 25 L DPBS). All microplates were kept incubated in the dark at 37C under 5% CO2 for 
a pre-treatment time of 16 h. Control microplates not receiving light treatments were kept in the 
dark while PS-treated microplates were irradiated under one of the following conditions: visible 
light (400-700 nm, 33 mW cm-2) from a 190 W BenQ MS 510 overhead projector, or red light 
(625 nm, 43 mW cm-2) from an LED array (Photodynamic Inc., Halifax, NS). Irradiation times 
using these two light sources were 51 and 39 min respectively to yield total light doses of 100 J 
cm-2. After PS treatments, all microplates were returned to the incubator for another 48 h. Cell 
viability was evaluated using a resazurin fluorescent dye assay according to a standard protocol 
(reference Hanson 2013 patent and O’Brien 2000 EJB). Briefly, 10 L aliquots of prewarmed, 
sterile filtered 0.6 mM resazurin reagent (Sigma Aldrich Canada) were added to all sample wells 
and subsequently incubated another 3-4 h. Viability was determined based on the ability of the 
blue resazurin dye to be metabolically reduced (by live cells) to the fluorescent red resorufin. 
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Fluorescence was recorded with a Cytofluor 4000 fluorescence microplate reader (excitation 530 
± 25 nm, emission 620 ± 40 nm). The concentrations of the metal complexes where cell viability 
was reduced by 50% (EC50 values) for cytotoxicity (dark) and photocytoxicity (light) were 
calculated from sigmoidal fits of the dose-response curves using GraphPad Prism 6.0 according to 
Eq. 1, where yi and yf are the intial and final fluorescence signal intensities. Generally, cells 
growing in log phase and of the same passage number have EC50 values reproducible to within ± 
25% in the submicromolar range, ± 10% below 10 M, and ± 5% above 10 M. Phototherapeutic 
indices (PIs), a measure of the therapeutic window, were represented by the ratio of dark to light 
EC50 values from the dose-response curves. 
𝑦 =  𝑦𝑖 + 
𝑦𝑖− 𝑦𝑓
1+ 10(log 𝐸𝐶50−𝑥)×(𝐻𝑖𝑙𝑙 𝑠𝑙𝑜𝑝𝑒)
                                             (1) 
 
7.2.10. Confocal microscopy 
The influence of the metal complexes 7-3 and 7-5 on SKMEL28 cells, in dark or light 
conditions, was monitored using confocal fluorescence microscopy. Live cells were imaged in 
DPBS using poly-L-lysine coated sterile glass-bottom Petri dishes (MatTek) with several 
treatments: (i) cells with no complex in dark, (ii) cells with no complex with light, (iii) cells with 
complex in dark, and (iv) cells with complex with light. SK-MEL-28 cells (approximately 
100,000) were transferred in 1 mL volumes to the dishes and placed in a 37C, 5% CO2 water-
jacketed incubator for approximately 3 hr to equilibrate. The cells were then washed with warm 
PBS followed by the addition of 50 M 7-3 or 7-5 (1 mL, prepared in DPBS and warmed in 
incubator) to the sample dishes containing cells. The dishes were returned to the incubator for 15 
min prior to further treatment. Light treated samples were irradiated with visible light for 26 min 
from a 190 W BenQ MS 510 projector (400–700 nm, power density 33 mW cm-2 for a total light 
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dose 50 J cm-2), where dark samples were covered with foil and placed in a dark drawer for the 
same amount of time. Dishes containing both dark and light samples were imaged 15 min post-
treatment using a Carl Zeiss LSM 510 laser scanning confocal microscope with a 60X oil objective 
lens. Excitation was delivered at 458/488 nm from an argon-krypton laser, and signals were 
acquired through a 505 nm long-pass filter. Pinhole diameters for all the treatments were at 1 AU 
(airy unit) equaling 98 m. The images were collected and analyzed using the Zeiss LSM Image 
Browser Version 4.2.0.121 software (Carl Zeiss Inc.). 
 
7.2.11. Bacterial survival assays 
Photodynamic inactivation (PDI) of Streptococcus aureus (ATCC 25923, Cedarlane) 
growing as planktonic culture, by 7-3 and 7-5, was probed using a standard broth microdilution 
method.28 In order to standardize the starting bacterial concentration for all experiments, a standard 
curve of McFarland barium sulfate turbidity standards was generated, representing approximate 
bacterial concentrations. McFarland barium sulfate standards 0.5, 1, 2, 3, 4, and 5, were prepared, 
representing approximately 1.5, 3, 6, 9, 12, 15  108 bacteria mL-1 respectively.  The absorbance 
at 562 nm was measured for all McFarland standards, using a BioTek EL800 microplate reader, 
and a standard curve was generated.  An inoculum of S. aureus was then prepared by transferring 
colonies from a room temperature secondary growth plate to a sterile 15 mL conical tube 
containing 2 mL sterile distilled water, and the contents were mixed well by vortexing. The 
absorbance at 562 nm was read and the approximate concentration was calculated according to the 
McFarland barium sulfate standard curve. The solution was further diluted in fresh TSB in order 
to match a starting bacterial cell concentration of approximately 1  106 CFU mL-1 and was used 
within 1 hr of preparation. Dark and light experiments were performed in duplicate in 96-well 
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microplates (Corning Costar, Acton, MA), where outer wells along the top and bottom contained 
200 L of sterile distilled water to prevent evaporation.  Dilutions of 7-3 and 7-5 were prepared in 
TSB media at 200 M (twice the desired top concentration of 100 M) and added to triplicate 
wells of the microplate and 1:2 serial dilutions were performed in wells containing 50 L TSB 
using an electronic multichannel pipettor. (final concentrations were 100, 50, 25, 12.5, 6.3, 3.1, 
1.6, 0.8, 0.4, 0.2, 0.1 µM). To sample wells, 50 µL bacterial inoculum was added (final 
concentration in wells were ~5 x 105 CFU mL-1). Final assay volumes in the wells were 100 µL. 
Both plates were incubated for 30 min prior to treatments. Dark treatment microplates were 
wrapped in foil and placed in a dark drawer, while PDI-treated microplates were irradiated with 
visible light (400 – 700 nm, 28 ± 0.9 mW cm-2) using a Solla 30W Cree LED light panel.  The 
irradiation time was 60 min to yield a light dose of approximately 100 J cm-2 to the microplate 
wells (lid on).  Both dark and PDT-treated microplates were incubated overnight.  Sample turbidity 
was measured as absorbance at 562 nm for all microplates and EC50 values (effective concentration 
at which ≥ 50% of bacterial growth is inhibited) for antibiotic (dark) and antimicrobial PDI (light) 
activity were calculated from sigmoidal fits of the dose response curves using Graph Pad Prism 
6.0 according to Eq 1 (as shown above in cell culture section), where yi and yf are the initial and 
final absorbance intensities. Data was normalized using triplicate control wells containing 50 L 
TSB and 50 L bacterial inoculum and were deemed as 100% growth. Bacteria-free control wells 
received 100 L TSB only.  Highly colored concentrations of PS were given duplicate control 
wells containing 50 L water containing PS and 50 L TSB (no bacteria). PS controls were 
prepared due to the color content of high concentration skewing the absorbance values of treated 
wells. PS control absorbance values were subtracted from the corresponding treated PS absorbance 
values to show true comparative growth rates. 
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7.2.12. Measurement of ROS in SKMEL-28 cells 
The generation of intracellular ROS was measured using the fluorescent stain 2,7′-
Dichlorofluorescin diacetate (DCFDA, Sigma D6883), following a simple microplate assay.29 
DCFDA is a cell-permeable probe that measures hydroxyl, peroxyl, and other ROS activity within 
the cell or the cellular environment. SKMEL28 cells were seeded at approximately 25,000 cells 
per well on two 96-well ultra-low attachment flat bottom microtiter plates (Corning 3595) and 
incubated overnight.  The spent media was carefully removed and the cells were washed with 1X 
buffer (Hank’s 1X Balanced Balanced Salt Solutions, HBSS, HyClone SH30268.01), followed by 
the addition of 100 L of 25 M DCFDA prepared in 1X buffer.  The two microplates were 
incubated for 45 min (37C under 5% CO2). Compound serial dilutions of 7-3 and 7-5 were 
prepared in 1X supplemented buffer (HBSS + 10% FBS).  The supernatant was carefully removed, 
the cells were washed once with 1X buffer, then 75 L 1X supplemented buffer was added to each 
sample well followed by 25 L aliquots of either 7-3 or 7-5 (final 9 concentrations in wells ranged 
from 4 pM - 120 M). Control wells in both microplates included: 1) Ir(III) complexes with 
DCFDA, no cells, 2) cells only, no DCFH-DA, 3) cells only with DCFDA, 4) Ir(III) complexes 
with cells, no DCFDA.  The microplates were incubated (pre-treatment) for 30 min.  The dark-
treatment microplate was kept in the dark (foiled and kept in dark place), while the light-treatment 
microplate was irradiated with visible light (400-700 nm, 33 mW cm-2) from a 190 W BenQ MS 
510 overhead projector for 26 min, yielding a light dose of 50 J cm-2. Fluorescence signals were 
measured at several time periods after irradiation (15 min, 30 min, 60 min, 90 min, 120 min) with 
a Cytofluor 4000 fluorescence microplate reader (excitation 485 ± 20 nm, emission 580 ± 50 nm).  
Relative ROS production is represented by plotting arbitrary fluorescence units versus the log 
concentration of test samples in both dark and light treatments. 
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7.3. Results and discussion 
7.3.1. Electronic absorption 
The UV−vis absorption spectra of 7-1 − 7-5 were measured in toluene, CH3CN, THF, and 
CH2Cl2 at room temperature.  The spectra in toluene (the preferred solvent due to the high 
solubility of the neutral complexes in it) are displayed in Figure 7.1, and the normalized spectra in 
the other solvents are provided in Figure 7.2.  The absorption band maxima and molar extinction 
coefficients are summarized in Table 7.1. 7-1 − 7-5 exhibited strong absorption bands with 
vibronic structure in the region of 280−460 nm, and broad, intense absorption bands centered 
between 500-600 nm.  The energies and spectral features of these low-energy absorption bands 
resemble those of the 1,3,5,7-tetramethyl-8-phenyl-BODIPY.75  However, the band maxima of 7-
1 − 7-5 are approximately 30-40 nm red-shifted compared to the 1,* absorption band of the 
1,3,5,7-tetramethyl-8-phenyl-BODIPY, and these bands are broader than that of 1,3,5,7-
tetramethyl-8-phenyl-BODIPY.  These characteristics imply that the NHC ligand interacts with 
the BODIPY motif and there could be some charge transfer character in this band (see discussion 
vide infra). 
Inserting a CC bond between the BODIPY motif and the phenyl ring in complex 7-1 led 
to a red-shift of approximately 13-nm compared to that of complex 7-2. This difference was 
attributed to the extended -conjugation within the NHC-BODIPY ligand of 7-1.  Varying the 
point of attachment of BODIPY on the NHC ligand also showed a noticeable effect on the energy 
of the low-energy absorption band.  Complex 7-4, with BODIPY attached at C5 of the 
benzimidazole ring blue shifted the low-energy absorption band by approximately 8 nm compared 
to the corresponding band in 7-1, where BODIPY is appended at C4 of the phenyl ring.  
Replacement the methyl substituents on C3 of benzimidazole in complexes 7-1 and 7-4 by 
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oligoether substituents as in 7-3 and 7-5 did not impact the energy of the low-energy absorption 
band but slightly attenuated the molar extinction coefficients for this transition. 
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Figure 7.1. UV−vis absorption spectra of 7-1 − 7-5 in toluene at room temperature. 
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Figure 7.2. Normalized UV-vis absorption spectra of 7-1 − 7-5 in different solvents. 
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Table 7.1. Photophysical parameters for complexes 7-1 − 7-5. 
 abs/nm (log ε 
/L·mol−1·cm−1) a 
em/nm 
(τem/s); Φem b 
T1−Tn/nm (τTA/s; log εT1−Tn/ 
L·mol−1·cm−1); ΦT c 
∆ d (λex/nm) 
7-1 294 (4.86), 335 (4.68), 
352 (4.56), 398 (4.40), 
430 (4.33), 543 (4.90) 
610 (4.96); 
0.041 
457 (42.1; -e), 679 (48.0; 
4.13); 0.51 
n.d.f 
7-2 286 (4.78), 347 (4.46), 
398 (4.29), 530 (4.87) 
583 (3.12); 
0.063 
458 (24.0; -e), 681 (28.7; 
3.83); 0.86 
n.d.f 
7-3 290 (4.86), 335 (4.69), 
352 (4.57), 397 (4.42), 
430 (4.33), 543 (4.88) 
610 (5.26); 
0.047 
455 (26.1; -e), 690 (32.1; 
4.11); 0.51 
0.38 (450); 
0.37 (534) 
7-4 322 (4.74), 350 (4.64), 
396 (4.40), 535 (4.88) 
587 (4.77); 
0.034 
449 (28.0; -e), 699 (30.9; 
4.09); 0.39 
n.d.f 
7-5 309 (4.87), 350 (4.73), 
395 (4.50), 535 (4.86) 
587 (4.89); 
0.010 
452 (52.9; -e), 690 (55.2; 
4.06); 0.40 
0.11 (352); 
0.22 (450); 
0.08 (534) 
aAbsorption band maxima (abs) and molar extinction coefficients (log ε) in toluene at room temperature. 
bEmission band maxima (em), lifetimes (τem), and quantum yields (Φem) in toluene at room temperature, c 
= 1×10−5 mol/L. The reference used was a degassed acetonitrile solution of [Ru(bpy)3]Cl2 (Φem = 0.097, λex 
= 436 nm)61  The emission lifetimes reported are the longer-lived 3ILCT/3MLCT phosphorescence lifetimes.  
The short-lived 1IL fluorescence lifetimes were unable to be reliably measured due to the resolution of our 
instrument. cNanosecond TA band maxima (T1−Tn), triplet excited−state lifetimes (τTA), triplet extinction 
coefficients (log εT1−Tn), and quantum yields (ΦT) measured in toluene at room temperature. SiNc in benzene 
(ε590 = 7×104 L mol−1cm−1, ΦT = 0.20)64 was used as the reference for calculating ΦT. dSinglet oxygen 
quantum yields (∆) were measured in acetonitrile and are corrected to within ±5%. eNot determined due 
to strong ground-state absorption, which does not satisfy the condition to apply singlet depletion method 
for estimation of εT1−Tn. fNot determined. 
 
To better understand the nature of the different absorption bands, time-dependent density 
functional theory (TDDFT) calculations were carried out for complexes 7-1 − 7-5 in toluene.  As 
shown in Figure 7.2, the calculated spectra matched well with the experimental spectra.  The 
natural transition orbitals (NTOs) corresponding to the major transitions contributing to the major 
absorption bands of 7-1 − 7-5 are presented from Table 7.2 to Table 7.4.  As the NTOs in Table 
7.2 indicated, the electrons of the S1 states were almost exclusively localized on the BODIPY 
moiety, while the holes were delocalized on the entire BODIPY−substituted NHC ligands and on 
the metal d orbitals.  Therefore, the S1 states in 7-1 − 7-5 have the mixed 1π,π* / 1ILCT (intraligand 
charge transfer, (NHC)→*(BODIPY)) / 1MLCT (metal-to-ligand charge transfer, 
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d(Ir)→*(BODIPY)) configurations, which contributed to the intense low-energy absorption 
bands.  For the absorption band(s) in the 370-450 nm region, the NTOs in Table 7.3 suggest major 
ligand-to-ligand charge transfer (1LLCT, (bhq)→*(BODIPY)) / 1MLCT transitions, admixing 
with some BODIPY-NHC localized 1IL (intraligand transition, i.e. 1π,π* / 1ILCT) characters.  In 
contrast, according to the NTOs shown in Table 7.4, the high energy, strong absorption bands at 
280-370 can be predominantly assigned to the spin-allowed bhq or BODIPY-NHC ligand-centered 
1π,π* transitions, mixed with 1LLCT, 1MLCT, and minor 1ILCT configurations. 
 
Figure 7.3. Normalized experimental and calculated absorption spectra with the respective 
oscillation strength. All absorption spectra are calculated by using the linear response time 
dependent DFT (TD-DFT) with the PBE1 functional and LAN2DZ/6-31G* basis set. Toluene are 
used as a solvent. Vertical bar indicates the oscillation strength of the transitions. 
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Table 7.2. NTOs for lowest-energy transitions of complexes 7-1 − 7-5 in toluene.  
 Sn Hole Electron 
7-1 S1  
533 nm 
f = 0.633 
  
7-2 S1 
480 nm 
f = 0.507 
  
7-3 S1 
531 nm 
f = 0.647 
  
7-4 S1 
515 nm 
f = 0.655 
  
7-5 S1  
513 nm 
f = 0.641 
  
 
Table 7.3. NTOs of the hole and electron of the moderate energy absorption band transitions of 
complexes 7-1 − 7-5, calculated by the TD-DFT method with PBE1PBE functional, LANL2DZ/6-
31G* basis and toluene as a solvent. 
 Sn Hole Electron 
7-1 
S2  
477 nm  
f = 0.0017 
  
S3  
429 nm 
f = 0.1557 
  
S4  
412 nm 
f = 0.1551 
  
S5  
411 nm 
f = 0.0442 
  
S7  
396 nm 
f = 0.3499 
  
7-2 
S2  
473 nm 
f = 0.0001 
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Table 7.3. NTOs of the hole and electron of the moderate energy absorption band 
transitions of complexes 7-1 − 7-5, calculated by the TD-DFT method with PBE1PBE 
functional, LANL2DZ/6-31G* basis and toluene as a solvent. (continued) 
 Sn Hole Electron 
 
S3  
424 nm 
f = 0.3307 
  
 
S7  
387 nm 
f = 0.1558 
  
7-3 
S2 
482 nm 
f = 0.0055 
  
S3  
424 nm 
f = 0.1796 
  
S4  
413 nm 
f = 0.1221 
  
S7  
395 nm 
f = 0.3579 
  
7-4 
S2  
500 nm 
f = 0.0396   
S3  
452 nm 
f = 0.1633   
S7  
401 nm 
f = 0.3959   
7-5 
S2  
496 nm 
f = 0.0862 
  
S3  
447 nm 
f = 0.1648 
  
S7  
399 nm 
f = 0.3930 
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Table 7.4. NTOs of the hole and electron of the high energy absorption band transitions of 
complexes 7-1 − 7-5, calculated by the TD-DFT method with PBE1PBE functional, LANL2DZ/6-
31G* basis using toluene as the solvent. 
 Sn Hole Electron 
7-1 
S13  
350 nm 
f = 0.1222 
  
S18  
340 nm 
f = 0.0389 
  
S21  
332 nm 
f = 0.2753 
  
S23  
322 nm 
f = 0.0901 
  
S30  
309 nm 
f = 0.3708 
  
7-2 
S18  
334 nm 
f = 0.1076 
(60%)   
Homo-1/Lumo+1 
(33%) 
  
S22  
325 nm 
f = 0.1125 
  
7-3 
S20  
333 nm 
f = 0.1144 
  
S21  
332 nm 
f = 0.2474 
  
S30  
309 nm 
f = 0.3345 
  
7-4 
S21  
334 nm 
f = 0.3787 
(50%) 
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Table 7.4. NTOs of the hole and electron of the high energy absorption band transitions 
of complexes 7-1 − 7-5, calculated by the TD-DFT method with PBE1PBE functional, 
LANL2DZ/6-31G* basis using toluene as the solvent. (continued) 
 Sn Hole Electron 
 
Homo-1/Lumo+1 
(28%) 
  
 
S27  
315 nm 
f = 0.4822   
7-5 
S21  
334 nm 
f = 0.2816 
  
S27  
316 nm 
f = 0.3603 
  
 
   
7.3.2. Photoluminescence 
The steady−state emission spectra for complexes 7-1 − 7-5 were measured in degassed 
toluene, CH3CN, THF, and dichloromethane at room temperature.  The normalized emission 
spectra in toluene are presented in Figure 7.3, and the emission maxima and lifetimes are compiled 
in Table 7.1.  The normalized emission spectra and the emission data in other solvents are provided 
in Figure 7.4 and Table 7.5.  As shown in Figure 7.3, all of the complexes exhibited broad and 
structureless luminescence in toluene ranging from 582 to 610 nm, which were mirror images to 
their corresponding 1IL absorption bands.  The emission signals showed bi-exponential decays, 
with a short lifetimes of several nanoseconds and a longer lifetimes of several microseconds.  The 
emission was only partially quenched by air.  These characteristics imply that the emission of these 
complexes could be mixed with 1IL fluorescence and charge transfer phosphorescence (3CT).  This 
fluorescence/phosphorescence mixing has been reported for a cationic dinuclear Ir(III) complex 
linked by BODIPY.42 
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Table 7.5. Emission characteristics of complexes 7-1 − 7-5 in different solvents at r.t. 
λem / nm)(τem / μs); Φem 
 CH3CN THF CH2Cl2 Toluene  
7-1 575 (0.21); 0.31% 608 (0.07); 0.89% 603 (0.05); 0.97% 610 (4.96); 4.11% 
7-2 559 (2.46); 3.01% 561 (4.19); 2.09% 547 (2.83); 5.46% 538 (3.12); 6.32% 
7-3 575 (0.61); 0.74% 560 (3.57); 0.91% 563 (0.06); 0.86% 610 (5.26); 4.69% 
7-4 578 (2.81); 6.61% 560 (3.57); 6.65% 571 (2.71); 5.27% 579 (4.77); 3.36% 
7-5 573 (0.41); 1.27% 561 (3.63); 5.45% 570 (3.61);11.7% 579 (4.89); 10.1% 
 
Similar to the trend observed from the UV-vis absorption experiments, the emission 
maxima for 7-1 and 7-3 were identical as were those for 7-4 and 7-5.  This indicates that the 
oligoether chain did not impact the energies of the emitting states in these complexes.  In contrast, 
the emission of 7-2 with BODIPY singly-bonded to NHC showed a pronounced blue-shift (27 nm) 
compared to that of 7-1, with the CC linker, due to the shorter π-conjugation and the reduced co-
planarity between BODIPY and NHC ligand in 7-2.  The attachment position of BODIPY on the 
NHC ligand also affected the emission energy as it did for the UV-vis absorption, namely, the 
emission maxima of 7-4 and 7-5 displayed a blue-shift of 23 nm with respect to those of 7-1 and 
7-3. 
To assign the nature of the emitting states for these complexes, TDDFT calculations were 
performed based on the optimized singlet triplet excited state geometries.  The singlet and triplet 
excited-state NTOs obtained for 7-1 − 7-5 are compiled in Table 7.6 for S1 and T2 states, and in 
Table 7.7 for T1 states.  Because neither the calculated T1 energies nor the energy trend matched 
the experimental results, and the emission lifetimes were much shorter than the lifetimes obtained 
from the ns transient absorption measurement (which will be discussed in the next section), we 
believe that the phosphorescence components of the observed emission from these complexes are 
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from the T2 states.  Based on the NTOs provided in Table 7.6, the fluorescent S1 states have mixed 
1ILCT/1,*/1MLCT configurations, while the T2 states are predominantly 3ILCT/3MLCT 
configurations mixed with minor 3,* character.  The S1 states and the T2 states are in energetic 
proximity, therefore, they both contribute to the observed emission.  However, these two states are 
not in thermal equilibrium because the emission decay was bi-exponential, with a short component 
of less than 10 ns and a longer lifetime of several microseconds. 
 
Figure 7.4. Normalized experimental emission spectra of 7-1 − 7-5 in deaerated toluene at room 
temperature.  The excitation wavelength was 543 nm for 7-1 and 7-3, 530 nm for 7-2, and 535 nm 
for 7-4 and 7-5.  The open-headed lines represent the calculated S1 fluorescence and the solid-
headed lines represent the calculated T2 phosphorescence. The inset shows the comparison of 
emission intensity in air-saturated and deaerated toluene solutions for 7-1. 
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Figure 7.5. Normalized emission spectra of complexes 7-1 − 7-5 in different solvents at r.t. (λex = 
436 nm). 
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Table 7.6. NTOs corresponding to the optimized S1 and T2 states of complexes 7-1 − 7-5 in 
toluene. 
S1 T2 
 Energy Hole Electron Energy Hole Electron 
7-1 647 nm 
  
623 nm 
  
7-2 598 nm 
  
538 nm 
  
7-3 644 nm 
  
621 nm 
  
7-4 609 nm 
  
586 nm 
  
7-5 605 nm 
  
584 nm 
  
 
Table 7.7. NTOs of the optimized 1st triplet state. All excited state calculations were done with 
the PBE1 functionals with LAN2DZ/6-31G* basis set and toluene as a solvent. 
T1 
Hole Electron 
7-1 
1121 nm 
  
7-2 
1192 nm 
  
7-3 
1122 nm 
  
7-4 
1143 nm 
  
7-5 
1143 nm 
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7.3.3. Transient absorption (TA)   
To further understand the triplet excited state characteristics of 7-1 − 7-5, especially the 
non-emitting T1 states in these complexes, nanosecond TA were collected in deaerated toluene at 
room temperature.  The TA spectra of 7-1 − 7-5 at zero-time delay upon 355-nm excitation are 
presented in Figure 7.5.  The TA parameters, such as the TA band maxima, triplet excited−state 
lifetimes and quantum yields, and triplet extinction coefficients, are compiled in Table 7.1.  Fitting 
of the TA signals revealed a long-lived species (ca. 28-55 s).  In addition, the TA spectral features 
of 7-1 − 7-5 were similar, with ground-state bleaching arising from the BODIPY-NHC localized 
1IL absorption. These spectra are also similar to that of the iodo-BODIPY reported in the 
literature.75 Therefore, the triplet excited states that produced the observed TA should have the 
same nature for all of the complexes, likely from the BODIPY localized 3,* state.  The lifetimes 
of 7-1 − 7-5 obtained from the decay of the TA signals are distinctively different from their 
emission lifetimes, indicating that the excited states observed by TA in these complexes are 
different from their emitting excited states.  The long TA lifetimes were assigned to excited states 
with 3,* characters. The NTOs for T1 states in Table 7.5 confirmed that the T1 states for these 
complexes are of 3,* configuration and localized exclusively on the BODIPY motif. 
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Figure 7.6. Nanosecond transient difference absorption spectra of complexes 7-1 − 7-5 in toluene 
at room temperature immediately after 355 nm laser pulse excitation. A355 = 0.4 in a 1-cm cuvette. 
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7.3.4. Singlet oxygen generation 
7-3 and 7-5 were designed with oligoether substituents as R3 (Chart 7-1) to increase the 
hydrophilicities of these neutral Ir(III) NHC complexes for improved aqueous solubility (which is 
a desirable property for in vitro biological testing). Our detailed photophysical and computational 
analyses of 7-3 and 7-5 (compared to their corresponding methyl-substituted 7-2 and 7-4 relatives) 
indicated that the addition of the oligoether groups did not alter the general excited state dynamics 
observed for these systems. Therefore, the more water-soluble 7-3 and 7-5 were further 
investigated for their photobiological activities.  
The abilities of 7-3 and 7-5 to generate singlet oxygen (1O2) were assessed as quantum 
yields for 1O2 production (∆) in MeCN relative to [Ru(bpy)3](PF6)2 as the standard (∆ = 56%). 
The direct method was employed, whereby sensitized 1O2 was detected by its phosphorescence 
centered at 1268 nm. MeCN was used as the solvent since 1O2 phosphorescence is quenched in 
aqueous solution.76 The value of ∆ for 7-3 was near 37% and largely independent of excitation 
wavelength, whereas that for 7-5 ranged from 8-22% as a function of excitation wavelength. 
Excitation at 352, 450, and 534 nm yielded values for ∆ of 11, 22, and 8%, respectively. 
7-3 was the more efficient 1O2 generator at all wavelengths investigated, which could be 
attributed, in part, to the fact that its quantum yield for triplet state formation is larger (51 versus 
40%). Clearly, the substitution position of the BODIPY chromophore, either on the meso-phenyl 
versus the benzimidazole portion of the NHC ligand, impacts the excited state dynamics and 
photophysical properties of the complexes. These structural differences may, therefore, be 
expected to also alter their photobiological properties. 
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7.3.5. Cytotoxicity and photocytotoxicity toward cancer cells  
Based on their abilities to generate 1O2 under cell-free conditions, albeit with modest 
efficiency, it was anticipated that both 7-3 and 7-5 would give rise to in vitro photobiological 
effects. The human melanoma cell line SKMEL28 was used to probe the cytotoxicities and 
photocytotoxicities of 7-3 and 7-5. Briefly, cells were dosed 1 nM-300 µM of 7-3 or 7-5 (dissolved 
in water supplemented with 10% DMSO (v/v) and serially diluted with phosphate buffered saline 
(PBS)) and incubated for 16 h before receiving a dark treatment or a light treatment. The 
illumination condition was 100 J cm-2 of either broadband visible or monochromatic red (625 nm) 
light. After a dark or light treatment, the cells were incubated for 48 h, treated with the resazurin 
cell viability indicator,77 and incubated an additional 2–4 h. The relative cell viabilities for the dark 
and light treatments of cells dosed with compound were quantified by the metabolic reduction of 
resazurin to its fluorescent product resorufin (Figure 7.6, Table 7.8). 
Table 7.8. Comparison of EC50 values (M) for SKMEL28 cancer cells dosed with complexes 7-
3 and 7-5. 
SKMEL28 cells 
 Dark Visa PIb Redc PIb 
7-3 > 300 9.66 ± 0.28 >31 53.7 ± 2.1 >6 
7-5 20.2 ± 1.3 0.15 ± 0.01 135 13.0 ± 0.1 2 
aVis−PDT: 16 h drug-to-light interval followed by 100 J cm−2 broadband visible light irradiation, 
bPI = phototherapeutic index (ratio of dark EC50 to visible-light EC50), 
cRed-PDT: 16 h drug-to-
light interval followed by 100 J cm−2 light irradiation with 625 nm LEDs. 
 
 
Figure 7.7. In vitro dose-response curves for complexes 7-3 (left) and 7-5 (right) in SKMEL28 
cells treated in the dark (black) and with visible (blue) or red (red) light activation. 
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7-3 was nontoxic toward SKMEL28 cells (EC50 >300 µM), while 7-5 was substantially 
more cytotoxic (EC50 = 20 µM). With broadband visible light activation, both compounds were 
photocytotoxic. The photocytotoxicy of 7-5 was submicromolar, with an EC50 value of 150 nM 
and PI of 135, while the visible-light EC50 value for 7-3 was approximately 10 µM and its PI was 
31. The photocytotoxicities of both compounds with red light were substantially attenuated (5-fold 
for 7-3 and over 85-fold for 7-5), giving rise to much smaller PI values (6 for 7-3 and 2 for 7-5). 
Despite having much higher cytotoxicity in the dark, 7-5 was the better in vitro 
photosensitizing agent according to both the magnitude of its photocytotoxicity and its 
phototherapeutic margin. This was initially surprising since the value of ∆ for 7-3 was 
significantly larger than that for 7-5. This discrepancy could be due to differences in 1O2 production 
under cell-free conditions versus the in vitro experiment, or that reactive oxygen species (ROS) 
other than 1O2 may be involved in the phototoxic mechanism.   
To probe for the involvement of ROS, more broadly defined, as a possible source of the 
photocytotoxic activity for 7-3 and 7-5, SKMEL28 cells were preincubated with the cell-
permeable and highly sensitive 2',7'-dichlorodihydrofluorescein diacetate (DCFDA) fluorogenic 
dye before performing (photo)cytotoxicity assays (Figure 7.7). The compounds were tested in the 
range of 4 pM to 126 µM, and a sub-lethal light dose of 50 J cm-2 broadband visible light was used 
for the light condition with a reduced incubation time of 30 min between compound addition and 
light treatment. DCFDA is deacetylated by cellular esterases to a nonfluorescent compound, which 
is subsequently oxidized by ROS to the highly fluorescent DCF product that can be detected by its 
characteristic emission.78  ROS that can be detected by this method include superoxide anion (O2
•-
), hydrogen peroxide (H2O2), hydroxyl radical (HO
•), and singlet oxygen (1O2), which react 
directly or indirectly with the deacetylated probe.79 
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Figure 7.8. Reactive oxygen species assay results for SKMEL28 cells treated with 7-3 (a), 7-5 (b), 
or the positive control tert-butyl hydrogen peroxide TBHP (c) using DCFH-DA as a ROS probe.  
Cells were treated in the dark (black bars) or with 50 J cm-1 visible light (blue bars). ROS 
production was measured at 120 min post-treatment. 
 
Dark treatments were included to quantify baseline ROS levels under the assay conditions 
for comparison, and tert-butyl hydrogen peroxide (TBHP) was used as a positive control (Figure 
7.7c). The signal produced by TBHP was relatively weak, but sufficient, owing to the short 
incubation that was necessary to ensure a sub-lethal treatment with photoactivated 7-3 and 7-5. 
ROS generation with 7-3 in the dark was minimal at all concentrations tested, while cells treated 
with 7-5 in the dark showed elevated ROS levels at concentrations greater than 1 µM. This 
observation may account for the cytotoxicity induced by 7-5 in the absence of a light trigger, 
whereby 7-5 was at least 15 more cytotoxic (in the dark) than 7-3. 
Light-treated complexes 7-3 and 7-5 increased the detected fluorescence from the DCF 
product in a dose-dependent manner over the dark controls and also in comparison to the positive 
control THBP (Figure 7.7). The highest concentration of light-treated 7-5 (126 µM) showed a 
slight decrease in the DCF fluorescence relative to the second highest concentration (39 µM). This 
attenuation is typical when the cells begin to lose viability, which is why it is important to choose 
a sub-lethal dose for ROS quantification. 7-5 produced significantly more DCF fluorescence than 
7-3 at the highest concentrations tested. Therefore, the much larger PI measured for 7-5 (compared 
to 7-3) may stem from its more efficient light-mediated ROS production. Which ROS is most 
important for the photocytotoxicity invoked by 7-5 is not known at this time, although we 
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hypothesize that ROS other than 1O2 may be involved based on the lower value of  ∆ measured 
for 6-5 under the cell-free condition. 
Confocal microscopy was used to observe the qualitative effects of 7-3 and 7-5 on 
SKMEL28 cells with a dark or visible light treatment of 50 J cm-2 (Figure 7.8). A concentration of 
50 µM was chosen because a marked difference in the dark cytotoxicity of 7-3 and 7-5 at this 
concentration was anticipated (since 50 µM is greater than the dark EC50 value of 7-3, but not of 
7-5). The light treatment was chosen to be 50 J cm-2 (half the dose of the cell cytotoxicity assays) 
and imaging was done at 15 min post-treatment to ensure that cells were imaged under sub-lethal 
conditions, where a comparison of cellular morphologies and uptake might be made. 
The differences in the 3MLCT emission quantum yields for 7-3 and 7-5 were apparent in 
the dark confocal images, where cellular uptake by 7-3 was detectable as a very weak signal but 
no signal was detected for 7-5. Qualitatively, there appeared to be more cellular debris from dead 
and dying cells treated with 7-5 in the dark (Figure 7.8a, bottom row) but emission was not 
detected. Both compounds caused a general change in the morphology of a large fraction of the 
cells treated in the dark, from the typical elongated and spindle shape to spherical.  
With light activation, intracellular emission from 7-3 was much more pronounced (Figure 
7.8b, top row). If the signal intensity is proportional to concentration, then photoactivated uptake 
of 7-3 results in accumulation in the cytoplasm and mitochondria but not in the nuclei. 
Interestingly, 7-5 produced luminescence in the cellular debris from dead and dying cells that were 
treated with visible light and very faint luminescence from the intact cells. Images of cells treated 
with 7-3 and light did not exhibit the dark clumps of cellular debris that were observed in the 
images of 7-5, possibly reflecting the differences in photocytotoxicities of these two compounds. 
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Photoactivated uptake also led to a larger concentration of 7-5 in cells (assuming that signal 
intensity is proportional to concentration), making its detection possible. Given that luminescence 
from 7-3 is almost five-fold more efficient than that from 7-5 (and this difference could be 
magnified in cells), the confocal imaging experiment cannot definitively establish that cellular 
uptake of 7-3 higher than 7-5. It would be expected that the higher dark toxicity of 7-5 would be 
correlated with better cellular uptake, but additional intracellular compound quantification 
methods were not carried out as part of this study. 
 
Figure 7.9. Laser scanning confocal microscopy images of SKMEL28 cells dosed with 50 M 7-
3 (top row) or 7-5 (bottom row) in the dark (a) or with 50 J cm−2 visible light (b). 
 
7.3.6. Cytotoxicity and photocytotoxicity toward bacteria  
The antimicrobial photobiological activities of 7-3 and 7-5 were also assessed using 
Streptococcus aureus (S. aureus) growing as planktonic cultures (Table 7.9, Figure 7.9). The 
compounds were tested at concentrations between 0.4 and 100 µM, and the light treatments were 
approximately 35 J cm-2 of visible light. Despite showing photobiological activity against 
SKMEL28 melanoma cells, 7-3 was inactive active against S. aureus both in the dark and with a 
light treatment. On the other hand, 7-5 was nontoxic to S. aureus in the dark but phototoxic with 
a visible light EC50 of approximately 7 µM (PI > 15). The observation that 7-3 was less 
photobiologically active (inactive) than 7-5 against S. aureus agreed with the trend in cancer cells, 
(a) (b) 
Dark 
emission DIC overlay emission DIC overlay 
Light 
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further highlighting the discrepancy between the 1O2 quantum yields and phototoxicities for these 
two compounds. It appears that ROS other than 1O2 are also important for the phototoxic 
mechanism against S. aureus. Why 7-5 might be a better ROS generator than 7-3 is not known at 
this time, but the substitution position of the BODIPY unit on the NHC ligand plays a major role 
in determining the biological and photobiological activities against the cell lines investigated in 
this study. 
 
Table 7.9. Comparison of EC50 values (M) for streptococcus aureus dosed with 7-3 or 7-5. 
streptococcus aureus 
 Dark Visa PIb 
7-3 >100 >100 - 
7-5 >100 6.67 ± 0.07 >15 
aVis−PDT: 35 J cm−2 broadband visible light irradiation; bPI = phototherapeutic index (ratio of 
dark EC50 to visible-light EC50). 
 
 
Figure 7.10. Bacterial cell survival dose-response bar graphs for complexes 7-3 (a) and 7-5 (b) 
in Streptococcus aureus, treated in the dark (black) or with 35 J cm-1 visible (blue) light. 
 
7.4. Conclusions 
New neutral iridium(III) complexes bearing BODIPY-substituted NHC ligands are 
reported.  Their photophysical characteristics were systematically investigated via spectroscopic 
methods and DFT calculations.  All complexes exhibited BODIPY-localized intense 1IL/1MLCT 
absorption at 530-543 nm and 1IL/3CT emission at 582-610 nm.  However, the lowest triplet 
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excited state of these complexes are the BODIPY−localized 3,* states.  It was demonstrated that 
the position of the BODIPY pendant on the NHC ligand impacted both the 1IL/1MLCT absorption 
and 1IL/3CT emission bands.  Complexes 7-1 and 7-3, with the BODIPY-ethynyl motif attached 
at C4 of the phenyl ring of the NHC ligand, caused a red-shift of the 1IL/1MLCT absorption and 
1IL/3CT emission bands compared to those in 7-4 and 7-5 that have BODIPY-ethynyl at C5 of the 
benzimidazole unit of the NHC ligand.  Meanwhile, both the lowest singlet excited state and the 
emitting states of 7-1 were lowered compared to those in 7-2, due to the extended π−conjugation 
induced by the ethynyl linker in 7-1.  In contrast, replacing the methyl substituents on C3 of 
benzimidazole in complexes 7-1 and 7-4 by oligoether substituents in 7-3 and 7-5, respectively, 
did not impact the energies of the lowest singlet and emitting excited states in the corresponding 
complexes. 
7-3 and 7-5 were photobiologically active toward SKMEL28 melanoma cells with visible 
light activation, with 7-5 possessing a much larger PI and higher photocytotoxicity. The 
photobiological trends in cancer cells did not correlate with cell-free 1O2 quantum yields. The 
DCFDA assay for intracellular ROS detection showed that 7-5 was much more effective at ROS 
production. 7-5 was also photobiologically active toward S. aureus, while 7-3 was not. Therefore, 
ROS other than 1O2 may play a role in the phototoxic mechanism toward both cancer cells and 
bacterial cells. These studies indicate that the substitution position of BODIPY on the NHC ligand 
plays a profound role in the cytotoxicity and photocytotoxicity of this new class of complexes. C4-
phenyl substitution of BODIPY compared to substitution at C5 of benzimidazole leads to lower 
1O2 quantum yields but more effective production of other ROS. Obviously, the impact of 
BODIPY substitution position at the NHC ligand is more pronounced on the photobiological 
activities than on the photophysical properties. Future studies are aimed at expanding this 
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structure-activity relationship in this new class of neutral Ir(III) NHC complexes, identifying the 
ROS mediator for phototoxic effects, and probing the photobiological activities against a larger 
number of cancer cell lines. 
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